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Abstract 
Background: In the UK, men who have sex with men (MSM) continue to be 
disproportionately affected with HIV and sexually transmitted infections (STI). 
Due to the increasing emphasis on using biomedical strategies like cART for 
prevention of sexual transmission of HIV, I examined HIV positive MSM’s sexual 
partnerships and behaviours; their attitudes towards biomedical and behavioural 
HIV transmission risk reduction strategies, and their association with sexual 
behaviour. I also examined their attitudes towards partner notification for STI, 
willingness and preferred methods to notify partners of STI in the future.   
Methods: 429 HIV positive MSM attending a central London clinic completed a 
computer assisted self-interview on sexual partnerships and behaviours, attitudes, 
preferences and willingness to notify partners for STI in the future. 24 purposively 
selected men participated in in-depth interviews.  
Results: Of 429 men, 380 men had been sexually active in the last year. The 
survey data showed that the prevalence of unprotected anal intercourse (UAI) with 
a serodiscordant (i.e., HIV negative or unknown status) primary partner and the 
most recent non-primary partner was high, 18.3% and 16.9% respectively. A 
substantial minority of men had positive attitudes towards biomedical and various 
behavioural HIV transmission risk reduction strategies. Duration of partnership, 
recreational drug use, and belief that undetectable viral load reduces the risk of 
HIV transmission during UAI were all independently associated with HIV 
transmission risk behaviours with a serodiscordant primary partner. Disclosure of 
HIV status and recreational drug use during sex were independently associated 
with UAI with the most recent serodiscordant non-primary partner. Of the 258 
men who had new partners, 53% had engaged in UAI with new partners. 
Prevalence of anonymous partnerships was high. Stigma associated with HIV/STI 
diagnosis, and the venues for meeting sexual partners also influenced men’s sexual 
partnerships and behaviour, and disclosure of HIV status.  
Approximately one in five sexually active men had not tested for STI and 25% of 
men had been diagnosed with STI in the last year. Young age; self-reported 
detectable viral load status; greater number of new anal sex partners; UAI with 
new and concurrent partners; having a seroconcordant primary partner; frequency 
of engagement in group sex were independently associated with STI diagnosis in 
the last year.  
The qualitative data highlighted that the majority of men felt an emotional 
responsibility towards and acknowledged the personal health benefits of notifying 
primary and regular partners of STI. A greater proportion of men would be less 
willing to notify casual partners of STI in the future (21%) compared to a primary 
partner (5.3%) and regular partners (7.5%). Attitudes such as ‘it is not my 
responsibility to notify partners of STI’, and the lack of previous experience of 
notification were independently associated with unwillingness to notify casual 
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partners of STI in the future. The qualitative study indicates that the lack of 
emotional responsibility; fear of stigma and breach of HIV-related confidentiality 
due to partner notification; and fear of criminalisation for HIV/STI transmission 
were barriers to notifying sexual partners of STI, especially casual and group sex 
partners. Patient-referral was the most preferred method of notifying partners of 
STI in the future, particularly a primary partner; whereas there was greater 
willingness for notifying regular, casual, and group sex partners using remote self-
led methods, provider referral or an anonymous e-card. The acceptability of 
sending an anonymous e-card and taking a home sampling kit for partners, and 
telephone assessment of partners for STI by clinic staff was low to moderate.  
Conclusion: The findings of this study underscore the need for sustained 
interventions to ensure sexual health of HIV positive MSM and prevent HIV/STI 
in MSM. They highlight that cART should be offered to sexually active HIV 
positive MSM, especially those in serodiscordant partnerships irrespective of CD4 
cell count to minimize the risk of onward HIV transmission in this population. 
Frequent STI testing of sexually active men should be integral part of routine HIV 
care. Various partner notification choices should be offered to those diagnosed 
with STI. Interventions to reduce stigma associated with homosexuality and HIV 
continue to remain vital in this population. Research examining the feasibility, 
acceptability, effectiveness, and cost effectiveness of integrating brief behavioural 
interventions to enhance regular STI testing, adherence to cART, address 
recreational drug use and mental health needs, and promote safer sex with routine 
HIV care is urgently needed.  
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Chapter 1: Introduction, rationale and aims of the thesis 
1. Introduction  
Since the diagnosis of the first case of human immunodeficiency virus (HIV) 30 
years ago, developments in the field of diagnostics, prevention, and treatment for 
HIV have changed the landscape of the HIV epidemic globally. Despite these 
changes, in late 2008 when I started developing the research proposal for my thesis, 
surveillance and epidemiological data from developed countries indicated that men 
who have sex with men (MSM) continue to bear a disproportionate burden of HIV 
and sexually transmitted infections (STI)
1
. Increase in HIV diagnoses among 
MSM was reported in developed countries like the United Kingdom (UK), the 
United States of America (USA), Australia and Netherlands (Centers for Disease 
Control and Prevention, 2003; National Centre in HIV Epidemiology and Clinical 
Research, 2004; Dougan, et al., 2007; Bezemer et al., 2008). In the UK, at the end 
of 2007, of the total estimated 77,400 people living with HIV (PLWH) an 
estimated 32,000 were MSM (Health Protection Agency 2008a; Health Protection 
Agency 2008b). Increase in new HIV diagnoses among MSM was also reported 
(Health Protection Agency, 2008a).  
Nevertheless, the availability of effective combination antiretroviral treatment 
(cART) since the mid-1990 has heralded a new era for HIV prevention and 
treatment. Studies published in the mid-1990 have showed that cART reduces 
plasma viral load, and the risk of opportunistic infections and mortality due to 
                                                 
 
1
 In this thesis, I have used the term STI to mean all STI other than HIV. 
24 
acquired immunodeficiency syndrome (AIDS) in PLWH (Hammer et al., 1996, 
1997; Mocroft et al., 1998, 2007). Moreover, in 2008, the Swiss National AIDS 
Commission issued a statement that an HIV positive person who is on cART with 
a suppressed viraemia and has no other STI is sexually non-infectious (Vernazza et 
al., 2008). This statement, henceforth referred to as the ‘Swiss statement’, 
emphasised the significance of adherence to cART to achieve and maintain 
suppressed viraemia. It received widespread attention in the UK and worldwide, 
and led to concerns about the implications of this statement on risky sexual 
behaviours (Bernard, 2008a, 2008b). Since the Swiss statement was published, no 
studies had been conducted in the UK to examine the association between risky 
sexual behaviours and cART status/viral load status among PLWH. Therefore, for 
my thesis I decided to examine the sexual behaviours and partnership patterns of 
HIV positive MSM in the UK to understand its implications for HIV/STI 
transmission and STI acquisition. I also decided to explore their awareness about 
the Swiss statement, and examine the association between risky sexual behaviours 
and cART/viral load status.  
Since 1996, there has also been a resurgence of STI in MSM in Western Europe 
(Ciesielski et al., 2005; Chauhan et al., 2006; Emerson et al., 2007; Singh et al., 
2007). Outbreaks of syphilis and lymphogranuloma venereum (LGV) have been 
documented in 11 and 9 Western European countries respectively (Dougan, Evans, 
et al., 2007). The incidence of Hepatitis C virus (HCV) has increased significantly 
in HIV positive gay and bisexual men in Brighton and London between 2001 and 
2006 (Giraudon et al., 2008). Given the significance of lack of co-infection with 
STI, as indicated in the Swiss statement, to ensure effectiveness of cART for 
prevention of sexual transmission of HIV and the high prevalence of STI among 
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HIV positive MSM, I thereby decided to explore the risk factors for STI, the 
attitudes of HIV positive MSM towards partner notification for STI and 
willingness to use various methods of partner notification for STI.  
In the subsequent part of this chapter, firstly I briefly provide an overview of the 
global HIV epidemic and history of AIDS, the pathogenesis of HIV, and 
development of cART. Next, I describe the epidemiology of HIV and STI in the 
UK, particularly in MSM. Subsequently, I describe the determinants of HIV 
transmission in MSM. I conclude with further details of the rationale for 
undertaking this work for my thesis, aims and overview of the thesis.  
1.1 Current state of the global HIV epidemic 
Globally, approximately 34 million people were living with HIV at the end of 
2010 (World Health Organisation, 2011). This highlights the significance of 
interventions for PLWH to ensure their physical, mental, sexual, reproductive and 
HIV-related health and wellbeing. Although by the end of 2010 there was a 
decline in new cases of HIV, 2.7 million new HIV infections were reported in 
2010 alone (World Health Organisation, 2011). Unlike the generalized HIV 
epidemic in sub-Saharan Africa, the HIV epidemic in North America, and Central 
and Western Europe continues to be predominantly concentrated among MSM 
(UNAIDS, 2010). There is growing evidence of resurgence of the HIV epidemic 
among MSM in North America and Western Europe (Likatavicius et al., 2008; 
World Health Organisation, 2011). Although HIV continues to be a significant 
public health challenge, tremendous progress has been made in understanding the 
pathogenesis of HIV since the first reports of AIDS.  
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1.2 A brief history of HIV/AIDS 
In the following sub-sections I provide a brief overview of emergence of AIDS 
and identification of HIV.  
1.2.1 Emergence of AIDS  
MSM have been at the centre stage of the HIV epidemic since the emergence of 
AIDS. The first report of five cases in Los Angeles, USA of a rare lung infection 
Pneumocystis carinii pneumonia (PCP), a condition associated with severe 
immunosuppression, (Centers for Disease Control and Prevention, 1981a), and a 
first case in London, UK  (du Bois et al., 1981) were reported in 1981 in MSM 
with no clinical immunodeficiency or an identifiable cause. This was followed by 
cases of Kaposi’s sarcoma (KS), a type of cancer, in New York and California in 
the USA (Centers for Disease Control and Prevention, 1981b). The earlier cases of 
PCP in the USA were among patients who did not know each other and had no 
known common contacts or knowledge of sexual partners who had similar 
illnesses. Due to the lack of evidence about the cause of the condition various 
theories about its possible cause emerged, like infection with cytomegalovirus 
(Centers for Disease Control and Prevention, 1981a; Dubois, et al., 1981; Hymes 
et al., 1981), an infective agent transmitted during homosexual practice, and 
exposure to substances, particularly amyl nitrite, rather than an infectious agent 
(Centers for Disease Control and Prevention, 1982a; Marmor et al., 1982).  
Because the condition was not given a uniform name, it was referred to in different 
ways e.g. “lymphadenopathy” (Centers for Disease Control and Prevention, 
1982b), “gay compromise syndrome” (Brennan and Durack, 1981). In 1982, 
reports of similar cases among Haitians (Centers for Disease Control and 
Prevention, 1982c) and haemophiliacs (Centers for Disease Control and 
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Prevention, 1982b) confirmed that this condition was not restricted only to MSM. 
Nevertheless, HIV came to be associated with behaviours considered immoral by 
sections of society, i.e., homosexuality, drug use and promiscuity. Towards the end 
of 1982, the condition came to be referred to as AIDS. 
1.2.2 Identification of the causative agent HIV  
In 1983, the Institut Pasteur, France, isolated a retrovirus from a Caucasian patient 
who had symptoms that preceded AIDS. It was suggested that this virus belongs to 
a general family of T-lymphotropic retroviruses that are horizontally transmitted in 
humans and may be associated with AIDS and was named as lymphadenopathy 
associated virus (Barré-Sinoussi et al., 1983). A year later, another study that 
compared AIDS patients to non-AIDS affected subjects reported that the serum 
samples from a greater proportion of AIDS patients contained antibodies to human 
T-lymphotropic virus (HTVL) III, a member of retrovirus family, i.e., a 
ribonucleic acid (RNA) virus, which differed biologically and immunologically 
from the previous isolates known as HTVL-I and HTVL-II (Gallo et al., 1984). 
This research suggested that HTVL-III might be the primary cause of AIDS. The 
identification that a retrovirus is responsible for the AIDS condition led to the 
development in 1985 of the first USA Food and Drug Administration approved 
enzyme linked immunosorbant assay (ELISA) test kit to screen for antibodies of 
HTVL-III. In 1986, the International Committee on the Taxonomy of Viruses 
proposed to name the AIDS virus as Human immunodeficiency virus (Coffin et al., 
1986).  
1.2.3 Human immunodeficiency virus 
In order to develop prevention interventions for a disease, it is important to know 
the causative agent and its interaction with the human body. HIV is a retrovirus, 
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and a lentivirus, i.e., it has a long incubation period with persistent infection. There 
are two different types of HIV viruses: HIV-1, which is predominantly found in 
Europe, USA, South America, Australia, New Zealand, Asia and Africa. HIV-2, 
which was first discovered in 1985, is predominantly found in West Africa. These 
viruses are structurally different: HIV-1 mutates rapidly and is more virulent than 
HIV-2. HIV-1 is further divided into three groups: M, N, and O. The majority of 
the HIV-1 strains responsible for the global HIV infections belong to group M, 
which is classified into 10 subtypes (World Health Organisation, 2011).  
Understanding the constitution and genetic material of HIV and the process 
through which it binds with the host cells has been a key factor in developing 
different classes of cART drugs for HIV. HIV is a retrovirus with RNA as its 
genetic material. The genome of the HIV virus encodes a reverse transcriptase 
enzyme, which allows deoxyribonucleic acid (DNA) to be transcribed from the 
RNA. Due to this feature, HIV can make copies of its own RNA genome as DNA 
(i.e. viral DNA). HIV infection attacks the white blood cells responsible for 
maintaining the immune system known as CD4+ “T-helper” lymphocytes 
(henceforth referred to as CD4 cells), leading to severe immunodeficiency due to 
their depletion (McCune, 2001). CD4 is a glycoprotein expressed on the surface of 
the CD4 cells and is a primary receptor for entry of HIV into host cells. The 
chemokine receptors (CCR5 and CXCR4) also act as coreceptors for HIV entry. 
HIV gains entry into the host CD4 cells by binding its protein, gp120, to CD4 as 
shown in Figure 1. Once it gains entry into a human CD4 cell, this viral DNA is 
able to integrate into the CD4 cell’s DNA, a process facilitated by the viral 
integrase enzyme. This enables the process of replication of the HIV virus from 
the viral DNA. The new complete HIV virus particles are assembled and released 
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from the infected CD4 cell. This process is facilitated by the HIV protease enzyme, 
which enables maturation of the virus particle (Mortimer and Loveday, 2001). 
cART have been developed to disrupt the replication of HIV during each of these 
phases, the details of which are described later in section 1.2.5. 
Figure 1. Life cycle of HIV  
Source: National Institute of Allergy and Infectious Diseases, 2012 
(http://www.niaid.nih.gov/topics/HIVAIDS/Understanding/Biology/pages/hivrepli
cationcycle.aspx) 
 
1.2.3.1 CD4 cells  
A CD4 cell count is the measurement of the number of CD4 cells detected per 
cubic millimetre (mm
3
) of blood. It is usually between 500-1120 cells/mm
3
 in 
HIV-uninfected individuals (Bofill et al., 1992). CD4 cell count is used as a 
surrogate marker of immunodeficiency because these cells are the primary targets 
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of HIV (Mellors et al., 1997). The depletion of CD4 cells increases the 
susceptibility of the HIV infected persons to opportunistic infections, cancers, and 
death. The risk of AIDS-related illnesses, e.g., KS, PCP increases if the CD4 cell 
count drops below 200 cells/mm
3
.  
1.2.3.2 HIV viral load 
HIV viral load is the level of HIV genetic material RNA that is present in the body 
fluids. In 1996 a viral load test that measures the amount of HIV RNA in an HIV 
positive person’s blood became available (Mascolini, 1996). Viral load in the 
blood plasma is measured as the number of copies of RNA per millilitre (mL) 
(Mellors et al., 1997). Repeat viral load test results as ‘undetectable viral load’ are 
regarded as an indication of successful suppression of the HIV in an individual. 
The viral load count characterised as undetectable varies depending on the 
technology that is available and used for testing, and ranges from a viral load of 
<400, <50, or <40 copies/mL. Plasma viral load is the strongest predictor of 
onward sexual transmission of HIV (Quinn et al., 2000; Attia et al., 2009; Cohen 
et al., 2011). 
1.2.4 Natural course of HIV infection: implications for HIV 
transmission and disease progression 
Understanding the natural course of HIV is important to recognize its implications 
for the clinical manifestations of HIV in infected individuals, and the course of the 
HIV epidemic. The natural progression from being infected with HIV to 
developing AIDS is a gradual process. The primary HIV infection phase is 
associated with flu-like symptoms within two to four weeks after being infected 
with HIV (Stekler and Collier, 2004). As shown in Figure 2, the levels of HIV 
RNA are high in this initial phase of the infection (Coutinho et al., 2001; Pilcher et 
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al., 2007). After the initial high level of viraemia during the primary phase of HIV 
infection, during the subsequent asymptomatic phase of HIV infection, virus 
production and clearance are believed to reach a balance leading to relatively 
stable level of HIV viral load concentration in the plasma. This balance is also 
known as ‘set point’ (Mellors et al., 1996). 
Figure 2. Representation of the natural history of HIV infection  
 
 
Source: Coutinho et al, 2001: pp. 1047  
However, it may increase gradually (Sabin et al., 2000). Subsequent to the latent 
phase, the levels of viraemia can increase depending on various factors like the 
initial viral load, a concurrent decline in the CD4 cell count, and lack of access to 
cART, making the HIV infected persons vulnerable to AIDS-related illnesses 
(Coutinho et al., 2001). The viral set point and CD4 cells set point can influence an 
HIV positive person’s disease progression. A higher viral load set point, and lower 
CD4 cells set point are correlated with a rapid disease progression and poorer 
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responses to treatment (Mellors et al., 1997) and high infectiousness (Wawer et al., 
2005). Without treatment, the average life expectancy of a person with HIV is 10-
12 years (Mellors et al., 1997). These stages of HIV infection are correlated with 
infectiousness, which is a “U-shaped” distribution indicating that infectiousness is 
high during the early days of HIV infection and in the last stage of the disease 
when the viral load is high (Jacquez et al., 1994; Wawer et al., 2005).  
In the next sub-section, I examine the development of cART and guidelines for 
starting treatment in PLWH.  
1.2.5 Antiretroviral treatment  
cART primarily controls the replication of the HIV virus and thus reduces the viral 
load, and prevents damage to the immune system (Hammer et al., 1997). Therefore 
the purpose of starting treatment with cART for an HIV infected person is to 
reduce and maintain low plasma viral load concentrations within the first few 
weeks of starting cART to reduce HIV related morbidity and restore immunologic 
function (Gazzard et al., 2008). Nevertheless, even after suppression of the viral 
load to undetectable levels, some patients can experience transient increases in the 
viral load levels to detectable levels known as ‘blips’ or experience viral load 
rebound. Studies have reported that a significant proportion of patients on cART 
experience blips in the viral load over time (Havlir et al., 2001; Greub et al., 2002).  
1.2.5.1 When to start cART 
The guidelines on when to start cART have been influenced by on-going research 
that aims to understand the benefits of starting cART at varying levels of CD4 cell 
count on morbidity related to HIV. The drugs for HIV are linked to the various 
stages they inhibit in the life cycle of HIV described in section 1.2.3. The first 
class of drugs to be approved for HIV in 1987 was nucleotide reverse transcriptase 
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inhibitors (NRTIs) and the first drug to be approved was called azidothymidine 
(AZT). The NRTIs prevent replication of HIV by interfering with the process of 
viral replication from RNA to DNA. A double-blind placebo-control trial of the 
efficacy of AZT showed that oral AZT administration can decrease mortality and 
the frequency of opportunistic infections among people with advanced disease due 
to HIV (Fischl et al., 1987). Subsequent trials showed that AZT slowed the 
progression to AIDS in patients with mild symptomatic disease (Fischl et al., 
1990). The AIDS Control Trial Group 019 study showed that in the short term 
AZT delayed the onset of AIDS and associated conditions in asymptomatic 
patients with CD4 cell counts of <500 cells/mm
3 
(Volberding et al., 1990). 
However, the subsequent Concorde trial showed that AZT did not have sustained 
benefits over time as there was no difference in survival or disease progression 
among asymptomatic patients randomised to immediately starting AZT compared 
to those assigned to the deferred treatment arm (Aboulker and Swart, 1993). The 
non-nucleoside reverse transcriptase inhibitors, approved in 1997, also prevent the 
replication of the HIV RNA to DNA. Other drugs like didanosine and the Protease 
Inhibitors (PIs) were also approved in the late 1990. The PIs bind to the active site 
of the HIV enzyme protease and interfere with the formation of the new HIV virus. 
Studies conducted in the mid-1990’s showed that cART was effective in treating 
HIV compared to monotherapy (Hammer et al., 1996, 1997). cART, also known as 
highly active antiretroviral treatment (HAART), is defined as a combination of at 
least three drugs from two different ART drug classes. This led to a growing 
interest in using combination therapy for controlling the progression of HIV 
infection. Subsequently, fusion inhibitors were approved in 2003. They block the 
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entry of the HIV virus into the host cells. The integrase inhibitors, first approved in 
2007, prevent the integration of the viral DNA with the host DNA.  
In 2008, the UK guidelines recommended that cART should be started for patients 
who have a chronic HIV infection, are symptomatic or severely 
immunocompromised, i.e., with a CD4 count less than 350 cells/mm
3
 (Gazzard et 
al., 2008). However, the results from a definitive multinational RCT reported in 
2011 has provided evidence that early initiation of cART (i.e., when CD4 cell 
counts is between 350-550 cells/mm
3
) compared to delayed initiation of cART (i.e., 
when CD4 cell count is <250 cells/mm
3
) reduces rates of sexual transmission of 
HIV as well as clinical events (Cohen et al., 2011). The results of this trial have led 
to increase in the focus on using cART for prevention of sexual transmission of 
HIV and have contributed to the revision of the UK as well as the USA guidelines 
for starting cART (U.S. Department of Health and Human Services, Panel on 
Antiretroviral Guidelines for Adults and Adolescents, 2012; Williams et al., 2012). 
This is discussed in greater detail in section 7.3.2.   
Since the first case of AIDS, global, regional and national surveillance systems 
have been set-up to understand the variation in the epidemiology of HIV, the 
nature of the HIV epidemics and factors associated with HIV transmission. The 
availability of cART has changed the landscape of HIV epidemiology by 
decreasing HIV related morbidity and mortality, and reducing the average 
infectivity of a person on cART with an effective viral suppression. In the 
following sub-section I examine the epidemiology of HIV in the UK, particularly 
in MSM and the epidemiology of STI in HIV positive MSM.  
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1.3 Epidemiology of HIV in the UK 
HIV can be transmitted sexually, through blood or blood products, and from 
mother-to-child. An understanding of the national epidemiology of HIV infection, 
regional variations, key drivers, and the stage of the infection at the population 
level is important to inform the development of appropriate HIV prevention and 
treatment programmes. It is equally important to understand the source of the 
surveillance data, its reliability, and limitations.  
In the UK, the surveillance system for HIV and STI has evolved over time in 
response to the changes in the HIV epidemic, development of diagnostic tests for 
HIV and the effect of cART on HIV prevalence (Dougan et al., 2008). The 
national surveillance system for AIDS was set-up in 1982. At the time of writing 
this thesis, the surveillance data for HIV was collected via various mechanisms, 
including unlinked anonymous seroprevalence surveys, the Survey of Prevalent 
HIV Infections Diagnosed (SOPHID), and HIV and AIDS New Diagnoses and 
Deaths surveillance. The national estimates of the number of PLWH in the UK are 
obtained by fitting a statistical model to the prevalence data collected through 
these surveys (Health Protection Agency, 2011a). The model assumes a 
subdivision of the target UK population aged 15-59 years into key mutually 
exclusive exposure subgroups, and produces estimates by geographical region, 
infection diagnosis status, and gender (Health Protection Agency, 2011a). In the 
following sub-section I describe the HIV prevalence in the UK. 
1.3.1 HIV prevalence in the UK 
By the end of 2010 the number of estimated PLWH in the UK was 91,500 and the 
estimated HIV prevalence was 1.5 per 1,000 people of all ages (Health Protection 
Agency, 2011a). As shown in Figure 3, there has been a tremendous increase in 
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the number of new HIV diagnoses since 1981 when the first case of HIV was 
diagnosed. However, these data should also be interpreted in the context of 
developments in the field of diagnostics for HIV. In the mid-1980’s, the annual 
number of new HIV diagnoses rose to approximately 3000 new cases due to the 
availability of HIV antibody test in 1985. This was followed by a decline in the 
new cases from 1985-1987 to approximately 2000 new cases per year. There was a 
subsequent increase from 1987 until 1991 after which the number of new 
diagnoses of HIV per year stabilized at 3000 new cases per year until 1996. After 
1996, there was a steep rise in the number of new HIV diagnoses, with the highest 
number of new diagnoses being in the year 2005 (7837 cases). 
Figure 3. Annual new HIV and AIDS diagnosis and deaths in the UK: 1982-
2010  
Source: UK Collaborative Group for HIV and STI Surveillance, 2010 
Since 2005, the number of new HIV diagnoses has declined but continues to be 
high compared to pre-1996. In 2010, the number of new HIV diagnoses was 6660 
(Health Protection Agency, 2011a) and the rate of new HIV diagnosis was 0.11 per 
1,000 population. AIDS related diagnosis and deaths increased from 1982 until 
1995 to approximately 2000 cases of each (Figure 3). Deaths due to HIV and 
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AIDS related diagnosis have declined rapidly since 1996 due to the availability of 
cART. Since 1996, the number of AIDS diagnosis and deaths has stabilized at 
approximately 500 cases per year.  The UK Collaboration of HIV Cohort data 
indicates that the life expectancy of people treated for HIV infection has increased 
between 1996-2006 by over 15 years (May et al., 2011). 
1.3.2 Undiagnosed HIV 
The benefits of cART are associated with its timely initiation (May et al., 2011). 
However, one of the biggest challenges in the UK is the high proportion of 
undiagnosed HIV cases. The source of data on undiagnosed HIV infections in the 
UK is the unlinked anonymous serological surveys conducted among pregnant 
women, injecting drug users (IDUs), and sexual health clinic attendees tested for 
syphilis. These unlinked anonymous surveys, started in the UK in 1990, monitor 
the prevalence of HIV within defined populations. Of the 91,500 HIV cases by the 
end of 2010, approximately 22,000 people were unaware of their infection (Health 
Protection Agency, 2011a). Moreover, timely diagnosis has implications for 
prevention of onward sexual and vertical HIV transmission. People who are 
unaware of their HIV status may engage in unprotected sex with implications for 
onward HIV transmission.  
1.3.3 Late and very late HIV diagnosis 
Late HIV and very late HIV diagnosis is defined as patients with a CD4 cell count 
of <350 cells/mm
3
 and <200 cells/mm
3
 respectively within three months of HIV 
diagnosis (Gazzard et al., 2008). Late HIV diagnosis continues to be a problem in 
the UK (Sullivan et al., 2005; Rodger et al., 2010), with an estimated 22% of 
adults diagnosed with HIV in 2010 having a CD4 cell count of <350 cells/mm
3  
(Health Protection Agency, 2011a). Late diagnosis is associated with the risk of 
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already having developed AIDS-defining conditions at the time of HIV diagnosis 
or developing one shortly afterwards (Girardi et al., 2007; Rodger et al., 2010). 
The data on CD4 cell count monitoring indicates that the key groups affected by 
late HIV diagnosis in the UK are heterosexual men, particularly black African men 
and older people (Health Protection Agency, 2011a).   
1.4 HIV among MSM in the UK 
MSM continue to be one of the two groups disproportionately affected with HIV 
in the UK. The following sub-section describes the prevalence and incidence of 
HIV and the level of undiagnosed and late HIV diagnosis in this population.  
1.4.1 HIV prevalence and incidence among MSM  
The British National Survey of Sexual Attitudes and Lifestyles (NATSAL) 
conducted in 2000 reported a significant increase in the proportion of MSM in the 
population compared to the 1990 NATSAL survey (Mercer et al., 2004). The 
prevalence of homosexual practices in the preceding five years among men aged 
16–44 years in the 2000 NATSAL survey was 5.5% in Greater London and 2.1% 
for the rest of Britain (Johnson et al., 2001). In 2010 the estimated number of 
MSM living with HIV in the UK, derived using the Office for National Statistics 
data, was 40,100 (Health Protection Agency, 2011a). Assuming that 3.4% of the 
adult male population in the UK in 2010 are MSM, one in 20 gay men are living 
with HIV nationally (47 per 1,000 population), and one in 11 in London (83 per 
1,000). The prevalence of HIV in MSM in England is high compared to other 
regions of the UK.  
As indicated in Figure 4, in 2010 the number of new HIV diagnoses was highest in 
MSM (3000 cases) compared to other groups. The number of new HIV cases in 
MSM has increased steadily from 1820 cases in 2001 to 2660 cases in 2005 and 
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stabilized at this level until 2006. However, there was an increase in the number of 
new cases to 2900 in 2007 following which again there was a decline in new cases 
to 2770 in 2008 and 2790 in 2009. Since 2001, the number of new diagnoses in 
MSM has reached the highest mark in 2010, i.e., 3000 cases. Of these 3000 cases, 
81% were probably acquired in the UK. The annual incidence of HIV among 
MSM, aged 15-44, living in England and Wales has increased from 0.5% per year 
in 2002 to 0.9% in 2007 (Presanis et al., 2011). A study conducted in Brighton has 
reported that the proportion of recently acquired infections in MSM was not only 
high but has increased between 1996-2007 (Fisher et al., 2007). 
Figure 4. New diagnosis of HIV by exposure groups in the UK: 2001-2010 
 
Source: UK Collaborative Group for HIV and STI Surveillance, 2010 
In 2010, approximately 90 HIV clinics and 50 laboratories participated in the 
national monitoring of recent HIV infections in England and Northern Ireland 
which incorporates results from an HIV antibody assay modified for the 
determination of HIV avidity as evidence of recent or long-standing HIV infection 
(Health Protection Agency, 2011a). The proportion of recently acquired infections 
was higher among MSM (24%), compared to heterosexual women (7%) and 
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heterosexual men (9%) indicating on-going HIV transmission in MSM. However, 
this is likely to be influenced by the differential uptake of HIV testing among these 
groups.  
1.4.2 Prevalence of undiagnosed and late diagnosed HIV in 
MSM in the UK 
The estimated prevalence of undiagnosed HIV in MSM in 2003 in England and 
Wales, derived using data from the community-based surveys, STI clinic 
surveillance data and a general population sexual behaviour survey, was 2.4% 
(Walker et al., 2011). Recent community based studies in MSM have reported that 
the undiagnosed HIV prevalence in MSM is high, i.e. 28% in London (Wayal et al., 
2008) and 41.7% in Glasgow and Edinburgh (Williamson and Hart, 2007). The 
number of undiagnosed HIV cases among MSM in 2010 was estimated to be 
10,300 (26%) and a further 39% of MSM were diagnosed late with HIV (Health 
Protection Agency, 2011a). This is lower than the proportion of late HIV diagnosis 
among heterosexual women (58%) and men (63%).  
1.4.2.1 HIV testing among MSM in the UK 
Improving uptake and frequency of HIV testing is important to reduce the risk of 
onward HIV transmission due to being unaware of one’s serostatus and to enhance 
timely access to treatment and care among those who are HIV positive. A 
community-based survey conducted in MSM in London indicates that the 
proportion of men who had ever tested for HIV has increased from 72.1% in 1998 
to 90.1% in 2008 (Lattimore et al., 2011). However, given the high prevalence of 
undiagnosed HIV among MSM, regular testing for HIV and partner notification 
among MSM is important to prevent onward HIV transmission. 
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1.4.3 Epidemiology of STI among MSM in the UK 
There has been a tremendous increase in the diagnoses of primary, secondary and 
early latent infectious syphilis among MSM in England with the number of 
diagnoses increasing from 440 in 2001 to 1490 in 2010 (Health Protection Agency, 
2011a). 35% of these diagnoses were among HIV positive MSM (Jebbari et al., 
2011). As depicted in Figure 5, since 2001 there has been an increase in the 
diagnosis of all STI in MSM in England. The number of gonorrhoea diagnoses in 
MSM in 2010 was 4,500, and chlamydia diagnosis was 5,000 (Health Protection 
Agency, 2011b). Approximately 800 MSM had a first episode of genital herpes 
and 2000 MSM had a first episode of genital warts.  
Figure 5. Diagnoses of selected STI in MSM in England: 2001-2010 
 
Source: UK Collaborative Group for HIV and STI Surveillance, 2010 
Of the total 520 LGV diagnoses in 2010, 99% were in MSM, with 80% among 
HIV positive MSM, and a significant proportion of these were re-infections 
(Health Protection Agency, 2011b). An enhanced surveillance system for newly 
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acquired HCV in MSM from 2008 to 2010 has shown that 228 cases were 
identified in STI clinics across London, Manchester and South East (Health 
Protection Agency, 2011b). Although some of the STI like syphilis, gonorrhoea 
and chlamydia can also be transmitted via oral sex, LGV is transmitted 
predominantly during unprotected anal intercourse (UAI). The increase in STI 
among HIV positive MSM is an indicator of sexual behaviours that facilitate STI 
transmission and acquisition. This suggests that there is a need to ensure on-going 
sexual health of MSM living with HIV.  
As mentioned previously in section 1.4.1, in 2010 there was an increase in the 
number of recent HIV infections in MSM in the UK. These data indicate that 
among MSM there has been an increase in the sexual behaviours that enhance HIV 
transmission and acquisition. Thus, there is a need to examine the sexual 
behaviour of MSM to understand its implications for the HIV epidemic. The 
following sub-section describes factors associated with HIV transmission. 
1.5 Determinants of HIV transmission  
Sexual transmission is the foremost risk factor for HIV transmission in adults 
worldwide (World Health Organisation, 2011). Using a simple mathematical 
model to explain HIV transmission dynamics May and Anderson postulated that 
the prevalence and spread of HIV/STI in a population is determined by the key 
parameter R0, the basic reproductive rate of an infection (May and Anderson, 
1987). R0 is influenced by βcd as explained in Box 1 (Hethcote and Yorke, 1984; 
May and Anderson, 1987).  
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Box 1. Factors affecting HIV transmission 
 
If the average number of infections that result from one infection is greater than 
one [R0>1] then the rate of HIV in the community will increase, and if the average 
number of infections is less than one [R0< 1] then the rate of HIV in the 
community will decrease (Garnett, 2002). 
Boerma and Weir proposed a hierarchical conceptual framework (Boerma and 
Weir, 2005) to study the distribution and determinants of HIV in the population. 
As shown in Figure 6, they postulated that the social and structural factors and 
intervention programs, termed as the underlying factors, affect the biological 
determinants of HIV (βcd) through the proximate determinants to affect the spread 
of HIV. This framework focuses on the identification of factors that can be 
influenced by changes in the contextual variables, i.e., underlying determinants, 
which influence the biological factors that influence health outcomes. As shown in 
figure 6, ‘β’, i.e., the efficiency of HIV transmission per contact is influenced by 
behavioural as well as biological factors like condom use, type of sex, viral load, 
STI, circumcision; ‘c’ is also influenced by behavioural factors like the rate of sex 
partner change, number of sex acts, nature of sex partnerships, and IDUs or blood 
transfusion, and ‘d’ is influenced by the treatment with cART and treatment of 
opportunistic infections.  
R0, the basic reproductive rate of the infection =βcd  
Β = the average probability that infection is transmitted from an infected 
individual to a susceptible partner, i.e., efficiency of transmission 
c = average rate of contact between an infected and susceptible individual, i.e., 
rate of partner change 
d = the average duration of infectiousness 
 
R0, the basic reproductive rate of the infection =βcd  
 
β= the average probability that infection is transmitted from an infected 
individual to a susceptible partner  
c= average rate of contact between an infected and susceptible individual 
d = the average duration of infectiousness 
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Figure 6. Proximate-determinants conceptual framework for HIV 
transmission  
 
Source: Boerma and Weir, 2005  
At the population level, factors like the interaction between the population 
prevalence of the infection, phase of the epidemic and socio-sexual networks and 
sexual mixing patterns (Wasserheit and Aral, 1996; Potterat et al., 1999; Aral et al., 
2005), access to sexual health care and treatment, namely cART and community 
viral load (Porco et al., 2004; Das et al., 2010) can also affect HIV transmission. 
This implies that in order to reduce HIV transmission, HIV prevention programs 
should influence βcd by developing interventions to influence the proximate 
determinants of HIV transmission, which in turn can influence the biological 
determinants and prevent HIV transmission. 
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1.5.1 Determinants of sexual transmission of HIV among 
MSM 
In the following section, I examine the proximate determinants of HIV among 
MSM. 
1.5.1.1 Exposure of susceptible to infected person (c) 
The exposure of susceptible persons to infected persons is influenced by various 
behavioural factors like the rate of sex partner change, age at sexual debut, socio-
sexual networks, etc among individuals. In the UK, multiple sexual partnerships 
are commonly reported by a substantial proportion of MSM (Weatherburn et al., 
2008). In addition, MSM, in particular HIV positive MSM, frequently meet sexual 
partners online via dating websites (Bolding et al., 2005, 2007). Gay and MSM 
dating websites like Gaydar, Manhunt, and Bareback.com etc. can facilitate 
geographical mixing, mixing of men with similar sexual preferences and meeting 
multiple sexual partners. These sites can also facilitate the organization of sex 
parties, which has implications for onward transmission of HIV. Similarly, 
sexually charged environments like saunas and sex on premises venues are also 
likely to facilitate access to sexual partners among men accessing these venues.  
1.5.2 Efficiency of transmission per contact (β) 
The efficiency of sexual transmission of HIV is influenced by various behavioural 
and biological factors described in the following sections.  
1.5.2.1 Type of sex  
One of the factors affecting the probability of HIV transmission is the nature of 
sexual contact between an infected person and a susceptible person (Mastro and de 
Vincenzi, 1996; Vernazza et al., 1999). The probability of HIV transmission 
associated with insertive or receptive unprotected anal intercourse (UAI) is higher 
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than other types of sex. Moreover, insertive unprotected anal intercourse (IUAI) is 
associated with greater risk of HIV transmission compared to receptive 
unprotected anal intercourse (RUAI) between an HIV positive person and an HIV 
negative person, i.e., between serodiscordant partners (Caceres and van Griensven, 
1994; Mastro and de Vincenzi, 1996; Vittinghoff et al., 1999). Similarly, the risk 
of HIV transmission associated with RUAI and IUAI with ejaculation is greater 
than RUAI and IUAI with withdrawal prior to ejaculation. 
The pre-cART estimates of the probability of HIV acquisition per 1000 episodes 
of RUAI with ejaculation, after assuming the risk of transmission per sexual 
contact between an infected and an uninfected partner to be constant, was 
estimated to be 0.005-0.03 (DeGruttola et al., 1989). Another study estimated the 
per-contact risk of HIV acquisition associated with RUAI when the partner was of 
known HIV positive status to be 0.82% (95% CI: 0.24-2.76%), and 0.27% (95% 
CI: 0.06-0.49%) with an unknown serostatus partner (Vittinghoff et al., 1999). The 
per-contact risk associated with IUAI with an HIV positive or unknown serostatus 
partner was estimated to be comparatively lower, i.e., 0.06% (95% CI: 0.02-0.19); 
and the estimated risk associated with receptive penile-oral sex was 0.04% (95% 
CI: 0.01-0.17) (Vittinghoff et al., 1999).   
Estimates of HIV transmission in the cART era indicate that the per-contact risk of 
HIV acquisition for RUAI if ejaculation occurred inside the rectum was 1.43% (95% 
CI: 0.48%-2.85%) and it was 0.65% (95% CI: 0.15%-1.53%) if withdrawal prior 
to ejaculation occurred during RUAI (Jin, Jansson, et al., 2010). This study also 
showed that the per-contact risk of HIV acquisition for IUAI in circumcised men 
was 0.11% (95% CI 0.02–0.24) and it was 0.62% (95% CI 0.07–1.68) in 
uncircumcised men. Despite the availability and effectiveness of cART, the 
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overlap in the 95% confidence interval (CI) of the per-contact risk of HIV 
acquisition due to engagement in RUAI suggests that the post-cART estimate is 
similar to that reported in the pre-cART era (Vittinghoff et al., 1999; Jin, Jansson, 
et al., 2010). This may be because the risk of HIV transmission is correlated not 
only with biological factors like access to cART and ensuing viral load but also 
with other population and individual level factors like disease stage, co-infection 
with STI, and sexual behaviour thus emphasising the relevance to examine the 
prevalence of these factors to understand their impact on the probability of HIV 
transmission.  
A recent mathematical model based on the USA national surveillance data from 
five cities estimated that the risk of HIV transmission was high among HIV 
positive men who engaged in RUAI and reported a higher number of episodes of 
RUAI with a main partner compared to casual partners (Sullivan et al., 2009). 
However, some MSM use various strategies to reduce the risk of HIV transmission. 
These strategies are also termed as seroadaptive behaviours (Snowden et al., 2009). 
Some men, especially if they are HIV positive, may decide not to engage in sex at 
all or may engage only in oral sex, which is associated with a very low risk of HIV 
transmission compared to anal sex. They may also engage in serosorting, i.e., have 
sexual partnerships only with men of the same HIV serostatus or engage in unsafe 
sex, namely UAI only if the partner is of identical serostatus (Snowden et al., 
2009). However, undiagnosed HIV prevalence and seroguessing, i.e., assuming the 
HIV status of the sexual partners to be the same as one’s own status, which can be 
faulty and lead to HIV transmission (Zablotska et al., 2009) are challenges to 
serosorting, especially among HIV negative MSM. Additionally, serosorting does 
not offer protection against STI in the event of UAI nor does it protect against the 
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risk of super-infection with other strains of HIV in the case of HIV positive MSM 
(Poudel et al., 2007). 
Some MSM may also engage in strategic positioning, i.e., an HIV positive person 
may choose to be the receiver and the HIV negative partner may choose to be the 
insertive partner in the event of UAI between serodiscordant partners (Van de Ven 
et al., 2002) or unknown status partners. MSM may engage in practices like 
strategic positioning if they perceive varying risk of HIV transmission associated 
with IUAI and RUAI. MSM may also decide to engage in UAI with withdrawal 
before ejaculation to reduce the risk of HIV. In this thesis, I have referred to the 
use of sexual positioning or non-engagement in certain types of sex to reduce the 
risk of sexual transmission of HIV as ‘behavioural risk reduction strategies’. An 
HIV negative and an HIV positive man may decide to engage in UAI if they 
believe that the HIV positive partner has an undetectable viral load and thus the 
risk of HIV transmission is low, also known as negotiation around viral load (Van 
de Ven et al., 2002; Jin et al., 2007). In this thesis, I have referred to relying on 
undetectable viral load status to decide engagement in UAI as ‘biomedical risk 
reduction strategy’ for prevention of sexual transmission of HIV. However, except 
condom use, both, the behavioural as well as biomedical risk reduction strategies 
may not necessarily offer protection against HIV acquisition/transmission (Jin et 
al., 2007). 
1.5.2.2 cART, viral load, and transmission risk 
A prospective study conducted in Rakai, Uganda showed that in heterosexual 
serodiscordant couples plasma viral load is the main predictor of the risk of HIV 
transmission (Quinn et al., 2000). This study also showed that HIV transmission 
was rare in among persons with viral load less than 1500 copies mL. By the late 
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1990’s, several trials had shown that cART is effective in preventing mother-to-
child transmission of HIV by reducing plasma viral load (Mofenson and McIntyre, 
2000). Among men, cART has also been shown to reduce the semen viral load 
(Gupta et al., 1997; Vernazza et al., 1997). Therefore, since early 2000 there has 
been a growing interest in the potential to use cART to reduce the risk of sexual 
transmission of HIV (Hosseinipour et al., 2002; Montaner et al., 2006). An 
ecological study from Taiwan reported a 53% reduction in new HIV positive tests 
after introduction of free access to cART (Fang et al., 2004). In addition, a 
reduction in HIV infectivity due to cART was also reported among MSM in San 
Francisco (Porco et al., 2004). The use of cART was independently associated 
with 86% reduction in HIV transmission in Spanish serodiscordant couples if the 
HIV positive partner was on cART (Castilla et al., 2005). A recent RCT has shown 
that early initiation of cART reduces the rate of sexual HIV transmission in 
serodiscordant couples (Cohen et al., 2011); however the study population was 
predominantly heterosexual serodiscordant couples. 
Several mathematical modelling studies have suggested that increasing the usage 
of cART among MSM can reduce AIDS-related death rate and HIV incidence rate 
(Blower et al., 2000; Velasco-Hernandez et al., 2002; Bezemer et al., 2008). 
However, all these studies also suggest that benefits of cART can be offset by 
increase in risky sexual behaviours. The lack of difference between the per-contact 
risk of HIV transmission associated with RUAI among MSM in the pre and post 
cART era reported in section 1.5.2.1 is a concern. It indicates that the relationship 
between viral load status and HIV infectiousness for sexual transmission for anal 
sex remains unproven (Baggaley et al., 2010). Thus, although cART is associated 
with reduced infectivity among heterosexual couples, these mixed results indicate 
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that there is a need for further research among MSM to examine the relationship 
between effectiveness of cART in preventing HIV transmission.   
1.5.2.3 Treatment with pre-exposure prophylaxis  
There is also an increasing focus on the potential for using cART as pre-exposure 
prophylaxis (PrEP) to prevent sexual transmission of HIV. A multinational RCT 
showed that daily intake of oral cART (emtricitabine and tenofovir disoproxil 
fumarate) by HIV negative MSM and transgender women who have sex with men 
reduced the risk of HIV acquisition by 44% (95% CI: 15-63; p= 0.005) (Grant et 
al., 2010). Recently in the USA, the FDA has approved the drug combination of 
300 mg tenofovir and 200 mg emtricitabine for daily use by uninfected adult to 
prevent sexual acquisition of HIV (Centers for Disease Control and Prevention, 
2012). However, PrEP offers only partial protection againt the risk of HIV. 
1.5.2.4 STI and HIV Transmission 
Bacterial STI are a surrogate marker of high-risk sexual behaviour. Being infected 
with STI increases the risk of both, HIV transmission and acquisition (Hayes et al., 
1995; Cohen et al., 1997; Fleming and Wasserheit, 1999). STI facilitate HIV 
acquisition by breaching protective mucosal barriers and recruiting susceptible 
immune cells like the CD4 cells and macrophages to the site of infection (Ward 
and Rönn, 2010). STI are associated with onward HIV transmission during 
primary HIV infection (Pao et al., 2005). Among HIV infected persons, STI, 
particularly ulcerative and inflammatory STI and those causing urethral/vaginal 
discharge, such as herpes simplex virus type 2 (HSV-2), chancroid, gonorrhoea, 
chlamydia, syphilis, chlamydia, trichomoniasis, bacterial vaginosis, urethritis, and 
cervicitis facilitate HIV shedding in the genital tract (Kalichman et al., 2011), thus 
facilitating onward HIV transmission. Syphilis increases the concentration of HIV 
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plasma viral load and reduces CD4 cell count (Buchacz et al., 2004). Genital ulcer 
disease (GUD) is an independent factor for shedding of HIV in the genital fluids 
(Ghys et al., 1997). However, another study did not find this relationship but found 
that GUD appeared to increase viral load in semen by increasing the blood plasma 
HIV concentrations (Dyer et al., 1998). Anal gonorrhoea among MSM in an 
Australian cohort was the strongest predictor of HIV acquisition (Jin, Prestage, et 
al., 2010).  
A RCT conducted in 1985 demonstrated that syndromic management of STI can 
reduce the incidence of HIV in the general population (Grosskurth et al., 1995). 
However, subsequent studies on the effect of STI management on HIV incidence 
have shown no positive effect (Padian et al., 2010). The lack of effectiveness of 
treating curable STI on HIV incidence at the population level is likely to be due to 
various factors like the stage of the HIV infection (i.e., mature epidemic), changes 
in sexual behaviours in the population over time and distribution of viral load in 
the community (Freeman et al., 2007; White et al., 2008).  
Although cART offers protection against the risk of HIV transmission, it does not 
offer protection against the risk of STI transmission or acquisition. The studies that 
have modelled the probability of HIV transmission in the cART era have not 
factored in the impact of STI (Bezemer et al., 2008; Wilson et al., 2008). Thus 
there is no robust evidence about the impact of co-infection with STI on HIV 
transmission in the cART era. Nevertheless, STI are associated with increased 
infectivity due to increase in viral load.  
1.5.2.5 Male circumcision 
Male circumcision is associated with reduced risk of heterosexual as well as 
homosexual HIV acquisition (Gray et al., 2008; Jin, Jansson, et al., 2010). As 
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mentioned earlier, the estimated per-contact probability of HIV acquisition during 
IUAI was lower in MSM who were circumcised, i.e., 0.11% (95% CI: 0.02-0.24) 
compared to 0.62% (95% CI: 0.07-1.68) in uncircumcised MSM (Jin, Jansson, et 
al., 2010).  
1.5.3 Duration of infectivity (D) 
HIV is not curable and can be transmitted throughout the course of infection. As 
described in section 1.2.4, the high level of viraemia during the primary phase of 
HIV infection can increase the risk of onward HIV transmission (Brenner et al., 
2007). Treatment with cART and treatment of other opportunistic infections can 
reduce the infectivity of an HIV positive person. Currently, however cART is not 
started immediately at HIV diagnosis. Undiagnosed HIV can also contribute to 
lack of access to timely cART and onward HIV transmissions. Therefore, the 
duration of infectivity due to HIV is associated with both, timely HIV diagnosis 
and treatment with cART.   
These data indicate that certain types of sexual behaviours significantly increase 
the risk of HIV transmission and acquisition among MSM, and these risks are 
moderated by various biological and pharmacological factors. In the following 
section, I explain the rationale for the work undertaken for my thesis.  
1.6 Rationale for thesis 
Since the availability of cART, globally there has been a decline in HIV related 
morbidity and mortality. HIV infection is now a manageable chronic condition. 
PLWH can lead healthier lives including sexual lives compared to the pre-cART 
era. This has led to a growing acknowledgement of the health care needs and the 
role of HIV prevention in PLWH, also termed as ‘positive prevention’ 
(International Alliance for HIV/AIDS, 2003).  
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The concept of early intervention among PLWH and their partners to prevent HIV 
transmission was promoted for the first time in 1989 (Francis et al., 1989). It was 
proposed that prevention interventions in PLWH are likely to have a greater 
impact on the epidemic for equivalent input of cost, resources and time than 
prevention focused on HIV negative persons (King-Spooner, 1999; Vernazza et al., 
1999). However, due to the lack of effective medication for HIV in the 1980s, 
there was reluctance to target HIV prevention interventions at PLWH due to the 
fear of blame and social stigma associated with HIV (Auerbach, 2004). Until early 
2000 HIV/STI prevention strategies did not address the unique prevention needs of 
PLWH and failed to acknowledge their efforts in preventing onward HIV 
transmission (Collins et al., 2000).  
Early discussions on positive prevention in the USA in early 2000 focused on 
expanding HIV prevention efforts to PLWH through the Serostatus Approach to 
Fighting the Epidemic (Janssen et al., 2001). In the UK, the National Strategy for 
Sexual Health and HIV emphasised the health care needs of PLWH (Department 
of Health, 2001).  Since then, there have been significant changes in HIV testing 
policies and as described previously in section 1.5.2.2, an increase in the debate 
about the benefits of starting cART earlier for HIV prognosis and prevention of 
sexual transmission of HIV.  
In the UK, there has been an increase in the prevalence of an older cohort on 
PLWH. MSM continue to be one of the groups disproportionately affected with 
HIV.  In the recent years as described previously in section 1.4.3, there have been 
outbreaks of STI among MSM, especially HIV positive MSM. These factors also 
have implications for provision of health care services as well as HIV prevention 
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among PLWH. In the backdrop of these changes, there is a need to re-evaluate the 
HIV prevention and health care strategies for PLWH. 
1.7 Overall goal of the thesis 
The overall goal of my thesis is to inform strategies for HIV/STI prevention 
among MSM in the UK in the context of the changing landscape of HIV epidemic 
in the UK and the increasing emphasis on HIV testing and cART for HIV 
prevention.  
In this following section, I briefly examine the existing range of interventions for 
PLWH.  
1.8 Interventions for PLWH 
The interventions for PLWH can be broadly categorised as interventions that 
address the health care needs, and HIV prevention needs of PLWH. I will briefly 
describe these interventions, focusing on interventions for HIV positive MSM. 
1.8.1 Routine clinical management of PLWH 
In the UK, the majority of PLWH access free HIV care and treatment via the NHS. 
At the time of starting this PhD, routine clinical care and treatment for PLWH was 
provided as per the 2008 UK guidelines for management of PLWH (Gazzard et al, 
2008). During the course of my PhD, some of the guidelines for routine 
monitoring and treatment of PLWH in the UK have changed and this is addressed 
further in section 7.3.2. As per the 2008 guidelines, all newly diagnosed HIV 
positive persons should be assessed for CD4 cell count, viral load, psychiatric 
history and substance abuse, bone profile, glucose, lipids and cardiovascular risk 
in the first six months following diagnosis. They should also be screened for STI, 
especially HIV positive MSM should be offered testing and vaccination for 
Hepatitis; offered support for partner disclosure and risk reduction counselling for 
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safer sex. cART should be offered to patients who have a chronic HIV infection, 
are symptomatic or severely immunocompromised, i.e., CD4 cell count less than 
350 cells/mm
3
. Subsequently depending on their cART status, they should be 
assessed periodically for CD4 cell count and viral load to monitor their HIV 
related health (i.e., every 4-6 months) and screened annually for risks of 
cardiovascular diseases, mental health including substance abuse and sexual health 
including hepatitis. Those on cART with poor adherence should also be assessed 
for mental health. PLWH with poor mental health should be offered referral for 
psychological support. These guidelines indicate that routine monitoring for HIV 
related treatment and care should also focus on other health risks among PLWH 
like cardiovascular diseases and mental health. Apart from offering risk reduction 
counselling for promoting safer sex among PLWH, these guidelines do not outline 
any other HIV prevention interventions among PLWH.  
1.8.2 Interventions for HIV prevention among PLWH 
Since 2000, several studies predominantly conducted in the USA have examined 
the efficacy of behavioural interventions for HIV prevention among PLWH. These 
studies have examined the feasibility and effectiveness of behavioural 
interventions to promote physical and mental health; enhance safer sex behaviours 
and consistent condom use; promote disclosure of HIV status; prevent abuse of 
recreational drugs. Studies have also examined the impact of voluntary counselling 
and testing on sexual behaviour in serodiscordant couples. A meta-analysis of 
RCTs conducted between 1988-2004 conducted by Crepaz and colleagues 
suggests that behavioural interventions are effective in reducing unprotected 
sexual behaviour as well as STI (gonorrhoea or chlamydia) acquisition among 
PLWH (Crepaz et al., 2006). This review highlights that interventions that were 
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effective in reducing risky sexual behaviours among PLWH were based on 
behavioural theories like social cognitive theory/social learning theory, theory for 
planned behaviour, or information-motivation-behaviour skills model; specifically 
designed to change HIV transmission risk behaviours or addressed other issues 
like adherence to medication, mental health along with HIV risk reduction 
behaviour; focused on skill building; delivered by health-care providers or 
counsellors; delivered to individuals on a one-to-one basis. However, due to the 
small number of studies conducted among HIV positive MSM there was no 
evidence of substantial effect of behavioural interventions in this group. Also, 
none of these RCTs were conducted outside the USA. The Seropositive Urban 
Men’s Intervention Trial (SUMIT) conducted to assess the effectiveness of a 
behavioural intervention to promote safer sex was the only trial included in this 
review by Crepaz and colleagues that was conducted exclusively among HIV 
positive MSM (Wolitski et al., 2005). It compared the efficacy of six 3-hour peer-
led group counselling sessions informed by behavioural theories for gay and 
bisexual HIV positive MSM focusing on sexual and romantic relationships, 
HIV/STI transmission, substance abuse, disclosure of serostatus and mental health 
with a single-session counselling focusing on safer sex, and transmission risks by 
local experts with 3 and 6 month follow-up. This trial highlighted that enhanced 
intervention was associated with only a limited reduction in HIV transmission risk 
at 3 months compared to the standard intervention and there were no other 
significant differences in other HIV transmission risk behaviours or serostatus 
disclosure during the 3 or 6 months follow-up period.  
Following the systematic review by Crepaz and colleagues and during the course 
of my PhD, there has been an increase in the number of positive prevention 
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trials/studies conducted exclusively among HIV positive MSM. Studies have 
shown that individually-tailored behavioural interventions using cognitive 
behaviour therapy (Morin et al., 2008), information-motivation-behavioural skill 
based counselling (Safren et al., 2011) or motivational interviewing (Golin et al., 
2012) are effective in reducing overall HIV transmission risk behaviours among 
HIV positive MSM. However, another RCT conducted in the USA to examine the 
effectiveness of an intervention to enhance disclosure among HIV positive MSM 
showed that although disclosure behaviours and attitudes improved in the 
intervention arm, prevalence of UAI in 3 months post intervention increased in the 
intervention arm compared to the control arm (Serovich et al., 2009). But this 
study does not provide data on the HIV status of UAI partners and it is likely that 
the observed increase in UAI was due to serosorting, which has implications for 
STI risk. Another recent prospective observational cohort study conducted in the 
USA has reported similar results (Patel et al., 2012). Despite 50% reduction in STI 
incidence observed in this study at twelve months among HIV positive MSM who 
had received a brief risk-reduction counselling provided by a health care 
professional with biannual STI testing, rates of UAI with seroconcordant partners 
increased and there was no change in UAI with serodiscordant or unknown HIV 
status partners.  
A systematic review of studies conducted between January 1990-December 2006 
among PLWH in developing countries has shown that HIV counselling and testing 
interventions can increase condom use among PLWH, especially among HIV 
serodiscordant couples (Kennedy et al., 2010). However, the majority of these 
studies were conducted among heterosexual populations. A RCT conducted in the 
USA among HIV negative MSM comparing a standard counselling session with a 
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standard counselling session plus counselling for high risk sexual behaviours 
showed that there was a significant reduction in UAI in the latter group with 
discordant casual partners but UAI did not decrease with serodiscordant primary 
partners (Dilley et al., 2002). Recreational drug use, especially use of crystal 
methamphetamine continues to be a significant challenge for safer sex and 
adherence to cART among PLWH. A systematic review of studies conducted 
among HIV positive MSM in the USA on the effect of abuse of drugs like crystal 
methamphetamine has shown that existing behavioural-theory based interventions 
have variable impact on treating this drug addiction highlighting the need for 
developing better interventions to address this challenge (Rajasingham et al., 
2012). 
The findings of these studies reiterate that behavioural interventions that focus on 
a broad range of issues like safer sex, mental health and coping, adherence to 
cART and disclosure of HIV status to sex partners; are intensive as opposed to a 
single session; are delivered on an one-to-one basis are effective in HIV 
prevention among HIV positive MSM. These studies also highlight that such 
interventions can also be delivered by trained counsellors or HIV positive peers. 
However, these data highlight the partial effectiveness of behavioural interventions 
for HIV prevention and health promotion among HIV positive MSM.  
With regards to biomedical interventions for HIV prevention among PLWH, as 
explained in section 1.5.2.2, there has been a growing emphasis on using cART for 
HIV prevention. Briefly, this emphasis was fuelled by the observed effectiveness 
of cART in early 2000 in preventing mother-to-child transmission of HIV. Data 
from ecological and longitudinal studies also suggested that there was a reduced 
risk of HIV transmission in serodiscordant couples if the positive partner was on 
59 
cART and had an undetectable plasma viral load. Thereby, it was hypothesised 
that if cART reduces plasma viral load, which is one of the strongest risk factor for 
sexual HIV transmission (Quinn et al, 2010), it can potentially reduce the risk of 
sexual transmission of HIV among PLWH receiving cART and have an 
undetectable viral load. At the time of starting this PhD, there was no evidence 
from RCT to support this hypothesis but several studies were underway to 
examine this hypothesis. For example, a HPTN 052 trial examining the 
effectiveness of earlier initiation of cART (CD4 cell count 350-500 compared to 
<250) on the risk of sexual HIV transmission and clinical events was underway in 
nine countries. As mentioned in section 1.5.2.2, it was also hypothesised that 
enhanced identification of HIV-infected individuals followed by ‘immediate’ 
initiation of cART irrespective of CD4 cell count or disease stage can reduce 
infectiousness at a population level. A HPTN 062 trial called TLC-Plus (Test, Link 
to Care, Plus Treatment) is currently underway to assess the effectiveness of this 
HIV prevention strategy. This trial will examine the impact of expanded HIV 
testing, linkage to care, viral suppression through adherence to cART, prevention 
for positives through risk-reduction counselling. Another cluster RCT HPTN 071 
called PopART, is also currently underway to evaluate the effectiveness of a 
combination of interventions including voluntary testing, offering male 
circumcision to men testing HIV negative, counselling and immediate initiation of 
cART (www.zambart.org). The findings of these studies can potentially influence 
the clinical practice of timing of initiation of cART among PLWH, and enhance 
our understanding of the effectiveness and effective components of combination 
prevention strategies for HIV prevention.  
60 
In the backdrop of the limited evidence on the effectiveness of behavioural 
interventions and lack of robust data on the effectiveness of biomedical 
interventions like cART for HIV prevention, there has been an increase in 
emphasis on using combination prevention strategies for HIV prevention, i.e. using 
behavioural, biomedical as well as structural interventions to prevent HIV 
(Vandenbruaene, 2007). It is also important to recognise the symbiotic relationship 
between the effectiveness of biomedical interventions and behavioural 
interventions. As mentioned previously in section 1.5.2.4, the effectiveness of 
cART for HIV prevention is likely to be compromised due to co-infection with 
STI, which can potentially influence infectivity. Given the growing emphasis on 
using cART for preventing sexual HIV transmission, it is vital to reduce the 
prevalence of STI co-infection among PLWH, especially among HIV positive 
MSM. Regular screening and partner notification for STI can potentially reduce 
the risk of increased infectivity due to STI and risk of HIV acquisition. Concerns 
have also been raised about the implications of cART related optimism on risk 
compensation, i.e., risky sexual behaviours. In the backdrop of this growing 
emphasis in the scientific community on using cART for HIV prevention, in this 
thesis I will examine the sexual behaviour and partnership patterns of HIV positive 
MSM, their attitudes towards risk reduction strategies for HIV prevention 
including the effectiveness of cART for prevention of sexual transmission of HIV 
and its impact on sexual behaviour, and attitudes towards notifying sexual partners 
for STI and preferred methods of partner notification.  
In the following section, I explain briefly the key components that I have 
examined in this thesis in order to inform the HIV/STI prevention interventions 
among HIV positive MSM, i.e., the sexual partnership patterns and behaviour of 
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HIV positive MSM, the association between risk reduction strategies and sexual 
behaviour and partner notification for STI. 
1.9 Keys areas examined in the thesis 
In the following section, I explain briefly the key components that I have 
examined in this thesis in order to inform the HIV/STI prevention interventions 
among HIV positive MSM, i.e., the sexual partnership patterns and behaviour of 
HIV positive MSM, the association between risk reduction strategies and sexual 
behaviour and partner notification for STI. 
1.9.1  Sexual partnership patterns and sexual behaviour of 
HIV positive MSM 
Understanding the sexual partnership patterns and behaviours of PLWH is vital to 
understand the course of the HIV epidemic. The increase in new HIV infections 
among MSM in the UK indicates continuing HIV transmission in this population. 
Sexual HIV transmission can occur only if an HIV infected person and an HIV 
uninfected person engage together in unprotected risky sexual behaviour. 
Therefore, in this thesis I have examined the sexual partnership patterns of HIV 
positive MSM, namely the HIV status of their sexual partners, and their sexual 
behaviour and practices. As mentioned earlier in section 1.5.2.1, some MSM may 
use various risk-reduction strategies to prevent the risk of HIV transmission and 
acquisition. Therefore, I also examined their attitudes towards behavioural and 
biomedical risk reduction strategies for HIV prevention. 
1.9.2 cART, viral load and sexual behaviour 
Subsequent to the availability of cART in 1996, there was an increase in HIV/STI 
and high-risk sexual behaviours in MSM in the UK (Elford et al., 2002, 2004a; 
Dodds et al., 2007) and abroad (Ciesielski, 2003). This led to concerns regarding 
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the negative effects of cART on sexual behaviours of MSM (Elford and Hart, 
2005). However, studies conducted in the UK in early 2000 and in 2007 showed 
that being on cART or having an undetectable viral load is not associated with 
risky sexual behaviours among PLWH (Stephenson et al., 2003; Elford et al., 
2007). A meta-analysis of studies conducted in the USA between 1996-2007 has 
also reported similar results (Crepaz et al., 2004, 2009). However, some studies 
have reported an association between optimism related to cART and an increase in 
risky sexual behaviour (Elford et al., 2002; Crepaz et al., 2009).  
As mentioned in section 1, the Swiss statement was issued in the year I started my 
PhD and there were debates about the potential increase in risky sexual behaviours 
due to the effectiveness of cART for prevention of sexual transmission of HIV. 
Given the growing emphasis on cART for HIV prevention, I have explored the 
awareness about the Swiss statement among HIV positive MSM and examined 
their attitudes towards cART for prevention of sexual transmission of HIV. I also 
examined the association between cART/viral load status as well as attitudes 
towards cART for prevention of sexual transmission of HIV with risky sexual 
behaviours.  
1.9.3 Partner notification for STI 
Partner notification, also known as contact tracing, is a process of informing the 
sex partners of a person diagnosed with HIV/STI of their probable exposure to 
infection(s) to enable timely testing and treatment, and to provide advice about 
preventing future infection (World Health Organisation/UNAIDS, 1999). The key 
objectives of partner notification are to control the spread of STI in the population 
by identifying previously undiagnosed infections, testing and treating sexual 
partners of persons diagnosed with STI, and preventing the development of 
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negative sequelae of undiagnosed STI. Partner notification can be effective in case 
finding compared to population level screening for STI because it focuses on 
individuals who have a high probability of being exposed to the infected persons. 
In the UK, the guidelines for health care providers working in STI clinics suggest 
that patients diagnosed with STI should be offered the choice of informing 
partners themselves known as patient referral, or providing details of the partners 
to a health adviser who can contact them without revealing the identity of the 
index case, i.e., the person diagnosed with STI known as provider referral (Society 
of Sexual Health Advisers, 2004). These guidelines also suggest offering contract 
referral to the index cases who intend to notify their sexual partners of STI. It 
entails that the index case agrees that a health adviser notifies their partners 
without naming the index case if the partner has not presented to the clinic within 
an agreed time.  
In the cART era, PLWH have a life expectancy similar to that of the general 
population, and are likely to be sexually active. The consistent high and 
disproportionate rate of STI co-infection in HIV positive MSM in the UK is a 
public health concern. It is an indication of highly prevalent sexual behaviours that 
facilitate STI transmission. It also signifies the need to revitalise existing measures 
of STI control among this population. Co-infection with STI can affect the 
immune system of PLWH (Sadiq, McSorley, et al., 2005; Sadiq, Taylor, et al., 
2005). As described in section 1.5.2.4, STI can also reduce the effectiveness of 
cART for HIV prevention by increasing the plasma/peripheral viral load among 
those on cART. Thus, timely diagnosis and treatment of STI in PLWH is vital to 
ensure their sexual wellbeing, reduce infectivity associated with co-infection and 
slow disease progression.  
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In theory, effective partner notification programs can influence HIV and STI 
incidence and reduce STI prevalence by enhancing timely diagnosis and treatment 
of HIV/STI. The focus of research related to partner notification has been on 
notifying the sexual partners of newly diagnosed HIV positive persons to test for 
HIV. Given the high prevalence of STI among HIV positive MSM, there is a need 
to enhance partner notification for STI control among MSM living with HIV.  
1.9.3.1 Systematic review of qualitative literature on partner notification 
The effectiveness of partner notification is likely to be influenced by its 
acceptability, and perceived and experienced barriers for notification of STI. 
Therefore, I conducted a systematic review of qualitative literature from 1990 to 
the 31
st
 August 2009 on the attitudes, barriers, experiences, and preferences 
regarding partner notification for STI among adolescents, and adult men and 
women using meta-ethnography. I undertook this work as a member of a research 
consortium of the European Partner Notification (EuroPN) project for the 
European Centre for Disease Prevention and Control. A review of quantitative 
studies on the effectiveness of different types of partner notification methods was 
undertaken by a separate group of researchers from the University of Bern led by 
Dr Nicola Low. The details of the systematic review are presented in Appendix 1 
because only two qualitative studies conducted among MSM were identified. 
However, as the review provides an overview of the barriers and facilitators to 
partner notification for STI, I will briefly present the key findings of this review.  
Overall, the systematic review highlighted that the experience of STI diagnosis 
and the operationalization of partner notification is influenced not only by the type 
of infection; but also by gender, the socio-cultural, religious, legal and policy 
framework governing STI control in the society. MSM, women, and African 
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American heterosexual men were worried about being perceived as ‘vectors of 
diseases’. MSM and bisexual men feared double discrimination due to STI 
diagnosis due to their perceived ‘deviant’ sexuality. The shame and immorality 
associated with STI influenced the strategies adopted for (non)disclosure of STI 
diagnosis to sexual partners. The characteristics of STI (for example, treatable, 
symptomatic, or recurrent) also influenced partner notification strategies.  
The review highlights that people diagnosed with STI face real fear of societal 
stigma and discrimination which motivates them to adopt strategies to protect 
themselves from it (Nack, 2000; Lichtenstein, 2003). Therefore, the decision to 
notify partners involves risk-assessment by the index case of the impact of 
notification on their personal wellbeing, relationships with their partners, and 
social status. Thus the index cases are likely to choose strategies like non-
disclosure, selective disclosure (i.e., informing some but not all partners), partial 
disclosure (i.e., lying about the cause of their infection in an attempt to manage the 
stigma associated with their condition), ‘stigma transference’ (i.e., blaming the 
partner for their diagnosis to avoid stigma) (Nack, 2000; Lichtenstein, 2003). The 
need to manage stigma is also reflected in the preference for notifying partners 
themselves. Due to the interdependent nature of sexual health, i.e., the risk of re-
infection; the challenges to hide symptomatic STI; the chronic nature of some 
infections; and the intimate nature of sexual partnerships, especially with main 
partners, the utility of coping strategies like ‘passing’, i.e., concealing one’s 
diagnosis with a stigmatised condition like STI (Nack, 2000) is limited. This 
explains the greater likelihood of main current partners being notified observed in 
the studies. However, in MSM a mutual acceptance of non-monogamy facilitates 
partner notification for STI and symbolises trust. Both trust and blame enable 
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partner notification, especially in the context of current main partners. Notifying 
casual and ex-partners was reported to be challenging due to its perceived threat to 
social standing.  
This review highlights that, to date, there is little published evidence on attitudes, 
barriers and preferences relating to STI partner notification in MSM, especially 
HIV positive MSM. However, the consistency of certain themes emerging across 
various populations, i.e., stigma and partner notification, suggest that this literature 
can nevertheless inform the research on partner notification among HIV positive 
MSM.  
1.9.3.2 Sexual partnership patterns and partner notification among MSM 
The sexual behaviour and partnership patterns of MSM are likely to influence 
partner notification for STI, and thus partner notification and STI control strategies 
in MSM should be informed by these factors. The outbreaks of syphilis in MSM 
have been linked to meeting sex partners via the internet, saunas, or bars (Ashton 
et al., 2003; Jebbari et al., 2011). A high proportion of MSM in the UK use the 
internet to meet sex partners via dating websites (Elford et al., 2004b; Bolding et 
al., 2005). HIV positive MSM are more likely to use chat rooms to meet sex 
partners than HIV negative and men who have not tested for HIV (Halkitis and 
Parsons, 2003; Bolding et al., 2005). HIV positive MSM use the internet to seek 
partners of same serostatus (Halkitis and Parsons, 2003; Bolding et al., 2005) and 
are more likely to report UAI with these partners (Elford et al., 2004b; Bolding et 
al., 2005). Gay men who seek sex partners via the internet are more likely to have 
had an STI compared to those who did not (Bolding et al., 2005). A syphilis 
outbreak among MSM in San Francisco was linked to internet use and a high 
proportion of partners of those diagnosed with syphilis were contactable only via 
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an internet email address (Levine et al., 2005; Hogben and Kachur, 2008). The 
internet has facilitated access to multiple sex partners and connected previously 
isolated sexual networks. These factors have generated interest in the use of 
internet based partner notification for STI among MSM (Levine et al., 2005; 
Hogben and Kachur, 2008).  
A needs assessment among MSM conducted in San Francisco, USA showed that 
men are usually willing to notify their primary partner for STI either themselves or 
via provider referral (Levine et al., 2008). However, they expressed preference for 
easy, convenient and anonymous way to notify casual partners. Studies conducted 
in the UK have shown that the existing partner notification methods described in 
section 1.9.3 were less effective for notification of casual and short term (< 7 days) 
partnerships (Bell et al., 1998). However, casual partnerships are more likely to 
contribute to the continued transmissions of STI (Tomnay et al., 2005; Lim et al., 
2008). Thus there is a need to develop partner notification methods that are 
effective for notification in casual partnerships.   
Given the multiplicity of sex partners among MSM, there is also a need to assess 
the uptake and effectiveness of partner notification methods like expedited partner 
therapy (EPT) where the patient diagnosed with an STI takes medication to deliver 
to the sex partner, and home sampling for specimens for STI testing that can 
reduce the time to testing and treatment of sex partners. The acceptability of EPT 
and home sampling for partner notification for STI has not been explored in MSM 
in the UK. There is also a growing interest in the role of new technologies like 
short messaging service (SMS) and email to enhance partner notification (Bell et 
al., 1998; Ashton et al., 2003; Singh et al., 2007; Jebbari et al., 2011). 
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The outcomes of partner notification for STI, for example, the number of partners 
tested or treated, are poor among MSM compared to heterosexual populations in 
the UK (van Duynhoven et al., 1998; Rogstad et al., 1999) as well as in other 
European countries (van Duynhoven et al., 1998; Rogstad et al., 1999). A study 
conducted in the USA indicates that although a significant proportion of MSM 
notified at least one partner for gonorrhoea and chlamydia, approximately 70% of 
exposed partners were not notified (Menza et al., 2008) limiting the effectiveness 
of partner notification to interrupt onward STI transmission. Similar observations 
were made in the UK during a syphilis outbreak where 64% of contacts were 
untraceable (Singh et al., 2007). The challenges related to untraceable partners 
among MSM (Engelgau et al., 1995; Rothenberg et al., 2000; Ogilvie et al., 2005) 
limits the effectiveness of partner notification as a STI control strategy. Thus there 
is also a need to develop new STI control strategies as well as prevention 
initiatives for MSM. In such situations, extended notification approaches like 
cluster investigations have been used in the USA (Engelgau et al., 1995; 
Rothenberg et al., 2000; Ogilvie et al., 2005), which has led to increase in the 
number of contacts identified during the syphilis outbreak (Ogilvie et al., 2005). 
Cluster investigation involves interviewing cases and their partners to trace the 
sexual and/or social contacts of cases as well as uninfected persons to elicit 
information about persons who may benefit from screening.  
Thereby in this thesis, I have examined whether the nature of sexual partnership 
patterns and sexual behaviour of HIV positive MSM influences their attitudes and 
willingness to notify partners for STI. I also investigated the willingness of HIV 
positive MSM to use various existing and new methods of partner notification, the 
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details of which are described in chapter 2 and the preferred methods of being 
notified for STI by sex partners.  
1.10 Research questions 
I have examined the following questions in this thesis: 
1.  What are the implications of sexual behaviour and sexual partnership 
patterns of HIV positive MSM for HIV transmission, STI transmission and 
acquisition, and partner notification for STI?  
2.  What are the views of HIV positive MSM towards cART for HIV 
prevention? How does the socio-cultural context of HIV/STI diagnosis, beliefs 
about the effectiveness of various biomedical and behavioural strategies for 
reducing the risk of HIV transmission influence and interact with sexual 
partnerships, sexual behaviour, and risk management choices among HIV positive 
MSM? 
3.  What are the factors associated with STI diagnosis and willingness to notify 
sexual partners of STI amongst HIV positive MSM?   
4.  What are the attitudes of HIV positive MSM towards partner notification for 
STI, and towards perceived and experienced barriers and facilitators for partner 
notification of STI? 
5.  What are the attitudes of HIV positive MSM towards notifying different 
types of sexual partners of STI and being notified of STI via various existing and 
new methods of partner notification in the future?  
1.11 Overview of the thesis 
I conducted the Sex, Health, Antiretroviral treatment and Partner Notification 
(SHARPN) project. I used mixed methodology, drawing from disciplines like 
behavioural sciences, social epidemiology and public health. This thesis comprises 
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of 7 other chapters summarised below. Details of the SHARPN project 
methodology are presented in the methods chapters, separately for quantitative and 
qualitative component of the study. The results of quantitative and qualitative 
analysis are presented in separate chapters. Each results chapter ends with a 
discussion of the findings in the context of existing literature and its implications 
for clinical practice, health policy and further research. The overall implications of 
the SHARPN study findings for clinical practice; health policy and research are 
presented in the final chapter 7 along with key recommendations. The contents of 
each of the remaining chapter are as follows: 
In chapter 2, I describe the details of the SHARPN project, i.e., the study design, 
development, and piloting of the study instruments, identification, and recruitment 
of the study participants and data collection, challenges and facilitators of the 
implementation of the study protocol. I also provide an overview of the measures 
taken in the study to ensure confidentiality and anonymity of the study participants, 
data management, and data analysis. 
In chapters 3 to 6, I present the results of the study. In chapter 3, I describe the 
response rate of the SHARPN survey and using the survey data, I describe the 
socio-demographic characteristics and HIV related health of the study population, 
their attitudes towards various risk-reduction strategies, and the sexual partnership 
patterns and networks, and sexual behaviour of HIV positive MSM with their 
primary partner, the most recent non-primary and new partners. I also describe the 
factors associated with risky sexual behaviours with a serodiscordant primary and 
the most recent serodiscordant non-primary partner.  
In chapter 4, I present the findings of the qualitative study on factors that influence 
the sexual partnerships, disclosure of HIV status within partnerships, and sexual 
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behaviour of HIV positive MSM; attitudes towards risk reduction strategies, 
namely cART and undetectable viral load for HIV prevention among these men 
and its relationship with their sexual behaviour and partnership patterns. 
In chapter 5, using the survey data, I describe the attitudes of HIV positive MSM 
towards partner notification for STI and previous experience of notification for 
STI. I describe STI testing and diagnosis among these men in the last year, 
examine the factors associated with STI diagnosis and lack of willingness to notify 
casual partners of STI, and willingness to notify sexual partners of STI in the 
future and use various traditional and novel methods of notification for STI. I also 
examine the willingness to be notified of STI by sexual partners and preferred 
methods for the same. 
In chapter 6, I present findings of the qualitative study on the attitudes of HIV 
positive MSM towards partner notification for STI, barriers and facilitators for 
willingness to notify different types of sexual partners of STI, willingness to use 
various methods of partner notification for STI, and experiences of notifying 
sexual partners of STI or being notified by sexual partners of STI. 
In the last chapter 7, I discuss the implications of the study findings for HIV/STI 
prevention interventions in HIV positive MSM, clinical practice, health policy and 
future research.  
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Chapter 2: SHARPN: methodology 
2. Introduction 
In this chapter, I first describe the methodology employed in the SHARPN project, 
the process of development, and validation of study instruments, data collection 
and ethics approval for the study. I then describe the details of data management 
and analysis, and discuss the facilitators and challenges to the implementation of 
the project.  
2.1 SHARPN study design 
A mixed methodology comprising a qualitative component (i.e. in-depth 
interviews) and a quantitative component (i.e., a cross-sectional survey) as shown 
in Figure 7 was used. The quantitative component of the SHARPN study was a 
repeat of the Sex, Health, Antiretroviral treatment Project (SHARP) survey 
conducted in 1999-2000. The SHARP survey was conducted to examine the 
association between cART and sexual behaviour among HIV positive MSM 
attending a specialist HIV clinic in central London, UK (Stephenson et al., 2003). 
Originally the focus of my thesis was to examine the changes between 1999-2000 
(i.e., the SHARP survey) and 2010 (i.e., the SHARPN survey) in the sexual 
behaviour of HIV positive MSM, and the association between cART status and 
sexual behaviour. However, in the context of the publication of the Swiss 
statement and the ensuing debates on cART for sexual HIV prevention, and 
observed increase in STI among HIV positive MSM in the UK, the focus of my 
thesis was modified. I have examined in greater detail the sexual behaviour and 
partnership patterns of HIV positive MSM, and the association between 
cART/viral load status, attitudes towards effectiveness of cART for HIV 
prevention and risky sexual behaviour using only the SHARPN survey data.  
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Figure 7. SHARPN study design  
 
 
A novel component on partner notification for STI was added to the SHARPN 
survey. The overall goal of the partner notification component of the SHARPN 
survey was to inform the development of strategies for partner notification for STI 
in HIV positive MSM. The methodology for the formative work on partner 
Study Site: HIV clinic, 
London, UK 
Quantitative study: cross-
sectional survey 
Piloting the survey  
(Dec 09-Jan10) 
-Cognitive interviewing techniques were 
used during face-to-face interviews 
(n=17) with HIV positive MSM attending 
the study site to pilot the 
comprehensibility and acceptability of the 
survey. 
-Survey was modified after cognitive 
interview and piloted as computer-
assisted self-interview (CASI) (n=14). 
Survey revision   
 (Jan/Feb 2010) 
- Based on the pilot interviews, the 
survey was revised.   
Survey  
 (May- Sep 2010)  
-Cross-sectional survey using CASI 
with HIV positive MSM (required 
sample size=411)  
Qualitative study: in-depth 
interviews 
Piloting the topic guide for         
in-depth interviews   
  (Feb-March 2010) 
-1 focus group discussion with HIV 
positive MSM was conducted to pilot 
the topic guide (n=7).  
-Pilot interviews to assess the 
acceptability of face-to-face, audio-
recorded interviews with me and 
acceptability and comprehensibility of 
topic guide were conducted (n=2) 
Topic guide revision    
(March 2010)     
- Based on the pilot interviews, the topic 
guide was revised.  
In-depth interviews 
 (May 2010-Feb 2011) 
-HIV positive MSM (required 
purposive sample=22-30)  
-Quota sampling was used to recruit 
participants (age, cART status, STI 
diagnosis in the last year were the key 
sampling criteria). 
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notification for STI among HIV positive MSM was informed by the Medical 
Research Council framework for developing and evaluating complex interventions 
(Campbell et al., 2000; Craig et al., 2008). This framework emphasises the 
iterative process involved in identifying the available evidence about the 
intervention and delineating appropriate theory of change, modelling the process 
and outcomes of the intervention, leading to testing the intervention through pilot 
studies to assess feasibility and acceptability prior to conducting an exploratory or 
definitive trial (Craig et al., 2008). Therefore, I conducted a systematic review of 
existing qualitative literature on the attitudes, barriers, experiences and preferences 
regarding partner notification for STI, which was described in section 1.9.3.1 
(Appendix 1). I contacted researchers to identify existing partner notification 
methods being used or developed in the UK and other countries like USA, 
Australia, particularly among MSM. The partner notification component of the 
survey was designed to examine the acceptability of partner notification for STI 
among HIV positive MSM and their willingness to use various existing and new 
methods of partner notification for STI in the future. Further details are described 
in section 2.5.1.3. 
HIV research has shown that it is not only important to understand the prevalence 
of risky behaviours but also understand the contextual factors within which risk 
occurs, and the meanings of the phenomenon observed (Martin, 2006). A 
qualitative study was conducted as part of the SHARPN project to gain insights 
into the context, the personal as well as structural factors and the meanings of the 
phenomenon being investigated. 
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In the following section, I present the details of the SHARPN study design and 
how these above-mentioned factors guided the process of study design and 
implementation.  
2.2 Study setting 
The SHARPN study was conducted in the same specialist HIV clinic in central 
London, UK where the SHARP study was previously conducted. When the 
SHARPN study was being designed, 13,226 of the 27,699 MSM accessing care for 
HIV in the UK were residing in London (Health Protection Agency, 2010). 
Approximately 3600 HIV positive patients were accessing HIV care in the study 
clinic and the majority of them were MSM (personal communication from the 
clinic’s Lead HIV Clinician, September 2009).  
2.3 Study population and eligibility criteria 
Eligible participants for both, the quantitative and qualitative component of the 
study, were HIV positive MSM, aged 18 and above who were registered with and 
attending the study clinic. Men for whom the probable route of HIV acquisition 
was marked as homosexual in the clinic records were categorised as MSM for the 
study purposes. Patients attending the clinic due to health-related emergency or ill 
health (as determined by the clinic staff) were ineligible to participate in the study. 
Patients who were either unable to read and write in English, or who could not use 
computers and the internet were also ineligible to participate in the quantitative 
component of the study.  
2.4 Ethical approval 
The SHARPN study was approved by the East London and the City Research 
Ethics Committee 1 and the reference number of the SHARPN study is 
09/H0703/120 (Appendix 2). The study was also approved by the Research and 
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Development department of the Camden National Health Services (NHS) Primary 
Care Trust (Appendix 3). 
2.5 Quantitative survey 
A single-site, cross-sectional survey among HIV positive MSM attending a 
specialist HIV clinic in central London was conducted. The following section 
describes the details of the development of the survey and administration.     
2.5.1 Development of the SHARPN survey 
One of the key aims of conducting the SHARPN project was to enable comparison 
of the changes in the sexual partnership patterns and behaviour of HIV positive 
MSM and examine the change in the relationship between cART status, viral load 
status, and sexual behaviour between the SHARP and the SHARPN surveys. Thus, 
SHARPN survey was largely a repeat of the SHARP survey. However, some new 
questions were added to the SHARPN survey to integrate developments since 
1999 in the understanding of the sexual behaviour and HIV/STI transmission 
dynamics in MSM, and the role of sexual networks and mixing on HIV/STI 
transmission as described in chapter 1. To enable the addition of new questions 
described in section 2.5.1.2, a section on mental health included in the SHARP 
survey was removed.  
I consulted local stakeholders such as the study clinic’s HIV clinicians and patient 
representatives of the HIV positive patients’ network during the process of survey 
development. I set up a research advisory committee comprising two HIV 
clinicians (Dr Simon Edwards and Dr John Richens), a health advisor (Mathias 
Chopin), a statistician (Dr Catherine Mercer), and my PhD supervisors Professor 
Graham Hart, Professor Jackie Cassell and myself. The research advisory 
committee members gave feedback during the process of survey development. The 
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patient representatives gave feedback on the acceptability of the terminology used 
in the survey. 
2.5.1.1 Areas of interest for which data was collected in both SHARP and 
SHARPN survey 
The survey (Appendix 4) comprised the following sections:  
1.  Socio-demographic details: age, first language, ethnicity, place of birth, 
residency in London, employment status, annual income, social welfare benefits, 
educational status, accommodation ownership, living arrangements. 
2.  General health and HIV diagnosis: overall self-assessed general health, year 
of HIV diagnosis. 
3.  Sexuality and sexual practices with a primary partner: sexual orientation, 
details of age at first sex, currently has a primary partner (i.e. men were asked if 
they had a sex partner who they consider to be their boyfriend/lover). Data was 
collected on age and HIV status of primary partner, disclosure of HIV status to 
primary partner, when started relationship with primary partner, overall condom 
use with primary partner during anal intercourse (AI) in the last six months 
(questions on condom use with primary partner were modified and some new 
questions were added, the details are explained in the section 2.5.1.2), and types of 
sexual partners in the last six months.  
4.  Sexual behaviour with new partners: men were also asked about their sexual 
behaviour with new partners (i.e., sex partners with whom men had had sex for the 
first time in last month or last year). The data on sexual behaviour with new 
partners was collected on an aggregate basis (i.e., ‘in the last month, did you have 
insertive or receptive anal intercourse (fucking) with your new partners?’). Men 
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were asked about the total number of new AI partners, type of anal sex, HIV status 
of new partners (questions on HIV status of new partners were modified).  
5.  HIV and health service use and treatments: ever diagnosis with AIDS, self-
reported recent CD4 cell count and viral load test results and self-reported changes 
in these in the last 12 months, cART status (ever and current), year of starting 
cART and details of current regimen, experience of sexual difficulties in last 12 
months, attitudes towards HIV medication. 
6.  Sexual behaviour with three recent sexual partners: men were asked on a 
partner-by-partner basis about their sexual behaviour with the three last persons 
with whom they had sex prior to their participation in the SHARPN survey. They 
were asked when they last had sex with each of these 3 recent sex partners, 
whether this was on a one-to-one basis or in a group-sex situation, type of sexual 
partner (i.e., primary partner, regular partner, casual partner, commercial sex 
partner, other), disclosure of HIV status to the partner, timing of disclosure, 
perception or knowledge of HIV status of partner and reasons for the same, place 
met and had sex with the partner, type of sex, recreational drug use and type of 
drug use, rating of quality of sex. Men who had engaged in group sex were asked 
about their sexual behaviour with a ‘main’ partner during group sex. 
7.  Peer and community: support to discuss about sex and relationship issues, 
HIV positive gay friends network, use of services for HIV positive gay men, 
perceptions of HIV positive gay friends’ sexual behaviour, membership of gay 
organisations, perceptions of their gay friends’ attitudes towards their sexual 
behaviour. 
8.  Attitudes towards risk reduction strategies and personal responsibility: HIV 
treatment optimism, i.e., attitudes towards HIV and its effects on health and sexual 
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life in the context of availability and effectiveness of cART; attitudes towards 
cART, viral load and sexual behaviour; and attitudes towards personal 
responsibility, HIV, safer sex.  
2.5.1.2 New questions added to the SHARPN survey 
In the SHARPN survey, new questions on areas of interest were added. The 
overall rationale for addition of new questions on sexual behaviour was: 
  To examine in greater detail the use of various risk reductions strategies 
(strategic positioning, serosorting, anal intercourse (AI) with or without 
withdrawal prior to ejaculation) by HIV positive MSM with different types of 
sexual partners and to understand participants’ knowledge of the HIV status of 
their sexual partners.  
  To examine the age and ethnic sexual mixing patterns among these men 
with different types of sexual partners. 
  To enable modelling the implications of the sexual behaviour, partnership 
patterns and sexual networks of HIV positive MSM for onward HIV transmission 
in the context of their cART and viral load status. 
New questions on the following areas of interest were added: 
  Sexuality and sexual practices with primary and new partners: ethnicity 
of the primary partner, civil partnership with primary partner, most recent sex with 
primary partner, year of HIV diagnosis of primary partner if positive, details of 
condom use or non-use in the last six months during both, insertive and receptive 
AI with primary partner and type of insertive and receptive AI, i.e., with or 
without withdrawal prior to ejaculation, total number of episodes of each type of 
AI, other types of sexual practices with primary partner including engagement 
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together in group sex, beliefs about primary partner’s concurrent sexual partners.  
With regards to sexual behaviour with new partners, questions on venues for 
meeting new partners in last six months, engagement and frequency of group sex, 
number of anonymous sexual partners in the last 12 months, type of AI, i.e., with 
or without withdrawal prior to ejaculation, number of known, assumed and 
unknown status new insertive and receptive AI partners.  
  HIV and health service use and treatments: meaning of undetectable viral 
load, testing and details of viral resistance test, drug holiday (reasons and period).  
  Attitudes towards risk reduction strategies: HIV transmission risks 
associated with various risk reduction strategies (i.e., engagement in withdrawal 
prior to ejaculation during anal sex, strategic positioning, and ejaculation during 
oral sex). 
  Partner notification: as mentioned earlier, partner notification for STI was 
not explored in the SHARP survey; therefore, a new section on partner notification 
was also added. The details are described in the following section. 
2.5.1.3 Development of the questions for the component on partner 
notification for STI 
The systematic review of qualitative literature on partner notification described in 
chapter 1 suggests that despite willingness to notify sexual partners for STI and 
acknowledgment of its health benefits, the stigma associated with STI, fear of 
blame and concerns of confidentiality ensuing due to this stigma, gender, race and 
the nature of sexual partnership are key barriers to partner notification. Therefore, 
in the SHARPN survey I included new questions on attitudes towards partner 
notification for STI/HIV, previous experience of ever notifying partners for 
81 
 
STI/HIV or being advised to notify partners, negative experiences of notification 
and perceived barriers and self-efficacy to notify partners of STI.  
One of the aims of the SHARPN survey was to assess the acceptability of existing 
as well as new strategies of partner notification for STI among HIV positive MSM. 
The acceptability of following new methods of partner notification for STI was 
examined: 
1. Accelerated partner therapy (APT): I was informed by Dr Escourt from the 
Barts and the London School of Medicine and Dentistry that she was conducting a 
pilot study among predominantly heterosexual population examining the 
acceptability of APT for STI like chlamydia and gonorrhoea (Sutcliffe et al., 2009; 
Estcourt et al., 2012). The key focus of APT is to reduce the time to treatment of 
sex partners and provide remote or face-to-face partner assessment by an 
appropriately qualified healthcare professional. One of the methods of APT that 
was being piloted was a ‘telephone assessment model’. As per this model, the 
contacts are assessed by a health care professional via telephone using a standard 
consultation guide following which the partner can collect a treatment pack from 
the clinic reception or have it delivered to them by the index patient. This is a 
modified version of patient delivered partner therapy (PDPT). PDPT is used in the 
USA where the index case is given medication to hand it to their sexual partners 
without prior medical assessment of their partners by a healthcare professional 
(Golden et al., 2005; Kissinger et al., 2005). Given the multiple sexual partnerships 
among MSM, it is vital to treat the index patients diagnosed with STI and reduce 
the time to treatment of their sexual partners to prevent the risk of re-infection to 
the index case and prevent onward transmission. Thus, in the SHARPN survey I 
examined the acceptability of the telephone assessment model.  
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2. Anonymous e-card: as mentioned in chapter 1, there is a growing interest in 
using the internet for partner notification in MSM as it is one of the key modes of 
meeting sexual partners among MSM. Participants were asked about their 
willingness to notify sexual partners of STI via an anonymous e-card, i.e., sending 
notification to sexual partners anonymously via a clinic website using tailored e-
cards, if such a service was provided by the clinic.  
3. Home sampling kits for specimen-collection: a study conducted among MSM in 
the UK has shown that 76% MSM were willing to use a home self-sampling kit to 
collect rectal and pharyngeal specimens using swabs (Wayal et al., 2009). In the 
SHARPN survey, I examined men’s willingness to take a home sampling kit for 
their sex partners to enable home sampling for specimens and returning these kits 
to the clinic for testing.  
Accordingly, I developed questions to examine the willingness of HIV positive 
MSM to notify different types of sexual partners and use different types of existing 
and new notification methods in the future. For example, men were asked: 
“Assume that you are diagnosed with STI and you have a primary partner. Please 
read each of the following options to inform him that he should get tested for STI. 
Let us know how likely are you to use EACH of the following options”. 
Participants were asked to rate the likelihood of using these methods using a Likert 
rating scale of 1-5, with 1 indicating very likely and 5 indicating very unlikely: 
i. Not contact my primary partner 
ii. I would inform him face-to-face 
iii. I would email him from my personal account 
iv. I would call him 
v. I would text him 
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vi. I would ask a clinic staff/health advisor to contact him without giving my name 
vii. I would ask a clinic staff/health advisor to contact him and give my name 
viii. I would send him an anonymous e-card (if such a service of e-cards without 
giving my name is provided by the clinic) 
ix. I would take a home sampling kit (if the clinic provides home sampling kit so 
my partner can take his samples at home and return samples to the clinic for 
testing 
x. I would ask clinic staff to do a telephone assessment of my partner while I am 
at the clinic and take his medication with me 
I also asked men about willingness to refer members of their social network (not 
necessarily sexual partners but friends) to screen for STI, and willingness to be 
contacted by the clinic to inform them to test for STI in the event of an STI 
outbreak. 
2.5.1.4 Validated question from other surveys 
When adding new questions to the SHARPN survey, where possible, attempts 
were made to use validated questions from other surveys specified below. Apart 
from the questionnaire of the Futures Five Study, which is available online, I had 
contacted the researchers to obtain copies of the following questionnaires:  
  Futures Five Study, a national survey of people living with HIV/AIDS, 2005 
Australia (Grierson et al., 2006): questions on risk reduction strategies;  
  Positive Health Study, 2005 Australia (Rawstorne et al., 2005; Zablotska et 
al., 2009): questions on knowledge of HIV status of new sex partners;  
  Partner Notification Study, 2008 UK (Woodward et al., 2010): questions on 
referring members of social network for STI screening; 
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I piloted all the new and modified questions using cognitive interviewing methods 
in a sample of eligible participants to determine the acceptability and 
comprehension. Participants’ whose first language was not English were 
purposively selected for these interviews. The details of pilot phase are described 
in section 2.5.4.  
2.5.1.5 Improving validity and reliability of the survey data 
Participants’ sexual behaviour and practices were measured through self-report 
and no specimens were collected for STI testing, a biological marker of risky sex 
behaviour. Various socio-cultural factors like stigma, taboos surrounding sexuality 
and fear of criminalisation for intentional transmission of HIV can affect the 
reporting of sexual behaviour and practices. Therefore, self-administration of the 
survey was considered optimal to ensure privacy for the study participants, reduce 
the reporting bias likely to be introduced by an interviewer-administered survey 
and improve reliability of the data.  
A key challenge in determining the validity of self-reported sexual behaviour data 
is the lack of availability of gold standard to compare this data to. A review of 
studies comparing computer assisted self-interview (CASI) with face-to-face 
interviews in STI clinics reported that CASI identified risky sexual behaviour 
more commonly than clinician interviews and was acceptable to participants as 
they felt it allowed honest reporting (Fairley et al., 2010; Richens et al., 2010). 
Thus, the SHARPN survey was administered using CASI and further details are 
described below in section 2.5.2. Internal consistency checks were developed in 
the questionnaire to determine the reliability of behavioural data reported by the 
participants. For example, data was collected on participants’ sexual behaviour 
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with new partners for varying timelines (one month and 12 months). These data 
were examined to assess internal consistency in reporting of sexual behaviours.  
2.5.1.6 Self-reported clinical data 
In the SHARP survey, data on clinical measures such as STI, recent plasma viral 
load and CD4 cell count test results, and current cART regimen, were collected 
from participants’ clinic records. However, in the SHARPN survey these data were 
collected anonymously through self-report to ensure anonymity of study 
participants and improve accuracy in reporting of the sexual behaviour data. 
Laboratory tests for these clinical measures are expensive and it was not feasible to 
conduct these tests for this project because SHARPN was a low budget project.  
Previous research has shown that self-reported CD4 cell count test results are 
reliable (Cunningham et al., 1997; Kalichman et al., 2000). While the reliability of 
self-reported plasma viral load is reported to be less accurate, it is most reliable 
when dichotomised into clinically relevant diagnostic categories as ‘undetectable’ 
and ‘detectable’ (Kalichman et al., 2000). These studies also indicate that self-
reported data on clinical measures like plasma viral load and CD4 cell count test 
results are likely to introduce optimistic bias, i.e., reporting of values depicting 
better health. Therefore, the following measures were taken to improve the 
reliability and validity of these self-reported clinical data. In order to improve the 
reliability of the data collected, the response options were presented in clinically 
relevant diagnostic categories of recent CD4 cell counts and recent plasma viral 
load. Participants were not expected to remember the ‘exact’ values of their recent 
test results, as was the case in both the above reported studies. In addition, to avoid 
misclassification bias, the response option of ‘don’t know/don’t remember’ was 
included so the participants did not feel obliged to randomly select a response 
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option if they did not remember their results. Since HIV positive patients 
registered at and attending the study setting are monitored for their CD4 cell 
counts and plasma viral load at least every 4 months (personal communication 
with clinic’s lead consultant), the probability of recall bias is likely to be minimal. 
To improve the reliability of response to the question on cART regimen, response 
options provided the class of the HIV drug as well as the brand names of the drugs. 
Given the high prevalence of STI among MSM, it was anticipated that they would 
be able to recall being diagnosed with STI in the last year. The survey was piloted 
to determine the feasibility of collecting these data through self-report and pilot 
results are presented in section 2.5.4.  
2.5.2 Survey design and administration 
The SHARPN survey questionnaire was developed in English, as the majority of 
the clinic’s population are able to communicate in English. However, a significant 
proportion of the clinic population’s first language is not English (personal 
communication with clinic staff). Therefore, in order to ensure clarity and 
accuracy in data collection, definitions of concepts/medical terms used in the 
questions were provided. This sometimes made the questions lengthy but was 
considered important to ensure that participants understood and interpreted the 
questions as intended. The majority of the questions were closed-ended with 
multiple choice response options. However, for questions on topics with limited 
existing literature, particularly questions related to partner notification, an 
additional open-ended response option was provided. Participants’ attitudes 
towards factors being investigated were explored using five-point Likert rating 
scales and if needed, additional options of ‘don’t know’, ‘declined to answer’ and 
‘not applicable’ were provided.  
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The 1999 SHARP survey was administered via computer tablets using 
Questionnaire Development System software (personal communication with Dr 
John Imrie who led the study). The SHARPN survey was administered via a web 
interface using Opinio software. Opinio is a web-based survey tool that allows 
creating and distributing surveys. Since the Internet is commonly used by HIV 
positive MSM in the UK to meet sexual partners (Bolding et al., 2005, 2007), it 
was anticipated that the majority of the eligible population would be familiar with 
using computers and the Internet. Using survey development software and CASI 
enabled skipping questions, i.e., depending on the participant’s response, ‘not 
applicable’ questions were skipped automatically and they were directed to 
appropriate questions depending on their response to the branching questions. This 
saved a considerable amount of time for the participant, which would otherwise be 
wasted trying to skip to next appropriate question if a pen and paper were used to 
administer the survey.   
The web interface of Opinio also meant the SHARPN survey could be 
administered from any computer with access to the Internet. The data were stored 
on a secure University College London (UCL) server. Once the web link for the 
survey was clicked, the survey opened in a separate window and the participant 
was automatically allocated a random study number. A percentage bar at the 
bottom of the survey page enabled the respondents to see what proportion of the 
survey was completed. The first page of the survey explained the survey rationale 
and the process of completing the online survey. The anonymity and 
confidentiality of the survey process was emphasised at this stage. The feasibility 
of administering the survey online was piloted, and the details of the pilot study 
are presented in section 2.5.4.2. 
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2.5.3 Identification and recruitment of participants for the 
SHARPN survey 
At the time of the survey, the study clinic was split between three floors. Regular 
blood test units and pharmacy for cART were located in the basement, the 
consultation rooms for pre-booked clinic appointments were located on the ground 
and the first floor and on-call/drop-in appointment rooms and STI screening was 
done on the ground floor. Prior to developing the study protocol, I had several 
meetings with the clinic staff to understand the clinic’s operating system. This 
enabled the development of a cost-effective recruitment and monitoring strategy 
for the study focusing on minimising the burden for the clinic staff. I was informed 
that registered HIV positive patients access the clinic for booked appointments or 
they access walk-in service for various reasons like STI screening, picking up HIV 
medication, regular blood tests for plasma viral load and CD4 cell count. Most 
HIV positive patients attend the clinic at regular intervals: every 3-4 months or as 
advised by their clinician or to provide blood samples or to collect their HIV 
medication. On these occasions, they interact with the nurses or phlebotomists who 
identified the eligible patients for the study and introduced them to me. The 
method of identification and recruitment of the participants was modified based on 
the pilot results and these changes are described in section 2.5.4.3. There were 
electronic display boards in the waiting areas on all the clinic floors. These display 
boards were used to disseminate the study information (Appendix 5). The study 
information sheets were put up in every consultation room in the clinic and in 
waiting rooms on every floor of the clinic.  
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2.5.4 Piloting the SHARPN survey 
The SHARPN survey was piloted in the following stages: 
2.5.4.1 Cognitive interviews 
All the new and modified questions were piloted prior to the survey. The first stage 
involved using cognitive interviewing methods (Willis, 2005) with an aim to 
understand participants’ interpretation of terminology used in the questions, 
comprehension of the questions and their ability to respond to the questions, i.e., 
memory retrieval and decision-making processes to derive their responses. I 
conducted face-to-face interviews with 17 purposively selected participants, 
identified as described in section 2.5.3, from January 2010-February 2010. A 
participant information sheet (Appendix 6) and a consent form (Appendix 7) for 
the cognitive interviews were used to obtain written informed consent of the 
participants. Purposive sampling was used to ensure that the pilot sample reflected 
the population eligible for the study and variation in age and language (not have 
English as a first language but are able to read and write in English). The latter was 
considered important because, as mentioned previously in section 2.5.3, I was 
informed that a significant proportion of the clinic’s population’s first language is 
not English.  
Of the 17 participants selected for cognitive interviews, 7 participants’ first 
language was not English, 4 were aged <30 years, 5 between 30-40 years, 8 
were >40 years. I took the participants to a quiet room in the clinic allocated for 
the study. Respondents were given a paper copy of the new questions that were 
included in the survey. They were asked to read approximately 10 questions at a 
time and highlight the questions they did not understand or had difficulty 
responding to. A combination of think-aloud technique (asking participants to say 
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their thoughts out loud while responding to the questions) and verbal probing 
techniques (such as asking participants to paraphrase the question in their own 
words and asking them to explain their interpretation of the question) were used 
during the interview. I used pen and paper to document bodily gestures, thinking 
aloud process and discussion during the interviews. This process helped me 
evaluate whether the participants understood and interpreted the questions as 
intended and their ability to respond to the questions.  
Some questions involved a long recall period, for example, questions on sexual 
behaviour in the year prior to the survey were asked. Thus, the feasibility of 
responding to such questions accurately was also examined during the cognitive 
interviews. Participants were also able to recall information related to their first 
sexual experience, and information on sexual partners they had had in the last 
month and last year. Most participants were able to recall information on their 
three most recent sexual partnerships; however, participants with sexual 
encounters five or more years ago struggled to recollect specific information about 
their sexual encounters. Participants were able to understand statements used to 
measure attitudes towards various factors, for example, implications of cART and 
viral load for prevention of HIV transmission. Participants were able to provide 
data on clinical measures like recent plasma viral load test result, recent CD4 cell 
count test results, their current HIV medication regimen, and recent STI diagnosis. 
Some participants had the ‘exact’ values of their recent CD4 cell count and plasma 
viral load test results written on a clinic appointment card, which they had kept in 
their wallet and referred to while responding to these questions. The majority of 
participants were also able to recall the name of their cART medications or had 
91 
 
them written on a clinic appointment card. A few men also had a list of their 
sexual partners written in a small pocket diary. 
The survey was modified based on the results of the cognitive interviews. Where 
needed further explanations of the terms/concepts used were added. For questions 
on the 3 most recent sexual partners, a skip was introduced for the questions on 
sexual behaviour and practices if the participants’ last sexual encounter was more 
than 5 years ago. Some men who were newly diagnosed with HIV had participated 
in the pilot due to which it was evident that there was a need to add a question on 
participant’s HIV status at the time of previous sexual encounters. 
2.5.4.2 Piloting the survey using CASI 
The next pilot phase involved administering the entire survey using a CASI. 
Following the cognitive interviews, the modified survey was set up online using 
the Opinio software as described previously in section 2.5.2. Another 14 
participants were identified as described in section 2.5.3 and recruited to the pilot. 
I took the participants to a quiet separate room in the clinic allocated for the study, 
which had a computer with Internet access. I provided them with a patient 
information sheet for the survey (appendix 8) and a consent form (appendix 9) and 
sought their written informed consent. Participants then completed the online 
survey. On average, as anticipated, participants took 30 minutes (range 25-55 
minutes) to complete the survey online. Pilot data were exported from Opinio and 
difficulties with data transfer were identified and resolved at this stage. During the 
online pilot following other issues also emerged: 
  Some participants suggested that they would be more comfortable if their 
regular clinician informed them about the study.  
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  I had to continually remind the nurses to recruit patients to the CASI pilot. 
The nurses expressed the need for some visual aid to prompt them to recruit 
patients to the study.  
  Occasionally, the clinic was busy and the room allocated for the study had 
to be used for regular clinic purposes.  
  Since a single room was allocated for the study, if more than one person 
agreed to participate in the pilot at the same time they had to wait. This led to 
some men declining to participate and was identified as a potential challenge to 
future participation rate and response bias. 
  The fluctuation in the clinic’s Internet speed and problems with the Internet 
connection (i.e., connection being slow or down) affected completion time of the 
online survey. Participants felt frustrated if the percentage bar on the survey page 
indicated that they had completed most of the survey but they could not save it 
because the connection was slow. 
  Some patients were willing to complete the online survey but did not have 
the time to do so during their current clinic visit.  
  Several participants were reluctant to provide written signed consent. The 
main reason for reluctance was concern about confidentiality of their HIV status. 
Patients felt that if the survey was anonymous, they should not be expected to 
write their name on the consent forms. Despite assurance that the consent forms 
were unlinked to the survey and stored in a secure manner, their fears remained 
unresolved.  
In the following section, I describe the changes made to the participant 
identification and recruitment strategy for the survey after the pilot interviews. 
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2.5.4.3 Modification of the survey protocol based on pilot results 
Based on the pilot interviews, the strategy used to identify and recruit participants 
to the survey was modified and is presented in Figure 8. The following changes 
were made as a result of the participants’ feedback: 
  The study protocol was amended to indicate that participation in the survey 
and its completion would be considered as an indication of implicit consent. Thus 
the participants were no longer required to provide written informed consent. The 
survey patient information sheet was modified to reflect this change (Appendix 
10). 
  During the pilot, some participants had expressed a preference to be 
recruited to the study by their clinicians. On average, approximately 60-80 patients 
have pre-booked appointments with the clinic doctors. Therefore, the protocol was 
amended to enable participants to be recruited with the help of clinicians, in 
addition to recruitment with the help of nurses and phlebotomy staff.  
 The clinic’s administration staff routinely attaches follow-up sheets to the 
patient’s clinic notes prior to appointment. In order to remind the clinic staff to 
recruit patients for the survey, a patient information sheet and a study sheet 
(Appendix 11) were attached to the patients’ notes with the help of the 
administration staff. The study sheet provided details of the eligibility criteria for 
the survey and researcher’s contact details, and enabled documentation of 
recruitment rate (i.e., whether the clinicians invited the patients to participate in the 
SHARPN project) and the participants’ response rate.  
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 The clinicians were asked to record whether they invited their patients to 
participate in the study or they considered the patient ineligible to participate in the 
study and the reasons for their decision.  
  If patients agreed to participate in the study, the clinic staff introduced them 
to me. I took the participants to the study room and logged them on to a computer 
in the study room where they completed the survey.  
  If patients felt unable to complete the survey in the clinic, they were offered 
the option to do so from home if they had access to a computer and Internet. In this 
case, patients were asked by the clinic staff to write their email address on the 
study sheet. These participants were emailed a survey link via Opinio. This 
approach offered participants flexibility to complete the survey in their own time 
and preferred setting. The survey was set-up to ensure anonymity. Although 
Opinio was used to send survey links using the email address of the participants, 
their responses were unlinked to their email address. The participants had the 
choice to save the survey at any point and complete it at a later stage. Information 
about what the participants could do if they wanted to stop halfway through the 
survey and return to it at a later stage and guidance on what to do when they 
completed the survey was provided at the beginning of the survey. 
 Participants who opted to complete the survey at home were sent two 
automatic reminders via Opinio to complete the survey. The first reminder was 
sent at the end of a week from the date of their recruitment to the study, and a 
second reminder was sent a week after that. A third and final reminder was 
emailed to all the participants prior to stopping the survey, irrespective of whether 
or not they had responded to the survey due to the anonymity of the participants. 
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Figure 8. Recruitment strategy for the SHARPN survey 
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 A survey patient information sheet and study sheet was also attached to the 
blank sexual health proforma used for sexual history taking by the clinic staff who 
conducted sexual health screens to act as a reminder to recruit the patients to the 
study.  
2.5.5 Monitoring and recruitment 
The administration staff put patient stickers containing patients’ clinic number on 
the study sheets to enable documentation of the decliner rate and avoid 
approaching the same patient twice (this was likely because the same patient could 
attend the clinic more than once during the study period). A study folder was kept 
in every consultation room and nurses’ station and the clinic staff deposited the 
study sheets in these folders. I collected these study sheets at the end of each day 
and sent the survey weblink via an email invitation to all the patients who had 
expressed a preference to complete the survey at home.  
I maintained a record of the clinic number of patients who had declined to 
participate in the survey. Their notes were flagged as ‘decliners of SHARPN’ by 
the clinic’s administration staff to avoid approaching them again for recruitment in 
the study. I also maintained a record of the clinic numbers of the participants who 
had agreed to participate in the survey and their notes were flagged as ‘recruited to 
SHARPN’. The data from the study sheets were used to estimate recruitment rate 
and participation rate. Opinio enabled estimation of the response rate among 
participants who had agreed to complete the survey from home.  
2.5.6 Data protection and confidentiality 
All consent forms of the pilot interviews were stored in a locked cabinet in my 
office. The pilot interview participants’ names and identifiable data were recorded 
only on their consent form. There was no documentation of the link between the 
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participants’ names and their pilot interview data to ensure participants’ 
confidentiality. The email addresses of the participants who wanted to complete 
the survey online in their own time were maintained in a password protected file 
on my password protected UCL computer. These data were not stored on memory 
sticks. Similarly, data collected via the online survey was stored on a secure UCL 
server. Once the data collection for the survey was over, the electronic data from 
Opinio was transferred to STATA and the file was stored in a password-protected 
computer in my office. 
2.5.7 Challenges and facilitators to recruitment to the survey  
The recruitment to the survey was not without its challenges. The key challenge 
was identifying and recruiting participants to the study. I had to rely on the clinic 
staff to identify and recruit participants to the study to ensure patient 
confidentiality. As there was no budget beyond my salary, no research nurse or 
member of clinic staff was specifically allocated to recruit patients for the 
SHARPN study. Therefore I had to remind the clinic staff on a daily basis to 
recruit patients to the study. I had to be physically present in the clinic every day 
during clinic hours to encourage the clinic staff to recruit patients. The recruitment 
rate dropped on days I was not present in the clinic. This made the recruitment 
process laborious for me and slowed down the qualitative study, as I did not have 
time to conduct face-to-face interviews during the survey. The other challenge was 
the Internet system in the clinic being extremely slow and affecting the speed of 
survey completion.  
However, the pilot phase was extremely important in flagging challenges to 
recruitment to the survey and consent procedures. The substantial modifications to 
the study protocol, described in section 2.5.4.3, facilitated recruitment and 
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improved participant response rate due to the flexibility to complete the survey at 
home. This also minimised the impact of the problems created due to the clinic’s 
slow internet system. As the study progressed, I developed a good rapport with the 
clinic staff and the clinic staff was familiarised with the study, which enhanced 
recruitment. I kept the clinic staff informed about the study recruitment by 
attending regular clinic meetings, sending monthly email updates on the study 
recruitment and sent email reminders to the clinicians’ to recruit patients for the 
study. I made presentations at various clinic staff meetings to keep them informed 
about the recruitment and any challenges, and also to seek their feedback. The lead 
consultant of the clinic, Dr Simon Edwards provided tremendous support and 
advice to improve recruitment rates.  
2.5.8 Sample size calculation for the SHARPN survey 
As mentioned previously in section 2.1, change over time in sexual behaviour in 
HIV positive MSM is not the focus of this thesis. However, the sample size 
calculation for the SHARPN survey was guided by the aim to enable comparison 
with the SHARP survey to examine changes in the sexual behaviour of HIV 
positive MSM, and the association between cART, viral load, and sexual 
behaviour. 
For the 1999 SHARP survey, 422 HIV positive MSM were recruited over a period 
of one year. It was anticipated that for the SHARPN survey 370 participants would 
provide 80% power to detect a statistically significant (p<0.05) increase of 
approximately 10.5% in the reporting of UAI during the last year compared to the 
SHARP survey in which the prevalence of UAI with one or more new partners in 
the last year was 39% (Stephenson et al., 2003). Therefore it was anticipated that 
the UAI with new partners in the last year would have increased from 39% in 1999 
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to approximately 49.5% in 2010. An increase of this magnitude in the practice of 
UAI in the last year was estimated based on the observed increase in UAI in the 
last year among HIV positive MSM in the gay men’s sexual health survey 
(GMSHS) conducted annually in London from 1996-2008 (Wayal et al., 2008). 
The GMSHS report indicates that the proportion of HIV positive MSM reporting 
UAI in the last year has fluctuated between 1996-2008; however there has been an 
overall increase of 10% since 2000 (49.6%-58%; p=0.006).  
The proposed sample size of 370 was expected to provide 80% power to detect a 
significant association in the SHARPN data alone between a binary risk factor (of 
approximately 50% prevalence) and UAI, where the strength of association is an 
odds ratio of 1.83 (prevalence 57.5% with risk factor, 42.5% without, i.e., a 
difference of 15% with an overall prevalence of UAI being 50%). cART and viral 
load status are the key exposure variables in the comparative analysis of the 
surveys, and the proportion of patients on cART was estimated to be around 80% 
(personal communication with the HIV clinicians). This sample size would 
provide more than 80% power to detect a difference of 20% in the prevalence of 
UAI between those receiving cART and have an undetectable viral load (54%) and 
those not receiving cART or have a detectable viral load (34%). It was estimated 
that at least 50% of the participants would opt to complete the survey from home 
in their own time. A dropout rate of 20% was anticipated, i.e., non-completion of 
the survey by those opting to do it at home. After taking into consideration the 
drop out rate, the recruitment of a total of 411 participants was considered 
necessary to achieve the required sample of 370 participants.  
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2.5.9 Data management and analysis 
In the following section, I describe the details of management and analysis of the 
survey data.  
2.5.9.1 Data Preparation  
The SHARPN survey data was imported from Opinio into Excel and then 
transferred to STATA 11.0 (Stata Corporation, College Station, Texas, USA).  The 
data imported from Opinio was in a non-numerical format (string format). To 
enable data analysis in STATA, I converted the entire dataset to numerical format 
and compiled a codebook of all the variables with variable names and variable 
labels.  
2.5.9.2 Data Checking 
The dataset was checked for range and consistency in the participants’ responses. 
The distribution of each variable used in the analysis was examined for errors and 
consistency. Categorical variables were checked for values beyond those pre-
specified in the survey by examining tabulations and cross-tabulations of variables 
and missing data were identified. For numerical variables, range checks using 
histograms were conducted to identify outliers, if any, to examine the distribution 
of the variable (i.e. normal or skewed), and identify missing data.  
2.5.9.3 Derived responses and item non-response  
Where possible, data was deduced depending on the nature of the question. For 
example, for men who reported not having anal sex in the last year, the number of 
anal sex partners in the last year was coded as ‘0’. Men were asked to rate their 
willingness for using various partner notification methods in the future on a Likert 
scale of 1-5, with 1 indicating ‘highly likely’ to 5 indicating ‘highly unlikely’. If 
men had expressed unwillingness to notify any of their sexual partners in the 
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future, then their response were coded as 5, indicating ‘highly unlikely’ to use any 
of the partner notification methods in the future. Data were recorded as missing if 
answers to the missing responses could not be derived from the responses to other 
questions as explained previously. Missing data were recorded using standard 
coding format, i.e., 9, 99 or 999. The highest level of item non-response was 15 
(3.5%) for the question on social welfare benefits. Except for this item, the item 
non-response for the variables used in the analysis was in the range of 0.5%-1.6%. 
These data indicate that, overall, the participants were able and willing to respond 
to the questions.  
2.5.9.4 Validity and reliability of responses 
The consistency of the participants’ responses to questions measuring similar 
information in the questionnaire survey was examined. For example, men were 
asked similar questions about their sexual behaviour with new partners in the last 
month and in the last year. Men first responded to the questions about their sexual 
behaviour with new partner in the last month and then in the last year. The 
participants’ responses to these questions were compared to examine internal 
consistency in their responses. For example, it was examined whether men had 
reported not engaging in AI in the last year and had reported having AI in the last 
month with a new partner. Similarly, consistency of participants’ responses to 
questions within the specified timeline (i.e., in last month) was also examined by 
comparing their responses to other questions on sexual behaviour in that time 
period. For example, it was checked whether the total number of ‘new anal sex 
partners’ reported in the last month was greater than the ‘total number of new sex 
partners’ reported in the last month. Where possible, inconsistencies in the 
responses to such questions were corrected. For example, the total number of new 
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sex partners in the last month was equated with the total number of new anal sex 
partners reported in the last month if the latter was greater than the former. Overall, 
there was good internal consistency in participants’ responses.  
2.5.10  Data reduction 
Continuous variables such as age, number of UAI partners were converted into 
categorical variables with meaningful categories based on published studies, to 
enable comparison with results from other studies. Categorical variables with 
several categories were converted into new variables with fewer categories by 
merging the existing categories into a meaningful smaller number of categories. 
The responses of variables collected using a Likert scale with a rating of 1-5, 
where 1 indicated ‘very likely’ and 5 indicated ‘very unlikely’, were also reduced 
by combining rating scores of 1 and 2 to indicate ‘willingness’ and rating scores of 
3-5 to indicate ‘unwillingness’. Data on attitudes towards partner notification for 
STI, willingness to notify sexual partners for STI in the future, and willingness to 
use various partner notification methods for notifying different types of sexual 
partners in the future were collected using Likert scales. All variables for which 
the responses were collected using Likert scales were treated in a similar fashion. 
Men were asked to rate their attitudes towards, for example, reduced infectivity 
due to cART and undetectable viral load status on a 5-point Likert scale (strongly 
agree/agree/not sure/disagree/strongly disagree) with an additional 3 options 
(‘don’t know’, ‘refused to answer’, and ‘not applicable’). For the purpose of 
analysis, the category of ‘don’t know’ was combined with ‘not sure’. 
2.5.11 Definitions of key outcome variables  
Prior to analysing the data, key outcome variables of interest were defined.  
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2.5.11.1 Unprotected anal intercourse  
Men who engaged in both or either RUAI or IUAI were treated as engaging in 
UAI. 
2.5.11.2 Receptive unprotected anal intercourse  
Both, men who reported ‘always’ or ‘occasionally’ engaging in RUAI without 
withdrawal prior to ejaculation, and men who reported ‘always’ or ‘occasionally’ 
engaging in receptive UAI with withdrawal prior to ejaculation were both treated 
as engaging in ‘RUAI’.   
2.5.11.3 Insertive unprotected anal intercourse  
Both, men who reported ‘always’ or ‘occasionally’ engaging in IUAI without 
withdrawal prior to ejaculation and men who reported ‘always’ or ‘occasionally’ 
engaging in IUAI with withdrawal prior to ejaculation were both treated as 
engaging in ‘IUAI’. 
2.5.11.4 Seroconcordant and serodiscordant primary partner  
Men whose primary partner was HIV positive were classified as having a 
‘seroconcordant’ primary partner. Men whose primary partner was either HIV 
negative or of untested/unknown HIV status were classified as having a 
‘serodiscordant’ primary partner. Thus seroconcordant and serodiscordant were 
mutually exclusive categories.   
2.5.11.5 Seroconcordant and serodiscordant most recent non-primary partner 
As described previously in section 2.5.1.1, men were asked about their sexual 
behaviour with three recent sex partners (i.e., the last 3 sex partners participants 
had sex with prior to participating in the SHARPN survey). Data on sexual 
behaviour with each of these three recent sex partners was collected on a partner-
by-partner basis. In this thesis I present the analysis of sexual behaviour with the 
‘most recent’ sex partner if this partner was not participant’s primary partner but 
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was a regular, casual, commercial sex partner, or other type of sex partner. This 
partnership was classified as the ‘most recent non-primary partnership’. 
Participants whose most recent non-primary partner was HIV positive were treated 
as having a ‘seroconcordant’ most recent non-primary partner and those who 
reported that their most recent non-primary partner was either HIV negative or 
they did not know their HIV status were treated as having a ‘serodiscordant’ most 
recent non-primary partner.  
2.5.11.6 Seroconcordant and serodiscordant new sex partnerships 
As mentioned previously in section 2.5.1.1, new sex partner was defined as a 
sexual partner with whom the participant had sex with for the first time in the last 
month or the last year. The data on sexual behaviour with new partners was 
collected on an aggregate basis (i.e., in the last month, did you have insertive or 
receptive anal intercourse (fucking) with your new partners?).  
Men were specifically asked about the number of new receptive and insertive AI 
partners they ‘knew’ were HIV positive or negative, they ‘assumed’ to be HIV 
positive or HIV negative, or who were of ‘unknown’ HIV status. Men who 
reported having sex ‘only’ with men they ‘knew’ to be HIV positive were treated 
as having ‘seroconcordant’ new partners if all their new partners were known to be 
HIV positive. If men reported that they had ‘assumed’ any of their new partners to 
be HIV positive, or had ‘assumed’ or ‘knew’ their new partners to be HIV negative 
or reported having ‘unknown’ status new partners, they were treated as having 
‘serodiscordant’ new partners.  
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2.5.12  Key exposure variables of interest and risk of 
misclassification bias 
It was important to consider the implications of the nature of study design (i.e., 
cross-sectional study) on the analysis of variables like time since men were 
diagnosed with HIV, cART status, and viral load status in order to examine the 
association of these variables with sexual behaviour, especially in the last year, to 
minimise misclassification bias. This was dealt with in the following ways:  
2.5.12.1 Time since HIV diagnosis 
The SHARPN survey was conducted between May-September 2010. Men were 
asked about the ‘year’ of their HIV diagnosis. Data on the ‘month’ of HIV 
diagnosis was not available. For men who reported being diagnosed with HIV in 
the same year as the year the survey was conducted (i.e., 2010) or in 2009, it was 
not possible to accurately determine the number of months prior to the survey the 
participant was diagnosed with HIV. Thus men who reported being diagnosed with 
HIV in 2010 and in 2009 were excluded from the analysis of sexual behaviour of 
HIV positive MSM in the ‘last year’ and ‘in the last six months’ as these men 
could have been HIV negative or undiagnosed HIV positive. Accordingly, fifteen 
men who reported that they were diagnosed with HIV in 2010 and 34 men who 
reported that they were diagnosed in 2009 were excluded from the analysis.  
2.5.12.2 cART status in the last year 
The data on cART status at the time of the survey was self-reported.  Data was 
collected on the year men started taking cART and if they were taking cART at the 
time of the survey. If men reported taking cART at the time of the survey, it was 
important to determine if these men were receiving cART at least for a year in 
order and to examine the association of cART status with sexual behaviour in the 
last year without the risk of misclassification bias. There was a likelihood of 
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misclassifying men who were ‘not on cART’ during the ‘whole of the last year’ as 
being on cART if men had started taking cART only a few months or weeks prior 
to the survey. For men who reported that they started taking cART in 2009 and 
2010, it was not possible to determine how many months prior to the survey they 
were receiving cART. Therefore, of the 346 men who reported currently taking 
cART, 21 men who had started taking it in 2010 and 37 men who had started it in 
2009 were excluded from the analysis of sexual behaviour in the last year and six 
months. 
Similarly, some men had reported ‘not being on cART’ at the time of the survey 
but had responded positively to the question on ‘ever’ receiving cART. It was not 
possible to determine when these men had ‘stopped taking cART’ because these 
data were not collected. Thus, it was difficult to determine if these men had 
stopped taking cART just a few months prior to the survey. However, only a small 
number of men in the SHARPN survey (n=7) who reported ‘ever’ being on cART 
reported not being on ART at the time of the survey and thus were retained in the 
analysis. 
2.5.12.3 Plasma viral load status 
Men were asked to report the numerical value of their recent plasma viral load test 
result as well as their recent plasma viral load status (i.e., whether it was 
undetectable, low, medium, high, or don't know). In the thesis, the latter is referred 
to as self-reported viral load status. No biological specimens were collected from 
the men during this study. In order to examine the consistency of their recent 
plasma viral load status with that during the ‘last year’, men were asked about 
changes in their plasma viral load status in the last year. Men who reported that 
they did not know or did not remember any of these data were excluded from the 
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analysis examining the association between plasma viral load status and sexual 
behaviour, i.e., 34 men. The concordance between the data on recent self-reported 
plasma viral load status and plasma viral load test results, and between the data on 
self-reported recent plasma viral load status and changes in the plasma viral load 
status in the last year were examined to determine the likelihood of 
misclassification bias in determining participants’ plasma viral load status during 
the last year.  
With regards to concordance between recent plasma viral load test result and self-
reported viral load status, of the 429 men, 14 (14.6%) men did not know their 
recent plasma viral load status. Of the remaining 414 men, 96 (22.4%) men had 
self-reported their plasma viral load to be detectable. Of these 96 men, 12 (12.5%) 
men had reported their recent plasma viral load test result to be <50 copies/mL. 
The remaining 72.9% of men who had self-reported their plasma viral load to be 
detectable also reported their viral load test results to be >50 copies/mL. Of 429, 
318 (74%) of men had reported their recent plasma viral load status to be 
undetectable. There was good concordance between self-reported plasma viral load 
status and recent plasma viral load test result (<50 copies/mL) among 93% of these 
318 men. A small minority of these men (0.5%) with a recent plasma viral load 
test result of >50 copies/mL believed themselves to be undetectable and 5% of 
men who did not know their recent plasma viral load test result also believed 
themselves to be undetectable. Overall, there was good concordance between 
recent plasma viral load test result and self-reported recent plasma viral load status.  
Men were also asked what does undetectable viral load mean and were provided 
with multiple choice options. While the majority of men viewed undetectable 
plasma viral load as a plasma viral load of 1-50 copies/mL, 6.8% of men believed 
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it to be equal to zero and 2.1% of men believed it to be between 50-50,000 
copies/mL. In addition, 11.7% of men did not know what level of plasma viral 
load is considered to be an undetectable plasma viral load.  
With regard to the changes in the viral load status in the last year, of the 429 men, 
318 men (74%) reported that their recent plasma viral load status was undetectable. 
Of these 318 men, 81% men reported that their plasma viral load status remained 
stable in the last year and 1% of men had reported that it had increased but was 
undetectable. Among these men, the risk of misclassifying those with a probable 
detectable plasma viral load during the last year as having an undetectable plasma 
viral load is highest among 11% of men who had reported a decrease in their 
recent plasma viral load status. A small minority of men who reported not 
knowing about the changes in their plasma viral load status in the last year (3%) 
reported their recent plasma viral load status to be undetectable. Of the 429 men, 
96 (22.4%) men reported their recent plasma viral load status to be detectable. Of 
these 96 men, the risk of misclassifying those who may have been undetectable in 
the last year as having had a detectable viral load is highest among men who 
reported their recent plasma viral load has increased in the last year (25%). 
Fluctuation in their viral load status was reported by 17.7% of these 96 men and a 
decrease in viral load status in the last year was reported by 15.6% of men. Since it 
was not possible to make any changes to these data, these data were not changed in 
the analysis examining the association between sexual behaviour and viral load 
status and this is acknowledged as a limitation of the study. In order to examine 
the association between plasma viral load status and sexual behaviour in the last 
year and last six months, data on plasma viral load status as opposed to recent 
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plasma viral load test result, was used as an indicator of their plasma viral load 
status. 
2.5.13  Descriptive and univariate analysis 
Data were analysed using STATA. Frequency tables with 95% CI and summary 
statistics were used to describe the study population. Chi-square tests (χ2) were 
used to examine the association between categorical variables or Fisher’s exact test 
in the case of small numbers. Student’s T-test and the Mann Whitney U test were 
used to examine the association between continuous variables and binary variables. 
For non-normally distributed data, non-parametric test such as the Kruskal-Wallis 
test was used. For the comparison of two non-independent groups, i.e., to compare 
if men were more likely to engage in RUAI compared to IUAI with their primary 
partner, McNemar test for categorical variables was used. Logistic regression was 
used for univariate analysis and to obtain unadjusted (crude) odds ratios (OR) with 
95% CI. All continuous and ordered categorical variables associated with the 
outcome variables of interest in univariate analysis were assessed for linearity 
using likelihood ratio test. 
For the analysis of sexual behaviour with a primary partner in the last six months, 
all men who reported having a primary partner were diagnosed with HIV more 
than a year ago, and whose duration of partnership with their primary partner was 
at least six months were included. For the analysis of sexual behaviour with new 
sexual partners in the last year, all men who reported having new partners in the 
last year and were diagnosed with HIV more than a year ago were included. The 
data on sexual behaviour with new partners was collected on an aggregate basis 
and thus the data analysis of sexual behaviour with new partners is based on 
aggregate data. For the analysis of sexual behaviour with the most recent non-
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primary partner, men who were diagnosed with HIV more than a year ago, were 
sexually active in the last year and reported a most recent non-primary partner 
were included.  
2.5.14   Multivariate analysis 
In the following sub-section, I will explain the analytical framework used during 
the various multivariate analyses conducted to examine the research questions. 
During multivariate analysis, if two explanatory variables were highly correlated, 
then only one of these explanatory variables was included in the multivariate 
analysis to avoid problems associated with collinearity. cART status and recent 
self-reported viral load status were highly correlated and thus, only recent self-
reported viral load status was included in the final model during analysis. 
2.5.14.1 Association between a primary partner’s HIV status and sexual 
behaviour 
With regards to sexual behaviour and practices with a primary partner, I 
hypothesised that: 
Hypothesis 1: HIV positive MSM who are in a serodiscordant partnership (i.e., 
have an HIV negative or unknown/untested status primary partner) are less likely 
to engage in sexual behaviours that increase the risk of HIV transmission to their 
primary partner compared to men who are in a seroconcordant partnership (i.e. 
have an HIV positive primary partner).  
Hypothesis 2: Men who have a serodiscordant primary partner are more likely to 
engage in strategic positioning (i.e., RUAI compared to IUAI). 
Hypothesis 3: Men who have a serodiscordant primary partner are more likely to 
engage in receptive unsafe oral sex than insertive unsafe oral sex.  
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In order to test the first hypothesis that men who have a serodiscordant primary 
partner are less likely to engage in sexual behaviours that increase the risk of HIV 
transmission compared to men who have a seroconcordant primary partner, the 
key explanatory variable of interest was being in a partnership with a 
serodiscordant primary partner (versus seroconcordant primary partner). The 
dependent variables of interest were: 
  Sexual activity in the last six months: sexually active but no AI, only IAI, 
only RAI, both RAI and IAI (versus no sexual contact), 
  UAI (versus no UAI), 
  RAI (versus no RAI), 
  RUAI (versus no RUAI),  
  RUAI with withdrawal prior to ejaculation (versus no RUAI with 
withdrawal prior to ejaculation),  
  IAI (versus no IAI), 
  IUAI (versus no IUAI),  
  IUAI with withdrawal prior to ejaculation (versus no IUAI with withdrawal 
prior to ejaculation),  
 Insertive unsafe oral sex (versus no insertive safe oral sex),  
 Receptive unsafe oral sex (versus receptive safe oral sex),  
 Insertive fisting (versus no insertive fisting),  
 Receptive fisting (versus no receptive fisting),  
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 Engagement in group sex along with primary partner (versus no engagement 
in group sex), 
 Perception that primary partner has other concurrent sex partners (versus 
not). 
 Had new sex partners (versus no new sex partners) 
 Had UAI with new sex partners (versus no UAI with new sex partners) 
All men who were in a relationship with a primary partner for at least six months, 
and were diagnosed with HIV more than a year ago were included in this analysis. 
Firstly, univariate analysis was conducted to examine the association between each 
dependent variable of interest specified above and the key explanatory variable of 
interest (serodiscordant status versus seroconcordant status primary partner) using 
logistic regression and crude OR and 95% CI were calculated. It was specified a 
priori that separate multivariate logistic regression analysis would be conducted to 
examine the association between the key explanatory variable of interest and each 
dependent variable of interest that was significant during the univariate analysis 
(p<0.2) adjusting for potential confounders, and adjusted odds ratios (AOR) and 
95% CI will be calculated.  
To identify potential confounding factors, univariate association between the key 
explanatory variable of interest and variables known to be associated with sexual 
behaviours of interest were examined. Age, employment status, recent plasma viral 
load status, attitudes towards reduced infectivity due to undetectable viral load 
status and risky sexual behaviour, recreational drug use during sex, time since HIV 
diagnosis, duration of partnership were identified as potential confounders from 
the existing literature (Van de Ven et al., 2005; Bouhnik et al., 2007; Elford et al., 
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2007; Suzan-Monti et al., 2011). These factors were treated as confounders and 
retained in the model if they were significantly associated with the key explanatory 
variable of interest during univariate analysis (p<0.2) or the crude OR and 95% CI 
of the association between the dependent variable and independent variable of 
interest changed by at least 10% when they were included in the model. 
Interactions between the independent variable of interest and confounding 
variables were examined.  
With regards to the above-mentioned 2
nd
-3
rd
 hypotheses that men who have a 
serodiscordant primary partner are more likely to engage in sexual practices that 
they perceive have lower risk of HIV transmission, the comparisons were based on 
non-independent data (i.e., the same participant could have had IUAI and RUAI 
with their primary partner). As mentioned previously in section 2.5.13, to test 
these hypotheses between non-independent observations, McNemar test for 
categorical variables was used. Only men who reported having a serodiscordant 
primary partner were included in the analysis. The dependent variables of interest 
were: 
 RUAI (versus IUAI) 
 Receptive unsafe oral sex (versus insertive unsafe oral sex) 
2.5.14.2 Association between the most recent non-primary partner’s HIV 
status and sexual behaviour 
With regards to the sexual behaviour with a most recent non-primary partner, I 
hypothesised that: 
Hypothesis 4: HIV positive MSM whose most recent non-primary partner was of 
serodiscordant HIV status were less likely to engage in sexual behaviours that 
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increase the risk of HIV transmission compared to men who had a seroconcordant 
status most recent non-primary partner.  
Hypothesis 5: Men who have a serodiscordant non-primary partner are more likely 
to engage in strategic positioning (i.e., RUAI compared to IUAI). 
Hypothesis 6: Men who have a serodiscordant non-primary partner are more likely 
to engage in receptive unsafe oral sex than insertive unsafe oral sex.  
In order to test hypothesis 4 that men who had a serodiscordant status most recent 
non-primary partner were less likely to engage in sexual behaviours that increase 
the risk of HIV transmission compared to men who had a seroconcordant non-
primary partner, the key explanatory variable of interest was had a most recent 
serodiscordant status non-primary partner (versus a seroconcordant non-primary 
partner). The dependent variables of interest were: 
 UAI (versus no UAI),  
 RUAI (versus no RUAI),  
 RUAI with withdrawal prior to ejaculation (versus no RUAI with withdrawal 
prior to ejaculation),  
 IUAI (versus no IUAI),  
 IUAI with withdrawal prior to ejaculation (versus no IUAI with withdrawal 
prior to ejaculation),  
 Insertive unsafe oral sex (versus no insertive safe oral sex),  
 Receptive unsafe oral sex (versus receptive safe oral sex),  
 Fisting (versus no fisting)  
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All men who reported that their most recent sex partner was a non-primary partner 
and who were diagnosed with HIV more than a year ago were included in this 
analysis. This analysis includes men who reported that they have a primary partner 
but their most recent sexual encounter was with a non-primary partner. Firstly, 
univariate analysis was conducted to examine the association between each 
dependent variable of interest specified above and the key explanatory variable of 
interest (serodiscordant versus seroconcordant HIV status most recent non-primary 
partner) using logistic regression and crude OR and 95% CI were calculated. It 
was specified a priori that separate multivariate logistic regression analysis would 
be conducted to examine the association between the key explanatory variable of 
interest and each dependent variable of interest that was significant during the 
univariate analysis (p<0.2) adjusting for potential confounders, and AOR and 95% 
CI will be calculated. It was specified a priori to include age in the model.  
To identify potential confounding factors, univariate association between the key 
explanatory variable of interest and variables known to be associated with sexual 
behaviours of interest were examined. Attitudes towards reduced infectivity due to 
undetectable viral load status during risky sexual behaviour, recreational drug use 
during sex, whether met partner via internet were identified as potential 
confounders from the existing literature (Van de Ven et al., 2005; Bouhnik et al., 
2007; Elford et al., 2007; Suzan-Monti et al., 2011). The univariate association 
between cART status and viral load status with the explanatory variable of interest 
was also examined. These factors were treated as confounders and retained in the 
model if they were significantly associated with the key explanatory variable of 
interest during univariate analysis (p<0.2) or the crude OR and 95% CI of the 
association between the dependent variable and independent variable of interest 
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changed by at least 10% when they were included in the model. Interactions 
between the independent variable of interest and confounding variables were 
examined. 
With regards to the above-mentioned 5
th
-6
th
 hypotheses that men who had a most 
recent serodiscordant non-primary partner were more likely to engage in sexual 
practices that they perceive have lower relative risk of HIV transmission, the 
comparisons were based on non-independent data (i.e., the same participant could 
have had IUAI and RUAI with their non-primary partner). As mentioned 
previously in section 2.5.13, to test these hypotheses between non-independent 
observations, McNemar tests for categorical variables were used. Only men who 
reported having a serodiscordant most recent non-primary partner were included in 
the analysis. The outcome variables of interest were: 
 RUAI (versus IUAI) 
 Receptive unsafe oral sex (versus insertive unsafe oral sex) 
2.5.14.3 Association between beliefs about HIV transmission risk reduction 
strategies and risky sexual behaviour  
With regards to factors associated with risky sexual behaviours among HIV 
positive MSM who had a serodiscordant primary or a most recent serodiscordant 
non-primary partner, I hypothesised that men who believed in reduced risk of HIV 
transmission due to behavioural and biomedical risk reduction strategies are more 
likely to engage in risky sexual behaviours compared to men who do not believe in 
these risk-reduction strategies. The following hypotheses were examined: 
Hypothesis 7: Men who believe that undetectable viral load reduces the risk of 
HIV transmission are more likely to engage in UAI compared to men who do not 
believe that. 
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Hypothesis 8: Men who believe that strategic positioning reduces the risk of HIV 
transmission are more likely to engage in RUAI than men who do not.  
Hypothesis 9: Men who believe that withdrawal prior to ejaculation during UAI 
reduces the risk of HIV transmission are more likely to engage in IUAI/RUAI with 
withdrawal prior to ejaculation compared to men who do not. 
Hypothesis 10: Men who believe that HIV is unlikely to be transmitted during 
unsafe insertive oral sex are more likely to engage in this behaviour compared to 
men who do not.  
To examine these hypotheses, the outcome variables of interest were:  
Hypothesis 7: UAI (versus no UAI),  
Hypothesis 8: RUAI (versus no RUAI),  
Hypothesis 9a: RUAI with withdrawal prior to ejaculation (versus no RUAI with 
withdrawal prior to ejaculation),  
Hypothesis 9b: IUAI with withdrawal prior to ejaculation (versus no IUAI with 
withdrawal prior to ejaculation),  
Hypothesis 10: Insertive unsafe oral sex (versus no insertive unsafe oral sex). 
The key independent variables of interest were:  
Hypothesis 7: strongly agree/agree that undetectable viral load reduces infectivity 
during UAI (versus disagree/strongly disagree/not sure), 
Hypothesis 8: strongly agree/agree that being a receptive partner during UAI 
reduces the risk of HIV transmission (versus disagree/strongly 
disagree/not sure),  
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Hypothesis 9a/b: strongly agree/agree that withdrawal prior to ejaculation during 
UAI reduces the risk of HIV transmission (versus disagree/strongly 
disagree/not sure), 
Hypothesis 10: strongly agree/agree that HIV is unlikely to be transmitted during 
insertive unsafe oral sex (versus disagree/strongly disagree/not sure). 
Firstly, the univariate association between each outcome variable of interest and 
the respective key independent variable of interest was examined using logistic 
regression and unadjusted OR and 95% CI were calculated. It was decided a priori 
that if a significant association (p<0.2) between the outcome variable and the key 
independent variables emerged during univariate analysis, then multivariate 
logistic regression analysis will be conducted to examine the association after 
adjusting for potential confounding variables known to be associated with the 
outcome variable, and AOR with 95% CI will be calculated. The univariate 
association between the factors known to be associated with the outcome variables 
identified from the existing literature, i.e., age, duration of the partnership (for 
primary partner only), disclosure of HIV status, time since HIV diagnosis, met via 
internet (non-primary partner only), viral load status, cART status, and recreational 
drug use during sex (Van de Ven et al., 2005; Bouhnik et al., 2007; Elford et al., 
2007) was examined using logistic regression and unadjusted OR with 95% CI 
were calculated.  
During multivariate logistic regression analysis, it was decided that variables 
identified in the literature as potential confounders would be treated as 
confounders if their introduction in the model changed the crude OR and 95% CI 
of the association between the dependent variable and independent variables of 
interest by at least 10% or if the p-value for the univariate association between the 
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dependent variable and the potential confounder was p<0.2. Interactions between 
the independent variables of interest and confounding factors were examined. 
2.5.14.4 Factors associated with STI diagnosis in the last year 
The aim of this analysis was to examine the association between STI diagnosis in 
the last year and independent variables related to sexual behaviour and sexual 
partnership patterns of HIV positive MSM. Therefore, the association of 
independent factors such as number of new AI partners in the last year, 
engagement in UAI (with any type of partner), type of UAI partners (only primary 
partner, only new partners or both), HIV status of primary partner, UAI with a 
serodiscordant status primary partner, engagement in group sex and UAI with a 
most recent serodiscordant status non-primary partner with STI diagnosis in the 
last year was examined after adjusting for socio-demographic (i.e., age, ethnicity, 
education, employment status, country of birth) and HIV-related factors (i.e., time 
since HIV diagnosis, recent CD4 cell count, cART status, self-reported recent viral 
load status).  
The analysis was restricted to men who reported being sexually active in the last 
year and were diagnosed with HIV more than a year ago. The outcome variable 
was a binary variable ‘diagnosed with STI in the last year’ (versus ‘not diagnosed 
with STI in the last year’. Age was specified as a priori factor to be retained in the 
model. Multiple logistic regression models were built. First, age and the socio-
demographic and HIV-related factors significantly associated with the outcome 
variable in the univariate analysis (p<0.2) were included together in a multivariate 
model and then dropped from the model using a stepwise backward model 
selection procedure (p<0.2) to form the base model. After retaining the variables in 
the base model, separate multivariate models were built to examine the association 
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of STI diagnosis in the last year with each of the independent variable of interest 
specified above. Interactions between the independent variable and variables in the 
base model were examined. 
2.5.14.5 Factors associated with unwillingness to notify casual partners of 
STI in the future 
I had planned to examine factors associated with unwillingness to notify any sex 
partners of STI in the future. However, due to the small number of men unwilling 
to notify any sex partners of STI, it was not possible to conduct this analysis. 
However, I conducted the analysis to examine factors associated with 
unwillingness to notify casual partners of STI. Men were asked about their 
willingness to notify casual partners of STI in the future. Casual partner was 
defined as men with whom men had sex only once or twice. For this analysis, all 
men willing to notify casual partners of STI via any method were classified as 
‘willing to notify’ and those not willing to notify casual partners of STI via any 
method were classified as ‘unwilling to notify’. Thus the outcome variable was: 
unwilling to notify casual partners for STI in the future (versus willing to notify 
them). 
Firstly, the univariate association between the factors of interest, i.e., socio-
demographic factors (i.e., age, education, ethnicity, employment status, country of 
birth) and HIV related factors (i.e., time since HIV diagnosis, viral load status, 
cART status, and CD4 status), previous experience of partner notification for STI, 
factors related to attitudes towards partner notification (i.e., ‘ever worried about 
breach of HIV-related confidentiality’, attitudes that ‘a sexual partner of a person 
diagnosed with curable STI has a right to be informed for STI exposure’, and ‘my 
sexual partner should inform me if they are diagnosed with any curable STI’), and 
self-efficacy i.e., comfort level to discuss about sexual partners with clinic staff, 
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and sexual behaviour and partnership factors (i.e., number of new sex partners, had 
UAI, used the internet to meet new sex partners) with each outcome variable of 
interest was examined. Factors significantly associated with the outcome variable 
in the univariate analysis (p<0.2) were included in a multivariate model and then 
dropped from the model using backward stepwise selection procedure (p<0.2).  
Age was specified a priori to be retained in the model. The changes to the 
unadjusted and adjusted OR and 95% CI of the variables were examined for effect 
of confounding. Possible interactions were examined. 
2.6 Qualitative study 
In the following section, I describe the details of the qualitative component of the 
SHARPN project.  
2.6.1 Key aims of the qualitative component of the SHARPN 
study 
The aims of the SHARPN qualitative study were: 
 To understand how the socio-cultural contexts and biomedical technological 
innovations (namely the recent debates about using cART for HIV prevention, 
HIV transmission probabilities perceived to be associated with different types of 
sexual behaviour) and nonmedical technological innovations (namely use of 
internet for sexual networking) influence and interact with the sexual partnerships, 
sexual behaviours and practices, and risk management choices made by HIV 
positive MSM. 
 To explore HIV positive MSM’s attitudes towards and barriers for partner 
notification for STI, and their previous experience of notifying sexual partners for 
STI 
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 To examine their willingness to notify different types of sexual partners and 
to use various methods of notifying sexual partners for STI in the future, and their 
preferences regarding being notified by their sexual partners for STI in the future. 
2.6.2 Study sample and methods of data collection  
I conducted face-to-face in-depth interviews with eligible participants. The study 
population was the same as described in section 2.3, i.e., men aged 18 and above, 
able to read and write in English and in good physical health (as determined by 
clinic staff); however the ability to use computers was not an eligibility criterion 
for participating in the in-depth interviews. Participation in the SHARPN survey 
was not a prerequisite for participating in the qualitative study.  The sample for the 
interviews was purposively selected. A quota matrix consisting of primary 
sampling criteria (age) and secondary sampling criteria (cART status) was 
developed (Table 1).  
Table 1. Sampling quota for in-depth interviews  
Age 
groups 
cART status 
 HIV positive patients on 
cART 
HIV positive patients not 
taking cART 
18-29 1-2 2-3 
30-44 4-5 2-3 
45-55 5-6 1-2 
55+ 5-6 1-2 
 
These criteria were selected to understand the experiences of men from different 
age groups and explore if their experiences varied according to their cART status. 
HIV prevalence in the UK varies by age group and the majority of HIV positive 
MSM are in the age group of 35 and above (Health Protection Agency, 2011a). 
Thus the quota for each age group was derived to reflect these variations. cART 
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status is also likely to vary depending on the age and time since HIV diagnosis, 
with older men being more likely to be on cART. Thereby, the quota for cART 
status in different age groups was derived to reflect these differences. The quota 
sampling criteria was modified following the pilot and the details are presented in 
section 2.6.5.3. Based on the quota sampling matrix, approximately 21-29 in-depth 
interviews were planned. I reviewed the interviews on an on-going basis to 
examine the need for change in the sample size or criteria.  
2.6.3 Development of a topic guide  
A topic guide for in-depth interviews was designed based on the review of 
literature on sexual behaviour and the systematic review on partner notification 
described in chapter 1 (appendix 1). Various vignettes were developed to depict 
variation in the type of sexual partnership; nature of STI diagnosed, and partner 
notification method in order to explore participants’ views about barriers to and 
acceptability of various partner notification methods in these different scenarios. 
The vignettes on partner notification explored the following hypothetical scenarios 
(appendix 12): 
 Preferred methods for notifying partners for STI:  men were given a list of 
various ways of notifying their sexual partners for STI in the future. This included 
patient referral methods, i.e., face-to-face notification or using remote notification 
methods like text, email, telephone call, and online chat/message. This list also 
included the option of anonymously notifying sex partners via an e-card or via the 
clinic staff (appendix 12, scenario 1). Participants were asked which of the 
methods they were most likely to use and why, and if they would use that method 
to notify all the different types of sexual partners. 
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 Views towards notifying an HIV positive primary partner for HCV if they 
are in a monogamous relationship and diagnosed with HCV after having a casual 
sex encounter at a party (appendix 12, scenario 2) 
 Views towards using either a home sampling kit and the telephone 
assessment model, i.e., the primary partner of the patient  diagnosed with 
chlamydia and/or gonorrhoea is assessed via telephone by a clinic staff and the 
patient takes medication for his partner, (appendix 12, scenario 3) 
 Views towards notifying regular fuck buddies, i.e., regular sex partners, and 
casual partners of HCV and syphilis diagnosis (appendix 12, scenario 4) 
 Views towards notifying sex partners they met at a sex party, which was 
organised via a dating website like Gaydar, for syphilis (appendix 12, scenario 5) 
 Views towards notifying sex partners and members of their social network 
(i.e., gay friends who they think engage in UAI) to test for LGV in the event of an 
LGV outbreak (appendix 12, scenario 6). 
2.6.4 Identification and recruitment of participants for in-
depth interviews 
The participants for the in-depth interviews were recruited from the same HIV 
clinic in central London, UK where the SHARPN survey was conducted. 
Participants for these interviews were identified with the help of the clinic staff. I 
shared the purposive sampling quota for the in-depth interviews with the clinic 
staff and asked them to introduce me to patients who met the quota criteria. If the 
patient was willing to participate in the study, the clinic staff introduced them to 
me. I re-checked the eligibility of these patients. If they were eligible and willing 
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to participate in a face-to-face interview, a feasible time and date for an interview 
in the clinic was arranged.  
When a participant arrived on the day of the interview, he was taken to a quiet 
room in the clinic allocated for study purposes, where all the interviews were 
conducted. All the participants of the interviews were requested to give a written 
informed consent (Appendix  15 and 16) and offered a copy of the consent form. 
As the interviews progressed, I requested the clinic staff to introduce me to the 
patients who meet the required quota sampling criteria that were not yet achieved. 
The topic guide was piloted and the results are presented in the following section.  
2.6.5 Piloting the topic guide  
A focus group discussion and two pilot interviews were conducted to pilot the 
topic guide for the in-depth interviews.  
2.6.5.1 Focus group discussion 
A focus group discussion was conducted in February 2010 to pilot the vignettes 
that were developed to examine willingness to notify partners of STI and use 
various partner notification methods in the future. A purposive sample of 7 HIV 
positive MSM was recruited from amongst the members of the clinic’s HIV 
positive patients’ network with the help of the clinic’s patient representative. 
Using members of an existing group was considered likely to facilitate discussion 
due to familiarity. An attempt was made to select participants who varied in age, 
ethnic background, years since HIV diagnosis, cART status, and sexuality (gay or 
bisexual). All the participants were given a focus group discussion study 
information sheet (Appendix 13) and were asked to provide written consent 
(Appendix 14). 
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The discussion was audio-recorded with the participants’ consent. Participants 
were provided with snacks and beverages as a token of gratitude for participating 
in the focus group discussion. Six of the seven participants were White, and one 
participant was Black Caribbean. While some participants were living with HIV 
for more than fifteen years, some men were diagnosed 2-4 years ago. All but two 
of the participants were receiving cART. I facilitated the focus group discussion 
and read out the vignettes to the group.  
The focus group discussion indicated the feasibility of using the vignettes for 
initiating discussion on attitudes to partner notification for STI and towards using 
various methods of partner notification. It also highlighted that some vignettes 
needed further clarification. Some topics not included in the topic guide came up 
frequently during the discussion: for example, the role of internet in meeting 
sexual partners among HIV positive MSM. The topic guide was modified based on 
the feedback received during the focus group discussion.  
2.6.5.2 Pilot in-depth interviews 
Two pilot in-depth interviews were conducted using the revised topic guide to 
reassess the comprehension of the concepts discussed, the feasibility of using 
vignettes and the acceptability and degree of comfort for the participants in 
discussing these topics during a face-to-face interview with me. These pilots were 
also conducted to assess the approximate time needed for the interviews and 
acceptability of audio recording the interviews. Written informed consent was used 
from both the participants (appendix 15 and 16). The pilot interview participants 
were a White British man in his early fifties and a Black Caribbean man in his 
mid-twenties and were recruited with the help of the clinic staff. They provided 
written consent and their interviews were audio-recorded with their consent.  
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The interview with the White British participant indicated that he was able to share 
his experiences of HIV partner notification. However, he had never been 
diagnosed with STI except at the time of his HIV diagnosis. He therefore found it 
difficult to respond to the vignettes on partner notification for STI. In addition, he 
was very sure that he would never need to notify his sexual partners for STI. He 
was nevertheless asked to comment on the clarity of the vignettes. He was able to 
understand the scenarios presented in the vignettes and his interview lasted for 
approximately 50 minutes.  
The interview with a young Black Caribbean participant was challenging. He 
responded to the ‘softer’ questions like “how long have you been using the 
services of this clinic?” However, despite being informed of the nature of the 
interview and agreeing to participate in the interview, he responded ‘decline to 
answer’ to every subsequent question related to HIV diagnosis or sex behaviour. I 
thus stopped the interview and discussed with the participant if he was comfortable 
with the interview process. At this stage, he revealed that he had never spoken to 
anyone, including the clinic health advisors, counsellors or his family members 
about his HIV diagnosis, which was 3 years ago. He was angry with himself, and 
experienced tremendous guilt due to his sexual behaviour and blamed himself for 
his diagnosis. I offered the participant the option to terminate the interview and 
referral either to the clinic’s psychology team or the patient representatives and 
offered him some time to reflect on these options. However, he decided to 
continue with the interview but declined referral to the psychologists or patient 
representatives. After this point the interview went well but took approximately 85 
minutes. The participant was able to understand the vignettes and terms used in the 
topic guide.  
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Both the participants were specifically asked about their experience of being 
interviewed by me, a young Asian female. The older participant said that my 
gender or ethnicity did not affect the accuracy or the extent of the information he 
shared. He, however, mentioned being cautious about using gay slang. The 
younger participant mentioned that my gender or ethnicity was not a concern for 
him. He felt reassured when I stopped the interview to re-check if he was willing 
to participate in the interview and found it easier to talk about his emotions 
because I am a female.  
2.6.5.3 Modification of the sampling criteria based on the pilot results 
I discussed the pilot results with both my PhD supervisors and we decided to 
modify the quota sampling criteria to reflect the pilot results. The purposive quota 
sampling criteria was modified to integrate an additional inclusion criterion, i.e., 
recent STI diagnosis, which was defined as being diagnosed with any STI (not 
HIV) in the three months prior to the date of being approached for the interview. 
The clinic staff in-charge of informing the patients of their recent STI test results 
and inviting them to the clinic for treatment if they tested positive flagged up the 
clinic notes of these men with a participant information sheet (appendix 15). This 
served as a reminder for the clinic nurses to invite those men recently diagnosed 
with STI to participate in the study. 
2.6.6 Data collection 
The data collection for the qualitative interviews started simultaneously with the 
survey in May 2010 and was completed in February 2011. I conducted all the 
interviews and used the modified topic guide for conducting the interviews. The 
interviews were recorded using a digital audio-recorder. Participants were given an 
option to opt-out of audio recording their interviews. I started the interview with 
129 
 
less sensitive issues, such as time since accessing the clinic services. This worked 
as an icebreaker prior to discussion about sensitive issues. The participants were 
handed the vignettes, one at a time, and were asked to read them. They were then 
asked about their views towards the scenarios. Although the scenarios usually 
specified the type of sexual partner or STI, participants’ views towards using the 
partner notification method specified in the scenario to notify other types of sexual 
partners were also explored. For example: in scenario 3 participants’ views 
towards using a home sampling kit and a telephone assessment model to notify a 
primary partner were examined. However, participants’ views towards using these 
methods for notifying other sex partners were also explored.  
I personally conducted all the interviews and therefore I was able to identify any 
new issues relevant to the study objectives that emerged during the interviews. A 
record of new themes added to the topic guide as the interviews progressed was 
maintained. Three men declined permission for their interviews to be recorded. 
The main reason for declining audio recording of the interviews was concerns 
related to confidentiality. One person who declined had not disclosed his HIV 
status to anyone, including his primary partner. Two others were concerned about 
the sensitive nature of the interview topic, interpreted by them as talking about 
their sexual behaviour, and preferred not to have their voice recorded. I took notes 
using a pen and paper during these interviews. At the end of each interview, I 
maintained a log of the key themes emanating from the interview and my 
perceptions of the interview process. Because the interviews were reviewed on an 
on-going basis, it was evident after the 20
th 
interview that no new themes were 
emerging from the subsequent interviews. Therefore, data collection was stopped 
after the 24
th
 interview. 
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2.6.7 My role as an interviewer  
Reflexivity refers to the interviewer’s influence on the process of data collection, 
analysis and interpretation and is an important component of qualitative research. I 
was mindful of the fact that my sex and ethnic origin, and my sexuality as 
perceived by the participant may affect the interview process. I was concerned 
about how an HIV positive man who has sex with men would perceive being 
interviewed by a young Asian female of unknown HIV status and sexuality. The 
fact that I knew they are HIV positive and have sex with men, while they did not 
know my HIV status and sexuality can create a power imbalance between us 
where information is not equally shared. At the end of every interview, I asked the 
participants about their experience of the interview process and being interviewed 
by me. They were also asked about their perceptions about being interviewed by a 
gay or a straight man, or a White female. During the interviews it was important to 
establish that I was not a part of the clinic staff to enable free exchange of 
participants’ views and attitudes towards the clinic services and staff. Therefore 
when the clinic staff introduced potential participants to me, I explained to them 
that I am a public health researcher associated with UCL and I am not employed 
by the clinic.  
2.6.8 Reflections on the interview process  
The experience of interviewing the participants was humbling and provided me 
with insights into the challenges some of these men had faced in their lives, not 
only due to their HIV positive status but also due to their sexuality, and their 
stories of despair and resilience. The participants perceived me as non-threatening 
and some treated me as though I were a therapist with whom they shared their 
darkest and deepest concerns and realities. One participant mentioned that he told 
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me all the dark facts about his life at the beginning of the interview because that is 
his mechanism of dealing with rejection. He feels that if someone gets through that 
and still talks to him, he does not feel the fear of being rejected due to his HIV 
status. These experiences made me acutely aware of my role and boundaries as a 
researcher. It also made me aware that participating in an interview is likely to be 
an emotional experience for some men and for me. 
When asked about their experience of being interviewed by an Asian female, most 
men said that they were pleased that a gay man did not interview them. Although 
not averse to the idea, some men felt that being interviewed by a gay man would 
be an unwanted “distraction”. Two men felt that they were wary of using gay 
slang and describing their sexual activity in detail. All the men felt that they would 
prefer not to be interviewed by a straight man and some felt that it would make 
them feel uncomfortable and judged. Men perceived me to be “professional” and 
“knowledgeable” about issues related to gay men and their sexual behaviour, 
which made them feel comfortable to talk about it. However, it is important to bear 
in mind, it was me who asked the participants about their experience of being 
interviewed and it is likely that men did not share their true experiences and may 
have led to desirability bias.  
Some men experienced distress during or at the end of the interview. They were 
offered the opportunity to terminate the interview or re-schedule it, but they chose 
to continue with the interview. These men were offered a referral to the clinic’s 
patient representative or a health advisor. However, all these men declined referral. 
One participant, who had not disclosed his HIV status to anyone and was 
diagnosed with HIV five years ago, felt that talking about his HIV diagnosis and 
experiences of living with HIV was not as bad as he had anticipated and hoped that 
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this experience would eventually help him to disclose his status to his primary 
partner. Another participant, who was distressed because his HIV negative partner 
was threatening him with legal action, was given information about Terrence 
Higgins Trust who provides support to HIV positive men on such issues.  
2.6.9 Data protection and confidentiality of the participants 
All the consent forms were stored in a locked cabinet in my office and the details 
were described earlier in section 2.5.6. The audio-recorded files were transferred to 
a secure computer and were password protected. The audio-recorded files were 
given numerical codes (e.g. IDI_1). The interviews were transcribed by an external 
agency that was bound by a confidentiality agreement signed between us and had 
substantial experience of transcribing sensitive qualitative data. The audio 
recordings were destroyed after transcription. The names and identifiable data of 
the participants were not audio-recorded, transcribed, or used in writing the thesis 
or related publications. Only anonymous quotes of the participants were used to 
reflect their opinions. 
2.6.10  Data management and analysis of the in-depth 
interviews 
Interviews that were not recorded were typed into a word document. The 
transcripts and interview logs were imported in to qualitative data management 
software NVivo, 6.0 (QSR International Ltd, Melbourne, Australia). A matrix 
based approach for ordering and synthesizing qualitative data known as 
‘Framework approach’ (Ritchie and Lewis, 2006) was used for analysis. The 
analysis of the data followed the key features of this approach specified below: 
 Familiarization with the data (reading and re-reading of the transcripts) 
 Developing a thematic framework/coding index  
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 Applying this framework to the entire dataset, i.e., coding the transcripts 
using the thematic framework and revising the thematic framework as the coding 
progresses 
 Charting themes using a matrix and conduct within and between case 
analysis 
 Developing descriptive and explanatory accounts of the data, identifying 
emerging concepts and typologies and finding associations and explanations for 
the patterns observed in the data. 
To begin with I read and re-read the hard copies of five interview transcripts. 
While reading each of these transcripts, I coded the emerging broad themes of 
interest manually on the hard copies. I maintained a separate log of these broad 
themes and documented the definition I assigned to these themes for purposes of 
clarity and to enable accurate coding of subsequent interviews. At the end of 
identifying the broad themes in all these five transcripts, I reviewed the log of all 
these themes and their definitions. At this stage I refined some of the themes and 
their definition. In case of some themes, I felt the need to divide themes into 
separate sub-themes, for example: I had a broad theme titled sexual partnerships. I 
sub-divided this broad theme into sub-themes: timing of sexual partnerships (i.e., 
current/ex), type of sexual partnership (i.e., casual/regular/primary), HIV status of 
partners. However, I did not want to over-code the data and de-contextualise it. 
Thereby, at this stage I opted not to make the themes too narrow. This formed the 
broad thematic framework for further coding. Then, I coded all the interview 
transcripts in NVivo using this thematic framework. Any new themes identified 
during this process were added to the thematic framework. This process led to the 
identification 66 broad/semi-broad themes (appenxid 17). Once the emerging 
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themes in all the interviews were identified, these themes were further categorised 
using the following 9 key areas:  
1. HIV diagnosis 
2. HIV and sexual behaviour 
3. cART 
4. Attitudes towards partner notification  
5. Experience of partner notification 
6. Preferred methods of partner notification 
7. Change over time in attitudes to HIV and cART 
8. Interview related challenges 
9. Other: for example, social support etc. 
 
Excel spreadsheets were used to chart the summarised data from each case 
(interview) for each of the sub-themes included under each of the above-
mentioned key areas of interest. An example of charting the data using an excel 
spreadsheet is presented in appendix 18. During this process, consistency was 
maintained in charting the data by using the rows in the spreadsheet to represent a 
separate case and the columns represented different sub-themes. A separate 
comments column was created in each spreadsheet to document any emerging 
interpretations that were immediately evident during the process of charting the 
data.  
When charting of all the themes was complete, a cross-case analysis for each 
theme in each of the key areas of interest was conducted to identify the diversity 
and similarity of the range of issues within each theme was conducted. This 
process enabled me to develop descriptive accounts for each theme and identify 
the key concepts and emerging patterns. Typologies for the descriptive accounts 
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were developed during the within-theme analysis. This process was conducted 
using the printed excel charts and large plain sheets of paper to document the 
emerging patterns. If any typologies were identified, attempt was made to 
understand if it applied to the entire data set and if each individual case mapped on 
to one and only one typology. This process led to the organization and re-
organisation of the cases in different typologies and identification of outliers, i.e., 
unique cases. After conducting the descriptive analysis for each theme, within-case 
analysis across all themes to identify emergent patterns was conducted.   
At every stage of the analysis, an effort was made to remain as close as possible to 
the original data. As the interviews were coded using NVivo and thematically 
charted in excel, it was convenient to access the charted data, and the original 
coded data in NVivo and the interview transcript. This allowed me to remain 
grounded in the data during the data analysis process. 
2.7 Study Timetable 
It was anticipated that recruitment for the SHARPN survey would span between 
January-September 2010. However, due to the need for substantial amendment to 
the study protocol and the survey following the pilot interviews, recruitment to the 
survey took place from May until September 2010. The qualitative interviews 
were conducted from May 2010 until February 2011. 
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Chapter 3. Sexual partnership patterns, and sexual 
behaviour of HIV positive MSM: results of the SHARPN 
survey 
3. Aims  
The aim of this chapter is to examine the sexual partnership patterns and sexual 
behaviour of HIV positive MSM and its implications for onward HIV transmission, 
risk of re-infection with HIV, STI transmission and acquisition, and partner 
notification.  
3.1 Specific objectives 
The specific objectives of this chapter are: 
1. To describe the response rate to the SHARPN survey, and describe the 
socio-demographic characteristics and HIV related health of HIV positive MSM, 
and their attitudes towards various HIV transmission risk reduction strategies. 
2. To describe the characteristics of men who have a primary partner, and 
examine their sexual behaviour with their primary partner and if it varies by 
primary partner’s HIV status. 
3. To describe the sexual behaviour of HIV positive men with their most recent 
non-primary partner and examine if it varies by the HIV status of their non-
primary partner. 
4. To examine the association between attitudes towards various HIV risk 
reduction strategies (i.e., reduced risk of HIV transmission during UAI due to 
undetectable viral load, strategic positioning, withdrawal prior to ejaculation, and 
no risk of HIV transmission during unsafe insertive oral sex) and risky sexual 
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behaviours with a serodiscordant primary partner and a most recent serodiscordant 
non-primary partner. 
5. To describe the sexual behaviour of men with new sexual partners. 
3.2 Methods 
The details of the methods of the SHARPN survey were presented previously in 
section 2.5. 
3.3 Results 
In this chapter I present the results of the SHARPN survey for the above-
mentioned objectives.  
3.3.1 Response rate to the SHARPN survey 
As shown in figure 9, of the 887 HIV positive MSM attending the study clinic 
during the SHARPN study period, 21 men (2.4%) were not eligible to be included 
in the study due to their lack of ability to use computers, read or write in English, 
or health reasons. Of the 866 eligible patients, 138 (15.9%) men were not 
approached by the clinic staff for study participation. Of the 728 men approached 
by the clinic staff, 113 (15.2%) men declined to participate in the study and the 
remaining 615 (84.8%) men agreed to participate in the survey. Of the 615 men 
who agreed to participate, the survey completion rate was 69.8% (429/615). Of the 
429 men who completed the survey, 18.2% of men (78/429) completed the survey 
in the clinic and the remaining 81.8% of men (351/429) completed the survey at 
home. The overall response rate among eligible clinic attendees was 59% 
(429/728). Among those who agreed to participate and complete the survey at 
home, the survey completion rate was 65.4% (351/537).  
  
1
3
8
 
  
Total number 
completed the survey 
(n=429 (69.8%)) 
HIV+ MSM attending the clinic 
during the study period (n=887) 
Eligible for inclusion    
 (n=866 (97.6%)) 
Not approached by 
the clinic staff          
 (n=138 (15.9%)) 
Approached by the 
clinic staff        
 (n=728 (84%)) 
Declined to 
participate 
  (n=113 (15.2%)) 
Agreed to participate 
(n=615 (84.8%)) 
Completed the survey 
in the clinic               
 (n=78 (18%)) 
Agreed to complete 
the survey at home 
 (n=537 (81.8%)) 
Completed survey at 
home 
   (n=351 (65.4%)) 
Did not complete the 
survey at home  
(n=186 (34.6%)) 
Ineligible for inclusion                 
(n=21 (2.4%)) 
Cannot use a 
computer 
(n=5) 
Cannot read or write 
in English  
(n=3) 
Health reasons  
(n=13) 
 Figure 9. Recruitment of study participants for the SHARPN survey 
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In the following sub-sections, I describe the socio-demographic characteristics and 
HIV related health of the survey participants. 
3.3.2 Socio-demographic profile of the study participants  
The socio-demographic characteristics of the 429 study participants are presented 
in Table 2. Overall, the study participants were middle-aged, with a median age of 
43 years (range: 22-74). 86.4% of participants were White and 61% of participants 
were born in the UK. The majority of participants had been educated beyond 
secondary school, self-identified as gay and were employed. 15 (3.5%) men self-
identified as being bisexual, of whom 11 men were White and 4 men were from a 
non-White ethnic background. A minority of men (8%) reported being medically 
retired or were unemployed (13.3%), and 21% of men were receiving social 
welfare benefits. Approximately 45% of men owned their accommodation whereas 
49% of men lived in rented accommodation.  
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Table 2. Socio-demographic characteristics of the study participants (N=429)
 
 
Characteristics 
1
n/N % (95 % CI) 
Age   
Median (range) years 422/429 43 (22-74) 
Age groups    
<=34 71/422  17.0 (13.4-20.6) 
35-44 169/422 40.0 (35.3-44.6) 
>=45 182/422   43.0 (38.3-47.8) 
Born in the UK   
Yes 262/429  61.0 (56.4-65.7) 
Ethnicity   
White 368/426 86.4 (83.1-89.6) 
Mixed 17/426  4.0 (2.1-5.8) 
Asian 13/426  3.0 (1.4-4.7) 
Black 15/426  3.5 (1.7-5.2) 
Other 13/426  3.0 (1.4-4.7) 
Education   
Beyond secondary school 309/429  72.0 (67.8-76.3) 
Sexual orientation   
Gay 410/425  96.5 (94.7-98.2) 
Bisexual 15/425   3.5 (1.7-5.3) 
Employment   
Employed 284/429   66.0 (61.7-70.7) 
Unemployed 57/429   13.3 (10.1-16.5) 
Medically retired 34/429   8.0 (5.3-10.4) 
Other 57/429 12.7 (9.4-15.7) 
Accommodation    
Own 191/427  44.7 (40-49.5) 
Rent 210/427   49.0 (44.4-53.9) 
Other 26/427   6.3 (3.8-8.4) 
 
Social welfare benefit   
Yes 87/414  21.0 (17.1-25.0) 
1 
Base varies due to item non-response 
 
3.3.3 General health and HIV related health 
The details of general health and HIV related health of the study participants are 
described in Table 3. Approximately three-quarters of men considered their 
general health in the last six months to be good or very good. The median number 
of years participants had lived with HIV was 9 years and the range was less than 1 
year to 28 years. While a minority of the study participants were diagnosed with 
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HIV less than a year ago (11.4%), 18.2% of participants were diagnosed 2-5 years 
ago and approximately 70% of participants were diagnosed more than five years 
ago.  
With regards to HIV related health, 16.8% of men reported ‘ever’ being diagnosed 
with AIDS. Of these, 41 (57.8%) men reported that they were diagnosed with 
AIDS the same year they were diagnosed with HIV. A small minority of the men 
reported that their CD4 cell count was <200 cells/mm
3
 (4.2%). Almost half of 
them had a CD4 cell count ≥500 cells/mm3, and 40.6% of men reported it to be 
between 200-499 cells/mm
3
. A small minority of men did not know their CD4 cell 
count test result (4.4%). The majority of men reported changes in their CD4 cell 
count in the last year while 28% of men reported their recent CD4 cell count to be 
stable in the last year. 9.1% of men were unaware whether their CD4 cell count 
had varied over the last year. An increase in CD4 cell count in the last year was 
reported by 38% of men, 7.5% of men reported a decrease, and 17.5% of men 
reported fluctuations in their CD4 cell count in the last year.  
74% of men reported their most recent plasma viral load status to be undetectable; 
while 71.8% of men reported that their recent plasma viral load test result was <50 
copies/mL. Some men (3.5%) reported a high recent plasma viral load test result 
(>100,000 copies/mL) and a further 7.2% reported their test result to be between 
10,000-100,000 copies/mL. A small minority of the men did not report their 
plasma viral load status (3.5%) and 10.8% of men did not know their recent 
plasma viral load test results. Approximately 67% of men reported that their 
plasma viral load status was stable in the last year; 7.9% of men did not know if it 
had varied during the last year. 
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Table 3. General and HIV related health of the study participants (N=429) 
Characteristics  
1
n/N  % (95% CI)   
Self-assessed overall health in last 6 months   
Good or very good 314/429  73.2 (69.0-77.4) 
Time since HIV diagnosis (years)   
Median (range) (N=429) 9 (<1-28)  
<1 49/429 11.4 (8.3-14.4) 
1-5 78/429 18.2 (14.5-21.8) 
6-9 93/429 21.7 (17.8-25.6) 
10-14 105/429 24.5 (20.4-28.6) 
>14 104/429 24.2 (20.2-28.3) 
Ever diagnosed with AIDS   
Yes 72/415 16.8 (13.7-21.0) 
Self-reported recent CD4 cell count (cells/mm
3
)   
< 200 18/429  4.2 (2.3-6.1) 
200-499 174/429  40.6 (35.9-45.2) 
>499 218/429  50.8 (46.1-55.6) 
Don’t know 19/429  4.4 (2.5-6.4) 
Self-reported changes to CD4 cell count in last 
year 
  
Stayed same 120/428  28.0 (23.8-32.3) 
Increased 162/428   38.0 (33.2-42.4) 
Went up and down 75/428   17.5 (13.9-21.1) 
Decreased 32/428   7.5 (5.0-10.0) 
Don't know 39/428   9.1 (6.3-11.8) 
Recent self-reported plasma viral load status   
Undetectable 318/429  74.0 (70.0-78.3) 
Low 42/429  10.0 (7.0-12.6) 
Medium 39/429  9.0 (6.3-11.8) 
High 15/429  3.5 (1.8-5.2) 
Don’t know 15/429   3.5 (1.8-5.2) 
Self-reported recent viral load blood test result 
(copies/mL) 
  
<50 308/429   71.8 (67.5-76.1) 
50-10,000 31/429   7.2 (4.8-9.7) 
10,000-100,000 31/429   7.2 (4.8-9.7) 
>100,000 13/429   3.0 (1.4-4.7) 
Don’t remember 
 
 
 
46/429   10.8 (7.8-13.7) 
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Table 3. Continued 
  
Characteristics 
1
n/N  % (95% CI)   
Self-reported changes in the viral load status in 
the last year 
  
Stayed same 286/429 66.7 (62.2-71.1) 
Increased 27/429 6.3 (3.9-8.6) 
Gone up and down 30/429 7.0 (4.6-9.4) 
Decreased 52/429 12.1 (9.0-15.2) 
Don't know 34/429 7.9 (5.3-10.4) 
Ever taken cART    
Yes 353/429   82.3 (78.7-86.0) 
Currently taking cART    
Yes 346/429   80.6 (76.9-84.4) 
2
Time since receiving cART   
Median (range) years (N=345) 6 (<1-24)  
<1  58/345 13.5  (10.3-16.8) 
1-6 134/345 31.2 (26.8-35.6) 
7-11 81/345 18.9 (15.2-22.6) 
>11 156/345 36.4 (31.8-41.0) 
2
Adherence to cART (doses missed in the last 
two weeks) 
  
None 287/344  82.8 (78.8-86.8) 
One 47/344 13.7 (10.0-17.3) 
>1 12/344 3.5 (1.5-5.4) 
1
Base varies due to item non-response 
2
Only among men who were receiving cART 
 
6.3% of men reported an increase whereas 12% of men reported a decrease in their 
plasma viral load in the last year. 82.3% of men reported ‘ever’ having taken 
cART, and 80.6% of men were receiving cART at the time of the survey. The 
median number of years since participants were receiving cART was 6 years and 
the range was less than one year to 24 years. The majority of men (83%) reported 
that they had not missed any doses of their HIV medication in the last two weeks. 
However, a minority (13.7%) had missed at least one dose and 3.5% of men had 
missed more than one dose of HIV medication.  
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In the following section, I describe the attitudes of the study participants towards 
various HIV transmission risk reduction strategies. 
3.3.4 Attitudes of men towards HIV transmission risk 
reduction strategies  
Men were asked about the implications of having an undetectable viral load on the 
risk of onward HIV transmission. 30% of men agreed that ‘Undetectable viral load 
means that HIV is unlikely to be passed on to a sexual partner’ (Table 4). 19% of 
men believed that ‘Undetectable viral load in my blood means that HIV is unlikely 
to be passed on to sexual partners even if we fuck without a condom’. With regards 
to the implications of having an undetectable viral load and risk of other HIV-
related infections, 19% of men believed that ‘Undetectable viral load in my blood 
means that I am unlikely to get other HIV-related infections’.   
82% of men believed that ‘I can get infected with another strain of HIV if I have 
unprotected sex with an HIV positive person’. A large proportion of men (85.5%) 
believed that ‘Getting another strain of HIV could reduce my treatment options in 
the future’. 62.3% of men believed that ‘having an STI like gonorrhoea means that 
HIV is more likely to be passed on to a sexual partner’. 
With regards to attitudes towards behavioural risk reduction strategies to prevent 
sexual transmission of HIV, 14.8% of men believed that ‘HIV is unlikely to be 
transmitted if a HIV negative person has insertive anal intercourse (he is doing the 
fucking) without a condom with an HIV positive partner’.  
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Table 4. Attitudes towards various risk-reduction strategies for prevention of 
sexual transmission and re-infection with HIV (N=429) 
 
1
n/N   % (95% CI) 
Undetectable viral load means that HIV is 
unlikely to be passed on to a sexual partner 
  
Strongly agree/agree 126/419  30.1 (25.7-34.5) 
Undetectable viral load in my blood means that 
HIV is unlikely to be passed on to a sexual 
partners even if we have unprotected anal 
intercourse 
  
Strongly agree/agree 79/416  19.1 (15.3-22.9) 
Undetectable viral load in my blood means that 
I am unlikely to get other HIV-related infections 
  
Strongly agree/agree 79/414  19.1 (15.3-22.9) 
I can get infected with another strain of HIV if I 
have unprotected sex with another HIV positive 
person 
  
Strongly agree/agree 243/418 82.1 (78.4-85.8) 
Getting another strain of HIV could reduce my 
treatment options in the future 
  
Strongly agree/agree 359/420  85.5 (82.1-88.9) 
Having an STI like gonorrhoea means that HIV 
is more likely to be passed on to a sexual partner 
  
Strongly agree/agree 258/414  62.3 (57.6-67.0) 
During anal sex withdrawing (pulling out) 
before ejaculation (cumming) can reduce the 
risk of passing on HIV to sexual partner(s) 
  
Strongly agree/agree 176/417 42.2 (37.4-46.9) 
HIV is unlikely to be transmitted if an HIV 
negative person has insertive anal intercourse 
(he is doing the fucking) without a condom with 
an HIV positive partner 
  
Strongly agree/agree 62/420 14.8 (11.4-18.2) 
HIV is unlikely to be transmitted if HIV positive 
partner ejaculates inside the mouth of an HIV 
negative partner during oral sex 
  
Strongly agree/agree 117/416 28.1 (23.8-32.5) 
1
Base varies due to item non-response  
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42.2% of men believed that ‘During anal sex, withdrawing (pulling out) before 
ejaculation (cumming) can reduce the risk of passing on HIV to sexual partner(s)’. 
Approximately one-third of men also believed that ‘HIV is unlikely to be 
transmitted if HIV positive partner ejaculates inside the mouth of an HIV negative 
partner during oral sex’.  
In the following section, I describe the details of overall sexual activity and sexual 
partnership patterns reported by the study participants and their sexual behaviour 
with different types of sexual partners.  
3.3.5 Sexual activity and sexual partnership patterns and 
behaviour of HIV positive MSM  
Of the 427 men who responded to the question on ‘age at the time of first sexual 
activity (any) with a male partner’, the median age was 16 years (IQR: 12-19) and 
range was 4 to 42 years. Of the 429 men, 99% of men reported that they had ‘ever’ 
engaged in AI with a male partner. The median age for engaging in AI for the first 
time with a male partner was 19 years (IQR: 16-22) and range was 7 to 42 years.  
Of the 429 participants, as mentioned in table 3, 49 men who reported that they 
were diagnosed with HIV less than a year ago were excluded from the analysis of 
sexual behaviour in the past year. Therefore 380 men who were diagnosed with 
HIV more than a year ago were included in this analysis. Of these 380, 84.7% (322) 
of men were sexually active in the last year (Table 5). While 16.4% of men 
reported having sex with only one partner in the last year, 12.1% of men had 2-4 
sex partners, 20.8% of men had 5-10 partners and the remaining 35.4% of men had 
more than ten partners. The median number of sex partners in the last year 
reported by these men was six. 52.4% (199/380) of men had a primary partner. 
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Table 5. Overall sexual activity, sexual partnerships and sexual behaviour of 
HIV positive MSM in the last year 
Characteristics All participants 
 
1
n/N % (95% CI) 
Sexually active    
Yes 322/380 84.7 (81.1-88.4) 
Number of sexual partners    
0 58/379 15.3 (11.7-18.9) 
1 62/379 16.4 (12.6-20.1) 
2-4 46/379 12.1 (8.8-15.4) 
5-10 79/379 20.8 (16.7-24.9) 
11-20 44/379 11.6 (8.3-14.8) 
>=21 90/379 23.8 (19.4-28.1) 
Median (range) 6 (0-400)  
Lower and upper quartiles  1-20   
Mean  (standard deviation) 20.9 (43.4)  
Had a primary partner   
Yes 199/380 52.4 (47.3-57.4) 
2
Had sex with new partners    
Yes 258/322 80.1 (75.7-84.5) 
2
Engaged in anal sex    
Yes 285/322 88.5 (85.0-92.0) 
3
Engaged in UAI    
Yes 170/285 59.7 (53.9-65.4) 
3
Serodiscordant UAI with a primary partner 
or a most recent non-primary partner 
  
Yes 44/285 15.4 (11.2-19.7) 
4
Type of UAI partner    
Primary partner only 33/170 19.4 (13.4-25.4) 
Primary partner and regular/new partners 37/170 21.8 (15.5-28.0) 
New/regular partners only 100/170 58.8 (51.3-66.3) 
1,2
Had group sex in the last 6 months   
Yes 129/304 42.4 (36.8-48.0) 
1
Base varies due to item non-response
  
2
Includes only men who reported being sexually active in the last year  
3
Includes only men who reported having AI in the last year 
4
Includes only men who had engaged in UAI in the last year 
 
As shown in Table 5, of the 322 men who were sexually active in the last year, 
approximately 80% of men had sex with new partners. 285 (88.5%) men had 
engaged in anal sex. Among men who had engaged in anal sex, 59.7% of men had 
engaged in UAI and 15.4% of men had engaged in UAI with either a 
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serodiscordant primary partner or a most recent serodiscordant non-primary 
partner. Of these 170 men who had UAI, 19.4% of men had engaged in UAI with a 
primary partner, 21.8% of men engaged in UAI with a primary partner as well as 
new partners, and 58.8% of men engaged in UAI with new/regular partners. 42.4% 
of men also reported that they engaged in group sex in the last six months.  
In the following section, I describe the nature of relationship, socio-demographic 
and HIV-related characteristics of men who had a primary partner. I compare the 
socio-demographic and HIV-related characteristics of men who had a 
serodiscordant primary partner with men who had an HIV positive primary partner. 
3.3.6 Characteristics of men who had a primary partner and 
their primary partner’s characteristics 
Of the 429 men, 221 men (51.5%) had a primary partner. As shown in Table 6, 
three-quarters of the participants had a live-in relationship with their primary 
partner and a quarter of them were in a civil partnership. A significant proportion 
of men (51.6%) reported having an HIV negative primary partner and a further 8.1% 
of men did not know the HIV status of their primary partner. As explained in 
section 2.5.11.4, men who had an unknown or HIV negative primary partner were 
termed as being in a serodiscordant partnership. The majority of men were in a 
long-term partnership with their primary partner as reflected in the median number 
of years of the duration of partnership (7 years). While 6.4% of men had been in a 
partnership with a primary partner for less than a year and 17% of men for a year, 
the remaining three quarters had been in a partnership for more than a year. The 
median number of years since HIV diagnosis among these men was 9 years and 
the range was less than one year to 28 years.  
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Table 6. Nature of relationship with a primary partner (N=221)  
 Characteristics 
1
n/N % (95% CI) 
Live with primary partner   
Yes 160/216   74.1 (92.1-97.9) 
Civil partnership    
Yes  57/221  25.8 (19.9-31.6) 
HIV status of primary partner   
HIV positive 89/221   40.3 (33.8-46.8) 
HIV negative 114/221   51.6 (44.9-58.2) 
Untested/don’t know 18/221   8.1 (4.5-11.8) 
Duration of partnership (in years)   
<1  14/218  6.4 (3.1-9.7) 
1 37/218   16.9 (11.9-21.9) 
2-7 65/218   29.8 (23.7-35.9) 
8-13 51/218   23.4 (17.7-29.1) 
>13 51/218   23.4 (17.7-29.1) 
Median (range) years (N=218) 7 (0.1-34)  
Time since HIV diagnosis (years)   
<1 22/221  9.9 (5.9-13.9) 
1-5  36/221 16.3 (11.4-21.2) 
> 5 163/221   73.8 (67.9-79.6) 
Median (range) years (N=221) 9 (<1-34)  
1
Base varies due to item non-response 
 
Of the 221 men who reported having a primary partner, 20 (9.9%) men had been 
diagnosed with HIV less than a year ago. 14 (6.4%) men were in a partnership 
with their primary partner for less than six months. These 34 men were excluded 
from the analysis examining sexual behaviour with a primary partner in the last six 
months because as described in section 2.5.12, they may not have been diagnosed 
with HIV during that time frame or may not have been in a relationship with their 
primary partner during that time. Thus, 187 men were eligible for the analysis of 
sexual behaviour with a primary partner. Of these 187 men, 81 men (43.3%) had a 
seroconcordant primary partner and 106 (56.7%) were in a serodiscordant 
partnership.  
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3.3.6.1 Socio-demographic and HIV related characteristics and attitudes 
towards risk reduction strategies among men who had a primary 
partner 
The socio-demographic and HIV related characteristics of the187 eligible men 
who had a primary partner and the comparison of these characteristics between 
men in a serodiscordant and a seroconcordant partnership is presented in Table 7. 
The majority of men who had a primary partner were aged 35 and above, White 
(88%), born in the UK (61.5%), educated beyond secondary school (76.5%), 
employed (81.2%) and 93% of men were receiving cART. 86.5% of men self-
reported their perceived plasma viral load status to be undetectable. 96% of men 
had a CD4 cell count of >200 cells/mm
3
. The median number of years since HIV 
diagnosis was 10 and range was 3 to 28 years. 
The median duration of partnership was 8 years (range 1 to 34 years). 16.9% of 
men had been in a partnership for a year, 32% of men for 2-7 years, and the 
remaining 51% of men were in partnership for more than 7 years. The majority of 
men had disclosed their HIV status to their primary partner, but 4.3% of men had 
not disclosed their serostatus. 21.9% of men reported using recreational drugs 
during sex with their primary partner. 18.6% of men agreed or strongly agreed that 
having an undetectable viral load reduces the risk of onward HIV transmission 
during UAI. 15.2% of men believed that ‘HIV is unlikely to be transmitted if a HIV 
negative person has insertive anal intercourse without a condom with a HIV 
positive partner’, whereas 41% of men believed that withdrawal prior to 
ejaculation during UAI reduces the risk of HIV transmission.  
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Table 7. Socio-demographic, partnership, HIV-related characteristics of men 
with a primary partner and by primary partner’s HIV status  
Characteristics 
1,2
Overall 
(N=187) 
n/N (%) 
1,2
Seroconc-
ordant 
partnership 
(N=81)  
n/N (%) 
1,2
Serodiscor-
dant 
partnership 
(N=106) 
n/N (%) 
Unadjusted OR 
(95% CI) 
Serodiscordant 
vs. 
seroconcordant 
partnership 
Age    p=0.49 
<=34 24/183 (13.1) 13/80 (16.3) 11/103 (10.7) 1 
35-44 75/183 (40.9) 33/80 (41.3) 42/103 (40.8) 1.54 (0.60-3.93) 
>44 84/183 (45.9) 34/80 (42.5) 50/103 (48.5) 1.73 (0.69-4.33) 
Ethnicity    p=0.54 
White 162/184 (88.0) 70/81 (86.4) 92/103 (89.3) 1 
Non-White 22/184 (11.9) 11/81 (13.6) 11/103 (10.7) 0.76 (0.31-1.86) 
Country of birth    p=0.95 
Outside UK 72/187 (38.5) 31/81 (38.3) 41/106 (38.7) 1 
UK 115/187 (61.5) 50/81 (61.7) 65/106 (61.3) 0.98 (0.54-1.78) 
Education    p=0.47 
Beyond secondary 
school 
143/187 (76.5) 64/81 (79.0) 79/106 (74.5) 1 
Up to secondary school 44/187 (23.5) 17/81 (20.9) 27/106 (25.5) 1.29 (0.64-2.57) 
Employment status    p=0.11 
Not employed 35/186 (18.8) 11/81 (13.6) 24/105 (22.9) 1 
Employed 151/186 (81.8) 70/81 (86.4) 81/105 (77.1) 0.53 (0.24-1.16) 
cART status    p=0.43 
Not receiving cART 13/187 (6.9) 7/81 (8.6) 6/106 (5.7) 1 
Receiving cART 174/187 (93.1) 74/81 (91.4) 100/106 (94.3) 1.57 (0.50-4.89) 
Self-reported recent viral 
load status 
   p=0.34 
Detectable 25/185 (13.5) 13/80 (16.3) 12/105 (11.4) 1 
Undetectable 160/185 (86.5)  67/80 (83.8) 93/105 (88.6) 1.50 (0.64-3.50) 
Self-reported recent CD4 
cell count (cells/mm
3
) 
   p=0.41 
>=200  175/182 (96.1) 78/80 (97.5) 97/102 (95.1) 1 
<200 7/182 (3.9) 2/80 (2.5) 5/102 (4.9) 2.01 (0.37-10.64) 
Time since HIV diagnosis    p=0.09 
Median (range) years 10 (3-28) 9 (3-28) 11 (3-26) 1.04 (0.99-1.09) 
Duration of partnership 
(in years)  
   p=0.12 
1 31/184 (16.9) 16/80 (20.0) 15/104 (14.4) - 
2-7 59/184 (32.1) 31/80 (38.8) 28/104 (26.9) - 
8-13 48/184 (26.1) 16/80 (20.0) 32/104 (30.8) - 
>13 46/184 (25.0) 17/80 (21.3) 29/104 (27.9) - 
Median (range) years 8 (1-34) 5.5 (1-30) 9 (1-34) 1.02 (0.99-1.07) 
3
Disclosure of HIV status 
to primary partner 
   - 
Yes 178/186 (95.7) 81/81 (100) 97/105 (92.4) - 
Recreational drug use 
during sex 
   p=0.65 
Yes 41/187 (21.9) 19/81 (23.5) 22/106 (20.8) 0.85 (0.42-1.71) 
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Table 7. Continued     
Characteristics 
1,2
Overall 
(N=187) 
n/N (%) 
1,2
Seroconc-
ordant 
partnership 
(N=81)  
n/N (%) 
1,2
Serodiscor-
dant 
partnership 
(N=106) 
n/N (%) 
Unadjusted OR 
(95% CI) 
Serodiscordant 
vs. 
seroconcordant 
partnership 
Undetectable viral load 
in my blood means that 
HIV is unlikely to be 
passed on to a sexual 
partner even if we have 
unprotected anal sex 
   p=0.66 
Agree/strongly agree 34/183 (18.6) 16/80 (20.0) 18/103 (17.5) 1.18 (0.55-2.49) 
HIV is unlikely to be 
transmitted if a HIV 
negative person has 
insertive anal intercourse 
without a condom with a 
HIV positive partner  
   p=0.27 
Agree/strongly agree 28/187 (15.2) 15/81 (18.5) 13/103 (12.6) 0.64 (0.28-1.42) 
During anal sex 
withdrawing (pulling 
out) before ejaculation 
can reduce the risk of 
passing on HIV to sexual 
partner(s) 
   p=0.44 
Agree/strongly agree 76/184 (41.3) 36/81 (44.4) 40/103 (38.8) 0.79 (0.43-1.43) 
HIV is unlikely to be 
transmitted if HIV 
positive sexual partner 
ejaculates inside the 
mouth of a HIV negative 
sexual partner during 
oral sex 
   p=0.74 
Agree/strongly agree 50/184 (27.1) 21/81 (25.9) 29/103 (28.2) 1.11 (0.58-2.16) 
I can get infected with 
another strain of HIV if I 
have unprotected sex 
with a HIV positive 
sexual partner(s) 
   p=0.57 
Agree/strongly agree 149/184 (81.0) 64/81 (79.0) 85/103 (82.5) 1.25 (0.59-2.62) 
Missed cART dose in last 
two weeks 
   p=0.37 
Yes 21/172 (12.2) 7/73 (9.6) 14/99 (14.1) 1.56 (0.59-4.07) 
1
Includes only men who were diagnosed with HIV >1 year ago and the duration of partnership with 
primary partner was at least six months 
2
Base varies due to item non-response 
3
Univariate analysis was not be conducted because 100% of cases in one category, i.e., all men in a 
seroconcordant partnership had disclosed their HIV status to their primary partner 
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27% of men believed that insertive unsafe oral sex is not associated with the risk 
of HIV transmission. 81% of men believed that they could get infected with other 
strain of HIV if they engage in unprotected sex with an HIV positive partner. 
Approximately one in five men had missed at least one dose of cART in the last 
two weeks. Table 7 also indicates that during univariate analysis, there were no 
significant differences in the socio-demographic factors, HIV-related health, 
partnership related factors and attitudes towards HIV transmission risk reduction 
strategies and risk of re-infection with HIV among men who had a seroconcordant 
primary partner and who had a serodiscordant primary partner. Neither was there 
any difference in recreational drug use during sex and adherence to cART by 
primary partner’s HIV status.  
3.3.6.2 Overall sexual behaviour with primary partner in the last six months 
Of the 187 eligible men included in the analysis, 26.5% of men had not engaged in 
any sexual activity with their primary partner in the last six months, 15.7% of men 
were sexually active but had not engaged in AI, 15.7% of men had engaged only in 
receptive AI, 9.7% of men had engaged only in insertive AI and 32.4% of men had 
engaged in both insertive and receptive AI (Table 8). Overall, 69 men (37.5%) had 
engaged in UAI. 48% of men had engaged in receptive AI. 57 men (30.9%) had 
engaged in RUAI and 34 (18.4%) men had engaged only in RUAI with withdrawal 
prior to ejaculation. Overall, 42.2% of men had engaged in insertive AI, 27.2% of 
men engaged in IUAI, and 19.7% of men had engaged only in IUAI with 
withdrawal prior to ejaculation. 
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Table 8.  Overall sexual behaviour with a primary partner in the last six 
months (N=185) 
 
Type of sexual behaviour 
1,2
n/N % (95% CI) 
Sexual behaviour with a primary partner    
No sexual contact  49/185 26.5 (20.1-32.9) 
Sexual contact but no AI 31/185 15.7 (10.4-20.9) 
Has only insertive AI 19/185 9.7 (5.4-14.0) 
Has only receptive AI  32/185 15.7 (10.4-20.9) 
Has both receptive and insertive AI 66/185 32.4 (25.6-39.2) 
Any UAI 
Had UAI   
Yes 69/185  37.5 (30.4-44.6) 
Receptive AI 
Had receptive AI   
Yes 89/185  48.1 (40.8-55.4) 
Had RUAI (with or without withdrawal prior 
to ejaculation) 
  
Yes 57/185  30.9 (24.2-37.7) 
Had only RUAI with withdrawal prior to 
ejaculation 
  
Yes 34/185 18.4 (12.7-24.0) 
Insertive AI 
Had insertive AI   
Yes 78/185  42.2 (34.9-49.3) 
Had IUAI  (with or without withdrawal prior 
to ejaculation) 
  
Yes 50/184 27.2 (20.6-33.7) 
Had only IUAI with withdrawal prior to 
ejaculation 
  
Yes 36/183  19.7 (13.8-25.9) 
1
Base varies due to item non-response 
2
Includes only men who were diagnosed with HIV more than a year ago and were 
in a partnership with their primary partner for at least six months 
 
In the following sections, I present the results of analysis examining each of the 
hypotheses outlined in section 2.5.14.1. 
3.3.6.3 Association between a primary partner’s HIV status and sexual 
behaviour 
Hypothesis 1: HIV positive MSM who have a serodiscordant primary partner are 
less likely to engage in sexual behaviours perceived to increase the risk of HIV 
transmission compared to men who have a seroconcordant primary partner. 
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As indicated previously in table 7, there were no significant differences in the 
socio-demographic, HIV-related health and partnership related factors, or attitudes 
towards HIV transmission risk reduction strategies and risk of re-infection with 
HIV between men who had a serodiscordant or a seroconcordant primary partner. 
Neither were there any differences in recreational drug use or adherence to cART.  
As shown in Table 9, unadjusted analysis showed that men with a seroconcordant 
primary partner were as likely not to have any sexual contact with their primary 
partner (23.8%) as men in a serodiscordant partnership (28.6%). There was no 
significant difference by primary partner’s HIV status in the proportion of men 
engaging in only insertive (OR: 0.99 95% CI: 0.32-3.01) or only receptive AI (OR: 
0.89, 95% CI: 0.35-2.29), but men in a serodiscordant partnership were less likely 
to engage in both receptive and insertive AI (21.9%) compared to men in a 
seroconcordant partnership (46.3%) (OR: 0.39, 95% CI: 0.18-0.85; p=0.19).  
Overall, men who had a serodiscordant primary partner were less likely to engage 
in UAI (18.3%) compared to those who had a seroconcordant primary partner 
(62.5%) (OR: 0.13, 95% CI: 0.06-0.26; p<0.001) and this difference remained 
after adjusted multivariate analysis (AOR: 0.11, 95% CI: 0.05-0.25; p<0.001). 
156 
 
 
Table 9. Sexual behaviour with a primary partner in the last six months by 
primary partner’s HIV status 
 
1,2
Seroconc-
ordant 
status 
(N=84) 
n/N (%) 
1,2
Serodiscor-
dant status  
 
 
(N=106) 
n/N (%) 
Unadjusted OR 
(95% CI) 
(Serodiscordant 
vs. 
Seroconcordant) 
3
Adjusted OR 
(95% CI)  
(Serodiscordant 
vs. 
Seroconcordant) 
Sexual activity with a 
primary partner  
  p=0.19 - 
No sexual contact  19/80 (23.8) 30/105 (28.6) 1 - 
Had sexual contact 
but no AI 
5/80  (6.3) 24/105  (22.9) 3.04 (0.99-9.33) - 
Had only insertive 
AI 
7/80  (8.8) 11/105  (10.5) 0.99 (0.32-3.01) - 
Had only receptive 
AI  
12/80  (15.0) 17/105  (16.2) 0.89 (0.35-2.29) - 
Had both receptive 
and insertive AI 
37/80  (46.3) 23/105  (21.9) 0.39 (0.18-0.85) - 
Overall UAI 
Had UAI   p<0.001 p<0.001 
Yes 50/80 (62.5) 19/104 (18.3) 0.13 (0.06-0.26) 0.11 (0.05-0.25) 
Receptive AI 
Had receptive AI   p=0.002 p=0.01 
Yes 49/80 (61.3) 40/105 (38.1) 0.39 (0.21-0.71) 0.43 (0.22-0.83) 
4
Had RUAI   p=0.62 - 
Yes 42/50 (84.9) 15/19 (81.8) 0.71 (0.18-2.72) - 
4
Had RUAI only with 
withdrawal prior to 
ejaculation 
  p=0.46 - 
Yes 26/50 (52.0) 8/19 (42.1) 0.67 (0.23-1.95) - 
Insertive AI 
Had insertive AI   p=0.002 p=0.01 
Yes 44/80 (55.0) 34/105 (32.4) 0.39 (0.21-0.71) 0.41 (0.20-0.81) 
4
Had IUAI     p=0.02 p=0.05 
Yes 40/50 (80.0) 10/19 (52.6) 0.28 (0.09-0.87) 0.28 (0.08-1.02) 
4
Had IUAI only with 
withdrawal prior to 
ejaculation 
  p=0.10 p=0.11 
Yes 29/49 (59.2) 7/19 (36.8) 0.40 (0.13-1.19) 0.37 (0.11-1.22) 
Type of UAI 
4
Type of UAI (only 
among those who had 
UAI) 
  p=0.04 p=0.09 
Both insertive and 
receptive UAI 
32/50 (64.0) 6/19 (31.9) 1 1 
Only IUAI 8/50 (16.0) 4/19 (21.1) 2.66 (0.60-11.76) 2.40 (0.51-11.47) 
Only RUAI 10/50 (20.0) 9/19 (47.4) 4.8 (1.37-16.81) 4.53 (1.13-18.25) 
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Table 9. Continued      
 
1,2
Seroconc-
ordant 
status 
(N=84) 
n/N (%) 
1,2
Serodiscor-
dant status  
 
 
(N=106) 
n/N (%) 
Unadjusted OR 
(95% CI) 
(Serodiscordant 
vs. 
Seroconcordant) 
3
Adjusted OR 
(95% CI)  
(Serodiscordant 
vs. 
Seroconcordant) 
Other types of sexual activity 
Insertive unsafe oral 
sex 
  p=0.01 p=0.05 
Yes 21/81 (25.9) 12/106 (11.3) 0.36 (0.16-0.79) 0.45 (0.20-1.02) 
Receptive unsafe oral 
sex 
  p=0.92 - 
Yes 25/81 (30.9) 32/106 (30.2) 0.97 (0.51-1.81) - 
Insertive fisting   p=0.57 - 
Yes 8/81 (9.9) 8/106 (7.6) 0.74 (0.27-2.08) - 
Receptive fisting   p=0.18 - 
Yes 9/81 (11.1) 6/106 (5.7) 0.48 (0.16-1.41) - 
Participated in group 
sex with primary 
partner 
  p=0.02 p=0.03 
Yes 24/81 (29.6) 17/106 (16.0) 0.45 (0.21-0.92) 0.46 (0.22-0.95) 
Primary partner has 
other sex partners 
  p=0.03 p=0.01 
Yes 43/80 (53.8) 40/106 (37.7) 0.52 (0.28-094) 0.45 (0.24-0.84) 
Had new sex partners   p=0.06 p=0.86 
Yes 47/81 (58.0) 62/106 (58.5) 0.33 (0.10-1.08) 0.94 (0.52-1.74) 
5
Had UAI with new 
partners 
  p=0.12 p=0.22 
Yes 29/47 (61.7) 29/62 (46.8) 0.54 (0.25-1.18) 0.60 (0.27-1.35) 
1
Base varies due to item non-response 
2
Includes only men who reported were diagnosed with HIV more than a year ago and were in 
partnership for at least six months 
3
Adjusted for time since HIV diagnosis, duration of partnership and employment status  
4
 Includes only men who engaged in UAI 
-No adjusted analysis was conducted because the univariate association between the dependent 
variable and independent variable was not significant (p<0.2) 
5
Includes only men who had new sex partners 
 
With regards to receptive AI, men who had a serodiscordant primary partner were 
less likely to engage in receptive AI (38.1%) compared to men who had a 
seroconcordant primary partner (61.3%) (OR: 0.39, 95% CI: 0.21-0.71, p=0.002) 
and (AOR: 0.43, 95% CI: 0.22-0.83; p=0.01). However, among men who engaged 
in UAI with their primary partner, there was no significant difference by primary 
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partner’s HIV status and the practice of RUAI (OR: 0.71, 95% CI: 0.18-2.72; 
p=0.62). Neither was there any difference by primary partner’s HIV status and 
engagement in RUAI with withdrawal prior to ejaculation (OR: 0.67, 95% CI: 
0.23-1.95; p=0.46). Eight men who practised RUAI with withdrawal prior to 
ejaculation with their serodiscordant primary partner reported 48 episodes 
(median=5, IQR: 1-15). Thirteen men in a serodiscordant partnership who engaged 
in RUAI with ejaculation reported 230 episodes (median=10; IQR: 1-80). 
Overall, men with a serodiscordant primary partner were also less likely to engage 
in insertive AI (32.4%) compared to men with a seroconcordant primary partner 
(55%) (OR: 0.39, 95% CI: 0.21-0.71, p=0.002) and (AOR: 0.41, 95% CI: 0.20-
0.81; p=0.01). Among men who engaged in insertive AI, those in a serodiscordant 
partnership were less likely to engage in IUAI (52.6%) compared to men in a 
seroconcordant partnership (80%) (OR: 0.28, 95% CI: 0.09-0.87, p=0.02) and 
(AOR: 0.28, 95% CI: 0.08-1.02; p=0.05). Seven men in a serodiscordant 
partnership who practised IUAI with withdrawal prior to ejaculation reported 136 
episodes (median=10; IQR: 4-30). Four men in a serodiscordant partnership who 
engaged in IUAI with ejaculation reported 53 episodes.  
Men in a seroconcordant partnership were more likely to engage in both RUAI and 
IUAI (64%) compared to those in a serodiscordant partnership (31.9%). The latter 
were more likely to engage only in RUAI (47.4%) compared to the former (20%) 
(OR: 4.8, 95% CI: 1.37-16.81; p=0.04) and this difference remained after adjusted 
multivariate analysis, although the p-value was not significant (AOR: 4.53, 95% 
CI: 1.13-18.25; p=0.09). A smaller proportion of men in a serodiscordant 
partnership engaged in insertive unsafe oral sex (11.3%) compared to those in a 
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seroconcordant partnership (25.9%) (OR: 0.36, 95% CI: 0.16-0.79, p=0.01) and 
(AOR: 0.45, 95% CI: 0.20-1.02; p=0.05). However, there was no difference by 
primary partner’s HIV status and engagement in receptive unsafe oral sex (OR: 
0.97, 95% CI: 0.51-1.81, p=0.92). Similarly, there was no difference in the 
practice of insertive fisting (OR: 0.74, 95% CI: 0.27-2.08, p=0.57) or receptive 
fisting (OR: 0.48, 95% CI: 0.16-1.41, p=0.18). Men in a serodisconcordant 
partnership were less likely to engage in group sex along with their primary 
partner (16%) compared to men in a seroconcordant partnership (29.6%) (OR: 
0.45, 95% CI: 0.21-0.92, p=0.02) and (AOR: 0.46, 95% CI: 0.22-0.95; p=0.03). 
Men who had a serodiscordant primary partner were also less likely to report that 
their primary partner has other sexual partners (37.7%) compared to men who had 
a seroconcordant partner (53.8%) (OR: 0.52, 95% CI: 0.28-0.94, p=0.03) and this 
difference remained after adjusted analysis (OR: 0.45; 95% CI: 0.24-0.84; p=0.01). 
There was no difference by primary partner’s HIV status and reporting of new sex 
partners or engagement in UAI with new partners. 
3.3.6.4 Serodiscordant primary partner and type of UAI  
Hypothesis 2: Men who have a serodiscordant primary partner are more likely to 
engage in strategic positioning (i.e., RUAI compared to IUAI). 
The hypothesis that men who have a serodiscordant primary partner are more 
likely to practise RUAI (n=15/104; 14.4%) compared to IUAI (n=10/104; 9.6%) 
was not supported in this data (McNemar χ2: 1.92; p=0.17).  
3.3.6.5 Serodiscordant primary partner and type of unsafe oral sex 
Hypothesis 3: Men who have a serodiscordant primary partner are more likely to 
engage in receptive unsafe oral sex compared to insertive unsafe oral sex. 
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This hypothesis was supported as men with a serodiscordant primary partner were 
more likely to engage in receptive unsafe oral sex (n=32/106; 30.2%) compared to 
insertive unsafe oral sex (n=12/106; 11.3%) (McNemar χ2: 13.3; p=0.003).  
In the following sections, I examine the association between risky sexual 
behaviour among men who had a serodiscordant primary partner and attitudes 
towards HIV transmission risk reduction strategies.   
3.3.6.6 Association between attitudes towards reduced risk of HIV 
transmission due to undetectable viral load status and risky sexual 
behaviour with a serodiscordant primary partner 
Hypothesis 7: Men who believe that undetectable viral load reduces the risk of 
HIV transmission during UAI are more likely to engage in UAI compared to men 
who do not. 
As described in section 2.5.14.3, the outcome variable for this analysis was ‘UAI 
with a serodiscordant primary partner (versus no UAI with a serodiscordant 
primary partner)’. 105 men, who had a serodiscordant primary partner, were 
diagnosed with HIV more than a year ago, and the duration of their relationship 
with the primary partner was at least six months were included in this analysis. As 
reported previously in Table 9, of these 105 men who had a serodiscordant 
primary partner, 19 (18.3%) men engaged in UAI.  
As shown in Table 10, there was no univariate association between UAI with a 
serodiscordant primary partner and attitudes towards reduced risk of HIV 
transmission during UAI due to undetectable viral load status (OR: 2.97; 95% CI: 
0.93-9.48, p=0.06). Self-reported viral load status, age, time since HIV diagnosis, 
and disclosure of HIV status to a primary partner were also not associated with the 
outcome variable of interest.  
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Table 10. Association between attitudes towards reduced risk of HIV 
transmission due to undetectable viral load and UAI with a serodiscordant 
primary partner (N=104) 
Factors Factor 
distri-bution 
in sample 
Had UAI 
(versus no 
UAI)  
Had UAI (versus 
no UAI) 
Unadjusted OR 
Had UAI (versus 
no UAI)   
Adjusted OR  
 
1,2
n/N (%) n (%) p-value 
(95% CI) 
p-value 
(95% CI) 
Undetectable viral load 
in my blood means 
that HIV is unlikely to 
be passed on to a 
sexual partner even if 
we have unprotected 
anal sex 
  p=0.06 p=0.01 
Disagree/strongly 
disagree/unsure 
84/103 (83.2) 13 (15.5) 1 1 
Agree/strongly agree 17/103 (16.8) 6 (35.3) 2.97 (0.93-9.48) 6.90 (1.51-31.36) 
Age   p=0.49 p=0.20 
<=34 10/101 (9.9) 3 (30.0) 1 1 
35-44 42/101 (41.6) 6 (14.3) 0.38 (0.07-1.93) 0.39 (0.06-2.41) 
>=45 49/101 (48.5) 10 (20.4) 0.59 (0.13-2.73) 1.52 (0.25-9.21) 
Duration of 
partnership (years) 
  p=0.003 p=0.002 
Median (IQR)  9/104 (2-14) 2 (1-5) 0.84 (0.76-0.95) 0.81 (0.71-0.92) 
Time since HIV 
diagnosis 
  p=0.98 - 
Median (IQR) years 11/105       
(8-16) 
12             
(8-19) 
1.04             
(0.95-1.13) 
- 
Disclosed HIV status    p=0.16 p=0.49 
No 8/103 (7.8) 3 (37.5) 1 1 
Yes 95/103 (92.2) 16 (16.8) 0.34 (0.07-1.55) 0.47 (0.05-3.91) 
Recreational drug use 
during sex  
  p=0.05 p=0.02 
No 83 (79.8) 12 (14.5) 1 1 
Yes 21 (20.2) 7 (33.3) 2.95 (0.99-8.84) 4.84 (1.18-19.84) 
Self-reported viral 
load status 
  p=0.35 - 
Detectable 12/104 (11.7) 1 (8.3) 1 - 
Undetectable 91/104 (88.4) 18 (17.5) 2.71 (0.32-22.39) - 
3
On cART   -  
No 6/104 (5.8) 0 (0.0) - - 
Yes 98/104 (94.2) 19 (18.3) - - 
1
Includes only men who had a serodiscordant primary partner 
2
Base varies due to item non-response 
3
No OR was calculated due to zero cases in a category. 
 
 
However, duration of partnership and recreational drug use during sex were 
associated with UAI with a serodiscordant primary partner. Every year increase in 
the duration of partnership with a serodiscordant primary partner was associated 
with a reduced risk of UAI (OR: 0.84; 95% CI: 0.76-0.95; p=0.003). Men who 
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used recreational drugs during sex with a serodiscordant primary partner were 
more likely to engage in UAI compared to men who did not use recreational drugs 
during sex (OR: 2.95; 95% CI: 0.99-8.84; p=0.05), although the 95% CI includes 
the null value.   
In the multivariate analysis, after adjusting for factors associated with the outcome 
variable of interest (p<0.2), men who agreed that undetectable viral load reduces 
the risk of HIV transmission during UAI were more likely to engage in UAI with a 
serodiscordant primary partner compared to men who did not (AOR: 6.90; 95% CI: 
1.52-31.37; p=0.01), however the 95% CI is wide. Men who had a shorter duration 
of partnership were also more likely to engage in UAI with a serodiscordant 
primary partner compared to men who had a longer duration of partnership (AOR: 
0.81; 95% CI: 0.71-0.92; p=0.002). Men who used recreational drugs during sex 
were more likely to engage in UAI with a serodiscordant primary partner 
compared to men who did not (AOR: 4.84; 95% CI: 1.18-19.84; p=0.02).  
It was not possible to check for interaction between beliefs about reduced 
infectivity during UAI due to undetectable viral load status and self-reported 
perceived viral load status due to the small number of men with a detectable viral 
load who had engaged in UAI with a serodiscordant primary partner, i.e., one. 
Thus the lack of association between self-reported viral load status and UAI 
should be interpreted with caution. 
In the following section I present the results of the analysis for hypothesis 8 to 10 
specified earlier in section 2.5.14.3.  
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3.3.6.7 Association between attitudes towards reduced risk of HIV 
transmission due to strategic positioning and RUAI with a 
serodiscordant primary partner 
Hypothesis 8: Men who believe that strategic positioning reduces the risk of HIV 
transmission are more likely to engage in RUAI than men who do not. 
As reported in Table 9, 15 (14.4%) men had engaged in RUAI with a 
serodiscordant primary partner. As shown in Table 11, there was no univariate 
association between beliefs related to reduced risk of HIV transmission due to 
strategic positioning during UAI and engagement in RUAI with a serodiscordant 
primary partner (OR: 3.54; 95% CI: 0.91-13.76; p=0.06). However, in univariate 
analysis shorter duration of partnership with a primary partner, and agreeing that 
there is a reduced risk of HIV transmission during UAI due to undetectable viral 
load status were independently associated with RUAI with a serodiscordant 
primary partner.  
In the multivariate analysis, as shown in Table 11, there continued to be no 
association between attitudes towards reduced risk of HIV transmission due to 
strategic positioning and engagement in RUAI with a serodiscordant primary 
partner (AOR: 2.18; 95% CI: 0.43-11.11; p=0.34). However, duration of 
partnership, and attitudes towards reduced risk of HIV transmission due to 
undetectable viral load status continued to be independently associated with RUAI 
with a serodiscordant primary partner. Men who had a longer duration of 
partnership were less likely to engage in RUAI with a serodiscordant primary 
partner compared to men who had a shorter duration of partnership (AOR: 0.86; 
95% CI: 0.76-0.98; p=0.02). Men who believed that the risk of HIV transmission 
is reduced during UAI due to undetectable viral load status were also more likely 
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to engage in RUAI with a serodiscordant primary partner compared to men who 
did not (AOR: 5.35; 95% CI: 1.29-22.10; p=0.02).  
  
1
6
5
 
Table 11. Association between beliefs about risk reduction strategies and risky sexual behaviours among men with a serodiscordant 
status primary partner (N=104) 
Risk reduction strategy of interest Factor  
distribution 
in sample 
Outcome variables of interest Unadjusted OR  
 
Adjusted OR  
 
 
1
n/N (%) n (%) p-value 
(95% CI) 
p-value 
(95% CI) 
2
 HIV is unlikely to be transmitted if a HIV 
negative person has insertive anal intercourse 
(he is doing the fucking) without a condom 
with a HIV positive partner 
 
RUAI (versus no RUAI) p=0.06 p=0.34 
Disagree/strongly disagree/unsure 89/101 (88.1) 11 (12.4) 1 1 
Agree/strongly agree 12/101 (11.9) 4 (33.3) 3.54 (0.91-13.76) 2.18 (0.43-11.11) 
3 
During anal sex withdrawing before 
ejaculation (cumming) can reduce the risk of 
passing on HIV to sexual partner(s) 
 
IUAI with withdrawal prior to 
ejaculation (versus no IUAI with 
withdrawal prior to ejaculation) 
p=0.01 - 
Disagree/strongly disagree/unsure 62/102 (60.8) 1 (1.6) 1 - 
Agree/strongly agree 40/102 (39.2) 6 (15.0) 10.8 (1.24-93.2) - 
During anal sex withdrawing before 
ejaculation (cumming) can reduce the risk of 
passing on HIV to sexual partner(s) 
 
RUAI with withdrawal prior to 
ejaculation (versus no RUAI with 
withdrawal prior to ejaculation) 
p=0.92 - 
Disagree/strongly disagree/unsure 62/102 (60.8) 5 (8.1) 1 - 
Agree/strongly agree 40/102 (39.2)
 
3 (7.5) 0.92 (0.21-4.10) - 
  
1
6
6
 
Table 11. Continued     
Risk reduction strategy of interest Factor 
distribution 
in sample 
Outcome variables of interest Unadjusted OR  
 
Adjusted OR  
 
 
1 
n/N (%) n (%) p-value 
(95% CI) 
p-value 
(95% CI) 
4
HIV is unlikely to be transmitted if HIV 
positive sexual partner ejaculates inside the 
mouth of a HIV negative sexual partner during 
oral sex 
 
Insertive unsafe oral sex (versus no 
insertive unsafe oral sex) 
p=0.02 - 
Disagree/strongly disagree/unsure 74/103 (71.8) 5 (6.8) 1 - 
Agree/strongly agree 29/103 (28.2) 7 (24.1) 4.39 (1.26-15.23) - 
1
N varies due to item non-response 
2
Adjusted for duration of partnership, attitudes towards reduced risk of HIV transmission during UAI due to undetectable viral load, and recreational 
drug use during sex 
3
Multivariate analysis was not conducted due to the small number of cases 
4
Multivariate analysis was not conducted because the outcome variable of interest was not associated with any socio-demographic, HIV-related or 
partnership related factors.
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3.3.6.8 Association between attitudes towards withdrawal prior to 
ejaculation during UAI and UAI with a serodiscordant primary 
partner 
Hypothesis 9: Men who believe that withdrawal prior to ejaculation during UAI 
reduces the risk of HIV transmission are more likely to engage in IUAI/RUAI with 
withdrawal prior to ejaculation compared to men who do not. 
As reported previously in Table 9, 7 (6.7%) men had engaged in IUAI with 
withdrawal prior to ejaculation, and 8 (7.6%) men had engaged in RUAI with 
withdrawal prior to ejaculation with a serodiscordant primary partner. In univariate 
analysis, both, engagement in IUAI with withdrawal prior to ejaculation during 
UAI and RUAI with withdrawal prior to ejaculation during UAI were associated 
with shorter duration of partnership and recreational drug use during sex.  
As shown in Table 11, men who believed that withdrawal before ejaculation 
during UAI reduces the risk of HIV transmission were more likely to engage in 
IUAI with withdrawal before ejaculation than men who do not (OR: 10.8; 95% CI: 
1.24-93.2; p=0.01). However, it was not possible to conduct a multivariate analysis 
adjusting for duration of partnership and recreational drug use due to the small 
number of cases, i.e., only one man who did not believe that withdrawal before 
ejaculation during UAI reduces the risk of HIV transmission engaged in IUAI with 
withdrawal prior to ejaculation.  
There was no association between beliefs about reduced risk of HIV transmission 
due to withdrawal prior to ejaculation and engagement in RUAI with withdrawal 
before ejaculation (OR: 0.92; 95% CI: 0.21-4.10; p=0.92).  
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3.3.6.9 Association between attitudes that there is no risk of HIV 
transmission due to unsafe insertive oral sex and engagement in 
unsafe insertive oral sex with a serodiscordant primary partner 
Hypothesis 10: Men who believe that HIV is unlikely to be transmitted during 
unsafe insertive oral sex are more likely to engage in this behaviour compared to 
men who do not. 
As reported previously in Table 9, 12 (11.3%) men engaged in unsafe insertive 
oral sex with a serodiscordant primary partner. As shown in Table 11, men who 
believed that HIV is unlikely to be transmitted during insertive unsafe oral sex 
were more likely to practise it compared to those who did not (OR: 4.39; 95% CI: 
1.26-15.23; p=0.02). In the univariate analysis, the outcome variable of interest 
was not associated with any socio-demographic, HIV related health or partnership 
related factors, thus adjusted analysis was not conducted. 
In the following section, I describe the sexual behaviour of the participants with 
their most recent non-primary partner in the last year.  
3.3.7 Sexual behaviour with a most recent non-primary sex 
partner  
As mentioned previously in 2.5.11.5, if the ‘most recent’ of the three recent sex 
partners of the participant was not their primary partner but was either a regular, 
casual, or other type of sex partner, then this partnership was defined as ‘most 
recent non-primary partnership’. Of the 380 men who were diagnosed with HIV 
more than a year ago, 198 (52%) men reported that their most recent sex partner 
was a non-primary partner.  
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3.3.7.1 Type of partnership, HIV status and type of sex with the most recent 
non-primary partner  
Data on HIV status of the most recent non-primary partner was available for 188 
of the 198 men whose most recent sex partner was a non-primary partner. Of these 
188 men, a significant proportion of them were of unknown HIV status (61.7%), 
10.6% were HIV negative partner and 27.7% were HIV positive. Therefore, 
overall 72.3% of men had a serodiscordant most-recent non-primary partner. The 
majority of men (42.8%) reported that their most recent non-primary partner was a 
regular partner. 29.9% of men reported that their recent non-primary partner was a 
known casual partner and 27.3% of men’s most recent non-primary partner was an 
anonymous casual partner.  
As shown in Table 12, among men whose most recent non-primary partner was a 
regular partner, 36.2% of men reported that he was HIV positive, 16.3% of men 
reported him to be HIV negative and 47.5% of men did not know his HIV status. 
A high proportion of men did not know the HIV status of their most recent non-
primary partner if he was an anonymous casual partner (90.2%) compared to if he 
was a regular (47.5%) or a known casual partner (57.1%).  Similarly, men whose 
most recent non-primary partner was an anonymous casual partner were less likely 
to report that he was HIV negative (2.0%) compared to men whose most recent 
partner was a regular partner (16.3%) or a known casual partner (10.7%).  
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Table 12. Type of partnership and HIV status of the most recent non-primary 
partner (N=187) 
Factors HIV positive 
 
(n=51) 
HIV 
negative 
(n=20) 
Unknown 
HIV status 
(n=116) 
p-value 
Type of partner    p<0.001 
Regular  29 (36.2) 13 (16.3) 38 (45.5)  
Known casual  18 (32.1) 6 (10.7) 32 (57.1)  
Anonymous casual  4 (7.8) 1 (2.0) 46 (90.2)  
 
Of the 198 men, 67% of men had engaged in one-to-one sex, whereas 33% of men 
had engaged in sex with their most recent non-primary partner in a group sex 
context. As shown in Table 13, men who had engaged in group sex were more 
likely to report that their ‘main’ group sex non-primary partner was HIV positive 
(40.0%) compared to men who engaged in one-to-one sex (22.6%). Men who had 
engaged in one-to-one sex were more likely to report that their most recent non-
primary partner was HIV negative (12.8%) compared to men who had engaged in 
group sex (5.5%). 64.7% of men had one-to-one sex with an unknown HIV status 
non-primary partner, whereas 54.6% of men reported that their main group sex 
non-primary partner was of unknown HIV status.  
As shown in Table 13, there were also differences in the type of partnership among 
men who had one-to-one sex and those who had engaged in group sex. The 
majority of men who had had one-to-one sex with their most recent non-primary 
partner reported that he was a regular partner (46.6%); whereas 33.3% of men who 
had engaged in group sex reported that he was a regular partner. Men who had 
engaged in group sex were more likely to report that their main group sex partner 
was an anonymous casual partner (40.7%) compared to men who engaged in one-
to-one sex (21.8%). Similarly men who engaged in one-to-one sex were more 
171 
 
likely to report that their partner was a known casual partner (31.6%) compared to 
men who had engaged in group sex (25.9%).  
Table 13. HIV status and type of partnership by nature of sexual activity with 
the most recent non-primary partner (N=187) 
Factors One-to-one 
sex (N=133) 
n (%) 
Group sex 
(N=54) 
n (%) 
p-value 
 
 
HIV status    0.03 
HIV positive 30 (22.6) 22 (40.0)  
HIV negative 17 (12.8) 3 (5.5)  
HIV unknown/untested 86 (64.7) 30 (54.6)  
Type of partner   0.03 
Regular  62 (46.6) 18 (33.3)  
Known casual  42 (31.6) 14 (25.9)  
Anonymous casual  29 (21.8) 22 (40.7)  
 
3.3.7.2 Disclosure of HIV status to the most recent non-primary partner by 
type of sex  
Overall, 44.7% of men had themselves directly disclosed their HIV status to their 
most recent non-primary partner, 8.4% of men had assumed that their partner 
knew their HIV status and a further 46.9% of men considered it unimportant to 
disclose their HIV status to their partner. As shown in Table 14, men were more 
likely to have themselves directly disclosed their HIV status to a regular partner 
with whom they had engaged in one-to-one sex (62.7%) compared to a known 
casual partner (47.6%) or an anonymous partner (7.4%). A high proportion of men 
considered it unimportant to disclose their HIV status to an anonymous casual 
partner (85.2%) compared to a regular partner (30.5%) and a known casual partner 
(47.6%). Irrespective of the partnership type, approximately 5-7% of men assumed 
that their most recent non-primary partner knew their HIV status.  
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Table 14 also shows that men were more likely to have directly disclosed their 
HIV status themselves to a regular group sex partner (64.7%) compared to a 
known casual (38.5%) or an anonymous (20.0%) group sex partner. Men were 
more likely to assume that a known casual group sex partner knew their HIV status 
(46.2%) compared to a regular group sex partner (5.9%). A high proportion of men 
felt that it is not important to disclose their HIV status to an anonymous group sex 
non-primary partner (80.0%) compared to a regular group sex partner (29.4%) and 
a known casual partner (15.4%). 
 
  
1
7
3
 
Table 14. Disclosure of HIV status to the most recent non-primary partner by type of sexual activity (N=178) 
Disclosure of HIV status  One-to-one sex (N=128) 
n (%) 
 Group sex (N=50) 
n (%) 
 
 Told 
himself 
Assumed 
partner 
knows 
his status 
Felt it is not 
important to 
disclose his 
status 
p-value Told 
himself 
Assumed 
partner 
knows 
his status 
Felt it is not 
important to 
disclose his 
status 
p-value 
Type of partner    p<0.001    p<0.001 
Regular  37 (62.7) 4 (6.8) 18 (30.5)  11 (64.7) 1 (5.9) 5 (29.4)  
Known casual  20 (47.6) 2 (4.8) 20 (47.6)  5 (38.5) 6 (46.2) 2 (15.4)  
Anonymous casual  2 (7.4) 2 (7.4) 23 (85.2)  4 (20.0) 0 16 (80.0)  
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3.3.7.3 Venue of meeting the most recent non-primary partner 
As shown in Table 15, men had met their most recent non-primary partner in 
various venues. Overall, the majority of men had met their partner via the internet 
(34.8%) followed by a bar (15.7%) and a sauna (11.2%). Some men had met their 
most recent non-primary partner in a sex venues such as a sex on premises venue 
(7.3%), cruising ground (7.3%), or a leather club (1.1%). 6.7% of men had met 
their partner through friends. Some men reported that they met him outside 
London (5.1%).  
Table 15. Venue of meeting the most recent non-primary partner  
Venue 
1
Overall  
 
(N=183) 
One-to-one 
partner 
(N=126) 
Group sex 
partner 
(N=54) 
 
n (%) n (%) n (%) 
Internet 62 (34.8) 48 (39.7) 13 (24.1) 
Bar 28 (15.7) 23 (19.0) 4 (7.4) 
Backroom 3 (1.7) 1 (0.8) 2 (3.7) 
Toilet 4 (2.3) 2 (1.7) 2 (3.7) 
College 2 (1.1) 2 (1.7) 0 (0.0) 
Sauna 20 (11.2) 10 (8.3) 10 (18.5) 
Private party 6 (3.4) 2 (1.7) 4 (7.4) 
Gymnasium 1 (0.6) 0 (0.0) 1 (1.9) 
Telechat 3 (1.7) 1 (0.8) 1 (1.9) 
Sex on premises venue 13 (7.3) 5 (4.1) 8 (14.8) 
Cruising ground 13 (7.3) 8 (6.6) 5 (9.3) 
Leather club 2 (1.1) 1 (0.8) 1 (1.9) 
Through friend 12 (6.7) 11 (9.1) 1 (1.9) 
Outside London 9 (5.1) 7 (5.8) 2 (3.7) 
Known partners 5 (2.8) 5 (3.4) 0 (0.0) 
1
Data missing for 15 participants 
  
 
The majority of men who had engaged in one-to-one or group sex had met their 
partner via the internet, 39.7% and 24% respectively. However, a high proportion 
of men had met their group sex partner in a sauna (18.5%) or a sex on premise 
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venue (14.8%) whereas 8.3% and 4.1% of men respectively who had one-to-one 
sex had met their partner in these venues.  
3.3.7.4 Sexual behaviour with the most recent non-primary partner: overall 
and by type of sexual activity 
As indicated in Table 16, overall 25.3% of men had engaged in UAI with their 
most recent non-primary partner. Approximately 14% of men had engaged in 
RUAI.  
Table 16. Sexual behaviour with the most recent non-primary partner: 
overall and by type of sexual activity 
Type of sexual 
behaviour 
Overall 
 
 (N=194) 
 
One-to-one 
partner 
(N=130) 
 
Group sex 
partner 
(N=64) 
 
 p-value 
(one-to-
one 
versus 
group 
sex) 
 n (%) n (%) n (%)  
UAI 49 (25.3) 29 (22.3) 20 (31.3) p=0.21 
RUAI (with or 
without withdrawal 
prior to ejaculation) 
28 (14.4) 14 (10.8) 14 (21.9) p=0.05 
RUAI only with 
withdrawal prior to 
ejaculation 
10 (5.2) 7 (5.4) 3 (4.7) p=1.00 
IUAI (with or without 
withdrawal prior to 
ejaculation) 
34 (17.5) 21 (16.2) 13 (20.3) p=0.54 
IUAI only with 
withdrawal prior to 
ejaculation 
14 (7.2) 10 (7.7) 4 (6.3) p=1.00 
Fisting 13 (6.7) 6 (4.6) 7 (10.9) p=0.09 
Unsafe insertive oral 
sex 
9 (4.6) 6 (4.6) 3 (4.7) p=1.00 
Unsafe receptive oral 
sex 
26 (13.4) 20 (15.4) 6 (9.4) p=0.27 
Recreational drug use 
during sex 
103 (55.9) 70 (53.9) 33 (61.1) p=0.41 
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5.2% of men had engaged only in RUAI with withdrawal prior to ejaculation. 17.5% 
of men who engaged in IUAI and 7.2% of men had engaged only in IUAI with 
withdrawal prior to ejaculation 6.7% of men had engaged in fisting. As shown in 
Table 16, men were more likely to have engaged in unsafe receptive oral sex 
(13.4%) compared to unsafe insertive oral sex (4.6%). Recreational drug use 
during sex was high (55.9%).  
Univariate analysis showed that there were no significant differences in the 
engagement in risky behaviours by type of sexual activity (one-to-one or group 
sex), except men who had engaged in group sex were more likely to have engaged 
in RUAI compared to men who had one-to-one sex (21.9% vs. 10.8%; p=0.05). 
In the following sub-section, I examine the association between sexual behaviour 
and HIV status of the most recent non-primary partner. 
3.3.7.5 Association between the most recent non-primary partner’s HIV 
status and sexual behaviour 
Hypothesis 4: HIV positive MSM whose most recent non-primary partner was of 
serodiscordant status were less likely to have engaged in sexual behaviours that 
increase the risk of HIV transmission compared to men who had a seroconcordant 
status most recent non-primary partner.  
Table 17 describes the association between the potential confounding factors 
described in section 2.5.14.2 and HIV status of the most recent non-primary 
partner.  There were no significant differences in the age, cART status, viral load 
status, whether met partner via the internet, recreational drug use during sex, and 
beliefs about reduced risk of HIV transmission due to engagement in strategic 
positioning, unsafe insertive oral sex, practising withdrawal prior to ejaculation 
during UAI and the HIV status of the most recent non-primary partner.  
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Table 17. Socio-demographic, HIV related factors and attitudes towards HIV 
transmission risk reduction strategies by HIV status of the most recent non-
primary partner (N=187) 
Characteristics Seroconc-
ordant  
(n=51) 
Serodiscor
-dant 
(n=136) 
Unadjusted OR 
(95% CI) 
(Serodiscordant 
vs. 
Seroconcordant) 
 n (%) n (%)  
Age   p=0.65 
<=34 7 (13.7) 13 (9.7) 1 
35-44 23 (45.1) 58 (43.3) 1.35 (0.48-3.83) 
>44 21 (41.2) 63 (47.0) 1.61 (0.56-4.58) 
cART status   p=0.10 
Not receiving cART 13 (25.0) 20 (14.7) 1 
Receiving cART 39 (75.0) 116 (85.3) 1.93 (0.88-4.25) 
Self-reported recent viral load status   p=0.32 
Detectable 12 (24.5) 23 (17.8) 1 
Undetectable 37 (75.5) 106 (82.2) 1.49 (0.67-3.29) 
Recreational drug use during sex   p=0.07 
Yes 34 (66.7) 71 (52.2) 0.54 (0.27-1.07) 
Undetectable viral load in my blood 
means that HIV is unlikely to be passed 
on to a sexual partner even if we have 
unprotected anal sex 
  p=0.02 
Agree/strongly agree 16 (31.4) 20 (15.0) 0.39 (0.18-0.84) 
HIV is unlikely to be transmitted if a 
HIV negative person has insertive anal 
intercourse without a condom with a 
HIV positive partner 
  p=0.96 
Agree/strongly agree 8 (15.7) 21 (15.7) 1.02 (0.42-2.48) 
During anal sex withdrawing (pulling 
out) before ejaculation can reduce the 
risk of passing on HIV to sexual 
partner(s) 
  p=0.89 
Agree/strongly agree 21 (42.0) 56 (42.1) 0.95 (0.49-1.84) 
HIV is unlikely to be transmitted if HIV 
positive sexual partner ejaculates inside 
the mouth of a HIV negative sexual 
partner during oral sex 
  p=0.78 
Agree/strongly agree 16 (32.0) 39 (29.3) 0.90 (0.45-1.82) 
Met partner via internet   p=0.18 
Yes 21 (40.4) 41 (30.2) 0.63 (0.32-1.23) 
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However, men whose the most recent non-primary was of serodiscordant status 
were less likely to believe that having an undetectable viral load reduces the risk of 
HIV transmission during UAI compared to men who had a seroconcordant most 
recent non-primary partner. 
As shown in Table 18, men with the most recent serodiscordant non-primary 
partner were less likely to have engaged in UAI (16.9%) compared to men who 
had a seroconcordant non-primary partner (54.9%) (OR: 0.16, 95% CI: 0.08-0.32; 
p<0.001) and this difference remained after adjusted multivariate analysis (AOR: 
0.21; 95% CI: 0.10-0.45). Similarly men with a serodiscordant non-primary 
partner were also less likely to have engaged in IUAI (9.6%) compared to men 
whose non-primary partner was of a seroconcordant status (43.1%) (OR: 0.14; 95% 
CI: 0.65-0.31; p<0.001) and (AOR: 0.17; 95% CI: 0.07-0.40; p=0.002). However, 
there was no significant difference in the practice of IUAI with withdrawal prior to 
ejaculation and HIV status of the most recent non-primary partner (OR: 0.66; 95% 
CI: 0.21-2.09; p=0.48).  
Men with a serodiscordant status non-primary partner were less likely to have 
engaged in RUAI (9.6%) compared to men whose non-primary partner was of a 
seroconcordant status (31.4%) (OR: 0.21; 95% CI: 0.09-0.49; p<0.001) and (AOR: 
0.24; 95% CI: 0.10-0.59; p=0.002). However, there was no significant difference 
in the practice of RUAI with withdrawal prior to ejaculation and HIV status of the 
most recent non-primary partner (OR: 0.51; 95% CI: 0.15-1.68; p=0.27). Men who 
had a serodiscordant non-primary partner were less likely to have engaged in 
insertive unsafe oral sex (1.5%) compared to those who had a seroconcordant non-
primary partner (13.7%) (OR: 0.09; 95% CI: 0.02-0.48; p=0.004) and (AOR: 0.11; 
95% CI: 0.02-0.59; p=0.01). However, there was no significant difference in the 
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practice of fisting or receptive unsafe oral sex by HIV status of the non-primary 
partner.  
Table 18. Sexual behaviour with the most recent non-primary partner by 
partner’s HIV status (N=187) 
 Serocon-
cordant 
(n=51) 
Serodis-
cordant 
(n=136) 
Unadjusted OR 
(95% CI) 
(Serodiscordant 
vs. 
Seroconcordant) 
1
Adjusted OR 
(95% CI) 
(Serodiscordant 
vs. 
Seroconcordant) 
 n (%) n (%)   
UAI   p<0.001 p<0.001 
Yes 28 (54.9) 23 (16.9) 0.16 (0.08-0.32) 0.21 (0.10-0.45) 
Insertive UAI   p<0.001 p=0.002 
Yes 22 (43.1) 13 (9.6) 0.14 (0.05-0.31) 0.17 (0.07-0.40) 
IUAI with 
withdrawal prior to 
ejaculation 
  p=0.48 - 
Yes 5 (9.8) 9 (6.6) 0.66 (0.21-2.09) - 
RUAI   p<0.001 p<0.001 
Yes 16 (31.4) 13 (9.6) 0.21 (0.09-0.49) 0.24 (0.10-0.59) 
RUAI with 
withdrawal prior to 
ejaculation 
  p=0.27 - 
Yes 4 (7.8) 7 (5.2) 0.51 (0.15-1.68) - 
Insertive unsafe oral 
sex 
  p=0.004 p=0.01 
Yes 7 (13.7) 2 (1.5) 0.09 (0.02-0.48) 0.11 (0.02-0.59) 
Receptive unsafe 
oral sex 
  p=0.39 - 
Yes 9 (17.7) 17 (12.5) 0.68 (0.28-1.64) - 
Fisting   p=0.37 - 
Yes 5 (9.8) 8 (5.9) 0.58 (0.18-1.88) - 
1
Adjusted for age, recreational drug use during sex, attitudes that HIV is unlikely to 
be transmitted during UAI due to undetectable viral load, and cART status 
 
In the following section, I examine the association between type of sexual 
behaviour and having a serodiscordant status most recent non-primary partner. 
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3.3.7.6 Serodiscordant most recent non-primary partner and type of UAI 
Hypothesis 5: Men who have a serodiscordant non-primary partner are more likely 
to engage in strategic positioning (i.e, RUAI compared to IUAI). 
Of the 187 men who had a most recent non-primary partner, 136 (72.3%) men had 
a serodiscordant status partner. There was no evidence to support the hypothesis 
that men are more likely to have engaged in RUAI (9.6%) compared to IUAI 
(9.6%) with their most recent serodiscordant non-primary partner to reduce the 
risk of HIV transmission (McNemar χ2: 0.01; p=1.00).  
3.3.7.7 Serodiscordant most recent non-primary partner and type of unsafe 
oral sex 
Hypothesis 6: Men who have a serodiscordant non-primary partner are more likely 
to engage in receptive unsafe oral sex than insertive unsafe oral sex. 
There was support for this hypothesis. Men with the most recent serodiscordant 
non-primary partner were more likely to have engaged in receptive unsafe oral sex 
(12.5%) compared to insertive unsafe oral sex (1.5%) (McNemar χ2: 11.84, 
p=0.0006).  
In the following section, I examine the association between attitudes towards 
various HIV transmission risk reduction strategies and risky sexual behaviour with 
the most recent serodiscordant non-primary partner. 
3.3.7.8 Association between attitudes towards reduced risk of HIV 
transmission during UAI due to undetectable viral load status and 
risky sexual behaviour with the most recent serodiscordant non-
primary partner 
In this sub-section, I examine hypothesis 7: Men who believe that undetectable 
viral load reduces the risk of HIV transmission are more likely to engage in UAI 
compared to men who do not. 
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Of the 136 men who had a serodiscordant most recent non-primary partner, as 
mentioned in Table 18, 23 men (16.9%) had engaged in UAI with their most 
recent serodiscordant non-primary partner. Of these 16.9% of men who had 
engaged in UAI, 7.4% of men did so with a regular partner, 5.9% of men with a 
known casual partner and 3.6% of men with an anonymous casual partner. There 
was no difference between type of sex partner and engagement in UAI with 
serodiscordant partner (Pearson’s χ2=20.4; p=0.36).  
As shown in Table 19, there was no univariate association between UAI with the 
most recent serodiscordant non-primary partner and beliefs about the reduced risk 
of HIV transmission during UAI due to undetectable viral load status (OR: 2.42; 
95% CI: 0.82-7.17; p=0.11). Neither was there an association between UAI with a 
most recent serodiscordant non-primary partner and cART status (OR: 2.49; 95% 
CI: 0.84-7.39; p=0.09) or self-reported plasma viral load status (OR: 0.69; 95% CI: 
0.22-1.20; p=0.51). There was also no association between age, time since HIV 
diagnosis, whether had met partner via the internet and UAI with the most recent 
serodiscordant non-primary partner. Recreational drug use during sex, and 
disclosure of HIV status were independently associated with UAI with the most 
recent serodiscordant status non-primary partner. Men who had used recreational 
drugs during sex were more likely to have engaged in UAI compared to men who 
did not (OR: 3.09, 95% CI: 1.14-8.42; p=0.02). Men who had directly disclosed 
their HIV status to their most recent serodiscordant non-primary partner were more 
likely to have engaged in UAI compared to men who had assumed that their 
partner knew their HIV status (OR: 4.51, 95% CI: 1.67-12.21; p=0.003).  
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Table 19. Association between UAI with the most recent non-primary 
serodiscordant partner and attitudes towards reduced risk of HIV 
transmission during UAI due to undetectable viral load (N=134) 
Factors 
1,2
Factor 
distribution  
Had UAI 
(versus 
no UAI)  
Unadjusted OR  
(95% CI) 
Adjusted OR  
(95% CI) 
 % (n/N) n (%) p-value p-value 
Undetectable viral 
load in my blood 
means that HIV is 
unlikely to be 
passed on to a 
sexual partner even 
if we have UAI 
  p=0.11 p=0.27 
Disagree/strongly 
disagree/unsure 
84.9 (113/133) 17 (15.0) 1 1 
Agree/strongly 
agree 
15.0 (20/133) 6 (30.0) 2.42 (0.82-7.17) 2.19 (0.53-8.93) 
Age   p=0.11 p=0.94 
<=34 9.7 (13/134) 5 (38.5) 1 1 
35-44 43.3 (58/134) 8 (13.8) 0.25 (0.07-0.98) 0.46 (0.10-2.12) 
>=45 47.0 (63/134) 10 (15.9) 0.30 (0. 08-1.11) 0.48 (0.09-2.68) 
Time since HIV 
diagnosis (years) 
  p=0.17 p=0.48 
Median (IQR)  11 (7-15) 9 (6-12) 0.94 (0.87-1.02) 0.96 (0.86-1.07) 
Recreational drug 
use during sex  
  p=0.02 p=0.04 
No 47.8 (65/136) 6 (9.2) 1 1 
Yes 52.2 (71/136) 17 (23.9) 3.09 (1.14-8.42) 3.29 (1.03-10.47) 
Self-reported viral 
load status 
  p=0.51 - 
Detectable 17.8 (23/129) 5 (21.7) 1 - 
Undetectable 82.2 (206/129) 17 (16.0) 0.69 (0.22-1.20) - 
cART status   p=0.09 p=0.26 
Yes 14.7 (20/136) 17 (14.7)  1 1 
No 1 85.3 (116/136) 6 (30.0) 2.49 (0.84-7.39) 2.17 (0.56-8.51) 
Met partner via 
internet 
  p=0.59 - 
No 69.9 (95/136) 15 (15.8) 1 - 
Yes 30.1 (41/136) 8 (19.5) 1.29 (0.50-3.34) - 
Assumed partner 
knows his status 
73.4 (94/128) 9 (9.6)  1 1 
Told himself 26.6 (34/128) 11 (32.4) 4.51 (1.67-12.21) 5.27 (1.70-16.27) 
1
Includes only men who had a serodiscordant non-primary partner 
2
Base varies due to item non-response 
 
 
When included in a multivariate model, there was no change in the lack of 
association observed during univariate analysis between attitudes towards reduced 
risk of HIV transmission during UAI due to undetectable viral load status and UAI 
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with the most recent serodiscordant non-primary partner (AOR: 2.19; 95% CI: 
0.53-8.93; p=0.27). However, recreational drug use during sex and disclosure of 
HIV status continued to remain independently associated with UAI with the most 
recent serodiscordant non-primary partner. Men who had used recreational drugs 
during sex were more likely to have engaged in UAI compared to men who did not 
(AOR: 3.29, 95% CI: 1.03-10.47; p=0.04). Direct disclosure of HIV status was 
associated with UAI compared to assuming that partner knows their HIV status 
(AOR: 5.27, 95% CI: 1.70-16.27; p=0.004). cART status, age, time since HIV 
diagnosis continued to remain insignificant in the multivariate model. 
In the following sub-section, I examine the association between attitudes towards 
strategic positioning and RUAI with the most recent serodiscordant non-primary 
partner. 
3.3.7.9 Association between attitudes towards reduced risk of HIV 
transmission due to strategic positioning and RUAI with a most 
recent non-primary partner 
Hypothesis 8: Men who believe that strategic positioning reduces the risk of HIV 
transmission are more likely to engage in RUAI than men who do not.  
As reported previously in Table 17, 15.7% of men who had a most recent 
serodiscordant non-primary partner believed that strategic positioning reduces the 
risk of HIV transmission during UAI. Table 18 shows that 9.6% of men had 
engaged in RUAI with the most recent serodiscordant non-primary partner. As 
shown in Table 20, there was no support for the hypothesis that men who believed 
in the reduced risk of HIV transmission due to strategic positioning were more 
likely to have engaged in RUAI with the most recent non-primary partner (9.5%) 
compared to men who do not (9.7%) (OR: 0.67; 95% CI: 0.18-2.44; p=0.55).  
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Table 20. Association between attitudes towards HIV transmission risk 
reduction strategies and risky sexual behaviours with the most recent non-
primary serodiscordant partner 
Risk reduction strategy of 
interest 
1,2
Factor 
distribution  
Outcome variables of 
interest 
Unadjusted OR  
 
 N  
n/N (%) 
n (%) p-value 
(95% CI) 
HIV is unlikely to be 
transmitted if a HIV 
negative person has 
insertive anal intercourse 
without a condom with a 
HIV positive partner 
 
RUAI (versus no RUAI) p=0.55 
Disagree/strongly 
disagree/unsure 
113/134 (84.3)  11 (9.7) 1 
Agree/strongly agree  21/134 (15.7) 2 (9.5) 0.67 (0.18-2.44) 
HIV is unlikely to be 
transmitted if a HIV 
negative person has 
insertive anal intercourse 
(He is doing the fucking) 
without a condom with a 
HIV positive partner 
 
RUAI with withdrawal 
prior to ejaculation 
(versus no RUAI with 
withdrawal prior to 
ejaculation) 
p=0.41 
Disagree/strongly 
disagree/unsure 
 77/133 (57.9) 3 (3.9) 1 
Agree/strongly agree  56/133 (42.1) 4 (7.1) 1.89 (0.41-8.84) 
HIV is unlikely to be 
transmitted if a HIV 
negative person has 
insertive anal intercourse 
(He is doing the fucking) 
without a condom with a 
HIV positive partner 
 
IUAI with withdrawal 
prior to ejaculation 
(versus no IUAI with 
withdrawal prior to 
ejaculation) 
p=0.88 
Disagree/strongly 
disagree/unsure 
 77/133 (57.9) 5 (6.5) 1 
Agree/strongly agree  56/133 (42.1) 4 (7.1) 1.10 (0.28-4.32) 
HIV is unlikely to be 
transmitted if HIV positive 
sexual partner ejaculates 
inside the mouth of a HIV 
negative sexual partner 
during oral sex 
 
Insertive unsafe oral sex 
(versus no insertive 
unsafe oral sex) 
p=0.53 
Disagree/strongly 
disagree/unsure 
 94/133 (70.7) 1 (2.6) 1 
Agree/strongly agree  39/133 (29.3) 1 (1.1) 2.44 (0.14-40.14) 
1
Includes only men who had the most recent serodiscordant non-primary partner 
2
N varies due to item non-response 
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In the following section, I examine the association between attitudes towards 
reduced risk of HIV transmission due to withdrawal prior to ejaculation during 
UAI and engagement in IUAI/RUAI with withdrawal prior to ejaculation. 
3.3.7.10 Association between attitudes towards reduced risk of HIV 
transmission due to withdrawal during UAI and UAI with 
withdrawal prior to ejaculation with the most recent non-primary 
serodiscordant partner 
Hypothesis 9: Men who believe that withdrawal prior to ejaculation reduces the 
risk of HIV transmission during UAI are more likely to engage in IUAI/RUAI 
with withdrawal prior to ejaculation compared to men who do not. 
As reported in Table 17, 42.1% of men believed that withdrawal prior to 
ejaculation reduces the risk of HIV transmission during UAI. Table 18 shows that 
5.2% and 6.6% of men had engaged in RUAI with withdrawal prior to ejaculation 
and IUAI with withdrawal prior to ejaculation respectively with their most recent 
non-primary partner. As shown in Table 20, 7.1% of men who agreed that 
withdrawal prior to ejaculation reduces the risk of HIV transmission during UAI 
had engaged in RUAI with withdrawal prior to ejaculation, whereas 3.9% of men 
who did not believe so also had engaged in this behaviour. However, there was no 
support for this hypothesis (OR: 1.89; 95% CI: 0.41-8.84; p=0.41).  
7.1% of men who agreed that withdrawal prior to ejaculation reduces the risk of 
HIV transmission during UAI men had engaged in IUAI with withdrawal prior to 
ejaculation, whereas 6.5% of men who did not believe so also had engaged in this 
behaviour. There was no support for this hypothesis (OR: 1.10; 95% CI: 0.28-4.32; 
p=0.88).  
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In the following section I examine the association between attitudes of lack of risk 
of HIV transmission during insertive unsafe oral sex and engaging in this 
behaviour with a serodiscordant non-primary most recent partner. 
3.3.7.11 Association between attitudes that there is no risk of HIV 
transmission during unsafe insertive oral sex and engaging in 
insertive unsafe oral sex with the most recent non-primary 
serodiscordant partner  
Hypothesis 10: Men who believe that HIV is unlikely to be transmitted during 
unsafe insertive oral sex are more likely to engage in this behaviour compared to 
men who do not. 
As reported in Table 17, 29.3% of men who had a most recent serodiscordant non-
primary partner believed that HIV is unlikely to be transmitted during unsafe 
insertive oral sex. It was reported in Table 18 that 1.5% of men had engaged in this 
behaviour with their most recent serodiscordant non-primary partner. As shown in 
Table 20, there was no support for the hypothesis that men who believe that HIV is 
unlikely to be transmitted during unsafe insertive UAI are more likely to engage in 
this behaviour compared to those who do not believe so (OR: 2.44; 95% CI: 0.14-
40.14; p=0.53). However, this result should be interpreted with caution due to the 
small number of men who engaged in insertive unsafe oral sex with their most 
recent serodiscordant non-primary partner.  
In the following section, I describe the sexual behaviour of participants with new 
sexual partners.   
3.3.8 Sexual behaviour with new sex partners in the last year  
As mentioned in section 2.5.1.1, the data on sexual behaviour with new partners 
was collected on an aggregate basis and not partner-by-partner basis. As reported 
in Table 5, of the 380 men who were diagnosed with HIV more than a year ago, 
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322 men (84.7%) were sexually active in the last year. Among these 380 men, 258 
men (67.9%) reported having sex with new sex partners in the last year (Table 21). 
The median number of new sex partners reported by these men was 4 and IQR was 
0-16. The highest number of new partners reported was 399. 31.8% of men 
reported that they had more than ten new partners in the last year. The 258 men 
who had had new partners reported a total of 6533 new sex partnerships. 
228 (88.3%) men had engaged in AI with new partners. The median number of 
new AI partners was six, the IQR was 2-20 and the range was 0 to 390. The 228 
men who had new AI partners reported a total of 5021 AI partnerships.  Three 
quarters of men reported that some of their new AI partners were anonymous, i.e., 
not contactable. The median number of anonymous AI partners was 9 (IQR: 3-24). 
6% of men reported that they had AI only with seroconcordant new partners, 
whereas the remaining 94% of men had seroconcordant as well as serodiscordant 
new AI partners.  
Among men who had engaged in AI, 61.6% of men had engaged in insertive AI. 
As shown in Table 21, 55.3% of men had engaged in insertive AI with known HIV 
positive new partners, 37% of men had assumed their partners to be HIV positive 
and 51.6% of men had unknown status new partners. 19.5% of men had known 
HIV negative insertive AI partners and 16.9% of men had assumed their partners 
to be HIV negative. Irrespective of the HIV status, the median number of new 
insertive AI partners was approximately 5. However, the range of known and 
assumed HIV positive insertive AI partners was high, i.e., 1-200 partners and 1-
300 respectively. Similarly, the range of unknown status insertive AI partners was 
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also high i.e. 1-300. The range of HIV negative new insertive AI partners was 1-30 
partners.  
Table 21. Sexual behaviour with new partners in the last year  
 
1
n/N  % (95% CI) 
2
Had sex with new partners   
Yes 258/380 67.9 (63.2-72.6) 
2
Number of new sexual partners    
0 122/380 32.1 (27.4-36.8) 
1  26/380 6.8 (4.3-9.3) 
2-4  47/380 12.4 (9.1-15.7) 
5-10  64/380 16.8 (13.1-20.6) 
>10  121/380 31.8 (27.1-36.5) 
Median (range), lower and upper 
quartiles 
4 (0-399), 0-16  
Mean (standard deviation) 17.2 (40.8)  
3
Had AI with new partners   
Yes 228/258  88.3 (84.4-92.3) 
3
Number of new AI partners    
0 33/258 12.7 (8.6-16.8) 
1 23/258 8.9 (5.3-12.3) 
2-4 44/258 16.9 (12.3-21.5) 
5-10 59/258 22.7 (17.6-27.8) 
>10 101/258 38.9 (32.9-44.8) 
Median (range), lower and upper 
quartiles 
6 (0- 390), 2-20  
Mean (standard deviation) 19.5 (39.3)  
4
Anonymous AI partners   
Yes 168/223 75.3 (69.6-81.1) 
Median (IQR; range) (N=168) 9 (3-24; 1-390)  
4
HIV status of new AI partners   
Only seroconcordant  13/222 5.9 (2.7-8.9) 
Both seroconcordant and serodiscordant 209/222 94.1 (91.0-97.3) 
Insertive anal intercourse (IAI) 
3
Had IAI    
Yes 159 /258 61.6 (55.4-67.6) 
5
HIV status of IAI partners   
6
Known HIV positive partners 88/159 55.3 (47.3-63.2) 
 
Median number of known HIV positive 
partners (lower and upper quartile, range) 
(N=88) 
 
 
 
5 (2-20, 1-200)  
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Table 21
. 
Continued   
 1
n/N  % (95% CI) 
5
HIV status of IAI partners
 
  
6
Assumed HIV positive partners 59 /159 37.1 (29.5-45.1) 
Median number of assumed HIV positive 
partners (lower and upper quartile, range) 
(N=59) 
7 (2-20, 1-300)  
6
Known HIV negative partners 31/159 19.5 (13.6-26.5) 
Median number of known HIV negative 
partners (lower and upper quartile, range) 
(N=31) 
5 (2-9, 1-30)  
6
Assumed HIV negative partners 27/159 16.9 (11.5-23.7) 
Median number of assumed HIV 
negative partner (lower and upper 
quartile, range) (N=27) 
5 (3-20, 1-60)  
6
Unknown status partners 82/159 51.6 (43.5-59.6) 
Median number of unknown status 
partners (lower and upper quartile, range) 
(N=82) 
5 (2-14, 1-300)  
3
Had IUAI   
Yes 106/258 41.1 (35.0-47.1) 
7
Type of IUAI   
Always had IUAI with ejaculation  19/106 17.9 (10.5-25.3) 
Always had IUAI with withdrawal prior 
to ejaculation 
32/106 30.2 (21.3-39.1) 
Practised IUAI with and without 
withdrawal prior to ejaculation 
55/106  51.9 (42.2-61.6) 
Receptive anal intercourse (RAI) 
3
Had RAI   
Yes 167/258 64.7 (58.7-70.5) 
8
HIV status of RAI partners   
6
Known HIV positive partners 82/167 49.1 (41.3-56.9) 
Median number of known HIV positive 
partner (lower and upper quartile, range) 
(N=82) 
5 (2-20, 1-200)  
6
Assumed HIV positive partners 57/167 34.1 (26.9-
41.86) 
Median number of assumed HIV positive 
partners (lower and upper quartile, range) 
(N=57) 
5 (3-15, 1-300)  
6
Unknown status partners 93/167 55.7 (47.8-63.4) 
Median number of unknown status 
partners (lower and upper quartile, range) 
(N=93) 
5 (2-15,1-300)  
6
Known HIV negative partners 43/167 25.7 (19.3-33.1) 
Median number of known HIV negative 
partners (lower and upper quartile, range) 
(N=43) 
3 (1-6, 1-20)  
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Table 21
. 
Continued   
 1
n/N % (95% CI) 
8
HIV status of RAI partners
   
6
Assumed HIV negative partners
 
35 20.9 (15.1-27.9) 
Median number of assumed HIV 
negative partners (lower and upper 
quartile, range) (N=35) 
5 (2-10, 1-60)  
3
Had RUAI    
Yes 113/258 48.7 (42.2-55.2) 
9
Type of RUAI   
Always had RUAI with ejaculation  22/109 20.2 (12.5-27.8) 
Always RUAI with withdrawal prior to 
ejaculation 
34/109 31.2 (22.3-40.0) 
Practised RUAI with and without 
withdrawal prior to ejaculation 
53/109 48.6 (39.1-58.2) 
Overall unprotected anal intercourse (UAI) 
3
Had UAI   
Yes 137/258 53.1 (46.9-59.2) 
10
Type of UAI    
Only IUAI 28 /137 20.4 (13.6-27.3) 
Only RUAI 31/137 22.6 (15.5-29.7) 
Both RUAI/IUAI 78/137 56.9 (48.5-65.3) 
1
Base varies due to item non-response 
2
Only
 
includes men who were diagnosed with HIV more than a year ago 
3 
Only
 
includes men who reported having new partners in the last year 
4 
Only
 
includes men who reported having AI with new partners in the last year 
5
Only includes men who reported having insertive AI with new partners in the last 
year 
6
Percentages will not add up to 100 because men had choice to report partners of 
varied serostatus 
7
Only includes men who reported having IUAI  
8
Only
 
includes men who reported having receptive AI with new partners in the last 
year 
9
Only includes men who reported having URAI 
10
Only includes men who reported having UAI 
 
As shown in Table 21, 106 (41%) men reported that they had engaged in IUAI 
with new partners. 51.9% of men had practised IUAI with as well as without 
withdrawal prior to ejaculation, whereas 17.9% of men had always engaged in 
IUAI with ejaculation and 30.2% of men had always engaged in IUAI with 
withdrawal prior to ejaculation. 64.7% of men had engaged in receptive AI with 
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new partners. Among men who had engaged in receptive AI, 49.0% of men had 
known HIV positive receptive AI new partners; whereas 34.0% of men had 
assumed their receptive AI new partners to be HIV positive. 55.7% of men 
reported that they did not know the HIV status of their new receptive AI partners.  
25.8% of men had had receptive AI with known HIV negative partners and 20.9% 
of men had new assumed HIV negative receptive AI partners. The median number 
of new receptive AI partners was five irrespective of the HIV status of the partners; 
however the median number of new HIV negative receptive AI partners was three. 
The range of known or assumed HIV status partners and unknown status new 
receptive AI partners was wide, i.e., 1-200 partners and 1-300 partners respectively; 
whereas the range was comparatively narrower for HIV negative receptive AI 
partners (i.e., 1-20). 113 (48.7%) men reported that they had engaged in RUAI 
with new partners. The majority of men had engaged in RUAI with as well as 
without withdrawal prior to ejaculation and 20.2% of men had always practised 
RUAI with ejaculation and 31.2% of men had always practised RUAI with 
withdrawal prior to ejaculation.  
Overall, the proportion of men who had engaged in UAI with new sexual partners 
was 53%. Among men who had engaged in UAI, the majority of men had engaged 
in both RUAI as well as IUAI (57%); whereas 20.4% of men had engaged only in 
IUAI and 22.6% of men had engaged only in RUAI.  
3.3.8.1 Venues of meeting new sex partners in the last six months 
Of the 258 men who had new partners in the last year, 233 men had had sex with 
new partners in the last six months.  In this section, I describe the venues for 
meeting new partners in the last six months among these 233 men. As shown in 
Table 22, the majority of men had met at least one or more new partner via the 
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internet (64.4%) A significant proportion of men had met their new partners in 
sexually charged environments like the saunas (37.8%), other sex on premises 
venues (34.2%), leather clubs (14.2%). Some men had met their new partners in 
bars or clubs (34.2%), backrooms or cruising grounds (21.3%), private parties 
(20%) and public toilets (9%). 
34 (15.5%) men had met their partners only via the internet, 9 (4.1%) only in the 
saunas and 12 men (5.5%) only in gay bars. A further 2.3% of men had met them 
only in cruising grounds. The majority of men had met their new partners only via 
gay social venues and internet (18.6%), and 8.6% of men had met them only in 
gay social venues. Almost 20% of men had met their new partners via gay social 
venues and social networks as well as via the internet.  
Table 22. Venues of meeting new sexual partners in the last year (N=258) 
Venue type 
1,2
n 
3
% (95% CI) 
Internet 145 64.4 (58.14-70.74) 
Saunas 85 37.8 (31.39-44.16) 
Bars  77 34.2 (27.97-40.47) 
Other sex on premises venues (other than saunas) 77 34.2 (27.97-40.47) 
Backrooms 48 21.3 (15.93-26.73) 
Cruising grounds 48 21.3 (15.93-26.73) 
Private parties 45 20.0 (14.73-25.27) 
Leather clubs 32 14.2 (9.62-18.82) 
Through friends 28 12.4 (8.1-16.79) 
Gymnasium 20 8.9 (5.14-12.63) 
Cottage (public toilet) 15 6.7 (3.38-9.95) 
College 6 2.7 (0.54-4.79) 
Telechats 2 0.9 (0.11-3.20) 
1
Only
 
includes men who were sexually active in the last year and had sex with 
new partners in the last six months 
2
Data on where men had met their new sexual partners was missing for 8 men 
3
 Percentages will not add up to 100 because multiple responses were allowed. 
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In the following section, I discuss the findings and compare the findings with those 
of other studies.  
3.4 Discussion of findings and comparison with other studies 
The SHARPN study was a repeat of the SHARP study. In the following section, I 
compare the socio-demographic and general and HIV-related health characteristics 
of the SHARPN and the SHARP survey participants. I also compare the SHARPN 
data with the data from the SOPHID survey. SOPHID is a cross-sectional survey 
of all individuals with diagnosed HIV infection who attend the NHS in England, 
Wales and Northern Ireland for HIV-related care. Almost all of the PLWH in the 
UK are thought to seek clinical care in the NHS specialist HIV outpatient clinics. 
Socio-demographic data (age, ethnicity, gender) and HIV related health data 
(cART status, viral load status) is collected as part of the SOPHID survey. 
Socio-demographic profile of the SHARP and SHARPN study participants and 
comparison with SOPHID data 
Questionnaire data for analysis was available for 413 and 429 men who had 
participated in the SHARP and SHARPN survey respectively. As shown in Table 
23, men in the SHARPN survey were older (median age: 43 years) than men in the 
SHARP survey (median age: 38 years) (OR 1.06; 95% CI: 1.04-1.08), less likely 
to be born in the UK (OR 0.64; 95% CI: 0.48-0.85), or receive social welfare 
benefits (OR 0.21; 95% CI: 0.15-0.29). There was no significant difference in the 
ethnicity of the participants between the surveys (p=0.35). Men in the SHARPN 
survey were more likely to be educated beyond secondary level (OR 1.56; 95% CI: 
1.16-2.08) and were also more likely to be employed and own their 
accommodation compared to the SHARP survey participants. 
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Table 23. 
*
Comparison between socio-demographic characteristics of study 
participants in the SHARP and SHARPN surveys 
 SHARP SHARPN p-value and 
unadjusted odds 
ratio (95% CI) 
Age N=413 N= 422 p<0.001 
Median (range) (years) 38 (21-64) 43 (22-74) 1.06 (1.04-1.08) 
 N 
n (%)   
N 
n (%)   
 
 
Age groups N=413 N=422 p<0.001 
<=34 133 (32.2)  71 (17.0)   1 
35-44 191 (46.2) 169 (40.0)  1.65 (1.16-2.36) 
>=45 89 (21.6)  182 (43.0)  3.83 (2.60-5.62) 
Born in the UK N=413 N=429 p=0.003 
Yes 293 (71.0)  262 (61.0) 0.64 (0.48-0.85) 
Ethnicity N=412 N=426 p=0.35 
White 373 (90.5)  368 (86.4)  1 
Mixed 11 (2.7)  17 (4.0)  1.57 (0.72-3.38) 
Asian 8 (2.0)  13 (3.0)  1.64 (0.67-4.20) 
Black 8 (2.0)  15 (3.5)  1.90 (0.79-4.53) 
Other 12 (2.8)  13 (3.1)  1.09 (0.49-2.43) 
Ethnicity group N=412 N=426 p=0.06 
White 373 (90.5)  368 (86.4) 1 
Non-White 39 (9.5)  58 (13.6)  1.50 (0.97-2.31) 
Education N=413 N=429 p=0.003 
Beyond secondary school 257 (62.2)  309 (72.0)  1.56 (1.16-2.08) 
Employment N=412 N=429 p<0.001 
Employed 199 (48.3)  284 (66.2) 1 
Unemployed 77 (18.7) 57 (13.3)  0.25 (0.16-0.39) 
Medically retired 93 (22.6) 34 (8.0) 0.87 (0.56-1.36) 
Other 43 (10.4) 57 (12.7) 0.51 (0.35-0.76) 
Accommodation N=413 N=427 p=0.004 
Own 139 (33.7)  191 (44.7)  1 
Rent 240 (58.1) 210 (49.2)  0.63 (0.47-0.84) 
Other 34 (8.2)  26 (6.1)  0.55 (0.31-0.96) 
Social welfare benefit N=412 N=414 p<0.001 
Yes 228 (55.3)  87 (21.0) 0.21 (0.15-0.29) 
*
N varies due to item non-response 
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General health and HIV related health of the SHARP and SHARPN study 
participants 
There was no difference in the self-reported general health in the last six months 
between the survey participants (p=0.27) (Table 24). The time since HIV diagnosis 
among the SHARPN participants was longer than the SHARP participants (OR 
1.06; 95% CI: 1.04-1.09). The SHARPN participants were more likely to report 
ever being on cART (OR 1.59; 95% CI: 1.14-2.22) and receiving cART at the time 
of the survey (OR 2.00; 95% CI: 1.45-2.74) than the SHARP participants (Table 
24). Compared to the SHARP survey, a greater proportion of the SHARPN survey 
participants reported recent plasma viral load test results to be <50 copies/mm
3
 
(71.8% vs. 36.4%) and recent CD4 cell count test results to be >200 (91.4% vs. 
75.5% %, p<0.001). The SHARPN survey participants were also less likely to 
report AIDS diagnosis in comparison to the SHARP participants (OR 0.57; 95% 
CI: 0.41-0.80) and less likely to be have missed doses of cART in the last two 
weeks. 
The observed age, ethnicity and cART profile of the SHARPN study participants 
were similar to that observed among HIV positive MSM in the SOPHID survey in 
London (Health Protection Agency, 2010). Thus, the observed age difference in 
the SHARP and SHARPN surveys reflects the ageing cohort of PLWH in the UK 
due to the availability of cART and continued HIV diagnosis in older age groups 
(Health Protection Agency, 2010). The increase in availability of better and 
tolerant cART regimens also explains the observed greater proportion of men with 
an undetectable viral load (74%) and longer duration of living with HIV 
(median=9 years) in the SHARPN survey compared to the SHARP survey (41%) 
and (median=5.5 years) respectively (Stephenson et al., 2003).  
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Table 24. 
1
Comparison of general health and HIV related health indicators of the 
SHARP and SHARPN survey study participants  
 
 SHARP SHARPN p-value 
 N 
 n (%)   
N 
n (%)   
Unadjusted Odds 
ratio  
(95 % CI) 
Self-assessed overall health in last 6 
months 
N=413 N=429 p=0.27 
Good or very good 300 (72.6)  314 (73.2)  0.92 (0.75-1.13) 
Time since HIV diagnosis (years) N=404 N=428 p<0.001 
Median (range) 8 (<1-18) 9 (<1 – 28) 1.06 (1.04-1.09) 
Ever taken ART N=410 N=429 p=0.006 
Yes 305 (74.4)  353 (82.3) 1.59 (1.14-2.22) 
Currently taking antiretroviral 
(ART) medication 
N=410 N=429 p<0.001 
Yes 277 (67.6)  346 (80.6)  2.00 (1.45-2.74) 
Time since receiving ART N=270 N=345 
2
p<0.001 
Median (range) years 3 (<1-17) 6 (<1-24) 2/25 (1.81-2.79) 
Self-reported recent CD4 cell count  N=408 N=429 p<0.001 
< 200 61 (14.9)  18 (4.2) 1 
200-499 213 (52.2)  174 (40.6) 2.76 (1.57-4.85) 
>499 95 (23.3)  218 (50.8) 7.77 (4.36-13.86) 
Don’t know 39 (9.6) 19 (4.4) 1.65 (0.77-3.52) 
Recent perceived viral load status N=407 N=429 p<0.001 
Undetectable 151 (37.1)  318 (74.0)  1 
Low 117 (28.8)  42 (9.8)  0.17 (0.11-0.25) 
Medium 43 (10.6)  39 (9.1)  0.43 (0.26-0.69) 
High 39 (9.6)  15 (3.5)  0.18 (0.09-0.34) 
Don’t know 57 (14.0)  15 (3.5)  0.12 (0.06-0.22) 
Self-reported recent viral load 
blood test result (copies/mm
3
) 
N=407 N=429 p<0.001 
<50 148 (36.4)  308 (71.8) 1 
51-10000 104 (25.5)  31 (7.2)  0.14 (0.09-0.22) 
10000-100000 69 (16.9)  31 (7.2)  0.21 (0.13-0.34) 
>10000 28 (6.9)  13 (3.0)  0.22 (0.11-0.44) 
Don’t remember  58 (14.3)  46 (10.7)  0.38 (0.24-0.58) 
Adherence to ART (doses missed in 
the last two weeks) 
N=277 N=347 p<0.001 
None 171 (61.7)  287 (82.9)  1 
One 69 (24.9)  47 (13.6)  0.40 (0.26-0.61) 
>1 37 (13.4) 12 (3.5)  0.19 (0.09-0.38) 
Ever had AIDS N=409 N=415 p=0.001 
Yes 26.6  16.8  0.57 (0.41-0.80) 
1 N varies due to item non-response 
2 Derived from using a log of the variable due to skewed nature of the data 
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The better employment status observed in the SHARPN survey compared to the 
SHARP survey is likely to be due to the improvement in HIV related health among 
PLWH.  
The overall SHARPN survey response rate, i.e., those who agreed to complete the 
survey among eligible patients was high (84%). However, the survey completion 
rate, i.e., actually completing the survey was lower (59%) compared to another 
study conducted in mid-2000 among PLWH including MSM attending six public 
hospitals in east London, henceforth referred to as the ‘East London study’ (Elford 
et al., 2007).  
Attitudes towards effectiveness of undetectable viral load for HIV prevention 
and personal health  
Overall, the majority of men did not agree that having an undetectable viral load 
reduces the risk of HIV transmission during UAI. There was difference in the 
proportion of men who believed in the effectiveness of undetectable viral load in 
preventing HIV transmission (30%) and its effectiveness in preventing HIV 
transmission during UAI (19%). One in five men believed that having an 
undetectable viral load is beneficial for their own health, i.e., it protects them from 
other HIV related infections or acquiring other strains of HIV. This finding 
suggests that men interpret the effectiveness of having an undetectable viral load 
for HIV prevention in different ways. The rationale for such subtle differences is 
difficult to measure via quantitative surveys. However, the qualitative study 
conducted as part of the SHARPN project provides greater insights into this 
finding and is discussed in the next chapter. Nevertheless, the observed proportion 
of men who believed that having an undetectable viral load reduces the risk of 
onward HIV transmission during UAI (19%) was greater than that observed in the 
SHARP survey (6.3%) (Stephenson et al., 2003). However, a high proportion of 
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men had missed at least one dose of cART in the last two weeks (17.2%) 
indicating the need to understand barriers to adherence to cART among these men. 
A high proportion of men also believed that they can get another strain of HIV if 
they have unprotected sex with other HIV positive MSM (82%) and were 
concerned that this could reduce their treatment options.  
Attitudes towards effectiveness of behavioural HIV transmission risk reduction 
strategies  
Compared to other sexual practices, a high proportion of men (42.2%) believed 
that withdrawal prior to ejaculation during UAI reduces the risk of HIV 
transmission. One-sixth of men also believed that strategic positioning reduces the 
risk of onward HIV transmission and one-third men believed that insertive unsafe 
oral sex by HIV positive persons is not risky. These findings suggest that studies 
examining sexual behaviour and practices of HIV positive MSM should examine 
how beliefs about the effectiveness of such risk reduction strategies interact with 
the sexual behaviour of these men to inform the development of appropriate 
interventions.   
Overall sexual behaviour of HIV positive MSM 
The majority of men were sexually active (84.7%) and a high proportion of them 
had engaged in UAI in the last year (59.7%). This is high compared to the 
observed UAI prevalence of 37.8% in the last three months reported in the East 
London study (Elford et al., 2007). Among men who had engaged in UAI, 19.4% 
of men had done so only with a primary partner and 58.8% with new or regular 
partners. Similar to the SHARP study (30%), a significant proportion of men had 
engaged in UAI with concurrent partners (21.8%) (Stephenson et al., 2003). 
Furthermore, 42% of men had engaged in group sex in the last six months and 33% 
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of men had engaged in group sex with the most recent non-primary partner. These 
findings suggest that the majority of sexually active HIV positive MSM engage in 
sexual behaviours that increase their risk of STI acquisition and transmission and 
should be tested regularly for STI. The high level of concurrent/group sex 
partnerships suggests that partner notification among this population is vital to 
prevent the spread of STI. It also suggests that in the event of STI diagnosis, men 
should be asked about engagement in group sex and men who have a primary 
partner should be asked to notify other sex partners. The overall prevalence of 
serodiscordant UAI in the SHARPN survey was 15.4%. Although this is lower 
than that observed in the east London study (20%), it can have implications for 
onward HIV transmission.  
Sexual behaviour with a primary partner 
Similar to several other studies conducted in the UK and abroad, a high proportion 
of men in the SHARPN survey had a primary partner, and a high proportion of 
them had a serodiscordant primary partner (Van de Ven et al., 2002; Stephenson et 
al., 2003; Xia et al., 2006; Bouhnik et al., 2007; Elford et al., 2007; Hasse et al., 
2010; Seng et al., 2011). The majority of men who had a primary partner were on 
cART (93%). Unlike another study conducted abroad (Suzan-Monti et al., 2011), 
there were no HIV related-health or socio-demographic differences between men 
who had a seroconcordant primary partner or a serodiscordant primary partner.  
Overall, a quarter of the men had not engaged in any sexual activity with their 
primary partner in the last six months irrespective of their partner’s serostatus. 
This finding suggests that non-engagement in sex with a serodiscordant primary 
partner may not be intentional to reduce the risk of onward HIV transmission. 
Overall, a high proportion of men had engaged in UAI with a primary partner 
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(37.5%) compared to respondents in the east London study (19.2%) (Elford et al., 
2007) and the SHARP survey (13%) (Stephenson et al., 2003). However, the 
overall prevalence of UAI with a primary partner does not reflect the variation in 
prevalence of UAI by primary partner’s HIV status and it’s the implications for 
HIV transmission. Similar to other studies, men were more likely to engage in UAI 
with a seroconcordant primary partner compared to a serodiscordant primary 
partner (Glass et al., 2004; Brewer et al., 2006; Bouhnik et al., 2007; Elford et al., 
2007). The finding that overall men who were in a serodiscordant partnership were 
more likely to engage in sexual behaviours that minimise the risk of HIV 
transmission compared to men who had a seroconcordant primary partner is 
similar to another study conducted in the USA (Parsons et al., 2005). Men were 
not specifically asked whether they had engaged in sexual practices with their 
primary partner because of their sexual preferences, or had consciously made the 
choice to engage in these behaviours to reduce the risk of HIV transmission. 
However, the observed lower likelihood of engagement in several risky sexual 
practices associated with greater risk of HIV transmission among men with a 
serodiscordant primary partner compared to men with a seroconcordant primary 
partner suggests that the former consciously make decisions to engage in sexual 
practices that minimise the risk of onward HIV transmission.  
Men with a serodiscordant primary partner were less likely to have engaged in 
UAI compared to men in a seroconcordant partnership. However, similar to a 
study conducted in the USA, there were no significant differences by primary 
partner’s serostatus and engagement in RUAI and unsafe receptive oral sex 
(Parsons et al., 2005) or other risky behaviours like fisting. The proportion of men 
who had engaged in UAI with a serodiscordant primary partner in the last six 
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months (18.3%) was higher compared to the SHARP study (13%) (Stephenson et 
al., 2003). Since 1998, a community based gym survey has been conducted 
regularly in central London among gay/bisexual men, henceforth referred to as the 
‘London gym survey’ (Elford et al., 1999). This survey reported, for the first time 
in 2008, an increase in UAI with a serodiscordant primary partner among HIV 
positive MSM, i.e., from 4.2% in 1998 to 8.1% in 2008 (Lattimore et al., 2011). 
Therefore, the observed increase in UAI with a serodiscordant primary partner in 
the SHARPN survey is likely to reflect an actual increase in risky sexual behaviour 
with a serodiscordant primary partner in the recent years among HIV positive 
MSM. Men who had engaged in UAI with a serodiscordant primary partner were 
equally likely to have engaged in IUAI and RUAI. Moreover, men who had 
engaged in UAI with a serodiscordant primary partner reported substantial 
episodes of IUAI and especially of RUAI. These findings reflect that the sexual 
practices of some men and their serodiscordant primary partner are likely to have 
implications for onward HIV transmission.  
Engagement in risky sexual behaviours like UAI, particularly RUAI, with a 
serodiscordant primary partner was associated with shorter duration of partnership, 
and similar to another study, with recreational drug use during sex (Hasse et al., 
2010). Unlike other studies, UAI with a serodiscordant primary partner was not 
associated with plasma viral load status (Van de Ven et al., 2005; Hasse et al., 
2010). However, this finding should be interpreted with caution due to the overall 
small number of men who had a detectable viral load. Both qualitative and 
quantitative studies among MSM have shown that UAI within a primary 
partnership is perceived as a symbol of trust and love (Davidovich et al., 2004; 
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Davis and Flowers, 2011) and probably explains the observed association in the 
SHARPN survey.  
Men who had engaged in risky sexual behaviours with a serodiscordant primary 
partner like UAI, particularly RUAI, and unsafe insertive oral were more likely to 
believe that the risk of HIV transmission was reduced due to having an 
undetectable viral load, or that unsafe insertive oral sex is not risky, respectively. 
These findings suggest that beliefs about behavioural and biomedical HIV 
transmission risk reduction strategies influence engagement in risky sexual 
behaviours with a primary partner.  
However, studies conducted among Australian MSM have shown that risk 
reduction strategies like withdrawal prior to ejaculation during UAI do not 
eliminate the risk of HIV transmission (Jin et al., 2007, 2009). Moreover, 
knowledge of a partner’s HIV status is a prerequisite to make informed decisions 
about using risk reduction strategies. The high prevalence of HIV serostatus 
disclosure to a primary partner was consistent with other studies (Stephenson et al., 
2003; Van de Ven et al., 2005; Xia et al., 2006; Elford et al., 2007). However, a 
minority of men in the SHARPN survey had an unknown status primary partner 
and 5% of men had not disclosed their HIV status to their primary partner. This 
finding suggests that HIV testing should be promoted among MSM in 
serodiscordant steady partnerships. Nevertheless, the proportion of men who had 
an unknown status primary partner was lower compared to the East London study 
(Elford et al., 2007), probably reflecting the steady increase in HIV testing among 
MSM in the last decade (Lattimore et al., 2011). 
Studies from the USA, Amsterdam and Netherlands suggest that most HIV 
transmissions among MSM are from primary partners (Davidovich et al., 2001; 
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Xiridou et al., 2003; Sullivan et al., 2009). Increases in risky sexual behaviours 
with serodiscordant primary partners can have greater impact on HIV incidence 
than the equivalent increases in sexual behaviour with casual partners (Xiridou et 
al., 2003). The observed risky sexual behaviours with serodiscordant primary 
partners suggest that there is a need to enhance HIV prevention interventions to 
support HIV positive MSM in a serodiscordant primary partnership.  
Sexual behaviour with new partners and the most recent non-primary partner 
The median number of new partners in the last year in the SHARPN survey (4) 
was lower than in the SHARP survey (12) (Stephenson et al., 2003). This is likely 
to be due to the older study population of the SHARPN survey. However, men had 
multiple new AI partners, a high proportion of which were anonymous. This 
presents a challenge for partner notification in the event of STI diagnosis among 
these men (Ashton et al., 2003; Singh et al., 2007; Jebbari et al., 2011). The 
prevalence of UAI as well as IUAI with new partners observed in this study was 
high compared to the SHARP survey (Stephenson et al., 2003). In line with other 
studies, it was observed that men had a high proportion of unknown or assumed 
HIV status new partners (Dodds et al., 2007; Williamson et al., 2008; Zablotska et 
al., 2009). A high proportion of men had an unknown HIV status most recent non-
primary partner. This finding suggests that men are less likely to engage in 
discussions about the HIV status with their new and casual partners. Similar to 
another study conducted in the USA, a significant proportion of men had not 
disclosed their HIV status to their most recent non-primary partner (Klitzman et al., 
2004), especially if this was a group sex anonymous casual partner because they 
considered it unimportant to do so or assumed that their partner knew about their 
serostatus. This finding suggests that health promotion interventions among MSM 
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should continue to emphasise the significance of engaging in safe sex with 
partners of unknown HIV status. 
There were no significant differences between the sexual behaviour of men who 
had engaged in one-to-one sex and those who had engaged in group sex with their 
most recent non-primary partner. However, in line with the observation in the 
context of a primary partner, men whose most recent non-primary partner was of 
serodiscordant status were less likely to engage in sexual behaviours that can 
increase the risk of HIV transmission compared to men with a most recent 
seroconcordant non-primary partner. These findings suggest that HIV positive 
MSM are less likely to engage in risky sexual behaviours with serodiscordant 
partners. Similar to the findings with regards to a primary partner, there was no 
difference in engagement in RUAI and IUAI among men who engaged in UAI 
with the most recent serodiscordant non-primary partner. Neither was there any 
difference in engagement in receptive unsafe oral sex and fisting by the most 
recent non-primary partner’s HIV status. This finding suggests that health 
promotion interventions among MSM should highlight the risk of STI like syphilis 
and pharyngeal gonorrhoea and chlamydia due to engagement in unsafe oral sex, 
and risk of HCV due to fisting, and the increased risk of onward HIV transmission 
due to co-infection with other STI in the context of serodiscordant UAI. 
Unlike the findings in the context of a primary partner, there was no association 
between engagement in risky sexual behaviours with a serodiscordant non-primary 
partner and attitudes towards various HIV transmission risk reduction strategies. 
However, similar to the finding among men with a primary partner, recreational 
drug use during sex was associated with UAI with a serodiscordant non-primary 
partner. This finding suggests that sexual risk-reduction interventions among 
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MSM should address issues related to recreational drug use during sex. Men who 
had directly disclosed their HIV status to their non-primary partner were more 
likely to engage in UAI. The observed association between direct disclosure of 
HIV status to the partner and engagement in risky sexual behaviours with a 
serodiscordant non-primary partner was the reverse of that observed in another 
study which showed that disclosure of HIV status was associated with reduced risk 
of engagement in serodiscordant UAI (Bouhnik et al., 2007). The SHARPN 
findings concur with those of other studies,which have shown that in the context of 
a non-primary partnership, disclosure of serostatus does not necessarily lead to 
safe sex (Marks and Crepaz, 2001; Guzman et al., 2006; Zablotska et al., 2009). 
The observed lack of association between viral load status, cART status and risky 
sexual behaviour with a serodiscordant most recent non-primary partner is 
consistent with findings from other studies conducted in the UK (Elford et al., 
2007) and aboard (Seng et al., 2011). This finding suggests that irrespective of 
their viral load status and cART status, men were likely to engage in UAI with a 
serodiscordant most recent non-primary partner, which can have implications for 
onward HIV transmission. In contrast with other studies, seeking sex through the 
internet (Elford et al., 2007) was not associated with UAI with a serodiscordant 
most recent non-primary partner. Neither was there an association between time 
since HIV diagnosis and UAI with a serodiscordant primary partner. The findings 
of this chapter should be interpreted in the context of the limitations described in 
the following section. 
3.5 Strengths and limitations 
In the following section, I discuss the strengths and limitations of the SHARPN 
survey. 
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3.5.1 Bias 
3.5.1.1 Recall bias 
The SHARPN survey is a cross-sectional study. Data on plasma viral load status 
and CD4 cell count were self-reported and thus amenable to recall bias. Thus, 
there is some possibility of misclassification bias with regards to the status of these 
biological markers during the last year.  Nevertheless, the majority of the 
participants reported that their plasma viral load status was stable in the last year.  
3.5.1.2 Sampling bias 
It was not possible to collect data on the socio-demographic profile of men who 
declined to participate in the study because the survey was anonymised. Data on 
the socio-demographic profile of men who agreed to complete the SHARPN 
survey at home but did not do so was not available due to the anonymous nature of 
survey and delinking with clinic patient number. Therefore, it is difficult to 
estimate the bias that is likely to be introduced due to the population that declined 
to participate and those who did not complete the survey. The median age of the 
study participants was 43 years, which reflects the aging cohort of PLWH and the 
median age of the MSM accessing the clinic. Therefore the study results reflect the 
behaviours and attitudes of older HIV positive MSM. However, the SHARPN 
survey participants’ socio-demographic profile is similar to the profile of the HIV 
positive MSM attending NHS sites in London for HIV related care (Health 
Protection Agency, 2010) indicating the generalisability of the study results to this 
population. Nevertheless, future studies should boost the sample of young HIV 
positive MSM to explore variations in behaviours and attitudes across various age 
groups. 
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The SHARPN survey was a cross-sectional survey with a convenience sampling 
strategy. Random sampling is linked to lower estimates of UAI compared to 
convenience samples (Dodds et al., 2006; Evans et al., 2007; Crepaz et al., 2009); 
thus the prevalence of risky sexual behaviours is likely to be over-estimated and 
should be interpreted with caution. Nevertheless, they depict the prevalence of 
risky sexual behaviour in this population accessing care in a NHS setting.  
3.5.1.3 Response bias 
Some men completed the survey in the clinic, whereas the majority of men 
completed the survey at home. Men who completed the online survey in the clinic 
did so in a quiet clinic room. It was not possible to compare the differences in the 
responses of men who completed the survey at home with those who completed 
the survey in the clinic because the survey was anonymously administered online 
and men were automatically allocated a study number. Therefore, it is not possible 
to estimate the response bias likely to be introduced due to the venue of survey 
completion. However, it would be safe to assume that men who opted to complete 
the survey at home had the privacy to do so and thus opted to do so.  
The data on sexual behavior was based on self-reported risk and it is likely that 
high-risk behaviours have been underreported due to social desirability bias 
(Fenton et al., 2001). Lower UAI is reported in studies conducted using 
interviewer-administered survey compared to self-administered surveys with or 
without computers (Crepaz et al., 2009; Fairley et al., 2010). The SHARPN survey 
was a self-administered computer based survey and thus is likely to have reduced 
such response bias.  
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3.5.2 Confounding 
The SHARPN survey was a cross-sectional study and thus the observed 
association between attitudes towards HIV transmission risk reduction strategies 
and sexual behaviour with primary partner observed in the study is likely to be due 
to post-hoc rationalisation of risky sexual behaviour and causation cannot be 
proved (Stolte et al., 2004). Therefore, there is need to conduct longitudinal cohort 
studies to examine the association between attitudes towards HIV transmission 
risk reduction strategies and its impact on engagement in risky sexual behaviour. 
3.5.3 Chance 
The prevalence of certain risky sexual behaviours among men who had a 
serodiscordant primary and the most recent non-primary partner was low. 
Therefore, the findings related to the association (or lack of it) between attitudes 
towards HIV transmission risk reduction strategies and sexual behaviour with a 
serodiscordant primary partner or a serodiscordant non-primary partner should be 
interpreted with caution. Similarly, the lack of association between risky sexual 
behaviours with a serodiscordant primary and the most recent non-primary partner 
and self-reported viral load status should also be interpreted with caution due to 
the low number of men who had a detectable viral load. Further research studies 
examining the factors associated with risky sexual behaviour among HIV positive 
populations should be powered to enable sub-group analysis, particularly taking 
into consideration the low prevalence of risk factors like detectable viral load and 
risky sexual behaviours with serodiscordant partners.  It is also important to bear 
in mind that the definition of serodiscordant partnerships vary between studies, i.e., 
in this study I have treated men who ‘assumed’ the status of their sexual partner to 
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be HIV positive as engaging in serodiscordant partnership. Not all studies 
necessarily have this information and can either overestimate or under estimate the 
prevalence of such behaviours. There is a need to develop standard questions to 
measure serodiscordant partnerships. 
3.6 Implications for clinical practice, policy and further research 
A high prevalence of sexual behaviours that can have implications for STI 
transmission as well as acquisition, HIV transmission and HIV super-infection was 
observed among HIV positive MSM accessing care in a NHS HIV clinic. 
Therefore, there is a need to develop effective interventions to prevent STI and 
reduce risky sexual behaviours among these men. These men regularly assess care 
in NHS HIV clinics, thus providing an opportunity for implementing clinic-based 
interventions for sexual risk-reduction and to enhance adherence to cART to 
prevent onward HIV transmission. Such interventions should be tailored to address 
the observed risky behaviours in stable as well as casual seroconcordant and 
serodiscordant partnerships. However, these interventions should be sensitive to 
the observed efforts of HIV positive MSM to minimize the risk of HIV 
transmission to serodiscordant partners and should complement them. These 
interventions should also address issues related to beliefs about various 
behavioural and biomedical HIV transmission risk reduction strategies, 
recreational drug use during sex, and disclosure of serostatus and its implications 
for the risk of HIV transmission. As mentioned previously, the SHARPN survey 
did not explore whether men had engaged in sexual practices like RUAI due to 
sexual preferences or had made a conscious decision to engage in such sexual 
practices to reduce the risk of HIV transmission. Future research should explore 
these differences as the nature of interventions would have to be different if the 
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observed risk is due to sexual preference as opposed to the attitudes towards 
effectiveness of HIV transmission risk reduction strategies. However, it is also 
important to understand the broader socio-cultural and psychological context of 
HIV diagnosis and its influence on the formation of the sexual partnerships and 
sexual behaviours of HIV positive MSM. The results of the qualitative study 
provide greater insights into these issues and are presented in the next chapter 4.  
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Chapter 4. Sexual identity, disclosure of HIV serostatus 
and HIV/HCV transmission risk reduction strategies: 
results of qualitative study 
4. Aims  
The overall aim of this chapter is to explore if and how the socio-cultural context, 
recent debates about the implications of undetectable viral load for prevention of 
sexual transmission of HIV, attitudes towards behavioural HIV transmission risk 
reduction strategies, and nonmedical technological innovations (namely, the use of 
internet for sexual networking) influence and interact with the sexual partnerships, 
sexual behaviour, and risk management choices made by HIV positive MSM.  
4.1 Objectives  
1. To describe HIV positive MSMs’ experience of being diagnosed with HIV, 
being co-infected with HCV, and how it relates to their sexual behaviour and 
partnership choices.  
2. To understand their attitudes towards disclosure of HIV and HCV status, 
strategies used for (non)disclosure, and factors influencing the formation of these 
strategies.  
3. To explore if and how recent debates about the reduced infectivity due to 
undetectable viral load and behavioural HIV transmission risk reduction strategies 
influence the sexual partnerships and sexual behaviour of HIV positive MSM, and 
HIV/STI risk management.   
4.2 Methods 
The details of the methods of the qualitative component of the SHARPN study 
were presented previously in section 2.6. 
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4.3 Results 
I interviewed twenty-four purposively selected HIV positive MSM. In the 
following section, I describe the characteristics of men who participated in these 
interviews followed by results of analysis of the interview data. 
4.3.1 Study participants 
All the interviews lasted for approximately 45-90 minutes each. As shown in Table 
25, it was difficult to recruit men below the age of 30, especially men who were on 
cART. This is because the overall proportion of men accessing care in the clinic 
who were below the age of 30 and on cART was low (only 2.7% of the clinic 
population in this age group were receiving cART at the time this survey was 
conducted). This is because according to the current clinic policy cART is initiated 
only for patients with a CD4 cell count of ≤350 cells/mm3. Young men are less 
likely to have lower CD4 cell counts and thus less likely to be on cART.    
Table 25. Proposed and actual recruitment of the purposive sample based on 
age and cART status 
Age 
Group 
Proposed sample Recruited sample Total 
recruited 
 HIV 
Positive 
MSM on 
cART 
HIV 
Positive 
MSM not 
on cART 
HIV 
Positive 
MSM on 
cART 
HIV 
Positive 
MSM not 
on cART 
 
18-29 1-2 2-3 0 2 2 
30-44 4-5 2-3 8 5 13 
45-55 5-6 1-2 8 1 9 
55+ 5-6 1-2 0 0 0 
Total 15-19 6-10 16 8 24 
 
A greater proportion of men aged 35-55 were recruited and no men aged ≥55 were 
recruited. The age range of the participants interviewed was 25-54 years. Sixteen 
participants were receiving cART and 8 were not on cART, one of them was 
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previously receiving cART but stopped taking medication due to its side effects. 
Except for one participant who was bisexual, all participants self-identified as 
being gay (Table 26). Participants belonged to diverse nationalities and ethnic 
groups. Eighteen men were White, of whom 13 were White British and 5 were 
from other White backgrounds (1 Scandinavian, 3 from Southern and Central 
Europe, and 1 from North Europe). Two men were British Black Caribbean, two 
East Asians, and two from South America. The majority of men had studied 
beyond secondary school. Eight men had a post-graduate degree and another nine 
had completed a university degree. Five men had a diploma or NVQ, one studied 
up to A levels and one up to O level. Three participants had been diagnosed with 
HIV before cART became available, five men during 1996-2000, and three men 
between 2001- 2005. Thirteen participants were diagnosed with HIV during 2006-
2011, two of whom had been diagnosed in late 2010. 
All participants were sexually active. Ten men reported having sex in the last week, 
13 men reported last having sex between seven days to four weeks prior to the 
interview, and one participant last had had sex more than four weeks prior to the 
interview. Six men did not have a primary partner. Of the remaining eighteen men 
who had a primary partner, six men had an HIV negative primary partner and two 
men did not know the HIV status of their primary partner. Most men who had a 
primary partner were in an open relationship, i.e., they had other sexual partners or 
engaged in sex with other partners along with their primary partner. Seven men 
had not engaged in or had stopped engaging in group sex, whereas the remaining 
seventeen men had engaged in group sex. 
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Table 26. Characteristics of in-depth interview participants  
Characteristics  N=24 
 Sexual orientation  
Gay 23 
Bisexual 1 
Ethnicity  
White British 13 
White other 5 
British Black Caribbean 2 
Asian 2 
Other 2 
Education  
Up to secondary school 7 
Beyond secondary school 17 
Time since HIV diagnosis  
Pre-1996 3 
1996-2000 5 
2001-2009 14 
2010-2011 2 
Recent sexual activity  
Last week 10 
Three weeks prior to last week  13 
More than four weeks ago 1 
Has a primary partner   
No 6 
Yes 18 
Recently engaged in group sex  
Yes 17 
Recently diagnosed with STI  
Yes 20 
 
On the occasion of recruitment to the study, eleven men were attending the clinic 
because they were contacts of an index patient diagnosed with STI. Four 
participants had not been diagnosed with any STI recently (in the last three months 
prior to the interviews), and the remaining twenty men had been recently 
diagnosed with STI. Some men had been diagnosed with more than one STI. Nine 
men were recently diagnosed with gonorrhoea, seven with chlamydia, four with 
syphilis, three with LGV and three with HCV. This study draws upon the attitudes, 
perceptions, and experiences of these HIV positive MSM from diverse age groups, 
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ethnic background, and variation in the duration since HIV diagnosis, cART status 
and sexual partnerships. The following section unpacks the factors influencing the 
sexual behaviour and partnership patterns of these men. The themes presented in 
the following section are accompanied with quotes of participants from the 
interviews. Quotes are distinguished by participant’s age group, ethnicity, time 
since HIV diagnosis and cART status. For example: mid-twenty year old Black 
British man living with HIV since 5 years and not on cART. The interviewer’s 
quotes are titled as ‘INT’ and the respondents’ quotes are titled as ‘RES’.  
 
4.3.2 HIV diagnosis and sexual behaviour: shock and ‘new 
sexual identity’  
The narratives of some men reflect that being diagnosed with HIV has several 
implications for their mental health and sexual choices. A young participant 
reported that following his diagnosis he consumed a lot of alcohol and engaged in 
UAI. He mentioned this towards the end of his interview, prior to which he had 
consistently mentioned that he did not engage in any sexual activity for almost a 
year following his HIV diagnosis, demonstrating that it is difficult for a person to 
acknowledge engaging in activities that are perceived to be socially unacceptable 
during face-to-face communication.  
However, as reflected in the quote below, the majority of men reported that due to 
the psychological effect of their diagnosis they did not engage in any sexual 
activity following their HIV diagnosis for approximately two months to a year: 
“The whole first year things just kind of went in one ear and out the other 
because I wasn’t concentrating. Yeah there was basically the whole first year I 
just didn’t have any kind of sexual contact with anyone”.   
Black British man in mid-twenties living with HIV for 4 years, not on 
cART 
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The following quote reflects that some men stifled their sexual desires following 
their diagnosis with HIV due to feelings of shame and guilt: 
“Desire, temptation, hunter feeling has disappeared.  If it is there, I suppress 
it. No adventure, nothing, since I was given the diagnosis.” 
Scandinavian man in late thirties living with HIV for 3 years, not on 
cART 
Most participants felt that they were confronted with a ‘new sexual identity’ due to 
their HIV diagnosis. A newly diagnosed participant narrated that he did not know 
what to expect from his sexual partners when he disclosed his HIV status, but was 
pleasantly surprised when his partner did not reject him. Several participants 
mentioned that pre-HIV diagnosis they did not like to practise safe anal sex. As 
reflected in the quotes below, being diagnosed with HIV made it easier for some of 
them to engage in UAI.  
“I would never have had a profile on there (barebacking website) because I 
would have just thought, oh that’s a bit sleazy, but I now have a profile on 
there.” 
White British man in mid-twenties living with HIV for 1 year, not on 
cART 
“There hasn’t been a change in my sexual behaviour, I am still as 
promiscuous which is a loaded term. The difference is prior to me being 
diagnosed with HIV I probably did worry about becoming diagnosed with HIV.  
Now that I am HIV positive I obviously think that worry’s gone”. 
White British man in mid-thirties living with HIV for 12 years, on cART 
4.3.3 Seroconcordant partnerships: fear of rejection, ‘shared 
stigma’ and ‘sense of belonging’ 
For some men their new sexual identity following HIV diagnosis manifested in 
seeking UAI partners who were also HIV positive. Tremendous psychological 
significance as well as feelings of need for sexual pleasure was attached by these 
men to engagement in “guilt free” UAI free of the fear of HIV transmission. 
Engaging in UAI with other HIV positive men symbolized acceptance of their 
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‘diseased identity’ by other men and they associated it with “feeling liberated” or 
a “sense of belonging”. Having UAI with other HIV positive men helped some 
men cope with their ‘otherness’. It enabled them to view their diagnosis from a 
non-isolating, non-threatening perspective and a sense of relief: 
“RES: After the diagnosis I didn’t change anything at all and I continued 
being as safe as I have always been and then it’s took one chance encounter 
where we happened to have unprotected sex and, well I can only put it into 
words now because I’ve talked about it with my therapist. But it was very 
liberating to feel that whoever I’m having sex with, if it’s unprotected the 
person knows exactly what they’re in for and I would say ninety five percent of 
the time they are positive themselves. It’s very liberating to not feel that I’m 
toxic to the person I’m having sex with. So for me having unprotected sex just 
lifted up a whole weight and it lifted the part of the pressure but also the 
feeling of being dirty in a way that we’re both dirty. 
INT:Do you yourself, in your mind, associate HIV infection with being dirty or 
was it something you’d seen around you? 
RES: I did, well I don’t know why but I did because I guess from my own 
perception, I would have been one of those people who had a slight misgiving 
towards, I was slightly HIV phobic before and then I became one of them so 
maybe I have an internalized self-hatred.” 
South European man in mid-thirties living with HIV for 7 years, on cART 
The narratives of these men reflect that engaging in “guilt free” UAI with 
seroconcordant partners is not merely a sexual act but symbolizes coming to terms 
with their identity as an HIV positive person. It represents a ‘shared stigma’ of 
HIV, which enables HIV positive men to bond together, as is evident from the 
quote presented below. For some men this bonding was not restricted only to 
sexual activity but they also engaged in conversations with seroconcordant status 
partners about their changed sexual identity, fears related to HIV and life in 
general.  
“I mean the HIV community if I can call it that is quite, what’s the right word?  
It is a community and HIV positive people do kind of stick together, they have 
sex together, they do the same things together and you know they were great. 
They’re quite happy to talk about sex and what they get up to. You can have 
tons and tons of sex, take loads and loads of drugs and hold down a very good 
job, as I do for example.  Nobody really notices and it’s great and you know 
it’s really chatty, gossipy, fun, and supportive.  Well community’s not quite the 
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right word because that implies a sort of closeness which I don’t think is 
necessarily there, it’s meshed together on the basis of just you know 
everyone’s got sort of shared experiences rather than sort of shared culture. 
But it’s definitely there. I’m friends with people I’ve never met who are HIV 
positive who I talk to regularly online.” 
White British man in mid-thirties living with HIV for 12 years, on cART 
Men who had engaged in UAI with seroconcordant partners were aware of the risk 
of re-infection with HIV. However, the stigma and shame associated with HIV, 
fear of HIV transmission and rejection by HIV negative men affected their sexual 
partnership choices. However, not all men had engaged in UAI with other HIV 
positive men. Some men, particularly men above the age of 40, were concerned 
about the risk of re-infection with other strains of HIV and practiced safe sex with 
other HIV positive men. They prioritised their physical health over sexual pleasure 
and considered it wise to refrain from UAI. 
“I’ve read that there are different strains of HIV. Some HIV strains are drug 
resistant to some regimes so on and so forth … so I’d rather not have 
unprotected sex. I’d rather have protected sex.” 
White British man in mid-forties living with HIV for 2 years, on cART 
“There was this consensus that, if you're HIV positive and I'm HIV positive, to 
hell with it, let's just have bareback sex. They were just completely ridiculous 
because again, we can get across our viral varieties. I don’t understand that, 
it's kind of making the situation worse.” 
British Black Caribbean man in early fifties living with HIV for 3 years, 
on cART  
Fear of onward HIV transmission among some men was real and intertwined with 
low self-esteem and low self-worth due to their HIV diagnosis. Some men 
perceived themselves as “toxic”, “dangerous” to their sexual partners, especially 
if their partner was HIV negative. The following quote reflects that although men 
were worried about HIV transmission they did not want to be treated or treat HIV 
negative men with “kid gloves” or be rejected by them: 
219 
 
“RES: I choose to generally have sex with positive people because it’s less of 
a head fuck. When someone is negative quite often they bring all their issues to 
you. I don’t want to be treated with kid gloves, oh lets go and put some latex 
on and gloves and … so I’m basically in a surgical gown. It’s like no. I don’t 
want that which a lot of negative people are. I feel dangerous. I want to have 
sex with someone because of who they are. Of course, because I want someone 
to have sex with me for the same reason but if they’re negative I am going to 
be very, oh are you okay? Are you comfortable? I will treat them like a child. 
Not so much that I’ll patronise them to death …but more as in I’ll be like a 
worried parent. You know, is the condom still there? Has it split? Is there 
enough lube? All this and I panic probably more than them. 
INT:Have you had an experience like that since your diagnosis? 
RES: No, I’ve avoided it. And also I don’t really get the opportunity presented 
very often …because most guys are just like, oh no sorry I’d prefer to go and 
have sex with someone negative and I’m just like, well you just want to have 
sex with someone who doesn’t tell you (that they have HIV).” 
White British man in mid-twenties living with HIV for a year, not on 
cART 
4.3.4 Serodiscordant primary partner: anxiety, risk 
management and sexual behaviour  
Some men were in a serodiscordant primary partnership at the time they were 
interviewed. In this section, I describe the sexual behaviour of these men with their 
primary partner. The details of men’s attitudes towards various HIV transmission 
risk reduction strategies are presented later in section 4.3.9. In this section, I 
contextualize men’s sexual behaviour with their primary partner in the context of 
their attitudes towards HIV transmission risk reduction strategies. The majority of 
men who had a serodiscordant status primary partner narrated their anxieties about 
having sex with them. A participant described having sex with his serodiscordant 
primary partner as a “huge inconvenience”. Another participant’s primary partner 
was a married bisexual man. According to this participant, his primary partner’s 
wife was unaware of her husband’s bisexuality and thus he was very concerned 
about HIV transmission. The following quote reflects how these men attached 
greater significance to the HIV negative serostatus of their primary partner and 
wanted to protect them from HIV: 
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“I mean the sexual relationship between us is that he is entirely passive in the 
relationship, it’s the way he is. So I was really worried about the danger. In 
the past, we’ve had a couple of incidences where the condom had gone on very 
late so I was really worried that there might have been some transmission. I 
was more worried about him than about myself if that makes sense.” 
White British man in mid-fifties living with HIV for 2 years, on cART 
Some men had chosen not to engage in anal sex with their serodiscordant primary 
partner and had opted for an open relationship. Whereas some participants had 
engaged in UAI with their serodiscordant primary partner either because they 
believed that there is no risk of HIV transmission due to being on cART and 
undetectable viral load or they practised IUAI with withdrawal prior to ejaculation. 
However, the quote below reflects that there are occasional relapses in practicing 
UAI with withdrawal prior to ejaculation:  
“We have sex without condoms but I don’t penetrate him very much, I never 
come inside, I never come in him, only one or two time I came inside him.” 
South European man in early thirties living with HIV for 4 years, on 
cART 
4.3.5 Serodiscordant regular and casual partners: sexual 
pleasure and ‘shared responsibility’  
Some participants reported engaging in anal sex with HIV negative casual or 
regular partners; however, not all of them had engaged in UAI with them. Some of 
these men had never been on cART, or had stopped taking cART. When asked 
about the HIV status of their sexual partners, a participant expressed that he 
continues to have sex with HIV negative men because he does not want to 
stigmatise himself:  
“It’s a mixture (HIV status of partners) but I would have to say that they are 
predominantly positive now. And that’s not something I want to search out. 
And I certainly don’t want to be the person who says I could never have a 
relationship with somebody who is not positive because of stigmatising myself 
or other people.” 
South European man in mid-thirties living with HIV for 7 years, on cART 
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For some men UAI with a regular or casual partner was an outcome of the need for 
sexual pleasure and the HIV status of their sexual partner was irrelevant. While 
some men emphasised that engagement in UAI was a shared responsibility, others 
felt that they do not want to be solely responsible for preventing HIV transmission. 
As indicated in the following quotes, some men had engaged in UAI with an HIV 
negative partner if their partner was willing to take the risk: 
“I don’t believe in nannying people. I believe in people getting sufficient 
amount of information for them to make an informed decision and if I’ve told 
them that I’m positive in advance and they still insist on having bare back sex 
despite being negative, that’s not my problem. It depends how good-looking he 
was or how big his dick was. I probably would have sex with him but I would 
obviously have safer sex with him. I mean if he was to say to me in the middle 
of us having sex can I fuck you bare back, I would say well that’s a decision 
for you. I am HIV positive but I’m not going to feel obligated, I have told you 
my status” 
White British man in mid-thirties living with HIV for 12 years, on cART 
“I always put the condoms there.  I think that I do my part when I warn them. 
They are adults. They are older than me.  They know what to do. They are 
completely aware of the risk as everything else. They said that they had 
already experienced having sex with positive persons. I provided condoms 
because it’s always in my house.  Even after that they decided to have 
bareback sex, well that's because they want, and they think they’re not going 
to get (HIV) because they did not (get it) before.” 
South American man in early-thirties living with HIV for three years, on 
cART 
4.3.6 Group sex, recreational drugs, UAI and STI 
Irrespective of age or cART status, group sex was a common feature in the 
discussions about sexual behaviour. As mentioned previously in section 4.3.1, 
seventeen men reported that they had recently engaged in group sex. Several men 
had a profile on barebacking websites, i.e., sites for men interested in engaging in 
UAI. They usually assume that other men who have profiles on such websites are 
HIV positive. Men had attended group sex parties which were either organized 
online or arranged with a small group of 3-4 known sex partners, sometimes along 
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with a seroconcordant primary partner. Men mentioned various reasons for 
engaging in group sex like the lack of need for disclosure of their HIV status or 
condom use, feeling a sense of belonging, the lack of pressure to perform sexually 
if they had sexual health problems, or recreational drug use.  
“Because of my problems with the libido, I need the stimulation of the group.  
I may choose to stay with one guy only, even just to be an observer.  Quite 
often, I need extra stimulation.” 
North European man in mid-thirties living with HIV for 13 years, on 
cART  
Men narrated their experiences of attending sex parties where both HIV positive 
and negative men were present. Some men felt that these mixed parties don’t work 
well because of the need to have a conversation about HIV status, wash dildos, and 
use condoms. Some men mentioned that HIV negative men usually take the role of 
an insertive anal sex partner at such parties.  However, it was a norm to assume 
that the men present at such parties are HIV positive, unless specified otherwise.  
As reflected in the quotes below, it was apparent that recreational drug use is a key 
feature of sex, particularly group sex. Use of recreational drugs like “crystal meth”, 
“ice” (methamphetamine), cocaine, “plant food” (mephedrone) was reported. As 
reflected in the quote below, sex parties with anonymous partners are common and 
men either intravenously inject recreational drugs or practice “booty bumping”, i.e., 
taking drugs rectally. 
“I think it’s three experiences that I had over the summer of kind of group 
sessions which were over a weekend so a couple of days. Most people in those 
groups were sort of people I haven’t met before or had only met in the last  
few months previous. But yes, a few people I’ve known for a long time I know 
have moved from sort of, booty bump to injecting.”  
White British man in early forties living with HIV for 11 years, on cART  
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As reflected in the quote below, men used recreational drugs during sex for 
various reasons like to relax their anal muscles and reduce pain, lose sexual 
disinhibitions, and give them energy to engage in group sex: 
“INT: Why do you use poppers when you have sex? 
RES: I think sometimes it just relaxes me. Anal penetration for me can be 
painful …so I find that it helps to relax me. And I guess the rush really …It’s a 
compromising thing but basically it is a relaxation thing. I think it does relax 
my anal muscles.” 
South Asian man in mid-forties living with HIV for 15 years, on cART 
A participant felt that the regular use of crystal meth has had an addictive effect on 
his sexual behaviour and enhanced his sexual risk-taking behaviour including 
engagement in group sex. He would engage in UAI with an HIV negative partner 
if he would be high on crystal meth as it “impairs” his judgement. Some men who 
had a serodiscordant primary partner prior to their seroconversion reported that 
recreational drug use made them feel uninhibited and engage in UAI with their 
HIV positive partner despite being aware of the risk of HIV transmission:  
“Yeah it started as a casual relationship and I knew that he’s HIV positive but 
we decided to pursue it. But I think it was a careless thing because we did 
involve recreational drugs, which actually led to….unsafe sex. I think…I don’t 
know at what point I actually got infected with HIV but I think that’s how.” 
South Asian man in late-thirties living with HIV for four years, not on 
cART  
However, some men were bored of attending sex parties because they were also 
tired of being frequently infected with STI. They had been attending such parties 
for a long time and eventually ended up seeing the same men attending various 
group sex parties. On the other hand, some men viewed the risk of STI diagnosis 
due to engaging in risky sexual behaviour at sex parties as “it comes with the 
territory”: 
“What made me stop?  This is going to sound horrendous, I think I’d fucked 
my way through London.  I started seeing the same guys going along to the 
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same ones. And it was like actually I’ve had you before and you’ve been at the 
last party. I don’t think I’m going to go to these anymore, maybe I should take 
a bit of time out. So there was a bit of that going on.  And also, and this I think 
is the main reason, the drugs have just got a lot less good.” 
White British man in mid-twenties living with HIV for a year, not on 
cART 
The following quote pointedly reflects why men engaging in group sex parties are 
at greater risk of STI acquisition and transmission: 
“But I’ve gone away a bit from party organisers because I once, and I guess 
they’re right but I once said yes to an invite to a party and then at the last 
minute I didn’t particularly want to go and I kind of used the fact that I had 
chlamydia at the time a bit as a screen so I told them well I really shouldn’t, 
I’ve been diagnosed with chlamydia and I’m still on antibiotics. And the 
organiser said well it’s really up to you but there’s no reason why you should 
be the only at this party(with an STI) … I kind of thought yes that’s the reality 
of it, I know that. But I didn’t like something in his cavalier attitude of 
knowingly, if it was him I would have said okay that’s nice, stay at home, take 
your course of antibiotics and deal with it, come back afterwards when you’re 
clean, if you know it, treat it. But there was something quite, well not quite 
shocking, a little bit shocking, a tiny bit shocking about his attitude in saying I 
don’t care, bring your chlamydia to the party.” 
South European man in mid-thirties living with HIV for 7 years, on cART 
4.3.7 HCV co-infection and stigma 
Although several men had engaged in group sex and were unconcerned about 
being diagnosed with STI, they were concerned about being infected with HCV. 
Men who were HCV negative felt that they have HIV and do not want to deal with 
another hassle and were scared of acquiring HCV. Some men stated their 
unwillingness to engage in sex with a HCV positive person on their online dating 
and barebacking profiles. They also mentioned their HCV negative status and date 
of last test on their online dating profiles. Some men specifically asked their sexual 
partners for their HIV and HCV status prior to engaging in sexual activity with 
them: 
“I’m really scared about Hepatitis C because they say that Hepatitis C at the 
moment is a big thing.  Everyone’s got Hepatitis C so it’s the only thing that 
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I’m really, really scared about. I think I’m more scared about Hepatitis C and 
forget the HIV because I hear about the treatment for Hepatitis C is horrible.” 
White British man in late-thirties living with HIV for 7 years, on cART 
 
Some men reported being HCV positive and few of them were recently diagnosed 
with it. Men who were HCV positive found it more difficult to come to terms with 
their HCV diagnosis in comparison to their HIV diagnosis. As reflected in the 
quotes below, this was because men felt that HCV is associated with a “strange 
stigma” on the London gay scene. HIV positive men co-infected with HCV are not 
considered to be a part of the “community” by other HIV positive men who are not 
co-infected. HCV co-infection was perceived as a barrier to engaging in UAI 
among HIV positive men. As a result HCV co-infected men feared rejection by 
other HIV positive gay men and experienced isolation.  
“I think it was just kind of what people were saying, how full on the effect of 
the treatment was and how you effectively had to take a year out of your life to 
deal with the horrible side effects of it. Within the gay community, people who 
have Hepatitis C are ostracised.  There is already this kind of fear around 
being accepted with HIV, having to tell people and the fear of abandonment, 
but within the gay community itself people with Hepatitis C tend not to speak 
about it.”  
South European man in mid-thirties living with HIV for 7 years, on cART 
(HCV positive)  
“It’s difficult being open about having Hep C in London. Even amongst people 
who are generally quite open minded, there’s a tendency to stigmatise if you 
tell somebody that you’ve got Hep C. It seems like there’s a lot of HIV positive 
men who would consider having a relationship or having sex with somebody 
else who was HIV positive with the assumption that they would have 
unprotected sex. But obviously when you are Hepatitis C positive that is not an 
option and so I’ve found that there is more resistance to the idea of being in a 
relationship with somebody who has Hepatitis C than I experience when I’ve 
just had HIV.” 
White British man in mid-thirties living with HIV for 7 years, on cART 
(HCV positive) 
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Being co-infected with HCV also affected the sexual partnerships of these men 
because in case of some men it meant the end of their sexual relationship with their 
HCV serodiscordant partner(s):  
“Both myself and my partner have had Hep C and he went through hell for the 
first three or four months this year doing interferon tests, treatment and he’s 
clear now.  Which is probably another reason why we won’t probably have sex 
together again. I’m not prepared to get treated for it until, well treatments 
more effective.” 
White British man in mid-thirties living with HIV for 12 years, on cART 
 “My partner that I had, we're now separated, ten years ago, I know at the 
time ten years back, at the beginning of our separation ...he was diagnosed 
with Hepatitis C. And I think it was probably the reason why he left.” 
British Black Caribbean man in early fifties living with HIV for 3 years, 
on cART  
As indicated in the quotes below, HCV co-infected men were more worried about 
the implications of HCV rather than HIV on their physical health. They feared that 
they might be more likely to die due to HCV than HIV.  
“But to have a kind of difficult strain of Hep C, which is what I have got and 
be co-infected and be in my fifties, it is going to be very difficult for me to kind 
of get a healthy liver again.  It is going to be really tricky.  I would be really 
lucky to clear this.  And it could be how I will die, through liver failure and I 
you know, it is serious.” 
White British man in early fifties living with HIV for 17 years, on cART 
(HCV positive) 
Nevertheless, HCV co-infected men reported that they used to or continue to 
engage in group sex and/or UAI with other HIV positive men. The stigma 
associated with HCV affected disclosure about it to sexual partners. Some men had 
disclosed their HIV status on their online profiles but they had not disclosed their 
HCV status online due to the fear of rejection. Some men would disclose their 
HCV status to their sexual partners only if they would be asked about it directly or 
they felt that there would a potential for a long-term relationship if the partner is 
HIV positive:  
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“I will disclose but Hepatitis C has this very strange stigma on the gay scene 
that HIV never had.  It’s never discussed, ever. And I don’t think there’s any 
way round of gay men to talk about it. Whenever there is any discussion of 
Hepatitis C it tends to be quite in a negative way. So people will put on their 
profiles if you are Hepatitis C do not contact me, I do not want to have sex 
with you [sternly].  It’s the absolute bad thing to have.” And if you have it then 
I think it’s quite easy to become ostracised. So most gay men don’t disclose.  
So I for example, I’ve told very, very, very few people that I’m Hep C positive.” 
White British man in mid-thirties living with HIV for 12 years, on cART 
(HCV positive) 
4.3.8 Disclosure strategies  
The narratives of these men indicate that their HIV disclosure strategies evolve 
over time. Men adopt different disclosure strategies depending on their personal 
circumstances, perceptions of risk of HIV transmission and fear of rejection. 
However, there were some commonalities in the disclosure strategies employed by 
these men in certain venues for meeting sex partners and in the context of 
engaging in certain types of sexual behaviours.  
4.3.8.1 Risk perceptions, stigma, and disclosure of HIV status 
The risk perceptions associated with sexual practises influenced men’s decisions 
about disclosure of HIV status. Disclosure of HIV status was considered irrelevant 
in the context of one-night stand casual partners, especially if men had engaged in 
oral sex or practised safe anal sex because they perceived that there was no risk of 
HIV transmission. The underlying factor for non-disclosure of HIV status was fear 
of rejection, especially if the partner was HIV negative. As reflected in the quotes 
below, men would disclose their HIV status to sex partners who they may meet in 
bars and pubs if there would be scope for sex that is perceived to be associated 
with risk of HIV transmission. Some men would disclose their HIV status only to 
casual partners they trust. Whereas, others would disclose their HIV status if they 
would meet their sex partner more than once. 
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“In the bars…..non-disclosure, people don’t. I think you would only disclose 
when you’ve got that person on the night bus holding your hand going with 
you …because you are going to scare that person off. You’ve already given 
them a stick to beat you with but if you make sure that that person actually 
really does want to come home with you and you’ve had a good chance to chat 
to them then I would disclose a little later but I still would.” 
White British man in mid-twenties living with HIV for a year, not on 
cART 
Men, particularly men who had internalized the stigma of HIV diagnosis, felt that 
disclosure of HIV status to a sex partner is difficult. Some men who had 
experienced rejection prior to their HIV diagnosis, the experiences of rejection by 
sexual partners following HIV diagnosis further enhanced their feelings of 
insecurity and low self-esteem related to seeking sex partners. Several men had 
faced sexual rejection by an HIV negative partner at some point following their 
diagnosis but they dealt with it in different ways. The quotes below reflect that 
while some men were negatively affected by their experiences of rejection and it 
subsequently made them wary of disclosing their HIV status, others felt that it was 
a learning curve and the more they disclosed, the more they gained confidence in 
disclosing their HIV status to sex partners. Some men felt that HIV is a reality of 
their life and they cannot let rejection affect them.  
“With HIV negative partners, it is difficult to disclose due to fear of rejection 
and their reaction whereas when others inform me that they are positive, it is 
easier.  I have had unpleasant experience of disclosure 15-16 years ago and 
faced rejection due to my status in London.  It was very sad, disappointing, 
and hurtful.” 
White British man in mid-forties living with HIV for 20 years, on cART 
“If you mention that you’re HIV positive it puts the other person in a position 
where they can behave in three different ways.  They can say that doesn’t 
really matter which you know happens, but fairly occasionally and I guess it 
just happen mostly, in London most often you’ll find that people don’t’ mind 
and when I talk about people who I’ve hooked up with who I’ve not disclosed 
my status to but then had to disclose it afterwards even though we’ve not done 
anything risky and they’ve still reacted negatively.  I mean they are in the 
minority but it’s the negative experiences that stick really …they’re the ones 
229 
 
that are the most memorable and they’re the ones that perhaps have the 
potential to modify your behaviour because they cause you more hurt.” 
White British man in mid-thirties living with HIV for 7 years, on cART 
4.3.8.2 Sex venues and ‘seroassumption’ 
Venues of sex also influenced disclosure of HIV status. An underlying assumption 
among men engaging in sex in saunas or other sex on premises venues was that 
non-disclosure of HIV status is the norm. These venues were perceived to be sex-
oriented, and discussion of issues like HIV status was perceived to be unnecessary. 
Thus, the sex partners men meet in such venues are usually anonymous. Men 
usually assume that all men present in such venues or men who agree to have UAI 
in such venues are HIV positive. 
 “I mean everyone at the sauna has gone there for sex. So you know there’s 
nothing else on the agenda. You don’t want their life story, you’re not going 
out for dinner with them you know.” 
White British man in late-forties living with HIV for ten years, not on 
cART 
A participant who used the internet to meet sexual partners prior to his HIV 
diagnosis stopped using it following-HIV diagnosis and started meeting sex 
partners in saunas due to the lack of the need for disclosure of HIV status. Several 
participants expressed preference to have sex in such venues because of the lack of 
need to discuss about HIV. The quotes below highlights the method of HIV status 
disclosure on dating websites is indirect, i.e., via preference for condom use. Men 
used various online pre-defined condom use options like “safe sex is negotiable”; 
“always practise safe sex”; “needs discussion”; “prefer unsafe sex” to indicate 
their HIV status. There was no consensus on which options indicate that a person 
is HIV positive or HIV negative. Some men use this web information to ‘interpret’ 
the HIV and HCV status of the sex partners they meet online. Men search online 
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for sex partners who express the same condom use preference as them and assume 
them to be HIV positive.  
 “No, usually they put, people who are HIV positive, they put safer sex, needs 
discussion. So that you know that if it needs discussion then, yeah, probably 
HIV positive. That’s how you look at that, let’s see who’s HIV positive because 
they wouldn’t say that.” 
Central European man in early thirties living with HIV for 4 years, on 
cART 
“People would disclose on line whether they practice safe or unsafe sex which 
is the kind of primary way of identifying …status …even though it doesn’t 
necessarily, that’s the first line of the code. but also there are, on line profiles 
on website which proclaim that that person always practices safe sex and they 
will also be on a bareback website, so there’s this kind of cross referencing 
thing, and sometimes there’s a sort of a visual code (pictures), which indicates 
the kind of sex somebody would be having, and the kind of sexual situations 
they would be engaged in …” 
White British man in late thirties living with HIV for 4 years, not on 
cART 
4.3.8.3 Criminalisation of intentional HIV transmission and disclosure of 
serostatus 
Some participants had a negative experience because they had not disclosed their 
HIV status to sex partners; for example, a participant was deeply scared of being 
sued by his HIV negative ex-partner for non-disclosure of HIV status. However, 
not all men were fully aware of current policy on criminalization of intentional 
transmission of HIV in the UK. Even though they had heard about it, they were 
confused about the various elements of the law. Some men felt that they did not 
know if they could be in trouble for not disclosing their HIV status to a sexual 
partner if they were engaging in safe sex. As reflected in the quotes below, some 
men were concerned about the abuse of this law by HIV negative men who engage 
in UAI despite disclosure of HIV status by the infected person, yet may later 
threaten to sue the HIV positive person.  
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 “I know it’s very mean to do it (have unprotected anal sex) on purpose but 
well it’s word against word. the guy can say that I didn’t warn them .What to 
do then” 
South American man in early-thirties living with HIV for three years, on 
cART 
Others felt that due to the effectiveness of cART in reducing the risk of HIV 
transmission, this law is outdated and should be changed: 
“Anyway I am not killing nobody. A person like me can still be alive with the 
tablets and with the therapy for a long time.  Being arrested for killing, for 
trying to killing somebody must be only when you are really trying to kill 
somebody, so this law is not good.” 
South European man in early thirties living with HIV for 4 years, on 
cART 
4.3.8.4 Disclosure of HIV status: a ‘shared responsibility’ versus ‘social 
responsibility’ 
Disclosure of HIV status and practising or negotiating safe sex was considered as a 
shared responsibility of men engaging in sex, whether on a one-to-one basis or 
group sex. Blaming only one partner for non-disclosure of HIV status and 
engaging in consensual UAI was considered inappropriate.  
 “It’s your responsibility to protect yourself.  If you’re going to a club and 
you’re going to have sex, chances are there will be guys in there who are HIV 
positive.  There just will be.  Anybody with half a brain will know that because 
they’re sexually very active.  I guess not all gay men are so sexually active but 
a lot are and there’s going to be a lot of it in there.  So use your head and use 
protection – that’s what protection is for. You have some responsibility for 
yourself.” 
White British man in mid-fifties living with HIV for last 4 years, on 
cART 
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 “Most of the situations people don’t talk, therefore I feel comfortable with 
that and while I’m not satisfied with my behaviour I’m looking for ways to 
change, but that’s how I go for sex at the moment because it suits my 
conversation needs. I expect that people are knowledgeable and therefore we 
are both responsible for what’s going on.” 
North European man in mid-thirties living with HIV for last 13 years, not 
on cART 
However, some men felt otherwise. They considered disclose of HIV status to 
their sexual partners as a “social responsibility”. Men usually disclosed their HIV 
status to protect themselves from rejection at a later stage and avoid hassle, as 
reflected in the following quote:  
“Yeah now that I’ve made that choice to just be honest about everything it’s so 
much easier because I won’t have to worry about anyone’s response to it 
because I know that I’m being a hundred percent honest. So whatever anyone 
thinks of that …it’s not my concern because I’ve been honest so whatever 
you’re doing that’s you know.” 
Black British man in mid-twenties living with HIV for 4 years, not on 
cART 
4.3.9 Attitudes towards cART, undetectable viral load status 
and its implications for HIV transmission 
Men were asked if they had read, heard or been advised by their clinicians about 
the reduced risk of HIV transmission if an HIV positive person is on cART and 
has an undetectable viral load. The majority of men had read about it in gay 
magazines or newsletters, whereas some men had heard about it from their friends, 
clinicians or sexual partners. Few men did not know about it. There were 
differences in men’s attitudes towards the reduced risk of HIV transmission if an 
HIV positive person is receiving cART and has an undetectable viral load.  
4.3.9.1 ‘Non believers’ of reduced infectivity due to undetectable viral load  
Being on cART and having an undetectable viral load was perceived to reduce the 
“degree of infectiousness”. However, although undetectable viral load was 
understood as having minimal HIV in the body, it was felt that it is not the same as 
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having“no HIV virus in the body”. They felt that even if an HIV positive person 
has an undetectable viral load, HIV virus would still be present, either in the anus, 
semen, pre-cum or somewhere in their anatomy:  
“It’s comforting, because that’s not quite the right word to use but you know 
what I mean. It’s not like a linear relationship but if you are undetectable you 
are less infectious. It is a kind of a loaded phrase but yes, you should be less 
infectious than if you had 500,000 count. I don’t think just because you are 
undetectable doesn’t mean that you don’t have HIV in your body or that, you 
are not infectious, you still are high risk.” 
White British man in mid-thirties living with HIV for 3 years, on cART 
“Undetectable means that they couldn’t find any antibody in the blood sample.  
That doesn’t mean that it is not in the semen or it is not up my backside, you 
know, it is still there, it is still present somewhere in my physiology, in my 
anatomy so it is like, no it is just that it wasn’t in that bit of blood.  I mean that 
is no reason to have unsafe.” 
White British man in early fifties living with HIV for 17 years, on cART 
Some men felt that even if an HIV positive person has an undetectable viral load, 
there is still a risk of HIV transmission and thus they would not engage in UAI 
with HIV negative partners:  
“Yeah so to me it’s like yes okay I’m less likely to pass it on to them. I know 
you can still pass it on but you are less likely. So the overriding fact is yes you 
can still pass it on.” 
South Asian man in mid-forties living with HIV for 15 years, on cART 
“How can you be so sure that I couldn’t possibly pass it on because that 
would mean that living on pills is the equivalent of being negative, can you 
take that risk? I don’t know, I have almost found it a completely irresponsible 
comment.” 
South European man in mid-thirties living with HIV for 7 years, on cART 
4.3.9.2 Swiss statement about cART, undetectable viral load and risk of HIV 
transmission 
Some participants who had read about the Swiss Statement felt that publishing 
research without firm evidence is “misleading” and “irresponsible”. Some 
participants were upset with their clinician’s advice that people on cART are non-
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infectious if they have an undetectable viral load. They considered such advice to 
be scary and irresponsible. Fear of HIV transmission, and love towards their 
partners were of greater significance than having UAI with their partners:  
“Swiss study obviously says that if you are able to get down to an undetectable 
that it would be the same as a HIV negative person having sex with a HIV 
negative person. However, I’m not comfortable with that and I think that’s a 
load of bullshit. I think it’s quite circumstantial. I understand that their thesis 
is that if you are able to get somebody to an undetectable viral load then the 
rate of transmission is, therefore, dramatically decreased. I think, of course, 
you then have a smaller chance of being able to infect somebody through a 
route of transmission, through anal sex or whatever …… however; you do still 
have a risk. That research should only be released when it is finally 
finished …not when you are talking about research that is on-going …because 
they are going to encourage people and they have, I’ve heard this quite a few 
times and I find it a bit creepy.” 
White British man in mid-twenties living with HIV for a year, not on 
cART 
Some men were concerned about the implications of engagement in UAI due to 
attitudes that undetectable viral load reduces the risk of transmission on HIV and 
STI transmission. They felt that there is an increase in unsafe sexual behaviour 
among HIV positive and HIV negative men due to beliefs about the reduced risk 
of HIV transmission due to being on cART and having an undetectable viral load. 
Few men who disagreed that the risk of HIV transmission was reduced due to 
cART and undetectable viral load narrated their pre-HIV diagnosis personal 
experiences when they were approached by HIV positive men on cART with an 
undetectable viral load to engage in UAI: 
“I’ve heard this quite a few times before my diagnosis and they would say, I’m 
HIV positive. But it was a few times that I had guys, certainly after the Swiss 
report came out that they would say, I’m HIV positive and they would be like, 
oh well I’m undetectable, and on medication therefore, the ability for me to, its 
impossible for me to infect you.” 
White British man in mid-twenties living with HIV for a year, not on 
cART 
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“You know, I think it happens between HIV positive people and negative 
people.  I mean, I’ve had that conversation with somebody once … quite a 
while ago. Having an undetectable viral load, therefore unsafe sex is okay. I 
was negative and he was positive.” 
White British man in late thirties living with HIV for 4 years, not on 
cART 
4.3.9.3 cART, undetectable viral load and unsafe sex: no protection from 
STI 
Men were aware that engaging in UAI due to being on cART and having an 
undetectable viral load would not protect them from the risk of other STI:  
“No, it’s not safe, there’s always the possibility to get infected from the other 
person. Nobody’s going to tell you their HIV status or nobody anyway will go 
a lot in the clinic to check, so it’s a possibility that if you have sex with 
somebody you can get infected with gonorrhoea and chlamydia or any type of 
virus.”  
South European man in early thirties living with HIV for 4 years, on 
cART 
“Well my viral load is undetectable and I will not practice unsafe sex. there’s 
two reasons really. One is the possibility of transmission …and then there is 
the possibility of other sexually transmitted diseases as well. So there are two 
elements.” 
White British man in mid-forties living with HIV for 2 years, on cART 
Some men who felt that being on cART and having an undetectable viral load 
reduces the risk of HIV transmission had engaged in group sex and had 
anonymous sex partners.  
4.3.9.4 ‘Believers’: implications for sexual HIV transmission due to cART 
and undetectable viral load  
Few participants considered being on cART and having an undetectable viral load 
as effective means of reducing the risk of sexual transmission of HIV during UAI. 
However, they differed in their perceptions about the nature of risk that was 
reduced due to undetectable viral load. Some men felt that having an undetectable 
viral load reduces the risk of HIV transmission to an HIV negative partner. Few 
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men reported engaging in UAI with HIV negative partners as a result of these 
beliefs. Few men also believed that being on cART and having an undetectable 
viral load reduces the risk of re-infection with other strains of HIV and thus it is 
safe to engage in UAI with HIV positive partners. A participant who did not 
believe that having an undetectable viral load reduces the risk of HIV transmission 
to HIV negative partners and was concerned about the risk of re-infection believed 
that having an undetectable viral load reduces the risk of HIV transmission during 
unsafe oral sex.  
4.3.9.5 cART and undetectable viral load: negotiations before engaging in 
risky sex 
Men who had engaged in UAI with HIV negative men reported that they had 
discussed about their cART and viral load status with their partner prior to 
engagement in sex. The quotes presented below reflect the nature of such 
interactions with HIV negative partners to determine the safety of engaging in UAI 
due to cART and undetectable viral load status: 
“I tell them that I am positive but I am taking medication and it is under 
control and you can’t get it, even if we had unprotected sex. My viral load is 
so low that it is unlikely that you will get.” 
 
“My experience is good.  I met somebody in a bar and he was negative and I 
told him I’m positive and he said that’s fine, it is not the end of a world. He 
just asked are you taking pills, yes, and well he was even curious to see the 
pills, so I showed him the pills. And he asked are you okay, you’re not having 
any problems, and I said no, and that was it.” 
Central European man in early thirties living with HIV for 4 years, on 
cART 
“The last new encounter did ask me about what the status and sort of a 
general question about my status. He wanted to know more of the finer details, 
like how my viral load was. He was negative. Oh he still wanted to do things 
with me.” 
White British man in mid-fifties living with HIV for 20 years, on cART 
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4.3.9.6 cART, undetectable viral load: no need for disclosure of HIV status  
As reflected in the quote below, few men considered it unimportant to disclose 
their HIV status to HIV negative partners prior to engagement in UAI due to the 
reduced risk of HIV transmission associated with being on cART and having an 
undetectable viral load status.  
“We had unprotected sex. So after that he asked me ...and I disclosed and he 
said ok, that’s fine, thank you for letting me know. I’m going to do the PEP 
and I said don’t. I said it’s up to you but I am having treatment and my viral 
load is undetectable and you are the top one…so you won’t get HIV but if you 
want (PEP) to its up to you.” 
White British man in late-thirties living with HIV for 7 years, on cART 
4.3.9.7 cART, undetectable viral load and strategic positioning 
A participant who had engaged in sex with serodiscordant status partners 
perceived the association between undetectable viral load status and reduced risk 
of HIV transmission as a “safety net” to protect his HIV negative partner in the 
event of an unplanned UAI. As reflected in the quote presented above in section 
4.3.9.6, some men perceived that strategic positioning reduced the risk of HIV 
transmission, especially if the HIV positive partner is on cART and has an 
undetectable viral load. Some participants also had misperceptions that being an 
IUAI partner reduces the risk of HIV transmission:  
“I think that amongst a very small group of people in the on-line community in 
London there’s a feeling that you know as long as you are not being the 
passive partner it doesn’t really matter.” 
South European man in mid-thirties living with HIV for 7 years, on cART 
4.3.9.8 Undetectable viral load, reduced risk of re-infection with HIV and 
sexual behaviour 
As mentioned in section 4.3.9.4, few men felt that having an undetectable viral 
load reduces the risk of re-infection with other strains of HIV. They prefer to have 
UAI with other HIV positive men who have undetectable viral load to protect 
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themselves against the risk of re-infection with HIV. These men specifically look 
for other HIV positive men with an undetectable viral load on bare backing 
websites: 
“People who are HIV positive are more likely to have unsafe sex. I suppose 
for me I feel slightly more the fact that my viral load is undetectable and if I 
take that to mean that the likelihood is far less, than I suppose I do make an 
assumption that I am unlikely to infect somebody else who is HIV positive. I’d 
feel quite wary about possible re-infection with a different strain, if I knew that 
other person was positive but not on treatment. If I was to take a risk and had 
unsafe sex and then there’s a definite preference to somebody who would 
describe their viral load to be undetectable, even if that doesn’t, mean there’s 
no virus present in their semen or in their pre-cum. There does seem to be 
some kind of evidence that it’s less likely to have HIV transmission if your 
treatment is effective and your viral load undetectable.” 
White British man in early forties living with HIV for 11 years, on cART  
In the following section, I discuss the findings of the qualitative study and how 
they complement and contradict the findings of the SHARPN survey presented in 
chapter 3. I also compare the findings with those of other studies. 
4.4 Discussion of findings and comparison with other studies 
The findings of the qualitative study suggests that a myriad range of socio-cultural, 
psychological, HIV related factors and HIV positive MSM’s attitudes towards 
various risk reduction strategies for prevention of HIV transmission influence their 
sexual partnership patterns, sexual behaviour and risk management.  
Experience of HIV and HCV diagnosis, sexual partnerships and sexual 
behaviour 
Several epidemiological studies have reported a decline in sexual activity among 
HIV positive MSM following HIV diagnosis (Gorbach et al., 2006, 2010). The 
emotional burden experienced by some men due to ‘felt stigma’, i.e., shame 
associated with being HIV positive, and the fear of ‘enacted stigma’, i.e., being 
discriminated against due to their HIV positive status (Scambler, 2004) explains 
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the reduction in sexual activity of some men following their diagnosis with HIV. 
Men are concerned about being rejected by their sexual partners and some men are 
concerned about disclosing their HIV status to their sexual partners. 
However, in case of some men HIV diagnosis facilitates engagement in guilt-free 
UAI with other HIV positive men. Studies in the UK have reported an increase in 
serosorting among HIV positive MSM (Elford, 2006; Lattimore et al., 2011). 
Similar to other studies, men engaged in UAI with other HIV positive MSM 
because they were concerned about the risk of onward HIV transmission to HIV 
negative partners (Cusick and Rhodes, 2000; Frost et al., 2008). However, in line 
with the findings of other studies, men also engaged in serosorting in the pursuit of 
sexual and emotional intimacy, the need for sharing the experiences of living with 
HIV (Cusick and Rhodes, 2000; Frost et al., 2008) and felt barriers to intimacy in 
serodiscordant partnerships (Frost et al., 2008). Serosorting by HIV positive MSM 
also needs to be understood in the context of their experience of being confronted 
with a ‘new sexual identity’ upon HIV diagnosis. Being diagnosed with HIV poses 
challenges associated with partner selection, and disclosure of serostatus. 
Serosorting is not merely a risk reduction strategy to prevent onward HIV 
transmission but a manifestation of agency exercised by HIV positive MSM 
against the stigma associated with HIV. It also reflects the need for sexual pleasure 
and sexual preferences, and acceptance by sexual partners. These qualitative data 
explain the observed high prevalence of UAI with a seroconcordant primary 
partner as well as the most recent non-primary partner, and the high prevalence of 
HIV positive new partners in the SHARPN survey. The sexual boundaries among 
MSM exist not only between HIV positive and negative MSM but also among 
HIV positive MSM. Similar to another study, the findings reflect the severe stigma 
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associated with HCV among HIV positive MSM (Owen, 2008). The lack of 
effective biomedical treatments and fear of side effects of treatment for HCV 
exposes men co-infected with HCV to stigma and discrimination from within the 
gay community. HCV co-infection is a barrier for engagement in UAI with other 
HIV positive MSM. Fear of stigma, isolation and ostracisation often leads to 
‘passing’, i.e., non-disclosure of HCV status by co-infected men (Nack, 2000) to 
protect themselves from discrimination.   
Most men who had participated in the qualitative interviews had engaged in group 
sex and were aware of the risk of STI associated with it. The reference by some 
men to seeing the same men at every group sex party indicates that a subset of 
MSM engage in multiple sex parties and can contribute to sustaining the 
transmission of STI in these networks.  Thus, men who engage in group sex should 
be encouraged to test regularly for STI. Recreational drug use during sex was a 
common feature among men who engaged in group sex.  
Disclosure of HIV and HCV serostatus  
The findings suggest that being confronted with a new sexual identity following 
HIV/HCV diagnosis is a challenging experience that exposes men to the risk of 
rejection and discrimination by sex partners, and can be a barrier to disclosure of 
HIV/HCV status. The SHARPN survey data reported in previous chapters has 
shown that several men had met their new partners in gay venues like saunas, sex 
on premises venues etc. The qualitative findings suggest that nondisclosure of HIV 
status is the norm in such venues, particularly saunas. This explains the high level 
of unknown serostatus and anonymous partners observed in chapter 3. A 
substantial proportion of men in this study had also met their new partners and 
most recent non-primary partner via the internet. Studies have shown that internet 
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dating can enhance serostatus disclosure (Elford et al., 2001; Bolding et al., 2005). 
However, the qualitative study findings suggest that online dating profiles can 
enhance seroassumption. Men who engaged in online dating usually assumed the 
HIV status of their sex partners based on their condom use preference expressed 
on their online dating profile as opposed to having a discussion about it. There 
seems to be no consensus among men about which type of condom preference is 
associated with HIV positive or HIV negative serostatus. These data suggest that 
there is a need to promote condom use with partners of unknown HIV status, met 
online or offline. Similar to other studies, the qualitative findings indicate that the 
fear of rejection by sexual partners, internalised stigma and shame due to HIV 
(Klitzman et al., 2004), perceptions that the responsibility for disclosure of 
serostatus is shared, especially of casual partners (Wolitski et al., 2003); and 
concerns about ignorance of HIV among HIV negative men affect disclosure of 
HIV status among these men. Disclosure of HIV status was also closely associated 
with the type of sexual activity men engaged in with their casual partners. Men 
considered it unnecessary to disclose their HIV status if they engage in safe sex.  
Most men were not fully aware of the guidelines for criminalisation for HIV 
transmission in the UK (Crown Prosecution Service, 2008). A participant was very 
worried about being sued for intentional HIV transmission by his serodiscordant 
ex-partner suggesting that the sexual lives of some HIV positive MSM are likely to 
be affected by the fear of negative consequences of their sexual behaviour. HIV 
positive MSM should be informed about the guidelines on criminalisation for HIV 
transmission and their rights and responsibilities. As shown in the next sub-section, 
men’s beliefs about the reduced risk of HIV transmission due to undetectable viral 
load can also have implications on disclosure of HIV status to sexual partners. 
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Attitudes towards HIV transmission risk reduction strategies and sexual 
behaviour 
Some HIV positive MSM, especially men above the age of forty, had a preference 
to engage in UAI with an HIV positive partner who has an undetectable viral load 
to protect themselves from the risk of super-infection with HIV. Apart from HCV 
diagnosis, the preference to engage in UAI with other HIV positive MSM who 
have an undetectable viral load status has further divided HIV positive MSM 
between those who have a detectable viral load and those who have an 
undetectable viral load.  
Most men were concerned about the presence of HIV in their body despite having 
an undetectable viral load and the associated risk of HIV transmission. However, 
in line with other studies, some men who were optimistic about the reduced risk of 
HIV transmission due to viral suppression had engaged in discussions with HIV 
negative partners on issues related to their cART and viral load status to facilitate 
UAI (Horvath et al., 2012). The perceived safety net of undetectable viral load 
status may enhance disclosure of HIV status among those on cART to facilitate 
UAI. However, in some cases it appears to encourage non-disclosure due to the 
perceived lack of risk of HIV transmission. The implications of both these factors 
need to be investigated further.  
Among some HIV positive MSM emotional bond manifests in the integration of 
HIV prevention rationalities like condom use during sex to prevent HIV 
transmission to an at-risk primary partner. However in the context of some 
serodiscordant primary partnerships and casual partnerships, UAI with 
serodiscordant partners was likely to occur in the context of perceptions of shared 
responsibility for engagement in UAI. It was also likely to be facilitated by 
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perceived protection from HIV transmission due to use of risk reduction strategies. 
However, some men had misperceptions about the effectiveness of these HIV 
transmission risk reduction strategies. Therefore, health promotion campaigns 
among MSM should address the HIV transmission risks associated with various 
risk reduction strategies and emphasise that none of these strategies offer complete 
protection against HIV transmission and do not offer protection against STI.  
4.5 Strengths and limitations 
As mentioned previously in the chapter 2, in-depth interviews were conducted 
with HIV positive MSM who were purposively sampled based on age and cART 
status from a single HIV clinic. In-depth interviews were considered appropriate 
for data collection to ensure confidentiality to the participants while exploring 
sensitive issues like attitudes towards cART, other risk reduction strategies and 
sexual behaviour; and partner notification for STI. A topic guide that was a 
combination of questions and vignettes on partner notification for STI guided the 
interviews. The vignettes depicting hypothetical scenarios of STI diagnosis and 
partner notification scenarios were a useful tool to facilitate discussion, and 
explore consistently the attitudes of participants towards partner notification for 
STI. The exploration of issues regarding sexual partnerships, behaviours etc during 
the interviews enabled contextualizing the participants responses to vignettes on 
partner notification. The matrix based approach used for data analysis facilitated 
comparison in a systematic manner across and within cases for emergent themes. 
This process also facilitated the development of descriptive as well as explanatory 
narratives. It enabled identification of perspectives which were unique compared 
to the majority of the participants, and understand the contextual factors of these 
cases. Nevertheless, the findings of the qualitative study should be interpreted in 
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the backdrop of the following strengths and limitations. 
4.5.1 Transferability and specificity of the study findings 
4.5.1.1 Study sample 
The qualitative study sample was purposively selected based on age and cART 
status. This sampling strategy enabled exploration of the study aims among men 
from different age groups and cART status. However, the majority of men who 
were recruited in this study were receiving cART and aged 29-54. This should be 
acknowledged when interpreting the results of this study. Epidemiological data 
presented in chapter 1 indicates that this study sample is representative of the age 
group of HIV positive MSM more likely to be diagnosed with STI. Therefore this 
is an appropriate age group to explore attitudes towards partner notification for 
STI. As mentioned in chapter 4, the overall proportion of men accessing care in 
the clinic who were below the age of 30 and on cART was low (only 2.7% of the 
clinic population in this age group were receiving cART at the time this survey 
was conducted). This explains the under-representation of this group in the study. 
Nonetheless, further studies should be conducted to explore attitudes of young 
HIV positive MSM and men older than 55 years towards cART and other risk 
reduction strategies for HIV prevention and its implications for sexual behaviour, 
and partner notification for STI.  
4.5.1.2 Study setting 
Men for in-depth interviews were recruited from a single HIV clinic in central 
London. As explained previously in chapter 2, the majority of this clinic’s 
population is White MSM. The study sample recruited for the qualitative study, as 
reported in chapter 4, was predominantly White MSM and few men were also 
from a non-White and mixed ethnic background. It is likely that other socio-
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demographic characteristics, i.e., age, education, employment status etc of HIV 
positive MSM attending the HIV study clinic in central London are different from 
those attending clinics in outer London or outside London and may potentially 
influence the study findings. Further studies to explore attitudes towards cART 
and other risk reduction strategies for HIV prevention and partner notification for 
STI should be conducted among HIV positive MSM in geographical areas outside 
central London and in other London clinics.  
4.5.1.3 Bias  
One of the aims of the qualitative study was to explore men’s attitudes towards 
partner notification for STI in the future. It is likely that men’s reported intentions 
towards partner notification for STI in the future may not necessarily reflect their 
future behaviour. Also, men who were recently diagnosed with STI or were 
contacts of men recently diagnosed with STI were recruited for the qualitative 
study. Therefore, the positive attitude of the majority of men towards partner 
notification for STI reported in this study should be interpreted with caution.  
It is also likely that men considered it desirable to report acceptability of partner 
notification of STI and refute engagement in unprotected sexual behaviours with 
serodiscordant status partners due to having an undetectable viral load. However, 
the study findings reveal that not all men had positive attitudes towards partner 
notification for STI. Some men reported engaging in unprotected sex with 
serodiscordant partners due to being on cART with an undetectable viral load and 
using behavioural strategies to reduce the risk of HIV transmission. This suggests 
that desirability bias may not have necessarily influenced the interview process. 
Also, the observed consistency in the SHARPN survey findings and the qualitative 
study results on partner notification for STI, and between future willingness to 
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notify partners of STI and recent partner notification experiences reported during 
interviews suggest that these data are likely to be reflective of HIV positive 
MSM’s partner notification behaviour and preferences.  
4.6 Implications for clinical practice, policy and future research 
The findings suggest that provision of psychological support to men immediately 
following their diagnosis with HIV continues to be important. Similar support 
should be offered by the clinics to men diagnosed with HCV. Serosorting is a 
deeper issue and not only practised for HIV prevention. It symbolises need for 
sexual pleasure, bonding due to common experiences related to HIV diagnosis 
with other HIV positive MSM and need for acceptance from other MSM. The 
consequences of serosorting and engagement in UAI in terms of risk of STI 
transmission and acquisition need to be addressed in this larger context. Health 
promotion campaigns among MSM should also address norms related to 
disclosure of serostatus in gay venues and on dating websites, and norms of 
disclosure associated with different types of sex.  
These findings confirm that risk-reduction interventions that do not address the 
socio-cultural and psychological context are likely to yield minimal, non-
sustainable results. Interventions for risk-reduction in HIV positive MSM should 
address the wider issues related to stigma and discrimination, not only from 
outside the gay community but also between HIV positive and negative MSM, and 
among HIV positive MSM.  
The qualitative study findings corroborate the SHARPN survey findings that 
attitudes towards the effectiveness of HIV transmission risk reduction strategies 
can influence engagement in risky sexual behaviours with a serodiscordant status 
primary partner. There is a need for further research to understand the prevalence 
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of use of ‘combination of risk reduction strategies’ for prevention of HIV 
transmission in MSM, i.e., are men more likely to engage in sexual behaviours like 
strategic positioning that are considered to reduce the risk of HIV transmission if 
they have an undetectable viral load.  
Both, the SHARPN survey and qualitative study findings confirm that a significant 
proportion of HIV positive MSM engage in sexual behaviours and other risky 
behaviours like recreational drug use during sex which have implications for both, 
HIV and STI transmission, and STI acquisition. In the next chapter, I examine STI 
diagnosis among these men in the last year, and the risk factors for the same. I also 
examine their attitudes towards partner notification for STI, willingness to notify 
sexual partners of STI in the future and the willingness to use various traditional 
and novel methods of partner notification for STI in the future.  
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Chapter 5: STI and partner notification for STI among 
HIV positive MSM: results of the SHARPN survey  
5. Aims  
The aim of this chapter is to understand testing and diagnosis of STI in the last 
year among HIV positive MSM, and their attitudes towards partner notification for 
STI and willingness to notify different types of sexual partners of STI in the future 
to inform the development of partner notification strategies for STI in HIV 
positive MSM. As mentioned previously in section 1, in this thesis, I have used the 
term STI to refer to all STI other than HIV.  
5.1 Specific objectives  
1. To describe the SHARPN survey findings on the attitudes of HIV positive 
MSM towards partner notification for STI.  
2. To describe STI testing and diagnosis in the last year, examine the factors 
associated with STI diagnosis, and describe partner notification following STI 
diagnosis in the last year. 
3. To describe the willingness of HIV positive MSM to notify different types of 
sex partners of STI in the future and their willingness to use different methods of 
notification for STI. 
4. To examine the factors associated with unwillingness to notify casual 
partners of STI in the future. 
5. To describe the preferred methods to be notified of STI by sexual partners in 
the future.  
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5.2 Methods 
The details of the methods were described previously in section 2.5 and data 
analysis in sub-sections 2.5.13 and 2.5.14. 
5.3 Results 
As described in section 3.3.1, 429 participants completed the SHARPN survey. In 
the following section, I describe these participants’ previous experience of 
notifying sex partners of STI, and attitudes towards partner notification for STI.  
5.3.1 Experience of and attitudes towards partner notification 
for STI  
As shown in Table 27, when asked if they have ‘ever’ been advised by the clinic 
staff to notify their sexual partners of STI, 329 (76.7%) of the 429 participants 
responded positively.  
Table 27. Previous experience of partner notification for STI  
Factors 
1
n/N  % (95% CI) 
Ever advised by the clinic staff to notify sexual 
partners following STI diagnosis 
  
Yes 329/429 76.7 (72.7-80.7) 
Ever worried about breach of HIV related 
confidentiality as a result of partner notification 
by self or clinic 
  
Yes 90/372 24.2 (19.8-28.6) 
Ever notified sexual partners of STI    
Yes 281/429 65.6 (61.0-70.0) 
2
Ever experienced physical violence   
Yes 8/278 2.9 (0.90-0.48) 
2
Ever experienced verbal abuse   
Yes 30/276 10.9 (7.17-14.5) 
2
Ever experienced a break-up as a result of PN   
Yes 58/264 22.0 (16.9-26.9) 
1
Base varies due to item non-response 
2
Includes only men who had ever notified sexual partners of STI 
 
Approximately a quarter of the men reported being worried about breach of HIV 
related confidentiality as a result of partner notification for STI. With regards to 
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previous experience of notifying sexual partners, 281 (65.6%) men had notified 
partners of STI. Of these, 2.9% of men had experienced physical violence from 
their partner following notification, 10.9% of men had experienced verbal violence, 
and approximately 22% of men had experienced a break-up with their partner as a 
result of notifying them of STI.  
As shown in Table 28, 11.4% of men agreed that notifying sexual partners for 
exposure to curable STI is not their responsibility. However, the majority of men 
disagreed that it is not their responsibility to notify their sexual partners of STI 
(75.2%). A further 13.5% of men were not sure about it. Compared to attitudes 
towards responsibility of notifying sexual partners for exposure to STI, a greater 
proportion of men felt that their sexual partners should notify them if they are 
diagnosed with STI, but this difference was not statistically significant (83.6% vs. 
75.2%, p=0.84). 7.8% of men disagreed that their sexual partners should notify 
them if they are diagnosed with STI. A sizable number of men were concerned 
about the negative impact of notifying their primary partner for exposure to STI 
(30%). 15.8% of men agreed that notification of sexual partners should be made 
legally binding for those diagnosed with STI whereas 62.2% of men 
disagreed/strongly disagreed and 22% of men were not sure about it. 
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Table 28. Attitudes towards partner notification for STI 
 
1
n/N  % (95% CI) 
I do not have any responsibility to contact my sexual 
partners if I am diagnosed with any curable STI 
  
Strongly agree/Agree 48/423 11.4 (8.3-14.4) 
Strongly disagree/Disagree 318/423 75.2 (71.0-79.3) 
Not sure 57/423 13.5 (10.2-16.7) 
My sexual partners should inform me if they are 
diagnosed with any curable STI 
  
Strongly agree/Agree 356/426 83.6 (80.0-87.1) 
Strongly disagree/Disagree 33/426  7.8 (5.1-10.2) 
Not sure 37/426  8.7 (6.0-11.4) 
A sexual partner of a person diagnosed with curable STI 
has a right to be informed for STI exposure 
  
Strongly agree/Agree 342/426 80.3 (76.5-84.1) 
Strongly disagree/Disagree 41/426 9.6 (6.8-12.4) 
Not sure 43/426 10.1 (7.2-12.9) 
I fear that contacting primary partner following 
diagnosis with STI can lead to break-up of the 
partnership 
 
 
Strongly agree/Agree 117/415 30.0 (25.4-34.6) 
Strongly disagree/Disagree 120/415 30.8 (26.2-35.4) 
Not sure 153/415 39.2 (34.4-44.1) 
2
Not applicable 25/415 6.0 (3.7-8.3) 
It should be legally binding for a patient diagnosed with 
curable STI to contact their sexual partner 
  
Strongly agree/Agree 66/418 15.8 (12.3-19.3) 
Strongly disagree/Disagree 260/418 62.2 (57.5-66.9) 
Not sure 92/418 22.0 (18.0-26.0) 
1
Base varies due to missing response 
285% of the men who chose ‘not applicable’ as their option did not have a primary partner 
 
5.3.2 Testing and diagnosis of STI in the last year  
Of the 429 men, the majority of men had tested for STI since their diagnosis with 
HIV (85.9%). As mentioned in section 3.3.5, 380 men were diagnosed with HIV 
more than a year ago and only these men were included in the analysis. As 
reported in Table 5, of these 380 men, 322 (84.7%) men reported being sexually 
active in the last year. As shown in Table 29, among men who were sexually 
active, 261 (82.6%) men had tested for STI in the last year  
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Table 29. STI testing and diagnosis among sexually active HIV positive MSM 
in the last year 
 
1,2
n/N  % (95% CI) 
Tested for STI   
Yes 261/316 82.6 (78.4-86.8) 
Diagnosed with STI    
Yes 81/321 25.2 (20.5-30.0) 
Sexual orientation of those diagnosed with STI   
Gay 79/81 97.5 (91.3-99.7) 
Bisexual 2/81 2.5 (0.1-8.6) 
Diagnosed with any bacterial STI   
Yes 69/321 21.5 (16.9-26.0) 
3,4
Type of STI diagnosis    
Syphilis 22/81 27.2 (17.3-37.1) 
Pharyngeal chlamydia 4/81 4.9 (1.4-12.1) 
Rectal chlamydia 20/81 24.7 (15.1-34.3) 
Urethral chlamydia 16/81 19.8 (10.9-28.6) 
Rectal gonorrhoea 21/81 25.9 (16.2-35.7) 
Urethral gonorrhoea 19/81 23.5 (14.0-32.9) 
Pharyngeal gonorrhoea 4/81 4.9 (1.4-12.1) 
Lymphogranuloma venereum 10/81 12.4 (6.1-21.5) 
Hepatitis A 2/81 2.5 (0.3-8.6) 
Hepatitis B 2/81 2.5 (0.3-8.6) 
Hepatitis C 6/81 7.4 (2.8-15.4) 
Genital warts 10/81 12.4 (6.1-21.5) 
Genital herpes 2/81 2.5 (0.3-8.6) 
1
Base varies due to item non-response 
2
Only among men who were sexually active in the last year
 
3
Only among men who were sexually active and diagnosed with STI in the last year
 
4
Percentages will not add up to 100 because this was a multiple choice question 
 
Among men who had tested for STI, 81 (25.2%) men were diagnosed with one or 
more STI. 97.5% of men who were diagnosed with STI self-identified as being gay 
men. The majority of men were diagnosed with bacterial STI (21.5%). Among 
men who reported being diagnosed with STI, the most common were syphilis 
(27.2%), rectal gonorrhoea and rectal chlamydia (approximately a quarter of men 
for each), urethral gonorrhoea (23.5%), urethral chlamydia (19.8%), pharyngeal 
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chlamydia (4.9%) and pharyngeal gonorrhoea (4.9%). Among viral infections, 
HCV diagnosis was reported by 7.4% of men, and genital warts (12.4%), Hepatitis 
A (2.5%) and B (2.5%), genital herpes (2.5%) diagnosis were also reported.  
In the following sub-section, I examine the factors influencing STI diagnosis in the 
last year. 
5.3.3 Factors associated with STI diagnosis in the last year 
As mentioned in 2.5.14.4, this analysis examined the association of STI diagnosis 
with sexual behaviour and partnership patterns of HIV positive MSM to 
understand its implications for partner notification, after adjusting for socio-
demographic and HIV related factors associated with STI diagnosis. As indicated 
in Table 30, in the univariate analysis, ethnicity, education, employment status, 
country of birth and recent CD4 cell count were not significantly associated with 
STI diagnosis in the last year. Age, time since HIV diagnosis, self-reported recent 
viral load status, and cART status were significantly associated with STI diagnosis 
in the last year. Men in the age-range of 35-44 (OR 0.21, 95% CI: 0.10-0.42) and 
men aged >=45 years (OR: 0.23, 95% CI: 0.11-0.47) were less likely to be 
diagnosed with STI compared to men aged below 35 years (p<0.001). Men were 
also less likely to be diagnosed with STI if they were receiving cART compared to 
those not on cART (OR: 0.39, 95% CI: 0.21-10.76; p=0.006), and had self-
reported undetectable viral load compared to men who had a detectable viral load 
(OR: 0.39, 95% CI: 0.21-0.72; p=0.003). Every year increase in time since HIV 
diagnosis was associated with reduced risk of STI diagnosis (OR: 0.95, 95% CI: 
0.90-0.99; p=0.02).  
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Table 30. Socio-demographic and HIV related health factors associated with 
STI diagnosis in the last year among HIV positive MSM (N=322) 
Factors Factor 
distribution in 
the sample 
Diagnosed 
with STI  
Unadjusted  
odds ratio  
3
Adjusted odds 
ratio (base model) 
 
 
 
1,2
n/N (%) 
 
n (%) 
p-value 
OR (95% CI) 
p-value 
AOR (95% CI) 
3
Age    p<0.001 p=0.0001 
<=34 49/317 (15.5) 26 (54.2) 1 1 
35-44 137/317 (43.2) 27 (19.7) 0.21(0.10-0.42) 0.21 (0.09-0.44) 
>=45 131/317 (41.3) 28 (21.4) 0.23 (0.11-0.47) 0.27 (0.13-0.58) 
Time since HIV 
diagnosis (years) 
  p=0.02 - 
Median (IQR) 10 (6-14) 8 (4-12) 0.95 (0.90-0.99) - 
Ethnicity    p=0.44 - 
White 276/319 (86.5) 68 (24.7) 1 - 
Non-White 43/319 (13.5) 13 (30.2) 1.31 (0.65-2.67) - 
Education    p=0.53 - 
Up to  secondary 
school 
88/322 (27.3) 20 (22.7) 1 - 
Beyond 
secondary school 
234/322 (72.7) 61 (26.8) 1.20 (0.67-2.15) - 
Employment    p=0.59 - 
Working 251/321 (78.2) 65 (26.0) 1 - 
Not working 70/321 (21.8) 16 (22.9) 0.84 (0.45-1.57)  
Born in the UK    p=0.06 - 
No 124/322 (38.5) 38 (30.9) 1 - 
Yes 198/322 (61.5) 43 (21.7) 0.62 (0.37-1.03) - 
Recent CD4 cells/ 
mm3 
  p=0.40 - 
>=200  299/313 (95.5) 77 (25.8) 1 - 
<200  14/313 (4.5) 2 (15.4) 0.52 (0.11-2.41) - 
Self-reported 
plasma viral load 
status  
  p=0.003 p=0.05 
Detectable 54/311 (17.4) 22 (40.7) 1 1 
Undetectable 257/311 (82.6) 54 (21.1) 0.39 (0.21-0.72) 0.51 (0.25-1.00) 
Receiving cART    p=0.006 
5
NI 
No 45/322 (13.9) 19 (42.2) 1 
5
NI 
Yes 277/322 (86.0) 62 (22.5) 0.39 (0.21-0.76) 
5
NI 
1
Includes only men who were sexually active in the last year and were diagnosed with HIV >1 year 
ago. 
2
Base varies due to missing values 
3
Age was specified as a priori factor to be retained in the model 
4
All demographic and HIV related variables significantly associated in univariate analysis with the 
outcome variable (p<0.2) were included in model and dropped using a stepwise backward selection 
model with variables significant at p<0.2 being retained to form the base model.  
5
NI: indicates variables not included in the model due to collinearity  
-These variables were dropped during multivariate analysis conducted using stepwise backward 
selection model (p<0.2)
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When all the socio-demographic and HIV related health factors that were 
associated with the outcome variable in univariate analysis (p<0.2) were entered in 
a multivariate model, age and self-reported viral load status continued to be 
significantly associated with STI diagnosis in the last year and formed the base 
model. Men in the age-range of 35-44 (AOR: 0.21, 95% CI: 0.09-0.44) and men 
aged >=45 years (AOR: 0.27, 95% CI: 0.13-0.58) were less likely to be diagnosed 
with STI compared to men younger than 35 years (p=0.0001). Men with self-
reported undetectable plasma viral load were less likely to be diagnosed with STI 
compared to those with self-reported detectable plasma viral load (AOR: 0.51, 95% 
CI: 0.25-1.00; p=0.05), although the 95% CI was wide. 
As shown in Table 31, after adjusting for the base model, men who had reported 
greater number of new AI partners in the last year were more likely to report 
having been diagnosed with STI in the last year (p<0.001). However, the 
association between the number of new AI partners and the risk of STI diagnosis 
was not linear (Log likelihood ratio test for linearity: χ²=48.3, p<0.001). Men who 
reported 5-10 new anal sex partners were more likely to report being diagnosed 
with STI in the last year compared to men with no or one new AI partner (AOR: 
4.99; 95% CI: 1.85-13.49). Similarly, men who reported >10 new AI partners were 
more likely to report being diagnosed with STI in the last year compared to men 
with no or one new AI partner (AOR: 15.9; 95% CI: 6.59-38.59). 
After adjusting for the base model, men who had engaged in group sex 1-5 times 
in the last six months were more likely to be diagnosed with STI in the last year 
(AOR 4.47, 95% CI: 2.27-8.81; p<0.001) compared to those who had not engaged 
in group sex. Men who had engaged in group sex >5 times were also more likely 
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to report being diagnosed with STI in the last year compared to those who had not 
engaged in group sex (AOR: 9.07, 95% CI: 3.50-23.48; p<0.001) (Table 31).   
After adjusting for the base model, men who had engaged in UAI with their sexual 
partners in the last year were more likely to report being diagnosed with STI in the 
last year compared to men who were sexually active but had not engage in UAI 
with their sexual partners (AOR: 3.60, 95% CI: 1.95-6.65; p<0.001).  Adjusted 
analysis indicated that men who had engaged in UAI with casual partners as well 
as a primary partner were more likely to be diagnosed with STI in the last year 
compared to men who had engaged in UAI only with a primary partner (AOR: 
7.64, 95% CI: 2.22-26.23; p=0.005). Similarly, as shown in Table 31, men who 
had engaged in UAI with casual partners or regular partners were also more likely 
to be diagnosed with STI compared to those who had engaged in UAI only with a 
primary partner (AOR: 4.14, 95% CI: 1.34-12.77). 
After adjusting for the base model, men who had a serodiscordant primary partner 
were less likely to report STI diagnosis in the last year compared to those who had 
a seroconcordant status primary partner (AOR: 0.23, 95% CI: 0.09-0.53; p=0.001). 
There was no significant difference between self-reported STI diagnosis among 
men who had engaged in UAI with a serodiscordant primary partner and those 
who had not (AOR: 0.94, 95% CI: 0.29-3.02; p=0.81).  
After adjusting for the base model, the HIV status of the most recent non-primary 
partner was no longer significantly associated with STI diagnosis in the last year 
(AOR: 0.59; 95% CI: 0.28-1.28; p=0.18). Similarly, there was no significant 
association between self-reported STI diagnosis among men who had engaged in 
UAI with a serodiscordant most recent non-primary partner and those who did not 
(AOR: 1.57, 95% CI: 5.54-4.49; p=0.39). 
  
2
5
7 
Table 31. Sexual behaviour and partnership factors associated with STI diagnosis in the last year among sexually active HIV positive MSM 
Factors Distribution in the sample Diagnosed with STI Unadjusted odds ratio 5Adjusted odds ratio 
 1n/N (%) n (%) p-value 
OR (95% CI) 
p-value 
AOR (95% CI) 
Number of new anal sex partners in the last year   p<0.001 6p<0.001 
0-1 118/319 (36.9) 8 (6.8) 1 1 
2-4 44/319 (13.8) 5 (11.4) 1.74 (0.53-45.66) 2.22 (0.65-7.56) 
5-10 59/319 (18.5) 15 (25.4) 4.64 (1.83-11.73) 4.99 (1.85-13.49) 
>10 98/319 (30.7) 52 (53.1) 15.4 (6.78-34.97) 15.90 (6.59-38.59) 
Group sex    p<0.001 p<0.001 
No group sex 155/284 (54.6) 22 (14.9) 1 1 
1-5 times in last six months 98/284 (34.5) 38 (38.8) 3.82 (2.08-7.02) 4.47 (2.27-8.81) 
>5 times in last six months 31/284 (10.9) 19 (61.3) 9.57 ( 4.08-22.43) 9.07 (3.50-23.48) 
2UAI in the last year   p<0.001 p<0.001 
Sexually active but no UAI 170/321 (52.9) 20 (13.3) 1 1 
UAI 151/321 (47.1) 61 (35.9) 3.66 (2.08-6.45) 3.60 (1.95-6.65) 
2Type of UAI partner   p=0.01 p=0.005 
UAI only with a primary partner 33/170 (19.4) 5 (15.2) 1 1 
UAI with a primary partner and casual/regular partners 37/170 (21.8) 19 (51.4) 5.91 (1.87-18.65) 7.64 (2.22-26.23) 
UAI with casual/regular partners 100/170 (58.8) 37 (37.0) 3.29 (1.16-9.25) 4.14 (1.34-12.77) 
3HIV status of primary partner   p<0.001 p=0.001 
HIV positive 73/176 (41.5) 25 (34.3) 1 1 
HIV negative/unknown status 103/176 (58.5) 11 (10.8) 0.23 (0.11-0.51) 0.23 (0.09-0.53) 
3,4UAI with a serodiscordant primary partner   p=0.92 p=0.81 
No 153/175 (87.9) 32 (20.9) 1 1 
Yes 22/175 (12.1) 4 (20.0) 0.94 (0.29-3.02) 0.86 (0.26-2.90) 
4HIV status of the most recent non-primary partner   p=0.04 p=0.18 
HIV positive 51/186 (27.4) 21 (41.2) 1 1 
HIV negative/unknown status 135/186 (72.6) 33 (24.4) 0.48 (0.24-0.97) 0.59 (0.28-1.28) 
4,7UAI with a serodiscordant most recent non-primary partner   p=0.07 p=0.39 
No 112/135 (82.9) 24 (21.4) 1 1 
Yes 23/135  (17.1) 9 (39.1) 2.35 (0.91-6.10) 1.57 (0.54-4.49) 
1Includes only men who were sexually active in the last year and diagnosed with HIV more than a year ago; 2 Includes only men who had UAI in the last year  
3Includes only men who had a primary partner; 4 Serodiscordant UAI was defined as UAI with HIV negative/HIV unknown status partner(s) ; 5 Adjusted for age, and self-reported viral 
load status (base model); 6The log likelihood test for linearity was:  χ²=48.3, df=3, p<0.001; 7Includes only men whose most recent sex partner was a serodiscordant non-primary partner 
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The following section describes partner notification following STI diagnosis in the 
last year. 
5.3.4 Clinic support and partner notification following STI 
diagnosis in the last year 
In this section, I describe men’s experiences of interaction with the clinic staff 
regarding partner notification following STI diagnosis in the last year. As 
described previously in Table 29, 81 men had been diagnosed with STI in the last 
year. Of these 81 men, data on advice given by the clinic for partner notification 
was missing for five participants. As shown in Table 32, of the 75 men for whom 
this data was available, 67 men (89.3%) were advised by the clinic to notify their 
sexual partner(s) to test for STI and 66.7% of these men were also given one or 
more types of assistance to notify their sexual partner: 28% of men were given a 
referral slip with the clinic details, 22% of men were given written information for 
their partner about the STI they were diagnosed with and 4% of men were given 
written information about where their partner can obtain a test for STI.  
Of these 75 men, data on partner notification was reported by 70 men. As shown in 
Table 32, of these 70 men, 42 (60%) men had notified at least one partner to test 
for STI. Of these 42 men, overall 17 men (40.5%) had notified their primary 
partner, 22 men (52.4%) and 24 men (57%) had notified their regular and casual 
partners respectively, and one man had notified his ex-partner. Men were asked if 
they had notified more than one sexual partner of STI and the methods of 
notification used by them. Of the 42 men who had notified at least one partner of 
STI, five men (11.9%) had notified only their primary partner, 7 men (16.7%) had 
notified only regular partners and 9 men (21.4%) had notified only casual partners.  
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Table 32. Clinic support and partner notification following STI diagnosis in 
the last year  
 
1
n/N % (95% CI) 
2
Advised by the clinic to notify sexual partners 
for STI 
  
Yes 67/75 89.3 (82.2-96.6) 
2
Provided additional assistance by the clinic for 
notification of sexual partner 
  
Yes 50/75 66.7 (55.74-77.6) 
3
Type of assistance provided   
Referral slip with clinic details 14/50 28.0 (15.1-40. 9) 
Written information about STI they were 
diagnosed with for their partners 
11/50 22.0 (10.1-33.9) 
Written information about where their partner 
can obtain a test for STI 
2.0/50 4 (1.6-9.6) 
2
Notified partners of STI   
Yes 42/70 60.0 (48.2-71.8) 
4
Types of sexual partners notified   
Primary partner 17/42 40.5 (24.9-55.9) 
Regular partners 22/42 52.4 (36.6-68.1)  
Casual partners 24/42 57.1 (41.5-72.8) 
Ex-partners 1/42 2.4 (0.1-12.6) 
4,5
Methods used for notifying partners    
Via an health advisor 1/42 2.4 (0.1-12.6) 
In-person 14/42 33.3 (18.5-48.2) 
Via a text message 13/42 30.9 (16.4-45.5) 
Via a phone call 20/42 47.6 (31.9-63.4) 
Via an email or online message 6/42 14.3 (3.2-25.3) 
1
N varies due to item non-response 
2 
Includes only men who were diagnosed with STI in the last year 
3
Includes only men who were given clinic advice and assistance following their 
STI diagnosis in the last year 
4
Includes only men who had notified their sexual partners of STI 
5
Percentages will not add up to 100 because of multiple choice question  
 
Only one man had notified his partners via a health advisor, 14 (33.3%) men had 
notified in person, 20 (47.6%) men via a phone call, 13 (30.9%) via a text message, 
and 6 (14.3%) men had notified their partners either via an email or an online 
message.  
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In the following section, I examine the willingness of men to notify different types 
of sexual partners for exposure to STI in the future and the willingness to use 
different methods of notification for STI.  
5.3.5 Willingness to notify sexual partners of STI in the future 
and use different methods of notification  
As shown in Figure 10, of the 427 men who responded, 330 (77.3%) men 
expressed willingness to notify all sexual partners if they were diagnosed with STI 
in the future. A further 19.2% of men would be willing to notify only some sexual 
partners, whereas 3.5% of men would be unwilling to notify any sexual partners if 
they were diagnosed with STI in the future. 
Figure 10. Willingness to notify different types of sex 
partners of STI in the future 
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As indicated in Table 33, men would be less willing to notify casual partners of 
STI in the future (21.1%) compared to primary partner (5.2%) or regular partners 
(7.5%). Similarly, men would be more willing to notify casual partners only via 
provider referral or an anonymous e-card (5.4%) compared to primary partner 
(0.2%) or regular partners (0.5%).  
Table 33. Willingness to notify different types of sexual partners and use 
different methods of notification by partnership type  
 
1
Type of sexual partners 
Preferred methods of notification Primary 
partner  
(N=423) 
n (%) 
Regular 
partners 
(N=427) 
n (%) 
Casual 
partners 
(N=426) 
n (%) 
Not notify  22 (5.3) 32 (7.5) 90 (21.1) 
Notify only via provider referral or 
anonymous e-card 
1 (0.2) 2 (0.5) 23 (5.4) 
Notify only themselves (patient referral) 297 (70.2) 237 (55.5) 191 (44.8) 
Notify via any methods (patient 
referral/provider referral/anonymous e-
card) 
103 (24.4) 156 (36.5) 122 (28.6) 
1
N varies due to item non-response    
 
The majority of men would be willing to notify their primary partner only via 
patient referral (70.2%) compared to regular partners (55.5%) and casual partners 
(44.8%). 24.4% of men would be willing to notify their primary partner via any 
method, (i.e., patient or provider referral or anonymous e-cards), whereas 36.5% 
and 28.6% of men would be willing to notify their regular and casual partners 
respectively by any methods. Overall, among men who reported willingness to 
notify sex partners of STI in the future, patient referral was preferable compared to 
other methods for notifying all types of sexual partners. 
Men were asked to rate their willingness to use different types of patient-led and 
provider-led methods of notification of STI for different types of sexual partners in 
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the future. Face-to-face notification was the most preferred method to notify of 
STI to both a primary partner (91.8%) and regular partners (69.7%), whereas 
phone call (38.9%) was the most preferred method for notifying casual partners in 
the future (Table 34). 45.2% of men also expressed preference to call a primary 
partner to notify him of STI and 59.9% of men to notify regular partners of STI in 
the future.  
Men reported greater willingness to use other remote methods like SMS via a cell 
phone and send email from their personal mail account in the future to notify 
regular partners and casual partners of STI compared to a primary partner. 31% of 
men would be willing to notify casual partners anonymously or non-anonymously 
via a health advisor, whereas 24% of men would be willing to use these methods 
to notify regular partners of STI. A smaller proportion of men would also prefer to 
notify their primary partner via a health advisor, either anonymously or non-
anonymously (8.9%). Similarly, men would be more willing to send anonymous e-
cards to notify casual partners of STI (15.2%) compared to a primary partner 
(4.7%) or regular partners (10.9%) in the future.  
Men were also asked about their willingness to take home sampling kit for 
chlamydia and gonorrhoea for their sexual partners in the future. Men would be 
more willing to take a home sampling kit for their primary partner (32.9%) 
compared to regular partners (9.8%) and casual partners (4.2%). Similarly, men 
would be more willing to take treatment for STI for their primary partner after his 
telephone assessment by a clinic staff (17.9%) compared to for their regular 
partners (5.8%) or casual partners (4.2%). 
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Table 34: HIV positive MSM’s willingness to notify different types of sexual 
partners of STI in the future via conventional and novel methods (N=429) 
 
1Type of sexual partners  
 Primary 
partner 
Regular 
partner(s) 
Casual 
partner(s) 
Methods of PN Very likely/ 
likely 
Very likely/ 
likely 
Very likely/ 
likely 
 n (%) n (%) n (%) 
Conventional methods     
Face-to-face  394 (91.8) 299 (69.7) 143 (33.3) 
Email 21 (4.9) 74 (17.3) 62 (14.5) 
Phone call 194 (45.2) 277 (59.9) 167 (38.9) 
SMS via cell phone 58 (13.5) 116 (27.0) 112 (26.1) 
Anonymously via a health 
advisor 
24 (5.6) 79 (18.4) 111 (25.9) 
Non-anonymously via a health 
advisor 
14 (3.3) 24 (5.6) 22 (5.1) 
Novel methods    
Anonymous e-card 20 (4.7) 47 (10.9)    65 (15.2) 
Take a home sampling kit  141 (32.9) 42 (9.8) 18 (4.2) 
Take medication after 
telephone assessment 
77 (17.9) 25 (5.8) 11 (2.6) 
1
Multiple response question so men could chose more than one method they 
were willing to use to notify their sexual partners for STI so the percentages will 
not add up to 100  
 
As shown previously in Figure 10, only 3.5% of men would be unwilling to notify 
any sexual partners of STI in the future. The following Figure 11 shows in greater 
detail the willingness of men to notify (or not notify) different types of sexual 
partners, i.e., primary partner, regular partners and casual partners, and preferred 
methods of notification for STI by partnership type. 3% of men would be willing 
to only notify primary partner, of which 1.9% of men would be willing to notify 
them only face-to-face and 1.2% would be willing to notify only via any patient 
referral methods. 0.9% of men would be willing to notify only regular partners. 0.2% 
of men would be willing to notify their regular partner only face-to-face, 0.2% 
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would be willing to notify via any patient referral methods and 0.5% were willing 
to notify them via any patient or provider referral method. No men expressed 
preference to notify only casual partners of STI in the future.  
13.6% of men would be willing to notify only primary partner and regular partners 
of STI in the future. Of these, 4.2% would be willing to do so only face-t-face, 6.8% 
only via any patient referral methods, and 2.6% of men via any patient or provider 
referral method. A minority of men would be willing to notify only primary 
partner and casual partners (0.9%). They would be willing to notify these partners 
only face-to-face (0.7%) and a further 0.2% of men via any patient or provider 
referral methods. 
Further 0.6% of men would be willing to notify only regular and casual partners of 
STI. 0.2% of these men would be willing to do so only face-to-face, 0.2% of men 
only via any patient referral methods and 0.2% of men would be willing to notify 
them only via provider referral methods.  
The majority of men (77.4%) who would be willing to notify all types of sex 
partners of STI in the future. 7.7% of men who would be willing to notify them 
only face-to-face, 35.8% of men who would be willing to do so only via any 
patient referral methods. 21.6% of men would be willing to notify all types of sex 
partners of STI via any methods (patient or provider referral methods). The 
proportion of men who would be willing to notify all types of sexual partners of 
STI only via provider referral was low (0.2%). 12% of men would be willing to 
notify all types of sexual partners of STI in the future but they would be willing to 
notify their primary partner only face-to-face and use other methods to notify their 
regular and casual partners.  
  
2
6
5
 
 Figure 11. HIV positive MSM’s willingness to use different methods of notification to notify different types of sex partners: 
detailed overview 
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5.3.6 Willingness to notify casual partners of STI in the future  
As mentioned previously in Table 33, 90 (21.1%) men would be unwilling to 
notify casual partners of STI in the future. 23 (5.4%) men would be willing to 
notify them only via provider referral or anonymous methods and 191 (44.8%) 
men would be willing to notify them only via patient referral methods. A further 
122 (28.6%) men would be willing to notify their casual partners of STI via any 
patient or provider referral methods. In the following section, I examine the 
univariate association between various socio-demographic factors, HIV related 
factors, attitudes towards partner notification, self-efficacy to notify partners of 
STI, and willingness and preferred methods to notify casual partners of STI in the 
future (i.e., unwilling to notify any casual partners of STI, willing to notify casual 
partners of STI only via provider referral/anonymous methods, willing to notify 
casual partners only via patient referral methods and willing to notify casual 
partners via any method of partner notification).  
5.3.6.1 Univariate analysis of factors associated with willingness and 
preferred methods of notification of casual partners for STI in the 
future 
In the univariate analysis, age, cART status and ethnicity were associated with 
willingness and preferred methods of notifying casual partners of STI in the future 
(Table 35). Men aged 35-44 years and >=45 reported greater unwillingness to 
notify any casual partners of STI in the future (23.1% and 21.8% respectively) 
compared to men aged <=34 years (15.5%). Younger men would be more willing 
to notify their casual partners in the future only via provider referral or anonymous 
methods (7%) compared to men of other age groups. Men aged >=45 years would 
be more willing to notify casual partners in the future only via patient referral 
methods (52.5%) compared to men aged <=34 years (36.6%). Young men (<=34 
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years) reported greater willingness to notify casual partners of STI via any 
methods of partner notification in the future (40.9%) compared to men aged 35-44 
years (32.5%) and >=45 years (20.7%) (p=0.02). Men from non-White ethnic 
background were more willing to use both patient and provider referral methods to 
notify casual partners of STI in the future (46.6%) compared to men from White 
ethnic background (26%). Men from White ethnic background would be more 
willing to notify casual partners only via patient referral methods in the future 
(47.4%) compared to men from non-White background (27.6%) (p=0.008). Men 
on cART would be more willing to notify casual partners of STI only via provider 
referral methods or anonymous methods in the future (6.4%) compared to those 
not on cART (1.2%). However, there was no association between the outcome 
variable of interest and education (p=0.41), employment status (p=0.53), country 
of birth (p=0.39), time since HIV diagnosis (p=0.41), recent CD4 cell count 
(p=0.64) or recent self-reported viral load status (p=0.34). 
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Table 35. Socio-demographic and HIV related factors associated with 
variation in preferred methods for notifying casual partners for STI in the 
future (N=429) 
Factors 
1
Unwilling 
to notify 
(n=90) 
1
Willing to 
notify only 
via provider 
referral/ 
anonymous 
methods 
(n=23) 
1
Willing to 
notify only via 
patient referral 
methods 
(n=191) 
1
Willing to 
notify via any 
methods 
(patient or 
provider) 
(n=122) 
p-value 
 n/N (%) n/N (%) n/N (%) n/N (%)  
Age      p=0.02 
<=34 11/89 (15.5) 5/23 (7.0) 26/186 (36.6) 29/121 (40.9)  
35-44 39/89 (23.1) 9/23 (5.3) 66/186 (39.1) 55/121 (32.5)  
>=45 39/89 (21.8) 9/23 (5.0) 94/186 (52.5) 37/121 (20.7)  
Time since HIV 
diagnosis (years) 
    p=0.41 
Median (IQR) 9 (4-14) 11 (8-15) 9 (5-15) 9 (4-14)  
Ethnicity      p=0.008 
White 77/89 (21.1) 20/23 (5.5) 173/189 (47.4) 95/122 (26.0)  
Non-White 12/89 (20.7) 3/23 (5.2) 16/189 (27.6) 27/122 (46.6)  
Education      p=0.41 
Up to 
secondary 
school 
21/90 (17.7) 4/23 (3.4) 59/191 (49.6) 35/122 (29.4)  
Beyond 
secondary 
school 
69/90 (22.5) 19/23 (6.2) 132/191 (43.0) 87/122 (28.3)  
Employment      p=0.53 
Yes 65/89 (20.4) 20/23 (6.3) 145/191 (45.5) 89/122 (27.9)  
No 24/89 (22.6) 3/23 (2.8) 46/191 (43.4) 33/122 (31.3)  
Born in the UK      p=0.39 
No 36/90 (21.6) 12/23 (7.2) 68/191 (40.7) 51/122 (30.5)  
Yes 54/90 (20.9) 11/23 (4.3) 123/191 (47.5) 71/122 (27.4)  
Recent CD4 cell 
count  
    p=0.64 
>/=200 80/83 (20.6) 22/22 (5.7) 172/182 (44.2) 115/120 (29.6)  
<200 3/83 (16.7) 0/22 (0.0) 10/182 (55.6) 5/120 (27.8)  
Currently 
receiving cART  
    p=0.02 
No 18/90 (21.7) 1/23 (1.2) 31/191 (37.4) 33/122 (39.8)  
Yes 72/90 (20.9) 22/23 (6.4) 160/191 (46.7) 89/122 (25.9)  
Perceived viral 
load status  
    p=0.34 
Detectable 2/862 (22.9) 2/23 (2.1) 42/185 (43.8) 30/117 (31.3)  
Undetectable 64/86 (20.3) 21/23 (6.7) 143/185 (45.5) 87/117 (27.6)  
1
N varies due to item non-response 
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The attitudes of men towards partner notification of STI were significantly 
associated with preferred methods to notify casual partners of STI (Table 36). Men 
who were concerned about the breach of HIV related confidentiality would be 
more willing to use only provider-led methods in the future (33.3%) compared to 
men who were not concerned about the breach of confidentiality (5.7%). Men who 
were less concerned about breach of HIV-related confidentiality would be more 
willing to notify casual partners of STI via any patient referral methods in the 
future (48.8%) compared to men who were concerned about it (35.6%). Men who 
disagreed that it is the right of their sexual partners to be notified for STI would be 
less willing to notify casual partners of STI in the future (37.4%) compared to men 
who agreed that it is the right of their sex partners (17%). Men who agreed or 
strongly agreed that it is the right of their sexual partners to be notified of STI 
would be more willing to themselves notify their casual partners of STI in the 
future (47.8%) compared to men who disagreed or were unsure about it (32.5%) 
(p=0.001). Men who disagreed that their sex partners should notify them of STI 
would be less willing to notify casual partners in the future (31.9%) compared to 
men who agreed (18.9%). Similarly, men who agreed or strongly agreed that their 
sexual partners should notify them of STI would be more willing to notify their 
casual partners via patient referral methods (47.9%) compared to men who 
disagreed or strongly disagreed (28.9%) (p=0.01). 
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Table 36. Attitudes, perceived self-efficacy, and sexual behaviour and 
partnership related factors associated with preferred methods for notifying 
casual partners of STI in the future 
1
Factors 
1
Unwilling 
to notify  
(n=90) 
1
Willing to 
notify only 
via provider 
referral/ 
anonymous 
methods 
(n=23) 
1
Willing to 
notify only 
via patient 
referral 
methods 
(n=191) 
1
Willing to 
notify via any 
methods 
(patient or 
provider) 
(n=122) 
p-value 
 n/N (%) n/N (%) n/N (%) n/N (%)  
Attitudes towards partner notification for STI 
Worried about 
breach of HIV-
related 
confidentiality 
 
    p=0.03 
No
 
55/73 (19.7) 16/19 (5.7) 136/168 (48.8) 72/109 (25.8)  
Yes
 
18/73 (20.0) 3/19 (33.3) 32/168 (35.6) 37/109 (41.1)  
It is the right of the 
sexual partner to be 
notified of curable 
STI
 
    p=0.001 
Agree/strongly 
agree
 
58/89 (17.0) 18/23 (5.3) 163/190 (47.8) 102/122 (29.9)  
Disagree/not 
sure/strongly 
disagree
 
31/89 (37.4) 5/23 (6.0) 27/190 (32.5) 20/122 (24.1)  
My sexual partners 
should inform me if 
they are diagnosed 
with any curable STI  
    p=0.01 
Agree/strongly 
agree
 
67/89 (18.9) 20/23 (5.6) 170/190 (47.9) 98/122 (27.6)  
Disagree/not 
sure/strongly 
disagree
 
22/89 (31.9) 3/23 (4.4) 20/190 (28.9) 24/122 (34.8)  
Perceived self-efficacy 
Comfort level to 
discuss about sexual 
contacts with clinic 
staff  
    p=0.78 
Uncomfortable 38/90 (23.0) 8/23 (4.9) 70/191 (42.4) 49/122 (29.7)  
Comfortable 52/90 (19.9) 15/23 (5.8) 121/191 (46.4) 73/122 (27.9)  
Ever notified sexual 
partners of STI  
    p=0.001 
No 45/90 (30.4) 9/23 (6.1) 49/191 (33.1) 45/122 (30.4)  
Yes 
 
45/90 (16.2) 14/23 (5.0) 142/191 (51.1) 77/122 (27.7)  
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Table 36. Continued      
Factors Unwilling to 
notify 
(n=90)  
Willing to 
notify only 
via provider 
referral/ 
anonymous 
methods 
(n=23) 
Willing to 
notify only 
via patient 
referral 
methods 
(n=191) 
Willing to 
notify via any 
methods 
(patient or 
provider) 
(n=122) 
p-value 
 n/N (%) n/N (%) n/N (%) n/N (%)  
Sexual behaviour and sexual partnership related factors 
New anal sex 
partners in last year  
    p=0.04 
0-1 38/89 (20.7) 15/23 (8.2) 85/190(46.2) 46/122 (25.0)  
2-4 7/89 (13.7) 4/23 (7.8) 26/190 (50.9) 14/122 (27.5)  
5-10 16/89 (22.5) 3/23 (4.2) 23/190 (32.4) 29/122 (40.9)  
>10 28/89 (23.7) 1/23 (0.9) 56/190 (47.5) 33/122 (27.9)  
Had UAI      p=0.31 
No  52/90 (22.8) 14/23 (6.1) 105/191 (46.1) 57/122 (25.0)  
Yes 38/90 (19.2) 9/23 (4.6) 86/191 (43.4) 65/122 (32.8)  
Met new partners 
via internet  
    p=0.005 
No 51/90 (20.7) 21/23 (8.5) 104/191 (42.3) 70/122 (28.5)  
Yes 39/90 (21.7) 2/23 (1.1) 87/191 (48.3) 52/122 (28.9)  
1
N varies due to item non-response 
 
With regards to perceived self-efficacy to discuss details of sexual partners with 
clinic staff, men who had not notified sexual partners for STI in the past would be 
less willing to notify casual partners in the future (30.4%) compared to men who 
had notified sexual partners of STI in the past (16.2%) (p=0.001). The latter would 
be more willing to notify their casual partners via any patient referral methods in 
the future (51.1%) compared to men who had not notified partners of STI 
previously (33.1%). There was no association between the outcome variable of 
interest and comfort level to discuss about sexual partners with the clinic staff 
(p=0.78).  
With regards to sexual partnership patterns and sexual behaviour, men with less 
than four new AI partners in the last year would be more willing to notify their 
casual partners of STI via provider-led or anonymous methods in the future 
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compared to men with greater number of new AI partners (p=0.04). Men who had 
not met their sex partners via the internet would be more willing to notify their 
casual partners of STI via provider referral or anonymous methods (8.5%) 
compared to men who had met their partners online (1.1%). There was no 
association between preferred methods to notify casual partners of STI in the 
future and engagement in UAI in the last year with any type of sex partners 
(p=0.31).  
5.3.6.2 Factors associated with unwillingness to notify casual partners of 
STI in the future  
In the following section, I examine the factors associated with unwillingness to 
notify casual partners of STI in the future (versus willingness to notify). The 
methods of analysis were described in section 2.5.14.5. As mentioned earlier in 
Table 33, approximately 21% of men would not be willing to notify casual 
partners of STI in the future. In the univariate analysis, none of the socio-
demographic, or HIV related factors were associated with unwillingness to notify 
casual partners of STI (Table 37).  
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Table 37. Univariate analysis of the association between socio-demographic 
and HIV related factors with unwillingness to notify casual partners of STI 
(N=429) 
 
Factors  Unadjusted OR (Unwillingness to 
notify versus willingness to notify) 
 p-value 
OR (95% CI) 
Age  p=0.42 
<=34 1 
35-44 1.63 (0.78-3.41) 
>=45 1.48 (0.71-3.09) 
Time since HIV diagnosis  p=0.42 
Median (IQR) 0.99 (0.95-1.02) 
Ethnicity  p=0.97 
White 1 
Non-White 0.99 (0.49-1.95) 
Education  p=0.27 
Beyond secondary school 1 
Up to secondary school 0.73 (0.42-1.26) 
Employment  p=0.59 
Yes 1 
No 1.16 (0.68-1.97) 
Born in the UK  p=0.81 
No 1 
Yes 0.94 (0.58-1.51) 
Recent CD4 cell count  p=0.70 
>/=200 1 
<200 0.78 (0.22-2.76) 
Currently receiving cART  p=0.86 
No 1 
Yes 1.05 (0.59-1.89) 
Self-reported viral load status  p=0.55 
Detectable 1 
Undetectable 0.84 (0.49-1.47) 
   
With regards to attitudes towards partner notification for STI, as shown in Table 
38, men who disagreed that it is the right of the sex partner to be notified of STI 
would be more likely to not notify casual partners of STI in the future compared to 
men who agreed with it (36.9% vs. 16.9%; OR: 2.86; 95% CI: 1.69-4.84; p<0.001). 
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Table 38. Attitudes, perceived self-efficacy, sexual behaviour, and partnership 
factors associated with unwillingness to notify casual partners of STI (N=429) 
Factors Unadjusted OR 
(Unwillingness to 
notify vs. willingness 
to notify) 
 p-value  
OR (95% CI) 
Attitudes towards partner notification for STI 
Worried about breach of HIV-related confidentiality 
 
p=0.92 
No
 
1 
Yes
 
1.03 (0.57-1.87) 
It is the right of the sexual partner to be notified of 
curable STI
 
p<0.001 
Agree/strongly agree
 
1 
Disagree/not sure/strongly disagree
 
2.86 (1.69-4.84) 
My sexual partners should inform me if they are 
diagnosed with any curable STI  
p=0.02 
Agree/strongly agree
 
1 
Disagree/not sure/strongly disagree
 
1.98 (1.11-3.49) 
Perceived self-efficacy 
Comfort level to discuss about sexual contacts with clinic 
staff 
p=0.41 
Uncomfortable 1 
Comfortable 0.81 (0.51-1.32) 
Ever notified sexual partners of STI  p=0.001 
No 1 
Yes 0.43 (0.27-0.70) 
Sexual partnerships and sexual behaviour  
Had UAI  p=0.40 
No  1 
Yes 0.81 (0.51-1.31) 
New anal sex partners in last year  p=0.53 
0-1 1 
2-4 0.61 (0.26-1.47) 
5-10 1.10 (0.57-2.14) 
>10 1.20 (0.69-2.09) 
Met at least some new sex partners via the internet  p=0.84 
Yes 1 
No 1.04 (0.66-1.68) 
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Similarly, as shown in Table 38, men who disagreed that partners should notify 
them of STI (31.4%) would be more likely to be unwilling to notify casual partners 
of STI in the future compared to men who agreed with it (18.8%) (OR: 1.98; 1.11-
3.49; p=0.02). Men who had previously notified partners of STI would less likely 
to be unwilling to notify casual partners of STI in the future (16%) compared to 
men who had ever notified partners of STI (30.4%)  (OR: 0.43; 95% CI: 0.27-0.70; 
p=0.001). There was no association between the outcome variable of interest, and 
any sexual partnership or sexual behaviour related factors and comfort level to 
discuss about sex with clinic staff.  
As shown in Table 39, when the variables associated with the outcome variable of 
interest in univariate analysis (p<0.2) were incorporated in a multivariate model, 
ever notification of sex partners of STI and attitudes towards partner notification 
like it is the right of the sex partner to be notified of STI continued to remain 
significantly associated with the outcome variable. Men who disagreed that it is 
the right of the sex partner to be notified of STI would be more likely to be 
unwilling to notify casual partners of STI in the future compared to men who 
agreed (AOR: 3.35; 95% CI: 1.60-7.01; p=0.001). Men who had notified sex 
partners of STI in the past would be less likely to be unwilling to notify casual 
partners of STI compared to men who had never done so in the past (AOR: 0.45; 
95% CI: 0.28-0.75; p=0.002). Attitudes that sexual partner should notify me if they 
are diagnosed with STI was no longer significantly associated with the outcome 
variable in the multivariate analysis. 
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Table 39. Factors associated with unwillingness to notify casual partners of 
STI (N=419) 
Factors  Adjusted odds ratios 
(Unwillingness to 
notify vs. willingness 
to notify) 
 
p-value 
AOR (95% CI)
 
1
Age p=0.77 
<=34 1 
35-44 1.31 (0.62-2.81) 
>=45 1.19 (0.56-2.53) 
It is the right of the sexual partner to be notified 
of curable STI 
p<0.001 
Agree/strongly agree 1 
Disagree/not sure/strongly disagree 3.35 (1.60-7.01) 
My sexual partners should inform me if they are 
diagnosed with any curable STI  
p=0.44 
Agree/strongly agree 1 
Disagree/not sure/strongly disagree 0.72 (0.32-1.63) 
Ever notified sexual partners of STI p=0.002 
No 1 
Yes 0.46 (0.28-0.75) 
1
Age was specified a priori to be retained in the model  
 
 
In the following section, I describe men’s attitudes referring members of their 
sexual and social network for STI testing in the event of a STI outbreak. 
5.3.7 Views towards notifying members of social network for 
STI 
Men were asked about their views towards notifying sexual partners and members 
of their social network who are not their sexual partners to test for STI in the event 
of outbreak of STI like LGV, Syphilis or HCV. 65% of men would be willing to 
advise their sexual partner to test for STI in the future if they were informed about 
an outbreak. 53% of men would be willing to notify members of their social 
network if they perceived them to be at risk of STI or know that they engage in 
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risky sexual behaviour.  The majority of men would be willing to be informed of 
an STI outbreak by the clinic (81.6%).  
In the following section, I describe men’s preferred methods to be notified of STI 
by their sexual partners in the future.  
5.3.8 Preferred methods to be notified by sexual partners of 
STI in the future 
Men were asked if they would be willing to be notified of STI by their sexual 
partners in the future. The majority of men felt that it was ‘important’ or 
‘extremely important’ that their sexual partners should notify them for exposure to 
STI in the future (97.5%). As shown in Table 40, the majority of men would prefer 
to be notified of STI in the future by their partners face-to-face (72%) and/or by 
telephone (58.4%). Approximately 30% of men would be willing to be notified via 
an email from their partner. 15% of men would be willing to be notified via an 
anonymous e-card. A few men (4.8%) would be willing to be notified of STI by 
their sexual partners in the future via any of these methods, whereas 13.9% of men 
would be willing to be notified only face-to-face. Some men would also be willing 
to be notified of STI in the future via provider-led methods. 44% of men would be 
willing to be notified of STI via a phone call from a health advisor, 34.2% of men 
would be willing to be notified via an email sent by the clinic and 23% via a text 
message sent by a health advisor and 20.8% of men via a letter from the clinic. 
There was a greater preference to be notified of STI in the future only via partner-
led methods (35.4%) as opposed to being notified only via provider-led methods 
(10.8%). No participants expressed a preference to be notified of STI in the future 
only via an anonymous e-card. 
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Table 40. Preferred methods to be notified by sexual partners for exposure to 
STI in the future (N=418) 
Methods of notifying partners  
1
n 
2
% (95%CI) 
 
Partner-led methods   
Face-to-face  302  72.0 (67.7-76.3) 
Email  131 31.3 (26.8-35.8) 
Phone call  244 58.4 (53.6-63.1) 
Mobile text message  127 30.4 (25.9-34.8) 
Anonymous e-card 63 15.1 (11.6-18.5) 
Clinic-led methods (health advisor/clinic 
staff) 
  
Email  143 34.2 (29.6-38.7) 
Phone call  185 44.0 (39.2-48.8) 
Text message  96 23.0 (18.9-27.0) 
Letter  87 20.8 (16.9-24.7) 
1
Excludes men who were not willing to be notified by their sexual partners of 
STI in the future 
2
Percentages will not add up to 100 because this was a multiple choice question 
 
In the following section, I discuss the findings of this chapter and compare them 
with those of other studies and the findings of the SHARPN survey presented in 
chapter 3.  
5.4 Discussion of findings  
In this chapter, I examined HIV positive MSM’s attitudes towards partner 
notification for STI, previous experience of partner notification for STI, STI 
testing and diagnosis in the last year, and factors associated with STI diagnosis 
among HIV positive MSM. I examined men’s willingness to notify different types 
of sexual partners of STI and to be notified of STI, willingness to use various 
methods of partner notification and factors associated with unwillingness to notify 
casual partners of STI.  
In the following sub-sections, I discuss the findings and compare them with those 
of other studies. 
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Attitudes towards partner notification for STI and previous experience of 
notifying partners of STI 
Almost a quarter of the men reported never having been advised by the clinic staff 
to notify their partners of STI following STI diagnosis. This finding suggests that 
the clinic staff should offer partner notification advice to all patients diagnosed 
with STI. Consistent with findings from another study, one in five men were 
worried about the breach of HIV related confidentiality as a result of partner 
notification (Woodward et al., 2010). Therefore, the clinic staff should discuss 
with patients about perceived threats to confidentiality due to partner notification 
for STI, and discuss strategies considered to be confidential to enhance partner 
notification.  
The majority of men perceived notifying partners of STI as their responsibility and 
considered that partners had a right to be notified of exposure to STI. However, 
one in ten men had experienced verbal abuse, and a small proportion of men had 
experienced physical violence following partner notification for STI. One in five 
men had experienced a break-up of partnership following notification for STI. One 
third of the men expressed fear of break-up with a primary partner following 
notification of STI in the future. The clinic staff as well as health promotion 
campaigns among MSM should promote normalisation of partner notification for 
STI to prevent the negative effects of notification and enhance its acceptability. It 
is important to explore the context and circumstances that are likely to lead to 
negative experiences following partner notification for STI. This is explored 
further in the qualitative study presented in Chapter 6. Although the majority of 
men considered partner notification for STI to be their personal responsibility, they 
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were unwilling for it to be a legal obligation. The majority of men expressed 
willingness to be notified of STI by their partners in the future. 
STI testing, diagnosis and factors associated with STI diagnosis in the last year 
Almost 20% of sexually active men had not tested for STI in the last year. Similar 
to other studies conducted in London and abroad, the burden of STI, particularly 
bacterial STI among HIV positive MSM was high (Elford et al., 2007; Wayal et al., 
2008; Mayer et al., 2010) and similar to that reported in the SHARP survey 
(Stephenson et al., 2003) indicating no substantial change in the risk of STI among 
these men over the last decade. Thus, there is a need for interventions to reduce the 
risk of STI diagnosis among HIV positive MSM. Although a majority of men 
reported being diagnosed with bacterial infections like syphilis, LGV, rectal and 
urethral chlamydia and gonorrhoea, a minority of men were diagnosed with HCV 
(7.4%) and genital warts (12.4%). Similar to a study conducted in the USA (Mayer 
et al., 2010), young age was associated with increased risk of STI diagnosis in the 
last year. Having a detectable plasma viral load, more than four new AI partners, 
greater frequency of engagement in group sex, engagement in UAI, engagement in 
UAI with concurrent partners were also independently associated with STI 
diagnosis.  
The distribution of number of sex partners and the sexual mixing patterns between 
those with different number of sex partners (Garnett et al., 1996; Aral et al., 1999) 
influences the individual as well as population level prevalence of STI and risk of 
STI acquisition or transmission. The SHARPN survey findings reported in chapter 
3 have shown that the proportion of men who had multiple new AI partners and/or 
had engaged in UAI with concurrent partners and/or had engaged in group sex, is 
high. Therefore, the observed association between having more than four new AI 
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partners, engagement in UAI with concurrent partners, greater frequency of 
engagement in group sex, and STI diagnosis has implications not only for the risk 
of STI acquisition among HIV positive MSM but also for the rate of spread of STI 
in this population.  
Men who had a serodiscordant primary partner were less likely to be diagnosed 
with STI compared to men who had a seroconcordant primary partner reiterating 
the SHARPN survey findings reported in Chapter 3 that the former are less likely 
to engage in risky behaviours with their primary partner compared to the latter. 
However, 11% of men who had a serodiscordant primary partner and 24.4% of 
men who had sex with the most recent serodiscordant non-primary partner were 
diagnosed with a STI. There was no difference in the risk of STI diagnosis among 
men who had or did not have UAI with their most recent non-primary 
serodiscordant or a serodiscordant primary partner. This finding is not surprising 
given the high level of multiple non-primary partnerships, the high proportion of 
concurrent/open partnerships observed among men who had a primary partner, and 
the engagement in risky behaviours other than UAI observed among these men in 
Chapter 3. The observed high prevalence of serodiscordant partnerships among 
these men, and the association between detectable plasma viral load status and STI 
diagnosis has implications not only for STI transmission and acquisition but also 
for onward HIV transmission.  
 Willingness to notify partners of STI in the future and factors associated with 
lack of willingness to notify casual partners of STI 
A significant proportion of men would be willing to notify partners of STI in the 
future. However, the overall willingness to notify partners of STI conceals the 
variation in willingness to notify different types of sex partners. Similar to other 
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studies, a greater proportion of men would not be willing to notify their casual 
partners of STI compared to a primary partner or regular partners in the future 
(Gorbach et al., 2000; Levine et al., 2008).  
Previous experience of notification for STI, and attitudes towards partner 
notification for STI were independently associated with the lack of willingness to 
notify casual partners of STI in the future. The observed association between the 
lack of previous experience of notification for STI and unwillingness to notify 
casual partners of STI in the future suggests that variables other than those 
included in the model influence the outcome. The qualitative study results 
presented in Chapter 6 provide greater insight into the reasons for unwillingness to 
notify casual partners compared to a primary partner or regular partners. The 
finding that men who disagree that it is the partner’s right to be notified of STI 
would be more unwilling to notify casual partners suggests that there is a need to 
promote personal and public health benefits of notification of casual partners of 
STI, given the high rate of partner change among HIV positive MSM observed in 
chapter 3.  
Willingness to use traditional methods of partner notification for STI in the 
future 
Similar to other studies conducted in the UK and abroad, the survey findings 
suggest that overall, patient referral would be the most preferred method for 
notifying partners of STI in the future (Gorbach et al., 2000; Levine et al., 2008; 
Coleman and Lohan, 2009; Rietmeijer et al., 2011). While face-to-face methods of 
notification would be the most preferred method to notify partners of STI in the 
future, a substantial proportion of men would be willing to notify their partners via 
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remote self-led methods of notification like a phone call or SMS sent from their 
personal mobile phones.  
However, the preferred methods of partner notification for STI varied according to 
the nature of sex partnership. Compared to other partners, a greater proportion of 
men would be willing to notify casual partners of STI only via provider referral. 
These findings suggest that the clinic should offer provider referral, especially for 
notification of casual partners of STI.  
Willingness to use novel methods of notification of STI in the future 
Overall, the willingness to use anonymous e-cards to notify partners of STI was 
low. Approximately one in eight men would be willing to notify regular or casual 
partners of STI via an anonymous e-card, while only one in twenty men would be 
willing to notify their primary partner via this method. A RCT conducted recently 
among MSM in the USA showed that the majority of MSM were unwilling to use 
the InSPOT, an anonymous e-card service to notify partners of STI (Kerani et al., 
2011). A similarly low level of acceptability of anonymous e-cards was reported in 
an evaluation of this service in another State in USA, which had also used 
advertisement campaigns to raise awareness of this service (Rietmeijer et al., 
2011). The use of InSPOT anonymous e-card notification was also associated with 
decreased HIV testing among sexual partners (Kerani et al., 2011). Thus an 
anonymous e-card service appears to have limited acceptability and utility among 
MSM.  
Internet-based partner notification via dating sites by clinic staff using email 
address given by index cases or by patients themselves to notify sex partners was 
not explored as part of the SHARPN project. However, studies conducted in the 
USA have reported that notification of partners via an anonymous email sent by a 
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public health specialist from a dating website was acceptable to notify partners 
other than regular partners of STI (Mimiaga et al., 2008). Such internet based 
partner notification by the health professionals via dating websites and also via 
closed emails like Yahoo for syphilis led to increase in the number of partners 
located, notified, tested and treated (Ehlman et al., 2010). Internet based partner 
notification via dating websites is currently not used in the UK. However, the 
GMFA, a gay men’s health charity in the UK, is currently piloting the 
acceptability of a sexual health messaging service in some London clinics that 
enables notification of sexual partners met via three gay dating websites (GMFA, 
2012). This service allows men to send emails via this service to partners met on 
these sites either anonymously or otherwise. The results of this pilot will provide 
greater insight into the acceptability of this method of notification of STI among 
MSM.  
A greater proportion of men would be willing to take a home sampling kit for STI 
or take medication for a primary partner following telephone assessment by clinic 
staff, compared to regular and casual partners. Overall, a greater proportion of men 
would be willing to take a home sampling kit for their partners compared to taking 
medication for partners after partner’s telephone assessment by a clinic staff. The 
reasons for this variation are explored in the following chapter.  
Similar to another study, half of the respondents would be willing to refer men in 
their social network to test for STI if they perceived that these men engage in risky 
sex (Woodward et al., 2010). A high proportion of men would also be willing to be 
notified by the clinic of an STI outbreak. This finding suggests that a notification 
by the clinic of an outbreak of STI could encourage men to test for STI.  
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Preferred methods to be notified of STI by partners 
The majority of men (97.5%) considered it important to be notified of STI in the 
future. In line with the preferred methods for notifying sexual partners of STI, men 
would be willing to be notified of STI by their sex partners in the future either 
face-to-face or via a phone call. None of these men wanted to be notified via 
anonymous methods. However, there was greater acceptability to be notified of 
STI compared to notifying partners of STI via provider referral methods. These 
data suggest that being an index or a contact can influence the preferred methods 
of notification for STI. 
In the following section, I discuss the limitations of the partner notification 
component of the SHARPN survey and the implications of the findings. 
5.5 Limitations 
Strengths and limitations of the SHARPN survey were described previously in 
section 3.5. In addition, there are following limitations. Participants were asked to 
self-report STI diagnoses in the last year and this is likely to be influenced by 
recall bias and social desirability bias. Men were asked about their willingness to 
notify sex partners of STI in the future and the willingness to use traditional and 
novel methods of notification for STI in the future. These data on willingness may 
not necessarily reflect actual behaviour in the future. A recent exploratory trial on 
partner notification for STI reported a lack of correlation between perceived 
uptake of contacts’ testing for HIV and syphilis after receiving remote partner 
notification (Sutcliffe et al., 2009) and actual behaviour after using remote partner 
notification methods (Estcourt et al., 2012). However, I have triangulated data on 
partner notification for STI using the SHARPN survey data and qualitative 
interview data.  
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5.6 Implications for clinical practice, health policy and future 
research 
The findings of this chapter suggest that not all sexually active men had tested for 
STI in the last year. The burden of STI among HIV positive MSM was high. Thus, 
there is a need for interventions to reduce the risk of STI and increase testing for 
STI among these men. The observed high level of concurrency, multiple AI 
partnerships and engagement in group sex among HIV positive MSM and their 
association with STI diagnosis in the last year suggests that partner notification 
could be effective in preventing onward STI transmission among HIV positive 
MSM. The observed high prevalence of serodiscordant partnerships also suggests 
that partner notification could lead to HIV case finding, and early diagnosis. It can 
enhance timely STI diagnosis and is vital to prevent increased infectivity of HIV 
due to co-infection with STI. 
Partner notification for STI was considered to be a responsibility towards sex 
partners by the majority of HIV positive MSM. However, partner notification 
interventions among HIV positive MSM should address the observed variation in 
willingness to notify partners of STI by partnership type by offering support 
tailored according to the nature of sexual partnerships. Although patient referral 
was the most preferred method to notify sexual partners of STI, a greater choice of 
partner notification options for men who have casual partners and engage in group 
sex may enhance notification of these types of sex partners. Such interventions 
should be sensitive to the need for HIV-related confidentiality and negative 
implications of partner notification for STI in certain circumstances.  
Currently proposed novel methods of partner notification for STI appear to have 
limited acceptability among HIV positive MSM. Nevertheless a minority of men 
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were willing to be notified of STI via these methods in the future. In the next 
Chapter, I present the results of the qualitative study that provide greater insights 
into the observed variation in willingness to notify different types of sexual 
partners of STI, particularly the lack of willingness to notify casual partners, and 
variation in the willingness to use traditional and novel methods of notification for 
STI.
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Chapter 6: Attitudes towards partner notification for STI 
and preferred methods of partner notification: results of 
qualitative study 
6. Aims 
The aim of this chapter is to understand in greater detail the influence of socio-
cultural context of STI/HIV diagnosis and biomedical advances in HIV treatment 
and care on HIV positive MSM’s attitudes towards partner notification for STI and 
the willingness to notify different types of sexual partners and willingness to use 
different methods to notify different types of sexual partners of STI. 
6.1 Objectives 
The specific objectives of this chapter are: 
1. To explore the attitudes of HIV positive MSM towards partner notification 
for STI and perceived barriers and facilitators for notifying sexual partners of STI.  
2. To explore their attitudes towards notifying different types of sexual partner 
of STI and being notified of STI in the future, and their willingness to use different 
types of partner notification methods for STI in the future.  
3. To describe their recent experiences of STI diagnosis and partner notification 
and explore their attitudes towards being notified by sexual partners of STI in the 
future.  
6.2 Methods 
The details of the methods of the qualitative component of the SHARPN study 
were presented previously in section 2.6. 
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6.3 Results 
The results presented in this chapter are based on the analysis of the data collected 
during the in-depth interviews conducted with a purposive sample of 24 men. The 
details of the sample recruited for these interviews were described in section 4.3.1.  
6.3.1 Attitudes of the participants towards partner notification 
for STI 
As described in the following section, there were several similarities in men’s 
attitudes towards partner notification for STI.  
6.3.1.1 Partner notification as a ‘right thing to do’ 
The following quotes reflect men’s moralistic perspective towards partner 
notification for STI. They viewed partner notification for STI as a “moral thing”, 
“responsible thing”, “common sense” and non-notification of partners for STI 
was considered as being “irresponsible”.  
“Actually most gay men are responsible. If they get something (STI), like I just 
have, they won’t just go to the clinic, get it sorted and not tell the people 
they’ve fucked. They generally will tell people.” 
White British man in mid-thirties living with HIV since 12 years, on 
cART 
This sense of morality was heightened in the context of concurrent partnerships. A 
few participants who had a bisexual partner felt that it was particularly important 
to notify these partners to prevent onward STI transmission to their partner’s 
partner(s):  
“It’s like a personal obligation really and if this person is not openly gay, on 
the down, who has a family …it happens often unfortunately, then his family 
need to be taken into consideration as well. I think this is one of the things in 
the back of my mind as well. So yes for me it’s a personal obligation.” 
South Asian man in mid-forties living with HIV since 15 years, on cART 
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6.3.1.2 Perceived health benefits of partner notification  
Most men viewed partner notification for STI to be important due to its personal 
sexual health benefits and to facilitate their sexual partners’ testing and treatment, 
especially if they are asymptomatic. Men also considered partner notification as 
important to prevent onward transmission of STI.  
“If someone’s given you an infection (STI) and they don’t know and then you 
find out that you have it, obviously if they don’t know then they could be 
passing it to other people so it’s just kind of common sense to let the previous 
partners know so that they can get tested and make sure they’re not putting 
other people at risk.” 
Black British man in mid-twenties living with HIV since 4 years, not on 
cART 
However, some men felt that notifying partners for STI is not easy. In the 
following section, I discuss the overall perceived barriers to partner notification for 
STI expressed by these men.  
6.3.2 Barriers associated with partner notification for STI 
Perceived barriers to partner notification for STI among these men were influenced 
by the socio-cultural context of STI diagnosis, and partnership factors.  
6.3.2.1 Fear of stigma and blame  
Several men felt that notifying partners of STI is a “difficult task” due to the 
stigma attached to STI. The following quote reflects that men perceived the stigma 
associated with STI as a barrier to notifying sexual partners of STI: 
“There’s like, oh my God you’ve given me gonorrhoea. It’s just like, well I 
could have given you a cold but you are not going to send me snivels. You are 
not going to contact that person by text message saying I hate you, look what 
you’ve done to me. There’s just so much stigma and I think that if people 
continue to do things like that, it’s not exactly going to help.” 
White British man in mid-twenties living with HIV since a year, not on 
cART 
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A participant who had multiple casual partners was worried about notifying his 
partners due to the fear of being perceived as a “slut”:  
“because it is not clear who you got the disease (STI) from then yes, but how 
you’re going to know if you have so many partners and it is a bit embarrassing 
as well and it can affect your personal relationships because you might meet 
somebody you like and then get a disease from somebody else and you have to 
contact all of them, so then it might be bad for your reputation.” 
Central European man in early thirties living with HIV since 4 years, on 
cART 
6.3.2.2 Low self-esteem 
As reflected in the quote below, the stigma associated with homosexuality can 
manifest in low self-worth and low self-esteem due to the internalisation of stigma 
and can affect partner notification for STI. A participant who engaged in deliberate 
self-harm when he was young, and another participant felt that being repeatedly 
diagnosed with STI is a “deeper issue” linked to lack of self-respect and a 
tendency to deliberately self-harm among gay men.  
“I think if the intention of coercing people to make contact and get them to go 
and have a test because they have got something. Why you have had 
unprotected sex with someone anyway, and having numerous kind of sexual 
partners and spreading something around, is to do with one’s self esteem.” 
White British man in early fifties living with HIV since 17 years, on 
cART 
6.3.2.3 Venues for meeting sexual partners and anonymity 
Some men described practical barriers to notifying sexual partners, i.e., their 
sexual partners may not be contactable, especially if they met them in saunas or 
other sex on premises venues.  
“I think it is a good idea but lots of people get, usually gay men have lots of 
sex, especially with people who have some kind of infection and it is very 
difficult to trace and ... get their partners.” 
Central European man in early thirties living with HIV since 4 years, on 
cART 
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6.3.2.4 Be responsible for your own health 
Some men were opposed to the idea of notifying sexual partners of STI, especially 
casual partners, due to beliefs that men who engage in risky sex should take 
responsibility for their behaviour and test regularly.  
“I think that you have to allow people to develop some form of … rely on 
people to take their regular tests, rely on people to look after themselves. 
They’ll always be rogues out there and you can’t do anything about it because 
if you tell them, they won’t do anything about it if they don’t want to.” 
White British man in mid-fifties living with HIV since 2 years, on cART 
6.3.3 Facilitator of partner notification for STI: ‘negotiated 
risk’  
Some men considered notifying sexual partners of STI as being respectful of the 
partnership. The following quote illustrates why notification for STI may not come 
as a surprise for some men and is perceived as the ‘right thing to do’ by men who 
mutually agree to engage in UAI with seroconcordant status primary partner 
and/or regular partners or have open relationship with their primary partner. In 
such situation, partner notification is perceived as the ‘social norm’. The de-
stigmatisation of having multiple sex partners and STI diagnosis in the context of 
open sexual partnerships facilitates self-led partner notification for STI: 
“I have become really close friends and we always have really great chilled 
time together. If I gave them something and didn’t tell them that would be a 
pretty shitty thing to do. The guys I have sex with they’re all positive, they’re 
very open about sex, I’ve shagged them loads of times, and they’ve all had STI 
god knows how many times over the years and they’re just not going to care. I 
mean they care but they’re not going to be embarrassed about it, it’s just you 
know part and parcel of having sex without condoms.” 
White British man in mid-thirties living with HIV since 12 years, on 
cART 
In the following section, I describe the participants’ attitudes towards using 
various methods of notifying partners of STI in the future and the variations in 
their preferences to use (or not to use) these methods. I explore if their preferences 
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vary by the nature of sexual partnerships. I also describe the perceived challenges 
and facilitators to use these methods in the future.  
6.3.4 Attitudes towards notifying different types of sexual 
partners and willingness to use different methods of 
partner notification for STI 
Men’s attitudes towards notifying different types of sexual partners for different 
types of STI and using different types of partner notification methods in the future 
were explored using vignettes depicting hypothetical scenarios as described earlier 
in section 2.6.3.  
In response to vignette 1, which listed various self-led and provider led methods of 
notifying partners of STI, men’s preferred methods of partner notification for STI 
varied according to the nature of sexual partnerships. The following quote reflects 
that one of the reasons for variation in the preferred methods of notifying different 
types of sexual partners of STI was due to the mode of communication with 
different types of sexual partners: 
“INT: You said you would prefer to contact your primary partner in a 
different way compared to your other partners? 
RES: Oh yes because I mean I’d just go home and tell him (primary partner). 
INT:So your primary partner you prefer telling face to face? 
RES: Oh yes. 
INT:And if it is a casual sex partner? 
RES: I would rather prefer to text from cell or online or email them, you   
know by whichever method I’d contact them before.” 
White British man in mid-forties living with HIV since 6 months, on 
cART 
In the following section, I describe men’s attitudes towards notifying a primary 
partner of STI and preferred methods for notifying a primary partner.  
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6.3.4.1 Attitudes towards and preferred methods for notifying a primary 
partner of STI in the future 
The nature of partnership with a primary partner influenced men’s attitudes 
towards notifying him of STI. Men who were in an open relationship with their 
primary partner felt that notifying their primary partner of STI would be easy and 
acceptable. However, men who were not in a consensual open relationship with 
their primary partner and had sex with other men felt that they would be worried 
about notifying him. Nevertheless, despite the perceived barriers to notifying a 
primary partner of STI like the fear of blame and anger, the ‘emotional 
connectedness’ and sense of responsibility towards him was reflected in men’s 
preference to notify him themselves.  
“RES: I would tell him (primary partner), it would take me some time to build 
the courage and find the right time but I guess I would have to, I would tell 
him yes, eventually, and it would be sort of not good.  
INT:And would you be telling him face to face or would you choose any other 
way of telling him?  
RES: I think if you are in a relationship with somebody, you know a stable 
relationship, you owe them the courtesy of face to face.” 
White British man in mid-thirties living with HIV since 3 years, on cART 
The responses of men to vignette 2 about notifying a primary partner of HCV 
diagnosis after a sexual encounter with a casual partner indicates that despite the 
stigma associated with HCV, and the fear of negative implications of notifying 
their primary partner for it, men would be willing to notify him due to issues 
related to sexual intimacy. Engagement in UAI, especially with a seroconcordant 
primary partner, in the event of diagnosis with HCV could lead to onward HCV 
transmission, thereby making it necessary to disclose their diagnosis. Few men 
who had engaged in UAI with their serodiscordant primary partner because they 
were on cART and had an undetectable viral load felt that notification will be 
important to protect their primary partner from HCV. Men also felt that if they 
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would decide to get treatment for HCV, the longer duration of treatment and the 
side effects of the medication would make it necessary for them to disclose about 
their HCV diagnosis to their primary partner. Men also felt a sense of emotional 
responsibility towards their primary partner, which would facilitate partner 
notification, especially for infections like HCV which was perceived to be “nasty”.  
“I would definitely tell the primary partner straight away (about HCV). You 
know it’s uncomfortable and really difficult situation but how could you have 
any kind of emotional connection with somebody and allow them potentially to 
become ill, and also re-infecting yourself as well, so it’s a personal thing too. 
There’s an emotional responsibility to a primary partner and you have to be 
up front about it, if you have done something that’s outside your agreement 
with them then you have to be sensible, adult about facing up to that.” 
White British man in early forties living with HIV since 11 years, on 
cART 
Participants considered it their “duty”, “responsibility” to notify their primary 
partner themselves because STI were considered to be a personal issue. Men felt 
that notifying a primary partner of STI via the clinic or a health advisor would be 
“impersonal” and “unfair”. Some men would be wary of providing their partner’s 
contact details to the clinic. However, a participant who had not disclosed about 
his sexual engagement with other casual partners to his primary partner would 
prefer to notify his primary partner and other partners anonymously via the clinic.  
6.3.4.2 Attitudes towards and preferred methods for notifying regular 
partners of STI in the future 
In response to vignette 1 and 4 about notifying regular partners of HCV and 
syphilis diagnosis, the majority of men felt that they would be willing to notify 
their regular partners for these STI. As reflected in the quotes below, the nature of 
relational dynamics with the regular partner influenced men’s choices of methods 
for notifying them. The majority of men felt that they would feel comfortable and 
confident to notify their regular partners. They would be willing to notify them 
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using patient referral methods compared to provider referral due to the mutual 
understanding of the risk of STI diagnosis associated with unprotected sex.  
 “No I don’t think that’s (provider referral) a good idea.  I don’t want no-one 
involved. I’d rather me contacted them face to face.  I don’t have any problem.  
I think either because of the people that have contact with are older than me. 
So all these people that’s older than me they are more like, I wouldn’t say 
open minded but they are more mature. They are likely to completely 
understand it (being diagnosed with STI) because we don’t use condoms.” 
White British man in late-thirties living with HIV since 7 years, on cART 
“It depends on how close I am to them. I mean if it was a regular partner and 
I had symptoms and I came down here, if it were a close partner it’s quite 
likely they would know I was coming down for a check-up and I would call 
them immediately or text them immediately in that context. If it was a regular 
partner who was also a friend but not a sort of very close friend I would let 
them know as soon as possible.”  
White British man in early forties living with HIV since 11 years, on 
cART 
Due to practical reasons like not living together, not meeting regular partners on a 
daily basis, some men would prefer to call, or send a SMS or email their regular 
partner to speed up the process of notifying them of STI:  
“The two regulars, I feel confident enough to tell them personally. I call them 
because I don’t see them enough. Well one I call and spoke to, the other one I 
sent a text.”  
South European man in mid-thirties living with HIV since 7 years, on 
cART 
A participant felt that even though provider referral may solve “medical issues”, it 
could create a lot of “interpersonal issues”, for example, it could lead to sexual 
rejection by the partners. 
6.3.4.3 Attitudes towards and preferred methods for notifying casual 
partners of STI in the future  
In response to vignette 4 about notifying casual partners of HCV and syphilis 
diagnosis, some men felt that since there were no personal health benefits of 
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notifying casual, especially men with whom they have a one-night stand and no 
emotional connectedness with casual partners, they would not feel the same level 
of responsibility to notify casual partners of STI. Similarly, for some men 
structural barriers like the fear of being blamed and the risk of criminal action for 
HIV transmission were barriers to notifying casual partners of STI. Some men, for 
whom anonymity was of paramount importance, felt that provider referral would 
be an acceptable way to notify casual partners of STI in the future. Some of these 
men expressed the view that they would have preferred to notify their casual 
partners via provider referral when they were recently diagnosed with STI. These 
men were willing to share the phone numbers or dating website details (like chat 
IDs) of their casual partners with the clinic staff if they had offered to notify them.  
Some participants would be willing to use other discreet methods of notification i.e. 
send an anonymous e-card or ask the clinic to anonymously notify their casual 
partners of STI in the future. A participant who had not disclosed his HIV status to 
his sexual partners and engaged in UAI with them felt that it is the personal 
responsibility of men to protect themselves and if at all he notifies his partners of 
STI in the future, he would do so via anonymous e-cards.  
“INT: Would you prefer the nurse to contact your primary partner and tell 
him? 
RES: No not my primary partner, my primary partner I would contact him. I 
will tell him. I would prefer the clinic to tell the ones that I met online and I 
have the number. I’d only met once. Yes I wouldn’t mind the clinic doing it.” 
South American man in early-thirties living with HIV since three years, 
on cART 
However, some men would be willing to themselves notify their casual partners of 
STI in the future. Men who were willing to themselves notify casual partners of 
STI in the future expressed a preference to notify them either via an online 
message sent from the dating website where they had met these partners or via a 
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SMS, depending on the mode of communication used to keep in touch with these 
partners. However, a participant felt that not all men check their online profiles 
regularly so their partners might not get the message immediately. In addition, 
some participants also felt that only paid members can send messages via some of 
the dating websites. Although sending messages from a website may be free, there 
is usually an upper limit on the number of free messages that can be sent and 
people may not want to use them for notifying partners for STI.  
6.3.4.4 Attitudes towards and preferred methods for notifying group sex 
partners of STI in the future 
In vignette 5 described in section 2.6.3, men were asked about the feasibility and 
willingness of notifying group sex partners met at a sex party which was organised 
via a dating website for syphilis. Two key barriers to notify group sex partners of 
STI were expressed: fear of being blamed and anonymity of sex partners. Most 
men who were diagnosed with HCV had engaged in group sex. They blamed their 
group sex partners for infecting them with HCV. In contrast to the willingness to 
notify a primary partner of HCV diagnosis as reported in section 6.3.4.1, men were 
sceptical about notifying casual partners of HCV diagnosis. Assumptions like 
deliberate transmission of HCV by someone during group sex, and the fear of 
being blamed for transmitting HCV, which is associated with greater fatality, and 
stigma are barriers for notification of casual partners for HCV. As shown in the 
quote below, a participant who had notified his regular partner of HCV did not 
notify his group sex partners due to assumptions that someone at the party 
deliberately transmitted HCV: 
“RES: Yes the most recent time was when I was diagnosed with Hepatitis C, 
which was in 2007. And as soon as I had that result I just phoned this guy I 
was having unprotected sex with. He was also HIV positive and we made this 
decision to have unprotected sex. We had discussed it and I knew the risks, 
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and lo and behold I had contracted Hepatitis C. I remember there were two 
other occasions when I had unprotected sex. One was in a group sex situation 
with two other guys and the other one was a one to one situation.  I didn’t 
contact them. 
INT:Why do you think you didn’t contact them? 
RES: It is a tricky question; it is tied up with blaming and this kind of balance 
between blaming and not taking responsibility. I remember thinking it is either 
these two in this group sex situation or it is either this other guy, not the one I 
had told.  I just had a feeling it wasn’t him, I don’t know why.  And there was a 
lot of blaming around it and I mean it felt like what I had contracted was like 
grievous bodily harm.  Why I didn’t contact either is something to do with, 
well one of these two groups in my mind has given it to me.  It is something to 
do with blaming and not being able to kind of accept responsibility for what 
had happened, something to do with that. 
INT:have you met them after that incident? 
RES: Yes I have met one of them after that. Yes in a sauna. and I didn’t say 
anything.” 
White British man in early fifties living with HIV since 17 years, on 
cART 
Some men had attended group sex parties which were organised by them or their 
friends, usually with a small group of known people, or were organised online via 
a gay/MSM website. As reflected in the quotes below, men felt that they would be 
able to contact the group sex partners they had met during a party organised by 
them or their friends because they may have their contact details. However, some 
men felt that they are usually unlikely to have the contact details of other men 
attending parties that are organised online and thus would not be able to contact 
them.  
“I just contact the people with whom I have contact, it is parties I have 
organised and it's no more than three people. Then I have the telephone 
number which I can contact them.” 
White British man in late-thirties living with HIV since 7 years, on cART 
Some men felt that they would be able to contact men they had met at a party if 
they would keep in touch with them after the party. They would be able to contact 
the party host and ask him to contact other members of the group. However, as 
shown in the quote below, some men felt that given the nature of group sex, while 
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notifying the party organiser of their STI diagnosis, they can easily deflect the 
blame away from them: 
“I would contact the organiser and say I’m sorry I have Syphilis. In people’s 
minds if you tell the group oh I’ve got Syphilis then somehow subconsciously 
they will blame you if they get it as well. But I guess in that sort of 
circumstance, well it’s fine and I guess the anonymity of it which makes it 
easier to say well I’m sorry I’ve just got diagnosed with Syphilis, I guess I 
would word it somehow that after the party I developed this, that somehow 
deflects the onus on I didn’t’ have it, I’m not to blame, it’s somebody there but 
I guess that’s just human psychology.” 
South European man in mid-thirties living with HIV since 7 years, on 
cART 
However, a participant who was told to attend a sex party despite his chlamydia 
diagnosis felt that the party organisers might not necessarily notify other members, 
especially for minor STI like chlamydia or gonorrhoea. Nevertheless, some men 
reported that a party organiser had contacted them after a group sex event to notify 
them to test for STI. As shown in the quote below, men who had engaged in group 
sex were notified to screen for STI despite the embarrassment associated with it: 
“That’s happened to me a few times actually where I’ve been to a party and 
then literally you know by the Tuesday or Wednesday texts start going around 
oh you know X has got the clap … you better go and get yourself tested. 
People never call each other. There’s obviously an embarrassment factor 
there which is curious considering what you’ve been doing with the guy for 
two days. So you just send online message or text message where you’re not 
actually having to verbally communicate with them. It’s a bit of a cop out but 
at the same time you feel like you’ve ticked the box” 
White British man in mid-thirties living with HIV since 12 years, on 
cART 
However, some men felt that they would not bother to notify the partners they had 
met at sex parties due to the lack of emotional connectedness with them. Some 
men also felt that men who engage in group sex should be aware of the risks 
associated with it and screen for STI regularly instead of relying on someone to 
notify them.  
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“I think again it's kind of you must be responsible if you go to something like 
that. It's like if you see the boiling water in there and if you want to go and put 
your hand there then obviously you will burn your hand. So it's the dangers, 
it's your responsibility.” 
White British man in late-thirties living with HIV since 7 years, on cART 
Perceptions that men who attend bare backing parties don't care about being 
diagnosed with STI and would not care about being notified or notifying the sexual 
partners they meet at such parties were also barriers to notifying group sex partners: 
“Usually these people have HIV, they test regularly for syphilis, so they’re not 
really bothered about contacting others, not for syphilis.” 
Central European man in early thirties living with HIV since 4 years, on 
cART 
In the following section, I describe men’s attitudes towards using novel methods of 
partner notification like anonymous e-cards, home sampling kits, telephone 
assessment of partners and notifying social network members to test for STI. 
6.3.5 Acceptability of novel methods of notifying partners for 
STI 
Men’s willingness to use novel methods like home sampling kits, telephone 
assessment model, sending anonymous e-cards and notifying members of social 
network to test for STI were explored using vignettes 1, 3 and 6 described 
previously in section 2.6.3. In the following section, I describe the attitudes of men 
towards these novel methods of partner notification for STI and their willingness 
to use these methods in the future. 
6.3.5.1 Attitudes towards using anonymous e-cards for notifying partners of 
STI in the future 
Men were asked about their willingness to anonymously notify their sexual 
partners of STI and the situations in which they were most likely to use this 
method of notification in the future. The option of notifying sexual partners of STI 
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via an anonymous e-card message was one of the options (option 7) in vignette 1 
which examined the preferred methods of partner notification for STI. Two 
divergent perspectives emerged from men’s responses towards sending an 
anonymous e-card to sex partner for notification of STI. While the majority of men 
would be unwilling to notify their partners via this method, a small minority of 
them would be willing to do so. 
As reflected in the quotes below, the majority of men across all age groups 
considered notifying partners of STI via an anonymous e-card as not taking 
responsibility for one’s own sexual behaviour. They felt that it is likely to create 
“confusion”, “panic”, and “anxiety” among those notified via this method.  
“The idea of anonymous contact feels cowardly to me. I think it would be very 
scary to get an anonymous contact and personally it would scare me because 
I’d think why haven’t they spoken to me. And just to have that sense of 
reassurance that I can talk to the person who is infecting me, even if they 
didn’t do that it is just nice, just sort of human. I hate the idea, I think I’ve said 
that many times.”  
White British man in early forties living with HIV since 11 years, on 
cART 
“I just think seriously are you that weak? Just bloody say. You know even if 
the person is going to be a bit pissed at you, so what. These things happen. 
People don’t get pissed at each other when you pass a cold on. They are just 
like, well you know never mind, sorry, shit happens …but I don’t understand 
why the same thing doesn’t happen when you end up, for the want of better 
words, fucking someone.” 
White British man in mid-twenties living with HIV since a year, not on 
cART 
On the other hand, as indicated in the quote below, the preference for anonymity 
among a small group of men was reflected in their willingness to send an 
anonymous e-card to notify their sexual partners of STI in the future:  
“I can imagine that maybe in some people’s circumstances that would make 
sense for whatever reason, I don’t know, depending on their personal, family 
circumstances or something where there is someone who is seriously at risk 
and wouldn’t be aware of it but for particular reasons it would be very 
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difficult for them to contact partners directly. So I can see that in limited 
circumstances that might be helpful.” 
White British man in mid-forties living with HIV since 6 months, on 
cART 
The following narrative of a participant who had engaged in UAI without 
disclosing his HIV status to his serodiscordant partners was willing to use this 
method due to the fear of being sued for HIV transmission. It also reflects that this 
method, albeit acceptable only to a few, may reach those who may be at greater 
risk of HIV: 
“INT:Why do you think you would prefer this (anonymous e-card)? 
RES: My identity is going to remain anonymous and just the clinic will ask him 
to come to the clinic for checking himself. 
INT:Will you be able to provide email addresses of your sexual partners to 
send an e-card or would you prefer to yourself send them an e-card using their 
email address? 
RES: No, I can provide maybe their email address to the clinic, and the clinic 
can send it.  
INT:and why do you think it is important to protect your identity, like why 
wouldn’t you want to tell your name to the person?  
RES: For the things like, I don’t want to say nothing, it is a risk to being 
arrested.” 
South European man in early thirties living with HIV since 4 years, on 
cART 
Despite these concerns, some men felt that if they were to receive an anonymous 
e-card they would go to the clinic to test for STI. However, as indicated in the 
quote below, some men were concerned about the authenticity of the message. 
They felt that there should be a clinic logo or some indication that they have 
received an email from a reliable service to avoid it being treated as a spam or a 
hoax.  
“RES: I think awareness is important for this (anonymous e-card service). If 
it’s found that yes there is this service that you may get an e-mail or something 
then I think possibly the effectiveness will be greater and they will say well 
hang on this is a legitimate source. So you better go and get it checked out. 
But I guess for a lot them, they would rather not be contacted that (anonymous 
e-card) way. 
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INT:What if you got a message from such an anonymous website? 
RES: I would definitely follow it up because of my condition, it’s like well no I 
think you’d better go and get.” 
South Asian man in mid-forties living with HIV since 15 years, on cART 
6.3.5.2 Attitudes towards using home sampling kits and telephone 
assessment method for partner notification in the future 
Men were asked about their willingness to use a home sampling kit and a 
telephone assessment model (vignette 3) to notify their primary partner who lives 
with them in the event of being diagnosed with chlamydia/gonorrhoea. Some men 
would be willing to use both these methods in the future, whereas some men were 
opposed to using both these methods. Some men would be willing to use a home 
sampling kit compared to the telephone assessment method to notify their primary 
partner in the future. In the following section, I describe the perceived facilitators 
and barriers to use both or either of these methods in the future.  
Reasons for lack of willingness to use these methods 
The lack of willingness to use these methods was linked to the greater significance 
men attached to the expertise of the clinic staff in matters related to sexual health. 
Men were concerned about their partners’ ability to collect their specimens 
accurately and valued the face-to-face interactions with the clinic staff. A 
participant felt that both these methods were “bureaucratic” and “impersonal”. 
“INT: How would you prefer to let your primary partner know if this kind of 
situation arises? 
RES: I would let him know and bring him back to the clinic. 
INT:Why do you think that you would want to do that? 
RES: I think it’s just more ... the nurses or the doctors to take the samples is 
more thorough than just kind of trying to follow instructions at home. And I’m 
not sure if they, can they assess for Gonorrhoea or Chlamydia over the phone? 
And even if they can, no I think I would want him to come to the clinic.” 
Black British man in mid-twenties living with HIV since 4 years, not on 
cART 
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Men, especially older men, were worried about the reliability of the test results of 
self-taken specimens, whether using a home sampling kit would be faster than 
testing in the clinic, and the effects of posting specimens via mail, as expressed in 
the following quote:  
“Coming to the clinic sometimes is incredibly traumatic, but on the other hand, 
you assume that everything will be done correctly. I suppose with a home 
sampling kit you’d have to have reason to believe that it would be as accurate 
or virtually close to the same levels of accuracy and there’d be a worry that 
you might be doing it wrong.” 
White British man in early forties living with HIV since 11 years, on 
cART 
Some men who were in a partnership with bisexual men felt that home sampling 
kits lack confidentiality which is vital in such situations, especially if their partners 
have not disclosed their bisexuality to their female partners/wives.  
“However, there is another person who due to his domestic situation does go 
for fairly regular check-ups but I mean he wouldn’t be able to use a kit, God 
knows what his wife would do if she found a home sampling kit.” 
White British man in mid-fifties living with HIV since 20 years, on cART 
As shown in the quote below, the telephone assessment model was also disliked 
due to practical concerns like the primary partner might be at work or might be 
busy when they call him. Some men would be wary of sharing their primary 
partner’s telephone number with the clinic. Similarly, some participants raised 
concerns about the reliability of telephone assessments. They were also concerned 
about the emotional response of their primary partner if he was unaware of their 
visit to the clinic and felt that they would not use this option without talking to him 
in advance.  
“I am not sure about the phone assessment because well there’s two things, 
one surely it can be asymptomatic so a phone assessment wouldn’t be possible 
anyway but other than that I think the whole issue of disclosure, where you 
might be seen as the person who has been the infector, you hope that the other 
person’s reaction will be straight forward and understanding. However, if you 
306 
 
call from the clinic and say right I am going to put you onto a doctor and they 
feel quite angry about a situation or angry at you. I wouldn’t like to do that 
unless I were perhaps at home with them and talk through it with them. You 
can then call the doctor, that would be more straight forward.” 
White British man in early forties living with HIV since 11 years, on 
cART 
Reasons for willingness to use these methods 
Some men who were willing to take a home sampling kit for their partner in the 
future felt that it is a “non-intimidating” alternative to the clinic environment. The 
following quotes indicate that a home sampling kit was considered to be 
“convenient” and “easy to use” as it would mean that their primary partner would 
not have to travel to the clinic for an STI screen. A participant felt that he would 
prefer to use a home sampling kit not only to test for bacterial STI, like gonorrhoea 
or chlamydia, but also to test for all STI, including HIV. He was diagnosed with 
HIV three years ago and had not disclosed his HIV status to his primary partner, 
and was scared to attend an HIV clinic due to fear of being seen at the clinic. 
“I would support it not only for Gonorrhoea or Chlamydia but other infections 
as well.  At home, people behave differently.  Tests, clinic environments are 
intimidating.  No issues about doing it at home as it is a safe environment and 
would find it easier to recommend.  I prefer it in comparison to health 
advisors or doctors calling my partner because if they called then it’s different, 
they don’t know where partner is or his situation.”   
Scandinavian man in late thirties living with HIV since 3 years, not on 
cART  
However, as shown in the following quote, a home sampling kit was not perceived 
as a viable option by men who had multiple sex partners: 
“INT:Why do you think he would prefer a home sampling kit? 
RES: He (primary partner) wouldn’t need to come here to get a test. 
INT:What if your partner gets a home sampling kit for you? 
RES: I would do it yeah. 
INT:And the main reason that you both may want to use it? 
RES: Yes just to save time but only with my primary partner. Yeah I think for 
buddies I wont use it because of going to each of them to give this thing.” 
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South American man in early-thirties living with HIV since three years, 
on cART 
Men who had a steady primary partner felt that telephone assessment of their 
partner would be a “quick” way to ensure his treatment and resume sexual activity. 
However, men would be willing to use this method to notify only their primary 
partner and not for notifying other types of sexual partners. 
“I think the second option (telephone assessment) makes more sense. I mean if 
I’m having regular sex with my partner then it probably makes sense for him 
to just take the medication anyway.” 
White British man in mid-thirties living with HIV since 7 years, on cART 
Some men would be willing to use either of these methods to enable testing and 
treatment of their primary partner. As reflected in the following quote, some men 
felt that although these methods are acceptable to them, ultimately it would be 
their partners’ choice to use them and they may decide to come to the clinic 
instead. 
“My feeling would be that it probably makes sense for him to take the 
medication anyway but I guess that if he was the type of person who didn’t like 
taking medication unnecessarily, then if he wanted to do the home sampling kit 
then he could do but that would be his choice rather than mine.” 
White British man in mid-thirties living with HIV since 7 years, on cART 
Although the discussion focused on using these methods to notify a primary 
partner, willingness to use of these methods for other partners was explored with 
men who reported having multiple sex partners. Some men who had regular 
partners would be willings to take a home sampling kit for them. However, as 
reflected in the following quote, they were cautious about maintaining their role as 
a ‘sex buddy’ and not taking on the role of a health care practitioner. 
“RES: I probably would not have a preference; I think I’d be happy to do 
either. I mean my other half wouldn’t have any issues at all with a doctor 
calling him while I’m sat next to the doctor saying I’ve got X and the doctor 
would like to ask something, or would you come in and do the same? 
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Conversely he wouldn’t mind if I went home with a home testing kit, sounds 
fun. 
INT:And would you use any of these methods for your regular partners? 
RES: Yeah. I think the vast majority of my regular partners would have no 
problems at all if I gave the clinic their phone number. So yeah that wouldn’t 
be problematic.  A home testing kit that would seem a little bit like I was 
playing district nurse I think. I’m not here for a fuck, I brought you this, bend 
over I’m going to shove something else up your arse. Yeah I wouldn’t have 
any problems with it at all.” 
White British man in mid-thirties living with HIV since 12 years, on 
cART 
6.3.5.3 Attitudes towards notifying members of social network of STI in the 
future 
Vignette 6, described in section 2.6.3, was used to explore mens’ views towards 
referring friends and acquaintances who they think engage in risky sexual 
behaviour, to test for STI in the event of a LGV outbreak. All but one participant 
felt that if there would be an outbreak of LGV or any other STI, they would be 
willing to inform their sexual partners and gay friends about it, either directly or if 
such a conversation comes up. However, they were divided in their attitudes 
towards referring members of their social network to test for these infections. 
Some men felt that they would inform their friends about the outbreak but not ask 
them to test for the STI even though they openly discuss issues related to sex. 
They associated asking friends to test for STI with being “self-righteous”, 
“playing the role of a doctor” or “stepping a line”. A participant felt that he 
would ask his friends to test only if they have symptoms. The following quotes 
reflect these varied views: 
“Would I ask my gay friends to test for LGV it there is an outbreak?  I’m not 
sure I would ask them to test. I think I would ask them to make themselves 
aware that there is an outbreak of things like that.” 
White British man in mid-thirties living with HIV since 12 years, on 
cART 
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“I would expect people to be generally aware that there are things out there 
anyway. So me saying oh there’s something out there I haven’t got it but you 
might want to test. Unless that topic came up in a conversation, otherwise it 
seems like why, I can’t imagine why I would do that (talk about it).” 
White British man in mid-forties living with HIV since 6 months, on 
cART 
However, some men were willing to refer their friends (as well as their primary 
partner and other sexual partners) to test for LGV if there was an LGV outbreak. 
As reflected in the following quote, some participants who were recently 
diagnosed with LGV had notified their sexual partners:  
“RES: Yes, I would most definitely ask friends to test for LGV out of concern 
for their health and to inform them.  I have done that before because it is 
important to pass on knowledge given to me. 
INT: You have done that before?  
RES: I was given a leaflet for LGV in this clinic and talked to a nurse who told 
me about LGV and how it is becoming a problem.  So I mentioned it to at least 
a few friends in discussion.   
RES: What was their reaction?   
INT: Some had never heard of LGV and were pleased that I told them; others 
had already heard of this.” 
White British man in mid-forties living with HIV since 20 years, on 
cART  
The significance men attach to medical expertise was a perceived barrier to inform 
peers about STI outbreak and to ask them to test for STI in the future. Need for 
provision of supporting information by the clinic to ensure the authenticity of the 
information they provide was expressed. An email link sent by the clinic providing 
information about the outbreak was considered sufficient to enhance the 
authenticity and accuracy of information they would provide to their peers. Some 
men also felt that the clinic should inform them via an email or a letter if such an 
outbreak occurred in the future.  
“INT:So you would tell your friends to go to the clinic for a test? 
RES: I’d certainly discuss that with my gay friends. I mean the best way to do 
that to be honest with you is to get an article…on-line that you can use as an 
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attachment and  send it to all my friends saying, look I read this really 
interesting article, I think you should all read it.” 
White British man in mid-forties living with HIV since 2 years, on cART 
However, a young participant felt that being contacted by the clinic to test for STI 
during an outbreak would make him feel that they are being presumptuous about 
his sexual behaviour. Nevertheless, he felt that he would like to receive 
information from the clinic about the outbreak so he can be careful and test for STI 
if he develops any symptoms.  
In the following section, I describe men’s experiences of interacting with the clinic 
staff following recent experience of STI diagnosis and partner notification.  
6.3.6 Shame, stigma and interaction with clinic staff for 
partner notification 
Most men usually screen for STI once in 4-6 months, whereas some men would 
screen for STI only if they are symptomatic. Men who had engaged in group sex 
screened for STI regularly, usually a week after group sex. As mentioned in 
section 4.3.1, of the twenty-four men who were interviewed, eleven were recent 
contacts, and twenty men were recently diagnosed with STI. In the following 
section, I describe men’s attitudes towards and experiences of interaction with the 
clinic staff following STI diagnosis.  
6.3.6.1 Perceived stigma and shame 
Most men who were recently diagnosed with STI had met a health advisor after 
their STI diagnosis. Some men complained about a long wait prior to meeting a 
health advisor on the day of their STI diagnosis. The following quote reflects a 
commonly expressed initial scepticism about meeting a health advisor, yet 
participants appreciated their interaction with an advisor. The fear of stigma, 
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shame and guilt associated with group sex was a barrier to disclosure of this 
behaviour to a health advisor.  
“INT:What did you think about meeting a person like X (health advisor) when 
you were diagnosed with an infection?  
RES: Initially I was quite sceptical. There is a feeling of doing something that 
is in the eyes of the clinic wrong, and in very personal terms, I was feeling 
quite ashamed. It’s very difficult to talk about sexual acts in most 
circumstances and to talk about the associated feeling of shame at having 
caught something and Syphilis is, you know it’s got a bit sort of cache, a big 
history. I thought I was going to be essentially told off. I assumed that it was 
just going to be a, sort of, a lesson in how to not contract sexually transmitted 
diseases.”  
White British man in early forties living with HIV since 11 years, on 
cART 
Few participants who had been diagnosed with chlamydia and syphilis were asked 
to notify their sexual partners by a health advisor. A week later they were informed 
of LGV diagnoses and again asked to notify their partners. These men had already 
notified their partners of chlamydia and syphilis diagnosis and felt embarrassed to 
notify them again for LGV. As the following quote indicates, their experience of 
re-notifying their sexual partners was unpleasant.  
“I mean when I contacted them to say, you know about Syphilis and then later 
I contacted them for LGV, they said well you have just recently told me about 
syphilis, I went for my check up and I was fine… I stopped contacting, I 
stopped going through the list because everybody seemed to be saying hey I’ve 
just been for a check-up, if it were there they would have found it.” 
White British man in early forties living with HIV since 11 years, on 
cART 
6.3.6.2 Disclosure of unsafe sex 
The following quote reflects that judgemental behaviour on part of the clinic staff 
may lead to losing opportunities of health promotion and providing risk reduction 
advice and support to the patients:  
“INT: How was your experience of talking to a health advisor? 
RES: They are very helpful. I had one, just once, it was here.  When I got this 
nurse, she was black; I was doing unprotected sex with my ex-partner who was 
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HIV negative.  I wanted to know what to do if he came inside me... you never 
know whether he can do anything about it. But she really, really criticised me. 
I wasn’t rude and didn’t reply, I didn’t answer her but I think it was very 
unprofessional for her”.  
White British man in late thirties living with HIV since 4 years, not on 
cART 
6.3.6.3 Useful advice 
The following quotes reflect that some men had pre-conceived negative notions 
about meeting a health advisor after being diagnosed with STI. Despite such 
preliminary scepticism, irrespective of the age group, the majority of men felt that 
their interaction with a health advisor following their STI diagnosis was useful for 
understanding the mode of transmission of STI, and helped them understand how 
to notify partners of STI, and determine the time frame and the number of sex 
partners they had to notify. Some men were unaware about the non-sexual routes 
of HCV transmission or probability of oral transmission of syphilis prior to being 
diagnosed with it and prior to their discussion with a health advisor. 
“I didn’t know that there’d be anything about partner notification, about that 
whole process. I thought it would just be about me and so I felt quite defensive 
about sort of sitting in front of someone, it felt like going to the headmaster. 
When he began to talk it was immediately clear that it was actually about a 
cooperative approach to looking at, possibly a range of problems that have led 
to the situation I was in, rather than just being told you shouldn’t have done 
this, next time do this or don’t do that which is what I’d imagined. I was 
incredibly pleased to have the opportunity to sit down and talk to him, with the 
way the conversation went. I thought he was brilliant in the way that he 
handled the issues and talked through quite gently. A lot of the issues that I 
was having which some of them I guess are more psychological than just the 
sort of matter of how to use condoms, how to avoid picking up sexually 
transmitted diseases. I do remember coming out and having a plan in my head, 
for how far back I needed to go and how I was going to contact and who, and 
also having a sense of how I was going to pitch that when I am speaking to 
them, which I didn’t have when I went in.” 
White British man in early forties living with HIV since 11 years, on 
cART 
“We (he and health advisor) spoke about sexual partners… He just kind of 
gave me some advice on the best way to sort of bring up the conversation and  
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how to prevent any further infections at the time that I was, that I had 
gonorrhoea and yeah it was just kind of educational like and useful.” 
Black British man in mid-twenties living with HIV since 4 years, not on 
cART 
 
In the following section I describe if men had notified their partners after their 
recent STI diagnosis and if so, how had they notified their partners.  
6.3.7 Non-notification of partners following-STI diagnosis 
Most participants who were recently diagnosed with STI had notified some or all 
of their sexual partners. Of those who had not notified their sexual partners of STI, 
some men were diagnosed with gonorrhoea, either rectal or pharyngeal, and one 
was diagnosed with syphilis. These men were unable to notify their partners 
because their contacts were anonymous. When the attitudes of men towards 
partner notification for STI in the future were explored, these men had expressed a 
preference for notifying partners anonymously via the clinic or an anonymous e-
card. A participant who had not notified his partners of STI recently had never 
notified his partners in the past and chose not to do so this time. He felt that it is 
not his responsibility to notify partners of STI and there is “too much 
bureaucratisation around STI”. With regards to notifying partners of STI in the 
future, this participant had stated that he would not notify his partners of STI in the 
future.  
6.3.8 Experience of notifying sexual partners following STI 
diagnosis 
Men who had a primary partner had notified them about their STI diagnosis in 
person, except for one participant who had notified his primary partner via a phone 
call. A participant’s serodiscordant primary partner was unaware that he had other 
sex partners and was upset at being notified. Another participant blamed his 
314 
 
unknown status primary partner for his diagnosis with latent syphilis. Some men 
who were recently diagnosed with STI had a serodiscordant primary partner and 
were in an open relationship. Some men had engaged in threesomes or group sex 
and some had done so along with their primary partner. Therefore, their STI 
diagnosis was not a surprise for them. These men had notified their primary 
partner and some of their group sex partners.  
These men had largely notified their regular partners either via a text message or a 
phone call. A participant had not notified one of his regular partners because he 
was abroad. Casual partners were notified via a text message or an online message. 
One participant, who was recently diagnosed with chlamydia, had notified a casual 
partner via Facebook. However, he felt that he would have preferred the clinic to 
anonymously notify his sexual partner who was his primary partner’s friend and 
thus, he was embarrassed to notify him. In addition, the notification led to 
complications as his message was interpreted as an attempt to blame this partner.   
A participant who had notified his regular partners for HCV was unable to contact 
approximately 20 anonymous contacts he had met at a recent group sex party. Few 
men who had engaged in a group sex party organised online had notified some of 
their partners to test for STI bevause they were in touch with them after the party 
or had engaged in group sex with a small group of known men and had texted all 
of them asking them to test for STI.  
The following narrative indicates that partners usually appreciated being notified 
of STI. However, there were a few instances where participants reported that their 
partners sent them a nasty text in return following notification. 
“I personally felt it would be irresponsible not to. Obviously, it’s a difficult 
thing, much nicer not to be in the situation to have to do that. But given that 
I’d discovered it and that there was a risk either from me to other people or 
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that I’d got it from other people or that particularly in a group situation it 
could have been passed around, you know it’s better to know than not  know. 
So my view was to let as many people know as possible in the nicest possible 
way and certainly not sort of saying I think it’s your fault. Just saying this has 
happened to me. I think the messages I sent all have that sort of fairly non-
committal way of saying it’s probably a good idea that you get checked out too.  
And most of the people who replied to me, I was very surprised, they were all 
saying thanks, that’s good of you and a lot of people don’t get in touch in that 
situation and I really appreciate that.  And some people didn’t reply so I 
wonder what they think, or they just ignored it.” 
White British man in early forties living with HIV since 11 years, on 
cART 
6.3.9 Attitudes towards being notified by sexual partners of 
STI 
Men’s attitudes towards being notified by their sex partners of STI were assessed 
using vignette 7. Most men perceived being notified for STI as a necessary evil 
with health benefits. Being notified by sex partners was considered to be important 
to prevent onward STI transmission, and facilitate timely treatment, especially in 
case of asymptomatic STI. Although some men considered it unpleasant to attend 
the clinic to test for STI following notification, men were willing to take the 
responsibility, especially if they had engaged in unsafe sex.  
“I really appreciated the fact that he did it (contacted me) and I thanked him 
for it. In terms of what preference I have for contacting me, I actually wouldn’t 
really care as long as they told me. I mean they could ring me, they could do 
the earnest chat. They could get a health visitor to do it.  They could do it 
however they wanted. If I had something I wouldn’t really want to be 
spreading it around for weeks and weeks without knowing.” 
White British man in mid-thirties living with HIV since 12 years, on 
cART 
“Absolutely yes and as quickly as possible in whatever means possible so that 
if I have contracted it I can get treatment and I am not passing it on to anyone 
else if I have contracted it.” 
White British man in early fifties living with HIV since 17 years, on 
cART 
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For the majority of men the mechanism by which they are notified for STI by their 
sex partners does not matter as long as they are notified. However, there was a 
strong preference among men to be notified by their partners face-to-face, 
especially by their primary partner. As the quotes below indicate, men were 
willing to be notified via a phone call, an online message, a text message, or any 
method of communication that they used to keep in touch with their casual and 
regular partners. Some men felt that notification may not be easy for everyone and 
were willing to be notified either via an anonymous e-card or by the clinic.  
“I’d prefer if they did it either over the phone or in person. But if they felt they 
couldn’t do that and they asked the clinic to do it or asked someone else to do 
it … as long as they tell me.” 
Black British man in mid-twenties living with HIV since 4 years, not on 
cART 
“Well again I’d go back to that same principle, by the normal method I 
communicate with them. So if it’s somebody I see every day, I suppose it would 
not be inappropriate for them to text but I would imagine they would speak to 
me. But if it’s somebody I see quite rarely but text every so often, a text would 
be how I’d expect. Or online messages.” 
White British man in early forties living with HIV since 11 years, on 
cART  
However, some participants were against being notified via an anonymous e-card. 
Some men felt that they would not blame, ostracize, or break-up with a partner 
who notifies them because being notified is important for them. However, there 
was an element of blame in the narrative of a participant who felt that he would 
regret having had sex with such a person. The following narrative reflects men’s 
dislike of being notified via provider referral: 
“No, I hate that idea (provider referral), I really do. It sounds so impersonal 
and if I was told by somebody I didn’t know or by some anonymous machine 
or an anonymous e-mail or text message I would find it, for some reason, I’d 
find it far more scary than being told by somebody I know, and I don’t know. It 
just feels, there’s almost a sense of responsibility, if you have sex with 
somebody there is, for me there’s an assumption that however small, there is 
317 
 
some kind of risk, even if you are as safe as you can possibly be, and you know 
to run away from that responsibility that goes with that is just, it feels 
completely wrong. It’s really bizarre because I almost feel like saying I prefer 
not to know and be contacted by something anonymous but of course that’s not 
the case. It would make me feel impersonal, it would make the whole thing feel 
dirty and more horrible and more sordid.”  
White British man in early forties living with HIV since 11 years, on 
cART 
6.3.9.1 Experience of being notified by sexual partners of STI 
As mentioned previously, eleven men were recently notified by their partners of 
STI. As reflected in the quote below, those with regular partners were notified via 
a phone call. Men with casual partners were notified via an email, a text message 
or an online message. All these participants subsequently screened for and were 
diagnosed with STI; they were grateful for being notified by their partners.  
“RES: I’ve got the text in my bag. The guy who texted me, I think it was the 
day before yesterday, just saying oh I, I just found out I might have LGV you 
might want to go and get yourself checked out. So as soon as I got that I sent a 
similar text to the two guys I played with at the weekend and the guy last week 
which basically said, the guy I had sex with a couple of weeks ago just texted 
me to tell me he might have LGV. I’m going to go to the clinic today you might 
want to go and get yourself checked out. Simple as that.  And you know every 
one of them come back saying thank you very much for coming back to me. 
INT:What was your reaction when you got this text? 
RES: mild irritation but nothing more than that. These things happen. In fact 
that was my response to him, I said thank you very much for telling me, these 
things happen. If we’re going to bare back then you know you’ve got to accept 
sometimes these things will happen.” 
White British man in mid-thirties living with HIV since 12 years, on cART  
Nevertheless, as reflected in the following quote, some men blamed their partner 
for putting them at risk of STI:  
“INT: What was your reaction to getting a call from him? 
RES: I was really, really, well the call fine, the news extremely angry actually. 
He said that I’d have to go and check myself out because he had been tested 
for syphilis and gonorrhoea. I immediately thought, did he know beforehand, 
you know etc. So I was pretty upset with him actually.” 
White British man in mid-forties living with HIV since 2 years, on cART 
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6.4 Discussion of the findings and comparison with other studies 
In this chapter, I explored the attitudes of HIV positive MSM towards partner 
notification for STI and notifying different types of partners of STI, and their 
willingness to use traditional and novel methods of partner notification for STI. I 
also described their experience of recent STI diagnosis and interaction with the 
clinic staff about partner notification for STI, and recent experiences of notifying 
partners of STI or being notified of STI. In this following section, I discuss the key 
findings and compare them with those of other studies. 
Attitudes towards partner notification for STI, willingness to notify sexual 
partners of STI and being notified by sexual partners of STI in the future 
Similar to other studies, the study results show that men valued the health benefits, 
and benefits related to sexual pleasure as a result of notifying partners of STI 
(Gorbach et al., 2000; Coleman and Lohan, 2009). In line with the SHARPN 
survey data presented in chapter 5, the qualitative findings reflect the variation in 
willingness to notify different types of sexual partners of STI. This observed 
variation is due to the nature of relational dynamics with sexual partners which not 
only influences men’s willingness to notify different types of sexual partners of 
STI but also the preferred methods of notification. Partner notification for STI 
symbolises moral and emotional obligation towards partners and mutual respect in 
the context of a primary partner, in partnerships where men mutually agree to 
engage in UAI, and have open non-monogamous partnerships. These findings 
concur with those of another study conducted in the USA (Gorbach et al., 2000). 
The normalisation and destigmatisation of STI diagnosis within open relationships, 
and among men who engage in UAI with seroconcordant partners is a facilitator of 
partner notification for STI.  
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However, consistent with the findings from other studies conducted in the USA, 
this study indicates men’s lack of willingness to notify casual partners of STI 
(Gorbach et al., 2000; Levine et al., 2008). Due to the lack of emotional 
connectedness, and lack of sexual health benefits of notifying casual partners of 
STI, men do not feel the sense of moral or emotional responsibility towards casual 
partners, which is felt towards notifying a primary partner and regular partners of 
STI. In line with the findings of other studies, some men also considered notifying 
partners of STI, especially casual partners and group sex partners, to be a difficult 
task (Gorbach et al., 2000; Coleman and Lohan, 2009) due to the stigma attached 
to STI diagnosis, and fear of being blamed for transmitting STI, particularly HCV; 
and internalized stigma. This is the first study in the UK to show that the fear of 
being criminalized for HIV transmission can be a barrier to notifying partners of 
STI, especially casual partners in circumstances of non-disclosure of HIV status. 
Anonymity of contacts and conferring greater significance to personal 
responsibility for one’s own health can also lead to non-notification for STI. Given 
the high prevalence and the association of multiple new partnerships and UAI with 
new partners in this population with STI diagnosis reported in chapters 3 and 5 
respectively, the observed lack of willingness to notify casual partner of STI has 
implications for onward STI transmission. It is important to encourage men who 
have multiple partners to test regularly for STI and notify casual partners of STI 
and develop effective strategies for achieving this.  
Nevertheless, the majority of men were willing to be notified of STI by their 
sexual partners. Although there was a greater preference to be notified via patient 
referral methods, a substantial proportion of men were willing to be notified via 
provider referral methods as well. Thus, in the context of partner notification for 
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STI, the clinic staff and health promotion campaigns should encourage men to do 
unto others what they want others to do for them. 
Experiences of interaction with clinic staff for partner notification of STI 
Some men were sceptical about meeting a health advisor following their STI 
diagnosis due to preconceived notions that they would be told off for their sexual 
behaviour or would have to wait for a long time. Therefore, clinics should make 
attempts to minimise the waiting time to be seen by a health advisor. Men are 
sceptical about disclosing engagement in group sex to a health advisor or clinic 
staff due to the fear of being told off for their sexual behaviour or fear of being 
judged.  
The findings also highlight the important role of the health advisors in educating 
patients diagnosed with STI about modes of STI transmission, particularly in the 
context of changing epidemiology of some STI like HCV, and charting out a plan 
and time frame for notifying sex partners of STI. Historically, the main route of 
HCV transmission was parenteral (Balogun et al., 2003). However, from 2000 
onwards in the UK and other European countries, USA, Canada and Australia, 
there have been reports of sexual transmission of HCV, particularly among HIV 
positive MSM (Turner et al., 2006; Bottieau et al., 2010, 2010; van de Laar et al., 
2010). Some MSM were not aware that HCV could be transmitted sexually 
confirming the need to promote awareness about these issues among MSM.  
Experience of partner notification following recent STI diagnosis 
Overall, there was concordance between men’s attitudes towards partner 
notification, willingness to notify partners of STI in the future, preferred methods 
of notification of STI reported in chapter 5 and chapter 6 and men’s partner 
notification behaviour following recent STI diagnosis. Following their recent STI 
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diagnosis, the majority of men had notified at least some sexual partners. Men who 
had a primary partner and were in a seroconcordant open partnership had notified 
their primary partner in person. Some men had notified their regular and casual 
partners via remote self-led methods like a text message, a phone call or an online 
message. However, some men had not notified all their sexual partners because 
some of their partners were anonymous. This was the case particularly among men 
diagnosed with STI after participation in a sex party organised via a commercial 
website. Some men had attempted to notify group sex partners via party organisers 
or themselves if they had their contact details. Therefore men who engage in group 
sex should be encouraged to notify partners or in case of anonymous partners, 
contact the party organiser for contact details of other men at the party or ask the 
party organiser to contact other men on their behalf following their STI diagnosis. 
However, this can be a difficult task and there is need for further research on the 
acceptability of these methods among men who engage in group sex and among 
commercial group sex website moderators.  
The majority of men had not experienced severe negative outcomes following 
partner notification for STI. However, some men had been worried prior to 
notification of partners of STI and some were blamed by their partners following 
notification of STI. Men appreciated being notified of STI by their partners. All 
men who had screened for STI following notification by their partners were 
diagnosed with one or more STI. This finding reiterates that partner notification is 
an important tool for STI case finding in this at-risk group and can reduce onward 
STI transmission among MSM. 
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Willingness to use novel methods of partner notification for STI 
Men were sceptical about using anonymous e-cards to notify any types of sex 
partner for STI in the future because they equated it with cowardice and lack of 
taking responsibility for one’s own sexual behaviour. The majority of men were 
also concerned about the authenticity of such e-cards and feared that they would be 
treated as a spam or hoax. However, a few men for whom confidentiality was of 
paramount significance were willing to notify partners, especially serodiscordant 
partners via this method in the future. Although this method is not acceptable to 
the majority of men, it is likely to enhance notification of some partners who may 
be at risk of STI as well as HIV.  
Some men were willing to use methods like the telephone assessment model or 
take a home sampling kit for a primary partner and regular partners for chlamydia 
and gonorrhoea in the future. However, with regards to the telephone assessment 
model, men were concerned about providing the contact details of their primary 
partner to the clinic and the feasibility of contacting a primary partner directly 
from the clinic. Nevertheless, some men welcomed the ease and speed with which 
their primary partner could be treated via this option. An exploratory trial 
conducted in the STI clinics in the UK showed that overall the telephone 
assessment model had higher and faster rates of partner treatment compared to 
routine notification (Estcourt et al., 2012). However, the uptake of HIV and 
syphilis testing among the users of this method was low (Estcourt et al., 2012), 
raising concerns about using this method in this population which has high 
proportion of serodiscordant partners and are at risk of syphilis.  
With regards to home sampling kits for chlamydia and gonorrhoea, some men, 
especially younger men, were willing to take a home sampling kit for their primary 
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partner and regular partners; especially if distance and time was a barrier for STI 
testing for their partners. However, men were concerned about the reliability and 
effectiveness of these remote methods of partner management and lack of 
interaction with the clinic staff. This result concurs with the results from other 
studies conducted among MSM in the UK (Sutcliffe et al., 2009; Wayal et al., 
2011). Studies conducted in the UK and abroad have shown the reliability of using 
self-taken specimens to screen MSM for pharyngeal and rectal chlamydia and 
gonorrhoea (Lampinen et al., 2006; Papp et al., 2007; Alexander et al., 2008) and 
HIV (personal communication with Fisher M., 2011). High acceptability to use a 
home sampling kit to screen for STI among MSM in comparison to a clinic visit 
has also been reported (Wayal et al., 2009). A RCT comparing offering a home 
sampling kit with conventional partner notification for chlamydia to male partners 
of women has shown that a greater proportion of partners of women who were 
given a home sampling kit were examined at a faster rate than partners in the 
conventional arm (Andersen et al., 1998).  
These findings suggest that home sampling kits could be a viable option to 
facilitate timely screening of a primary partner and regular partners of MSM. 
However, there is a need to address the above-mentioned concerns related to self-
sampling for specimens and the accuracy of results of self-taken specimens to 
enhance its acceptability. The acceptability of home sampling for HIV among 
MSM (personal communication with Fisher M., 2011) indicates that this method 
can enable to overcome barriers to HIV testing due to remote partner management 
for STI and accelerated methods of partner notification. 
The observed high level of anonymous new partners in the last year reported in 
chapter 3 indicates that strategies like notification of sexual partners for STI alone 
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may not be effective for STI control in this population. The SHARPN survey 
results have shown that approximately 50% of men expressed willingness to 
advise members of their social network to test for STI. However, the qualitative 
findings suggest that although the majority of men were willing to talk about 
issues related to STI outbreaks with members of their social network, they were 
sceptical about asking them to test for STI due to the need to maintain boundaries 
in their social relationships. They also wanted the clinic to provide them with some 
published literature about the STI outbreak to ensure the members of their social 
network that this information is authentic. The majority of men were willing to be 
notified by the clinic in event of an outbreak of STI. This can be one of the 
mechanisms to improve STI testing among MSM in the event of STI outbreak.  
6.5 Strengths and limitations 
The strengths and limitations of the qualitative study were presented previously in 
section 4.5. The focus of the in-depth interviews was to explore men’s attitudes 
towards partner notification for STI in the future. It is likely that men’s reported 
intentions towards partner notification for STI in the future may not necessarily 
reflect their future behaviour. However, the consistency between the results on 
partner notification of the SHARPN survey and the qualitative study, and between 
future willingness and recent partner notification experiences suggest that these 
data are likely to be a useful guide to partner notification behaviour of these men.  
6.6 Implications for clinical practice, health policy and future 
research 
The findings of this chapter suggest that in theory, partner notification for STI 
(both notifying and being notified) is acceptable to HIV positive MSM. The 
signficance of interaction with the clinic staff following STI diagnosis was also 
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evident. However, in order to improve the uptake of partner notification, there is a 
need to address various perceived and experienced barriers associated with partner 
notification for STI. These include fear of criminalisation for HIV transmission, 
fear of being blamed for STI transmission and fear of being judged by the clinic 
staff. There is also a need to highlight the personal and public health benefits of 
notifying casual partners of STI in the context of high rate of partner change. 
Partner notification methods like sending anonymous e-cards have limited 
acceptability among HIV positive MSM but can enhance notification of at-risk 
partners. There is a need to conduct further research to assess the effectiveness and 
uptake of such methods of partner notification for STI. The development of novel 
methods of remote management of partners for STI should integrate mechanisms 
for enabling remote testing for HIV and syphilis. They also need to address 
concerns related to reliability and accuracy of such methods and concerns about 
the lack of interaction with clinic staff to improve their uptake. One of the ways of 
addressing the latter concern could be offering web-based interaction with the 
clinic staff if needed.  
The next chapter is the last chapter of the thesis. In the last chapter I discuss the 
relevance of the SHARPN findings for clinical practice, policy and research.  
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Chapter 7: Implications of the SHARPN study findings  
7. Introduction 
As mentioned previously in section 1.7, the overall aim of my thesis was to inform 
strategies for HIV/STI prevention among MSM in the UK in the context of 
increasing emphasis on HIV testing and cART for HIV prevention.  
As mentioned in section 1.10, in this thesis I explored the following research 
questions: 
1. What are the implications of the sexual behaviour and sexual partnership 
patterns of HIV positive MSM for HIV transmission, STI transmission and 
acquisition, and partner notification for STI?  
2.How does the socio-cultural context of HIV/STI diagnoses, beliefs about the 
effectiveness of biomedical and behavioural risk reduction strategies for 
preventing HIV transmission influence and interact with sexual partnerships, 
sexual behaviour, and risk management choices among HIV positive MSM? 
3.What are the factors associated with STI diagnosis and willingness to notify 
sexual partners of STI amongst HIV positive MSM?   
4.What are the attitudes of HIV positive MSM towards partner notification for STI, 
and perceived and experienced barriers and facilitators for partner notification of 
STI? 
5.What are their attitudes towards notifying different types of sexual partners of 
STI and being notified of STI via various traditional and novel methods of partner 
notification in the future?  
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In the following section, I will summarise the findings of the SHARPN study. 
7.1 Summary of the findings of SHARPN study 
7.1.1 Sexual partnership patterns and sexual behaviour of 
HIV positive MSM 
The majority of HIV positive MSM in the SHARPN survey were on cART, were 
sexually active, and had multiple AI partners (seroconcordant and/or 
serodiscordant). The prevalence of anonymous new partners was high. Men who 
had non-primary/new partners were less likely to disclose their serostatus to their 
partners or be aware of their partners’ HIV status. The survey findings highlight 
that a high proportion of men had a serodiscordant primary partner, or a 
serodiscordant most recent non-primary partner, or unknown/serodiscordant new 
AI partners. Overall, men who had a serodiscordant primary partner or a most 
recent serodiscordant non-primary partner were less likely to engage in sexual 
behaviours that increase the risk of HIV transmission compared to men who had a 
seroconcordant primary partner or a most recent seroconcordant non-primary 
partner. Nevertheless, a significant minority of men had engaged in UAI and 
fisting with a serodiscordant primary partner or a most recent serodiscordant non-
primary partner. Duration of partnership and recreational drug use during sex were 
independently associated with HIV transmission risk behaviours with a 
serodiscordant primary partner. Age, time since HIV diagnosis, disclosure of HIV 
status was not associated with transmission risk behaviours with a serodiscordant 
primary partner. Recreational drug use and direct disclosure of HIV status were 
independently associated with transmission risk behaviours with a most recent 
serodiscordant non-primary partner. Plasma viral load status was also not 
associated with engagement in UAI with a serodiscordant primary or the most 
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recent serodiscordant non-primary partner suggesting that men engaged in UAI 
with these partners irrespective of their plasma viral load status, which has 
implications for onward HIV transmission. A high proportion of men had engaged 
in UAI and other risky practices like fisting and group sex with a seroconcordant 
primary and a most recent seroconcordant non-primary partner. These findings 
suggest that the sexual behaviour of HIV positive MSM has implications for the 
risk of sustaining STI transmission and acquisition.  
7.1.2 Attitudes towards HIV transmission risk reduction 
strategies and sexual behaviour 
Although a significant minority of HIV positive MSM were optimistic about the 
reduced risk of HIV transmission and re-infection with HIV due to viral 
suppression; the majority of men were concerned about the risk of HIV 
transmission despite having an undetectable viral load. A significant minority of 
men were also optimistic about behavioural risk reduction strategies like strategic 
positioning and withdrawal prior to ejaculation during UAI. However, some men 
had misperceptions about the effectiveness of behavioural HIV transmission risk 
reduction strategies. 
There was an association between positive attitudes towards reduced risk of HIV 
transmission due to undetectable viral load and engagement in UAI/RUAI, and an 
association between attitudes that there is no risk of HIV transmission due to 
unsafe oral sex and practicing insertive unsafe oral sex with a serodiscordant 
primary partner. But no association between attitudes towards various HIV 
transmission risk reduction strategies and engagement in transmission risk 
behaviours with a most recent serodiscordant non-primary partner was observed. 
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 The qualitative findings suggest that some men engage in negotiations based on 
cART and viral load status prior to engagement in UAI and/or engage in URAI or 
withdrawal prior to ejaculation during UAI with serodiscordant partners to reduce 
the risk of HIV transmission. However, the notions of shared responsibility and 
sexual pleasure assume greater significance in the context of non-primary partners. 
These data suggest that the scientific debates about cART for prevention of sexual 
transmission of HIV, and attitudes towards behavioural risk reduction strategies 
for preventing HIV transmission influence sexual behaviour of some HIV positive 
MSM.  
7.1.3 Risk context of HIV/STI diagnosis  
The qualitative data indicates that being confronted with a ‘new sexual identity’ 
following HIV-diagnosis; the fear of stigma, rejection, and discrimination 
influence sexual partnerships and sexual behaviour of HIV and HCV co-infected 
men and serostatus disclosure strategies. Serosorting based on HIV status 
symbolises the agency exercised by HIV positive MSM in response to the ‘felt 
stigma’ and ‘enacted stigma’, especially among men newly diagnosed with HIV, 
and their efforts to prevent onward HIV transmission. Some men not only 
serosorted by partner’s HIV status but also viral load status due to the perceptions 
of reduced risk of re-infection with HIV.  
However, serosorting or ability to use other HIV transmission risk reduction 
strategies is likely to be compromised due to the lack of discussion about 
serostatus with sexual partners or ‘seroassumption’, i.e., assuming the HIV status 
of sexual partners. The qualitative data suggests that seroassumption among these 
men was influenced by the social norms of serostatus disclosure in different types 
of venues of meeting sexual partners including online. However, the survey data 
330 
 
indicates that disclosure of HIV serostatus does not necessarily lead to safer sex 
with a serodiscordant non-primary partner.  
Men were concerned about being co-infected with HCV. Those who were co-
infected with HCV faced or feared isolation due to their co-infected status, as it is 
a barrier to serosorting and engagement in UAI. These data bring to the fore the 
sub-divisions within HIV positive MSM based not only on their viral load status 
but also HCV status, and the stigma and discrimination within HIV positive MSM.  
7.1.4 STI diagnosis and risk factors for STI 
Although a high proportion of sexually active men had tested for STI in the last 
year, one in six men had not. The observed high level of unprotected sexual 
behaviour was reflected in the high burden of STI diagnosis among HIV positive 
MSM. Young age, detectable viral load status, greater number of new AI partners, 
engagement in UAI, engagement in UAI with concurrent partners, having a 
seroconcordant primary partner, greater frequency of engagement in group sex 
were independently associated with the risk of STI diagnosis. The observed high 
prevalence of engagement in group sex, concurrent and multiple new partnerships, 
and its association with STI diagnosis has implications not only for the risk of STI 
acquisition and transmission but also the rapid spread of STI in these sexual 
networks. Time since HIV diagnosis, ethnicity, education status, employment 
status, country of birth, recent CD4 cell count were not associated with STI 
diagnosis in the last year. A significant proportion of men did not believe that 
being co-infected with STI could increase the risk of onward HIV transmission. 
The observed high prevalence of STI among men who had sex with a 
serodiscordant primary and most recent serodiscordant non-primary partner 
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suggests that partner notification among HIV positive MSM provides opportunities 
for STI as well as HIV case finding and timely treatment.  
7.1.5 Attitudes towards partner notification for STI and 
willingness to notify sexual partners and be notified of 
STI in the future  
Both the survey and qualitative study findings suggest that the majority of men 
were willing to notify their primary partner and regular partners of STI compared 
to notifying casual partners. Men acknowledged the personal health benefits of 
partner notification for STI and reported a greater sense of moral and emotional 
responsibility towards notifying primary and regular partners during the qualitative 
interviews. Therefore, patient referral methods were the most preferred methods 
for notifying sexual partners of STI in the future, especially a primary partner and 
regular partners.  
Attitudes like it is not my responsibility to notify sexual partners of STI and 
previous non-notification of sexual partners for STI were independently associated 
with the lack of willingness to notify casual partners of STI in the future. The 
qualitative findings suggest that the lack of emotional connectedness with casual 
partners was a barrier to notify casual partners of STI in the future. Socio-cultural 
and psychological factors like the fear of blame and stigma associated with 
STI/HIV, fear of breach of HIV-related confidentiality, fear of criminalisation for 
HIV transmission and other negative implications of notifying partners of STI like 
break-up were also perceived barriers to notify sexual partners, especially 
casual/group sex partners of STI in the future. Men willing to notify casual 
partners would be willing to do so using remote self-led, provider-led methods or 
via an anonymous e-card method. The majority of men wanted their partners to 
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notify them for STI in the future via patient referral methods. However, greater 
acceptability to be notified via provider referral methods compared to using these 
methods for notifying their partners for STI was observed in both the survey and 
qualitative study. Group sex partner notification via the party organiser or directly 
notifying some group sex partners of STI was reported but perceived to be unlikely 
majority of the time due to anonymity of partners. Overall these data highlight the 
need to enhance regular screening for STI among MSM, especially among men 
who have casual partners and engage in group sex. 
Men’s recent experience of interaction with the clinic staff following STI 
diagnosis highlights their scepticism towards interaction with the clinic staff due to 
the fear of being judged for their sexual behaviour. However, some men felt that 
their interactions with the clinic staff were informative and useful to understand 
the epidemiology of STI transmission, and look-back period and devise strategies 
to notify their partners of STI.  
7.1.6 Attitudes towards using novel methods of partner 
notification for STI in the future 
Both, the survey and qualitative findings suggest that although unacceptable to the 
majority of men, few men would be willing to use anonymous e-card method to 
notify partners of STI in the future, especially casual partners. This method of 
notification may increase notification among men who engage in risky sex with 
serodiscordant partners or unknown HIV status partners, and among men who are 
worried about confidentiality related to HIV.  
Similarly, the findings suggest that some men were willing to take home sampling 
kits, or medication for their primary partner and regular partners after a telephone 
assessment by a health care professional following their diagnosis with 
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chlamydia/gonorrhoea. However, they were concerned about the accuracy of these 
methods and the lack of opportunity to seek advice from a medical expert due to 
remote partner management. Some men were also concerned about the impact of 
using these methods on confidentiality.  
The survey results suggest that a significant proportion of men would be willing to 
be notified by the clinic in event of STI outbreak and refer men from their social 
network to the clinic to reduce the undiagnosed burden of STI. However, the 
qualitative findings highlight the scepticism of HIV positive MSM to directly ask 
men from their social network to test for STI, but they would be willing to mention 
about an STI outbreak to them. They felt the need to have additional information 
from the clinic about an outbreak of STI to support their discussion with their 
peers about this matter. Overall, the findings of the SHARPN study highlight that 
men’s preference for specialised sexual health care and advice can be a barrier for 
novel methods of remote management of partners for STI.  
In the following section, I will examine the overall strengths and limitations of the 
SHARPN study.  
7.2 Overall strengths and limitations of the SHARPN study 
As mentioned previously in chapter 2, mixed methods approach was used in the 
SHARPN study. Mixed methods design was considered appropriate to enable 
comparison, validation, and triangulation of the study results. The survey enabled 
examining the prevalence of variables of interest (i.e. sexual behaviours and 
partnership patterns) and the relationship between variables of interest. Whereas 
face-to-face interviews enabled understanding the meanings men attach to the 
phenomena of interest and the range of experiences and perspectives of HIV 
positive MSM. The survey and in-depth face-to-face interviews were conducted 
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simultaneously. The decision to use a concurrent study design was made for 
pragmatic reasons like time constraints, i.e., to maximize data collection in the 
PhD timeframe. The quantitative and qualitative study results are presented in 
separate chapters; however the discussion of the chapters subsequent to the first 
results chapter based on the survey results compared and contrasted the 
quantitative and qualitative study findings reported in the previous chapters. This 
allowed identification of divergent study findings as well as similarities in the 
phenomena under investigation and provided contextual insights into the observed 
phenomena.  
Overall, the results of the survey and qualitative study complemented each other as 
described in the discussion of results chapters and the summary of the key findings 
presented in this chapter. For example, the survey results suggest that a small 
minority of men believe that having an undetectable viral load reduces the risk of 
HIV transmission and engaged in UAI due to such beliefs. The qualitative study 
findings indicate that these survey findings may be because overall the majority of 
HIV positive MSM were skeptical about the effectiveness of reduced risk of HIV 
transmission due to undetectable viral load. There was also subtle divergence in 
the survey and qualitative study findings. For example, the survey data indicates 
that a significant proportion of men were willing to notify members of their social 
network to test for STI in the event of an STI outbreak. However, the qualitative 
findings suggest that although men were willing to discuss about an outbreak of 
STI with members of their social network they were not comfortable to refer them 
to test for STI. They felt so due to the need to maintain boundaries in their social 
relationships. These insights are important in understanding the feasibility of 
developing peer referral methods for HIV or STI testing in the future. They also 
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highlight the significance of conducting qualitative research prior to developing 
questionnaire for measuring new concepts to understand such subtle differences.  
Given the limited data on partner notification for STI among HIV positive MSM in 
the UK, it would have been ideal to conduct the qualitative study prior to 
conducting the survey. However, as mentioned previously, concurrent design was 
used for data collection. The qualitative study findings highlight the significance 
of factors like self-efficacy, perceived social norms, level of emotional 
connectedness with sexual partners, nature of sexual partnership categorized as 
open/closed influence attitudes towards and preferences for partner notification for 
STI. Therefore, future studies can potentially draw on the results of this study to 
inform development of constructs to examine the attitudes and preferences to 
partner notification for STI in this population.  
During the course of the SHARPN study, several policy and research 
developments occurred in the field of HIV in the UK and globally. Thereby, I will 
provide a brief overview of the relevant HIV/STI prevention, and HIV treatment 
and care policies, and the legal framework for criminalisation for sexual 
transmission of HIV/STI to contextualize the SHARPN findings. 
7.3 Policies and legal framework of relevance to HIV/STI 
prevention in MSM 
In the UK, the current policies for sexual health, and HIV prevention and treatment 
and care have evolved over the last decade and are continually changing with 
developments in the field of research, and changes in government funding 
strategies. In the following sections, I will provide a brief overview of these 
changes.  
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7.3.1 Current policies and programmes for sexual health, 
HIV/STI prevention and HIV treatment  
The Department of Health (DH) in England published the first National Strategy 
for Sexual Health and HIV in 2001 (Department of Health, 2001). Reducing HIV 
transmission and the prevalence of undiagnosed HIV, improving health and social 
care for PLWH, and reducing stigma associated with HIV are some of the key 
aims of this strategy. Improving sexual health was also prioritised in the 2004 
White Paper ‘Choosing Health: making health choices easier’ (Department of 
Health, 2004), which emphasised the need for national campaigns for promoting 
safer sex, especially among young people; modernising sexual health services; and 
national screening for chlamydia. Thus, promoting sexual health and HIV 
prevention is recognised as an important aspect of health care and service 
provision in the UK.  
The DH supports targeted HIV prevention in MSM through the Community HIV 
and AIDS Prevention Strategy (CHAPS), which is co-ordinated by the Terrence 
Higgins Trust (Department of Health, 2002). ‘Making it Count’ is a collaborative 
planning framework developed by CHAPS since 2002 for HIV prevention and 
health promotion in MSM. The key focus of this framework is on ‘benefits-driven 
change’, i.e., emphasising the positive aspects of precaution rather than the 
downside of risk and making such precautionary alternatives available. It draws on 
health promotion and social marketing models for developing interventions in 
MSM for HIV/STI prevention. The DH encourages commissioners and providers 
of sexual health and HIV prevention services to adopt this framework for local 
prevention activity. 
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However, the Health and Social Care Act 2012 which will be implemented from 
April 2013 will change the existing mechanisms of planning and funding of the 
NHS in the UK (Health and Social Care Act, 2012). This Act abolishes the 
Strategic Health Authorities (SHAs) and Primary Care Trusts (PCTs) that are 
currently responsible for development and provision of health services. The PCTs 
were responsible for engaging with their local populations to improve health and 
well-being, commissioning comprehensive services within allocated resources 
across all service sectors and directly providing services where this gives best-
value (National Health Service Reform and Health Care Professions Act, 2002). 
The SHAs provided strategic leadership and were responsible for ensuring that 
local systems operate effectively and deliver improved performance.  The Health 
and Social Care Act 2012 proposes to create a NHS Commissioning Board and 
establish Clinical Commissioning Groups (CCGs), which will commission the 
majority of NHS services. While the responsibility for HIV treatment and care 
commissioning will lie with the NHS Commissioning Board, i.e., nationally 
managed; the Local Authorities, advised by the CCGs, will be responsible for 
provision of other sexual health and STI services, sexual health promotion, and 
HIV prevention and testing services. Public Health England will be responsible for 
improving public health through expert advice, including HIV testing and 
prevention, by working closely with the local authorities. The Public Health 
Outcomes Framework will be used to assess the performance of local authorities; 
for example, late HIV diagnosis is one of the proposed outcomes to assess the 
performance of local authorities. 
However, there are concerns that the proposed changes may lead to fragmentation 
and lack of coordination between HIV treatment and care, STI service provision, 
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and HIV prevention. This may potentially affect the health and social care needs of 
PLWH in the UK. For example, it is not clear, as of now, who will be responsible 
for commissioning services for provision of PEP under this new Act. Appropriate 
measures need to be taken to ensure that HIV prevention needs of PLWH are not 
neglected due to the fragmentation of HIV treatment and prevention service, which 
as reflected by the SHARPN findings are vital for HIV/STI prevention in MSM.  
Ongoing research has played a significant role in the development of cART as well 
as informing policies about when to start cART. In the UK, the guidelines on who 
should be offered cART changed over the period of the SHARPN study. I describe 
these changes in the following section. 
7.3.2 Revised guidelines for offering cART to PLWH 
In early 2012 the British HIV Association (BHIVA) amended the guidelines on 
when to start cART. The revised guidelines suggest that evidence regarding the 
reduced risk of sexual transmission of HIV due to cART should be discussed with 
all patients, and those with a CD4 cell count of >350 cells/mm
3
 willing to start 
cART to reduce the risk of HIV transmission should be offered cART (Williams et 
al., 2012). However, the guidelines emphasize that initiating cART in such 
scenarios should be the patient’s choice, and recommends condom use to protect 
from STI and residual risk, and that patients should be informed that the evidence 
on effectiveness of cART in reducing the risk of HIV transmission relates to 
vaginal and not anal sex (Williams et al., 2012). The BHIVA guidelines also 
recommend that cART can be initiated for primary HIV infection if the person’s 
CD4 cell count is <350 cells/mm
3
 or they have any AIDS-defining illness.  
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7.3.3 Criminalisation of HIV/STI transmission  
In England and Wales, in the past persons have been convicted for HIV/STI 
transmission under the Offences against the Person Act 1861 (Offences against the 
Persons Act, 1861). This Act has been used for convictions for ‘intentional’ or 
‘reckless’ transmission of HIV/STI as these infections are considered to cause 
‘grievous bodily harm’ to the infected persons.  However this Act was originally 
not designed to deal with HIV transmission and the number of prosecutions due to 
this Act caused controversy.  In March 2008 the Crown Prosecution Service (CPS) 
published a policy statement which clarifies that charges of reckless or intentional 
transmission of HIV/STI can be made if the person knows that they have HIV/STI, 
understands how these infections are transmitted, knows that the partner is HIV 
negative and engaged in unprotected sex, and HIV/STI transmission occurs 
(Crown Prosecution Service, 2008). CPS has also clarified that prosecutions are 
unlikely to take place as a result of one-off sexual encounters due to the challenges 
of proving recklessness in such situations, and scientific evidence must be used to 
show that the defendant actually infected the complainant.  A person cannot be 
convicted under the Offences against the Person Act 1861 for HIV/STI 
transmission if the person had engaged in unprotected sex with informed consent 
of the complainant to the risk of HIV/STI infection, if disclosure of serostatus had 
occurred, or if condoms were used consistently. Since 2003, the majority of 
convictions in the UK have been for reckless transmission as opposed to 
intentional transmission, and for HIV transmission (National Aids Trust, 2011). 
The public debates surrounding these convictions and the CPS statement have 
given rise to concerns about criminalisation among PLWH. At the time of writing 
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this thesis, there is an ongoing debate about how clinicans could support patients 
in the current policy climate.  
In the following section, I discuss the relevant SHARPN findings and implications 
for HIV/STI prevention in MSM.  
7.4 SHARPN findings: implications for policy, clinical practice 
and research 
Subsequent to the publication of the Swiss Statement in 2008, the SHARPN study 
is the first study to re-examine the association between cART and sexual 
behaviour in the UK. It is also the first study conducted in the UK to provide 
insights into the attitudes, barriers and preferences of HIV positive MSM towards 
partner notification of STI. The findings re-confirm that being on cART with an 
undetectable viral load is not associated with risky sexual behaviour among HIV 
positive MSM. On the contrary, the observed lack of association between viral 
load status and engagement in HIV transmission risk behaviours, and the high 
prevalence of serodiscordant partnerships lend support to the revised BHIVA 
guidelines of offering cART for HIV prevention irrespective of CD4 cell count to 
reduce the risk of HIV transmission in this population. The findings suggest that 
STI testing and partner notification should be offered during routine clinic visits to 
sexually active men to reduce the risk of infectivity due to co-infection and re-
infection with STI, and transmission risk behaviours. HIV/STI prevention 
interventions in this population cannot ignore the wider socio-cultural 
determinants of health like stigma, fear of criminalisation and rejection. The 
SHARPN findings highlight the urgent need to conduct research studies to develop, 
and assess the feasibility, acceptability, effectiveness and cost effectiveness of 
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brief interventions offered to PLWH during routine clinic visits to reduce STI, 
transmission risk behaviours, and provide psychological and adherence support. In 
the following section, I discuss the relevant SHARPN findings and how they 
support the proposed combination prevention strategies specified in Box 1. 
7.4.1 Recommendations for clinical practice and policy  
7.4.1.1 cART for prevention of sexual transmission of HIV  
The observed lack of association between plasma viral load status and engagement 
in HIV transmission risk behaviours signifies that men engaged in these 
behaviours irrespective of their plasma viral load status. This is a concern because 
plasma viral load status is a vital factor in onward sexual HIV transmission. This is 
especially important because there has been an increase in new HIV diagnoses in 
MSM in the UK in 2011 despite almost 80% of the HIV positive persons being on 
cART (as per previous guidelines they would have started cART when their CD4 
cell count was less than or equal to 350 cells/mm
3
) and had an undetectable viral 
load (Health Protection Agency, 2011a). Undiagnosed HIV infections may partly 
explain this observed increase in new HIV diagnosis among MSM. However, the 
role of untreated diagnosed HIV infections among HIV positive MSM who also 
have a high burden of co-infection with other STI remains unclear but an 
important parameter in HIV transmission dynamics. Therefore, the revised 2012 
BHIVA guidelines that recommend offering cART to patients with a CD4 cell 
count of >350 cells/mm
3
 willing to start cART to reduce the risk of HIV 
transmission (Williams et al., 2012) is a significant step in enhancing the public 
health benefits of cART for prevention of sexual transmission of HIV. However, 
adherence to cART of PLWH who start cART for prevention of sexual 
transmission of HIV should be monitored regularly. 
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Some MSM use cART and viral load status to guide their decisions about 
engagement in HIV transmission risk behaviours. Knowledge of viral load status 
depends on monitoring via regular blood testing.  In the UK, those on cART are 
usually tested for viral load once every six months. Therefore, it is likely that 
changes in viral load status due to treatment failure, co-infection with STI, or other 
health related problems might go unnoticed. This can have implications for 
onward HIV transmission. Thus, HIV positive MSM who decide to start cART to 
reduce the risk of HIV transmission may need to be tested more frequently for 
viral load, and screened regularly for STI. MSM should also be informed about the 
availability of PEP for HIV prevention and the need to start PEP within 78 hours 
(Benn et al., 2011). 
The observed association between attitudes towards effectiveness of undetectable 
viral load in preventing HIV transmission and engagement in HIV transmission 
risk behaviours with a serodiscordant primary partner demonstrates the 
behavioural challenges associated with promoting cART for HIV prevention. The 
revised UK safer sex guidelines stipulate that effective cART and undetectable 
viral load significantly reduces the risk of HIV transmission and advice using 
condoms to further minimise the risk of HIV transmission (Clutterbuck et al., 
2012). 
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Box 1. Combination HIV/STI prevention strategies among MSM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, it is vital that HIV prevention messages about safer sex targeting MSM 
should also emphasize the limited effectiveness of cART for prevention of sexual 
transmission of HIV due to co-infection with STI, and promote awareness that 
being on cART with an undetectable viral load does not protect against STI and 
the existing evidence on the effectiveness of cART for HIV prevention relates to 
predominantly heterosexual population.  
 Offer cART for HIV prevention to sexually active men, especially men in 
serodiscordant partnerships with a CD4 cell count >350 cells/mm
3
 and monitor 
adherence to cART 
 Promote awareness about the partial effectiveness of cART for HIV 
prevention and other behavioural risk reduction strategies 
 Promote HIV testing among sexually active serodiscordant partners  
 Increase frequency of STI testing among sexually active men 
 Improve sexual history taking parameters to enhance sexual risk assessment 
and effectiveness of partner notification for STI 
 Offer choices of partner notification strategies for STI 
 Spread awareness about sexual transmission of HCV and risk factors 
associated with HCV transmission 
 Address internalised stigma and stigma towards HIV and HCV among HIV 
positive MSM 
 Address social norms of serostatus disclosure 
 Improve awareness of the legal framework for criminalisation for HIV/STI 
transmission 
 Conduct periodic surveillance of sexual behaviour and partnership patterns 
of MSM 
 Develop and evaluate interventions to promote safer sex, improve HIV 
testing among serodiscordant couples, and frequency of STI testing and 
partner notification 
 Model the impact of STI partner notification on STI transmission dynamics 
among MSM 
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7.4.1.2 Promote awareness about partial effectiveness of behavioural risk 
reduction strategies for prevention of sexual transmission of HIV 
Beliefs about behavioural HIV transmission risk reduction strategies such as 
withdrawal prior to ejaculation during UAI or strategic positioning were also 
associated with UAI with a serodiscordant primary partner. However, there was no 
association between such beliefs and UAI with a most recent serodiscordant non-
primary partner. Factors associated with risky sexual behaviour with a 
serodiscordant primary partner are different from those with a serodiscordant non-
primary partner. Nevertheless, HIV prevention campaigns among MSM should 
address the partial effectiveness of behavioural risk reduction strategies for 
prevention of sexual HIV transmission (Jin et al., 2009) and lack of effectiveness 
of these strategies against the risk of STI.  
7.4.1.3   Promote regular HIV testing of serodiscordant partners  
Awareness of sexual partners’ HIV status is vital for prevention of HIV 
transmission/acquisition. As described in section 3.4, although the majority of HIV 
positive MSM in a serodiscordant primary partnership had disclosed their HIV 
status to their primary partner, some men had not. A significant proportion of men 
had an unknown status primary partner. Therefore, primary partners of HIV 
positive MSM who are unaware of their HIV status should be encouraged to test 
for HIV, and serodiscordant partners who engage in UAI with their partner should 
be encouraged to test for HIV regularly.  
7.4.1.4 Increase frequency of STI testing  
The observed high STI prevalence among HIV positive MSM is a challenge to the 
effectiveness of cART for prevention of sexual transmission of HIV. The recent 
Health Select Committee on HIV/AIDS has emphasised the significance of STI 
control for HIV prevention (House of Lords: Select Committee on HIV and AIDS 
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in the United Kingdom, 2011). Currently, national guidelines recommend an 
annual full sexual health screen for PLWH regardless of their sexual history 
(Fakoya et al., 2008). However, given the observed risk factors associated with 
STI diagnosis among HIV positive MSM, i.e., multiple new partners, engagement 
in group sex, engagement in UAI with serodiscordant partners and concurrent 
partners, developing interventions that not only enhance STI testing but also the 
frequency of STI testing are vital for timely STI diagnosis and treatment, and 
partner notification.  
A review of studies conducted between 1990-2011 among MSM has shown that 
syphilis serology included with blood tests performed as part of HIV monitoring is 
effective for syphilis retesting in MSM and detection of asymptomatic syphilis 
(Zou et al., 2012). This review also reported that other clinic-based interventions 
like use of a computer alert on an electronic medical record, recall for retesting 
post STI diagnosis, introduction of clinic guidelines on STI screening are effective 
in increasing screening rates for chlamydia and gonorrhoea. These data suggest 
that integrating STI testing with existing routine monitoring of PLWH, and using 
novel technologies may enhance STI testing in HIV positive MSM.  
7.4.1.5 Improve sexual history taking for sexual risk assessment and partner 
notification 
Sexual history taking from patients attending sexual health clinics for STI 
screening is an integral part of sexual risk assessment and essential to identify the 
anatomical sites that should be screened for STI. This data is also important to 
inform partner notification in the event of STI diagnosis and has implications for 
HIV/STI case finding. Engagement in group sex was one of the risk factors for STI 
diagnosis among HIV positive MSM. A high prevalence of serodiscordant 
partnerships was also observed among these men. The current national guidelines 
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for sexual history taking suggest that all individuals being assessed for risk of STI 
should be asked about the gender of their partners, type of sexual contact (anal, 
oral etc.), condom/barriers use, relationship with the partner (live-in, regular, 
casual partner), duration of relationship and ability to contact the partner, time 
interval since the last sexual contact, and symptoms in the partner including known 
or suspected STI, and if applicable, any risk of sexual infection presented by the 
partner (Brook, G et al., 2012). These guidelines do not propose collecting data on 
the HIV status of sexual partners or whether the sexual encounter with the partner 
was in the context of one-to-one sex or group sex. However, this information is 
vital to assess the feasibility of offering PEP to serodiscordant/unknown HIV 
status sexual partners and implications of partner notification for STI on HIV/STI 
transmission dynamics.  
Collection of these data is not recommended in the guidelines probably due to 
issues related to sensitivity of the nature of these questions, and concerns about 
confidentiality and its implications for the risk of criminalisation for HIV 
transmission. The SHARPN findings confirm that HIV positive MSM were 
reluctant to disclose engagement in group sex to a health care professional. 
Currently, data on sexual behaviour is collected by the STI clinics either using a 
self-administered pen and paper proforma which is completed by the patients or by 
the clinic staff offering STI screen using a computer assisted interview or pen and 
paper. Using confidential methods like CASI to collect sexual behaviour history 
may encourage reporting of such sensitive sexual behaviours and facilitate 
effective partner notification for STI. A RCT conducted in the UK has shown that 
CASI or computer-assisted personal interview encourages greater disclosure of 
sensitive information compared to traditional method. However it also highlighted 
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the need to ensure that the clinic staff acts upon disclosures made during self-
interview (Richens et al., 2010). An Australian study reported that using CASI 
approach is acceptable to patients as well as the clinic staff in a sexual health 
setting and does not increase the time of consultation (Vodstrcil et al., 2011). With 
increasing emphasis on using electronic patient records, electronic methods of data 
collection for sexual history should be used to enhance reporting of sensitive 
sexual behaviours.  
In the UK, the National Audit Group conducts audit of clinical practice in sexual 
health clinics against the British Association of Sexual Health and HIV (BASHH) 
Clinical Effectiveness Group National Guidelines (McClean et al., 2012). 
Currently, the process outcome measures for partner notification for STI are the 
percentage of index cases documented as offered at least one discussion for partner 
notification with a health care worker, percentage of index cases having the 
outcome of an agreed contact action or decision not to contact documented for all 
contacts, the number of contacts whose attendance for STI care is documented, and 
the number of all contacts whose attendance at a sexual health service is 
documented as verified by health care worker within the four weeks of the date of 
first partner notification discussion. Given the multiplicity of new partnerships, 
concurrent partnerships, engagement in group sex observed among HIV positive 
MSM, notifying different types of sexual partners is likely to have varying degrees 
of impact on STI transmission dynamics. For example, notifying a primary partner 
and new partners of a HIV positive person diagnosed with STI will have different 
implications for preventing onward STI transmission and re-infection rates 
compared to notifying only the primary partner of a person who has concurrent 
partners. Therefore, the documentation of the nature of sexual partnership with 
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contacts and the type of contacts with successful verification of attendance at a 
sexual health service should also be included as auditable measures to understand 
the effectiveness of partner notification in this population. 
7.4.1.6 Offering choices of partner notification strategies for STI 
Given the nature of sexual partnerships and behaviours observed among HIV 
positive MSM, partner notification strategies among MSM should be tailored 
according to the nature of sexual activity (not only anal or oral etc. but also 
whether it was one-to-one sex or in a group setting). The association between 
attitudes like ‘it is not my responsibility to notify sexual partners for STI’ and the 
lack of willingness to notify casual partners of STI indicates that health promotion 
campaigns should emphasise the relevance of notifying all sex partners to prevent 
STI transmission and risk of re-infection. Given the strong preference to be 
notified by sexual partners for STI, ‘Do unto others as you would have others do 
unto you” should be evaluated as a health promotion message to promote partner 
notification. As mentioned previously, the stigma associated with STI/HIV, 
especially with HCV cannot be ignored in efforts to improve uptake of partner 
notification and its effectiveness. Therefore a wide range of notification methods 
including provider referral should be offered to override some of these personal, 
partnership, and structural barriers to partner notification. 
7.4.1.7 Spread awareness about sexual transmission of HCV  
HIV positive MSM were concerned about being infected with HCV. Some men 
were unaware that engagement in fisting is one of the risk factors for HCV. 
Although the mechanisms of how HCV is transmitted sexually are not fully 
understood, there is a need to promote safer sex education, and advice use of 
gloves, and use of water based lubricant among men who engage in fisting 
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(National Institute for Health and Clinical Excellence, 2007) via clinic-based as 
well as community based interventions. The risk of reinfection with HCV also 
needs to be emphasized. 
7.4.1.8  Address internalised stigma and stigma towards HIV and HCV 
within MSM community 
The SHARPN qualitative findings confirmed that stigma continues to be a 
significant barrier to disclosure of serostatus and partner notification for STI. 
There have been a variety of policy initiatives aimed at reducing HIV/STI related 
stigma. Reducing stigma associated with HIV/STI is one of the key aims of the 
2001 National Strategy for Sexual Health and HIV (Department of Health, 2001). 
CHAPS implements programmes to reduce stigma related to HIV. The focus of 
these programmes has been on normalisation of HIV by disseminating information 
about HIV, training of health care staff about stigma reduction, empowering 
PLWH via outreach programmes to challenge stigma through skill based 
programmes and counselling, and greater involvement of PLWH in health 
promotion and commissioning of services. Print media is used to raise awareness 
about the 2005 Disability Discrimination Act (DDA). According to the DDA 2005, 
definition of disability includes PLWH from the point of diagnosis and it is illegal 
to discriminate against PLWH in employment, education, and provision of 
services (Department of Health, 2007). The latest Health Select Committee on 
HIV/AIDS has suggested that HIV awareness should be incorporated in national 
sexual health campaigns to promote public health and prevent stigmatisation of 
PLWH (House of Lords: Select Committee on HIV and AIDS in the United 
Kingdom, 2011). However, the SHARPN findings revealed that internalised 
stigma, and stigma within HIV positive MSM community is also a powerful 
barrier to disclosure of HCV status, and to notify partners of HCV diagnosis. 
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Therefore policies and programmes addressing HIV related stigma should also 
address stigma within HIV positive MSM community towards those co-infected 
with HCV and internalised stigma.  
7.4.1.9 Address social norms of serostatus disclosure  
The observed high prevalence of unknown status sexual partners and assumptions 
about the sexual partners’ serostatus especially casual/anonymous partners’ is a 
concern from HIV transmission perspective. HIV negative MSM who engage in 
UAI, especially with unknown HIV status and/or anonymous contacts should be 
encouraged to screen regularly for HIV. Health promotion campaigns among 
MSM should continue to address social norms of serostatus disclosure in different 
venues for meeting sexual partner, especially the internet, saunas and sex clubs, 
and its impact on HIV and STI transmission, and STI acquisition. 
7.4.1.10 Improve awareness of the legal framework relating to HIV/STI 
transmission 
The lack of awareness and confusion about the legal framework relating to 
HIV/STI transmission observed in the SHARPN qualitative interviews are barriers 
to serostatus disclosure and partner notification for STI. Health promotion 
campaigns among PLWH should promote awareness about the revised CPS 
guidelines and mechanisms to protect oneself against the fear of conviction for 
HIV/STI transmission, i.e., by using condoms, disclosure of HIV status prior to 
sexual intercourse etc. As expressed by some participants, the law needs to be 
revisited in the light of the revised BHIVA guidelines that recommend offering 
cART to PLWH who want to prevent onward HIV transmission. Legal 
implications of subsequent HIV transmission in such situations need to be 
delineated and made clear to PLWH and clinicians alike.   
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7.4.2 Recommendations for research 
In the following section I will discuss the relevance of SHARPN findings for 
further research. 
7.4.2.1 Periodic behavioural surveillance of sexual partnership patterns and 
sexual behaviour  
As reported in chapter 3, overall UAI with sexual partners, and UAI with a 
serodiscordant primary partner observed in the SHARPN survey has increased 
compared to the SHARP survey. Similarly, the prevalence of optimism about the 
reduced risk of HIV transmission during UAI due to viral suppression has 
increased since the SHARP survey. However it is important to examine whether 
these observed changes in sexual behaviour and attitudes of HIV positive MSM 
are real or chance findings. This will be explored in a comparative analysis of the 
SHARP and SHARPN survey data, which as mentioned in chapter 2, is not within 
the scope of this thesis, but a wider aim of the SHARPN project.  
Nevertheless, given the substantial risk of STI and high prevalence of unsafe 
sexual behaviour in this population, periodic assessment of changes in sexual 
partnership patterns, sexual behaviour and attitudes of MSM is crucial to 
understand its implications for developing HIV/STI prevention strategies. As 
mentioned previously in chapter 3, data on epidemiological, socio-demographic 
profile and prevalence of PLWH in England, Wales and Northern Ireland is 
currently collected bi-annually in London and annually outside London through 
the SOPHID cross-sectional survey of all individuals with diagnosed HIV 
infection who attend the NHS for HIV-related care. For each survey, providers of 
HIV care collate a list of all individuals who have attended for HIV-related care 
and provide anonymised epidemiological (cART status, viral load status, CD4 cell 
count) and demographic data (age, sex, ethnicity, post code etc.) on each patient to 
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the HPA. However, currently no data on sexual behaviour or partnership patterns 
is collected as part of this survey. At the time of writing this thesis a project 
conducted by UCL in collaboration with HPA was underway to examine the 
feasibility of using SOPHID as a sampling frame to roll-out a longitudinal 
behavioural and healthcare needs survey in a random sample of PLWH. It aims to 
examine their sexual and other health-related risks, prevalence of chronic diseases 
and patterns of accessing care. These data will enable assessment of trends in 
sexual behaviour of PLWH, and inform the development of sexual behaviour and 
other health related interventions for PLWH. However, it is important to ensure 
the anonymity of PLWH who participate in such surveys due to the sensitive 
nature of these data and potential risk of criminalisation for HIV transmission. 
7.4.2.2  Interventions to promote safer sex 
The recent Health Select Committee on HIV/AIDS acknowledges the significance 
of behavioural risk reduction interventions to prevent HIV in the UK (House of 
Lords: Select Committee on HIV and AIDS in the United Kingdom, 2011). 
Reducing rates of UAI without disclosing HIV status to sexual partners or 
knowing partners’ HIV status is one of the strategic programme goals of the 
CHAPS 2011 Making it Count framework to reduce HIV incidence in MSM in 
England (CHAPS Partnership, 2011). In this study, paradoxically direct disclosure 
of HIV status was independently associated with UAI with a most recent 
serodiscordant non-primary partner, irrespective of cART/viral load status. As 
described in section 3.4, this finding is in line with findings from other studies 
conducted in the USA and Australia. This signifies the complex relationship 
between disclosure of serostatus and sexual behaviour, and challenges for 
developing appropriate interventions to enhance disclosure.  
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The CHAPS framework for HIV prevention in MSM uses a benefits-driven 
approach to reduce risky behaviours (CHAPS Partnership, 2011). This is 
contradictory to the data available from a RCT conducted in the USA among 
predominantly HIV positive MSM in a clinical care setting which showed the 
effectiveness of using a loss-framed approach (focusing on negative consequences 
of unsafe sex) compared to gain-framed approach (focusing on positive 
consequences of safe sex) in reducing HIV transmission risk behaviours 
(Richardson et al., 2004). As described in chapter 1, studies conducted in the USA 
have shown that interventions using cognitive behavioural therapy or motivational 
interviewing over several sessions are effective in promoting safer sex. However, 
there has been no research conducted in the UK to examine the effectiveness of 
such interventions for risk reduction. Thus, there is a need to conduct research to 
develop, and examine the feasibility, acceptability of integrating risk reduction 
interventions with routine care and assess their effectiveness.  
7.4.2.3 Interventions to improve HIV testing among serodiscordant partner 
The BHIVA 2011 guidelines for routine monitoring of PLWH, and management 
of sexual and reproductive health of PLWH propose that a full sexual health screen 
should be offered to all PLWH following HIV diagnosis and at least annually 
thereafter (Fakoya et al., 2008; Asboe et al., 2012). The annual sexual health 
screen provides an opportunity to invite the primary serodiscordant partner of an 
HIV positive person for a sexual health screen. Novel methods like offering a 
home sampling kit for saliva collection to a serodiscordant primary partner and 
returning specimens by post can also be used to facilitate HIV testing. However, 
the acceptability and feasibility of using these methods for improving HIV testing 
among serodiscordant couples should be piloted.  
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7.4.2.4 Interventions to improve frequency of STI testing 
Recall of predominantly HIV negative MSM in London for STI testing after three 
months of being diagnosed with bacterial STI using a telephone reminder was 
shown to be feasible and led to STI and HIV case-finding (Harte et al., 2011). In 
Australia, sending a SMS reminder to high-risk MSM was also a successful recall 
strategy for STI/HIV testing (Bourne et al., 2011). Existing data from the USA of 
various recall strategies for gonorrhoea and chlamydia screening at three months 
showed that the telephone recall method was the least costly method in terms of 
cost per new infection treated compared to counselling with a brief 
recommendation to return followed by a telephone reminder after 3 months; a brief 
recommendation to return with no reminder; and a $20 incentive received on 
return (Gift et al., 2005). However, these studies have been conducted 
predominantly among HIV negative MSM.  
Given the high prevalence of STI among HIV positive MSM, there is a need for 
further research to examine the effectiveness of recall strategies for STI testing 
among HIV positive MSM who have multiple and concurrent sexual partners, 
engage in UAI, and group sex. Similarly, no research studies have been conducted 
in the UK to examine the effectiveness and cost-effectiveness of using electronic 
medical record alerts or linking routine blood monitoring with STI testing among 
HIV positive MSM. Research should be conducted to examine the effectiveness 
and cost-effectiveness of such strategies to improve STI testing and retesting 
among HIV positive MSM. 
7.4.2.5 Anonymity of sexual partners and partner notification for STI 
Individual level partner notification methods are likely to have limited impact on 
STI control among HIV positive MSM due to the observed high prevalence of 
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anonymous sexual partnerships. Development of novel methods like internet-based 
partner notification via dating websites, and increasing testing and retesting for 
STI via methods described in section 7.4.1.4 is vital to curb the prevalence of STI 
in this population. There was some evidence of the acceptability of referring 
members of social network among men in the SHARPN study. In the USA, 
offering HIV counselling and testing via HIV positive MSM as peers; offering 
MSM peer recruiters financial incentives to refer their peers for HIV, STI and viral 
hepatitis testing; and offering financial incentives to the recruits who test for 
STI/HIV have all been shown to be effective strategies to identify new HIV cases 
and the latter was also a cost-effective strategy (Jordan et al., 1998; Golden et al., 
2006). However, no studies have been conducted in the UK to explore the 
acceptability and feasibility of such approaches. Men were also willing to be 
notified by the clinic in the event of an outbreak of STI like LGV. This can be one 
of the methods to recall MSM to test for STI but again currently, there is no 
evidence on the uptake of STI testing among MSM as a result of recall for STI 
testing in the context of an STI outbreak and this warrants further research.   
7.4.2.6 Further research on partner notification for STI in MSM 
Developing interventions to improve partner notification for STI/HIV in clinical 
and community settings was one of the research priorities of the 2001 National 
Strategy for Sexual Health and HIV (Department of Health, 2001). However, as 
reported in the systematic review of studies on partner notification for STI in 
section 1.9.3.1 and appendix 1, there are very few studies examining partner 
notification for STI in MSM and no studies have been conducted on partner 
notification for STI among HIV positive MSM/PLWH (Low et al., 2012). 
Therefore, there is a need to conduct further research among PLWH on partner 
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notification for STI. However, studies conducted to evaluate partner notification 
for STI in MSM should be designed to address the following challenges.  
The results of the SHARPN study have shown that men would prefer to use 
different methods of partner notification for STI for different types of sex partners. 
For example, they would be more willing to notify primary partner of STI via 
patient referral methods and use remote self-led methods or provider-led methods 
to notify casual partners. This was also observed in an exploratory non-randomised 
comparative study conducted in the UK where index patients, who were 
predominantly heterosexual, expressed strong preferences for particular methods 
of notification for STI for different types of sexual partners (Estcourt et al., 2011). 
Another major challenge in evaluating the effectiveness of partner notification 
strategies reported by Estcourt and colleagues is that the sexual partners might 
decide to achieve treatment via some other method. Recently a study was 
conducted in the USA among MSM to assess the efficacy of PDPT and a web-
based partner notification service for improving partner treatment and notification 
compared to standard partner management (Kerani et al., 2011). This study 
showed that conducting partner notification RCTs among MSM might not be 
feasible due to difficulty in enrolling MSM in the trial. However, the authors felt 
that this may be because the enrolment was done via telephone. This trial also 
showed that men had strong preferences for partner notification methods and were 
unwilling to use web-based partner notification method. Another challenge in 
assessing the effectiveness of partner notification strategies is the variation in the 
primary and secondary outcomes measured in the trials, which makes it difficult to 
compare the results of the trials (Trelle et al., 2007). This review by Trelle and 
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colleagues also highlights that very few trials have examined the impact of partner 
notification methods on reducing transmission of STI.  
These data indicate that prior to proceeding to an RCT, it is important to conduct 
formative research to assess the feasibility and acceptability of the interventions 
that have been developed. The MRC framework for development and evaluation 
of complex interventions provides a useful iterative pathway for developing and 
evaluating interventions (Craig et al., 2008). The study conducted by Estcourt and 
colleagues shows the feasibility of using this framework for developing partner 
notification intervention (Estcourt et al., 2012). Given the limited evidence on the 
acceptability and feasibility of various methods of partner notification of STI in 
MSM, there is a need to conduct non-randomised controlled studies in this 
population prior to conducting definitive RCTs. Moreover, due to the above-
mentioned challenges and achieving enrolment at an individual level, the 
feasibility of using other study designs like cluster RCTs should be explored. 
There may also be a need to define outcome measures based on the type of sexual 
partnership and consider its impact on estimating the required sample size.  
7.4.2.7 Modelling the impact of partner notification for STI among MSM 
A study estimating the impact of partner notification for chlamydia on the 
prevention of secondary infections among heterosexual populations in the UK has 
shown that partner notification of casual partners rather than regular/live-in partner 
is likely to prevent more secondary transmissions per partnership (Mercer et al., 
2011). Several participants in the SHARPN survey had multiple new casual 
partners. Thus, the observed lack of willingness among HIV positive MSM to 
notify casual partners can have negative implications for the prevention of 
secondary STI transmission. Moreover, as reported in chapter 3, a substantial 
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proportion of MSM who had a primary partner also had concurrent partners, and a 
substantial proportion of men perceived that their primary partner has concurrent 
sexual partners. Thus, treating a primary partner of HIV positive MSM may have 
greater public health impact in preventing secondary STI transmissions compared 
to the heterosexual population, and in reducing STI re-infection rates among these 
men. However, it is important to bear in mind that Mercer and colleagues have 
estimated the impact of partner notification in heterosexual population. There is a 
need to estimate the impact of partner notification for different STI on prevention 
of secondary infections in MSM.  
7.5 Conclusions 
The SHARPN findings reiterate the significance of HIV/STI prevention among 
HIV positive MSM. They support the current debate that cART should be offered 
to sexually active HIV positive MSM, especially those in serodiscordant 
partnerships, irrespective of CD4 cell count to minimize the risk of onward HIV 
transmission in this population. Frequent STI testing of sexually active men, and 
interventions to support and maintain adherence to cART should be offered as part 
of routine HIV care to ensure effectiveness of cART for HIV prevention. Various 
partner notification choices should be offered to those diagnosed with STI. 
Interventions to reduce stigma associated with homosexuality and HIV continue to 
remain vital in this population. In the UK, research examining the feasibility, 
acceptability, effectiveness, and cost effectiveness of integrating brief behavioural 
interventions to enhance regular STI testing, adherence to cART, address 
recreational drug use and mental health needs, and promote safer sex with routine 
HIV care among PLWH is urgently needed. 
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Appendices 
Appendix 1: Systematic review of qualitative literature on 
partner notification 
Introduction 
In this appendix, I report the findings of a systematic review of qualitative 
literature on the attitudes, experiences, and preferences regarding partner 
notification for STI and HIV among adolescents, and adult men and women. I 
briefly describe the history of partner notification followed by an overview of the 
existing systematic reviews on partner notification. Then I describe the aims of this 
review, methodology used and findings. 
History of partner notification 
It was introduced in the mid-nineteenth century Europe and early 20th century 
USA in response to the syphilis epidemic (Gostin and Hodge, 1998). The earliest 
references to partner notification were made in Europe in the contagious disease 
laws in the mid-nineteenth century (Adler, 1980) and the 1930s in the USA 
(Parran, 1937). In the UK, the Contagious Disease Acts of 1864 and 1866 were 
passed in response to the increasing incidence of STI, particularly syphilis, 
amongst the military that led to the establishment of open-access STI clinics 
(Cowan et al., 1996). Unlike Sweden and Norway where partner notification is 
mandatory, in the UK partner notification is voluntary (Arthur et al., 2005).  
Since its origin, partner notification has generated debate about the right to 
confidentiality of the infected person (i.e., the index case) and the right of the 
infected person’s partners (i.e., the contact) to be informed about the risk of 
STI/HIV. The recognition of syphilis as a STI, and the availability of diagnostic 
400 
 
tests and treatments shifted the focus from the right to privacy of the index patient 
to the contact’s right to be informed about exposure to STI (Gostin and Hodge, 
1998). However, with the emergence of HIV in the early 1980’s and the criticism 
of HIV partner notification by the gay and civil rights groups, in the absence of 
HIV treatment, the index patients’ privacy was emphasised (Bayer and Toomey, 
1992) re-problematising partner notification.  
Currently, partner notification is most commonly practiced in European countries 
and the USA for gonorrhoea, chlamydia, syphilis, and HIV (Low et al., 2012). 
Partner notification usually takes the form of patient referral or provider referral. 
Some countries encourage index patients to inform their contacts, with or without 
the assistance of a health care provider (i.e., voluntary partner notification), for 
example the UK. Other countries oblige the health care providers to inform the 
contacts with or without the index patients’ consent (i.e., compulsory partner 
notification), for example Sweden. The majority of European Union (EU) 
countries carry out partner notification within specialist STI clinics with a focus on 
bacterial STI (Arthur et al., 2005).  
Evidence on effectiveness of partner notification  
A key question with regards to partner notification is whether it is effective in 
reducing onward STI/HIV transmission. A review of the empirical evidence of 
case finding effectiveness partner notification for syphilis, gonorrhoea and 
chlamydia in the USA showed that a new case of these STI was found every 4-5 
cases interviewed and for HIV partner notification a new case was found every 2-3 
cases (Brewer, 2005). It also highlighted that provider referral is effective and 
plays a central role in case finding, and cluster investigations can play a vital role 
in case finding in settings with high disease incidence. Another review of studies 
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conducted in the USA also reported that partner notification can lead to case 
finding (gonorrhoea, chlamydia, HIV, syphilis) while provider referral results in 
more partners being notified and evaluated compared to patient-referral (Macke 
and Maher, 1999).  
A review of RCTs has shown that in patients with HIV or any STI, provider 
referral alone or a choice between patient and provider referral increases the rate of 
partners presenting for medical evaluation when compared with patient referral 
alone (Mathews et al., 2002). It also showed that contract referral, when compared 
with patient referral among patients with gonorrhoea, results in more partners 
presenting for medical evaluation; and that verbal, nurse-given health education 
together with patient-centred counselling by lay workers, when compared with 
standard care among patients with any STI, results in small increases in the rate of 
partners treated  (Mathews et al., 2002). These reviews indicate that partner 
notification leads to new case-finding for STI and HIV, and partner notification for 
STI and HIV via provider referral or choice of patient referral or provider referral 
is effective compared to only patient referral.  
However, despite increasing evidence of the effectiveness of provider referral, 
patient referral remains the most commonly used method of partner notification. 
Most EU countries use a patient referral method, whereas contract referral methods 
are used sometimes in Sweden, Ireland, and the UK (Arthur et al., 2005). Some 
studies have also shown that both patients (Apoola et al., 2006) and providers 
(Hogben et al., 2004) prefer patient referral. However, current methods of patient 
referral only reach 40-60% of named sexual partners (Low et al., 2004; Arthur et 
al., 2005).  
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Another systematic review of RCTs (Trelle et al., 2007) examined the 
effectiveness of novel patient referral methods for chlamydia, gonorrhoea, 
trichomonas, and non-specific urethritis like PDPT and Home sampling kits. As 
described in chapter 1, PDPT is used in the USA where the index case is given 
medication to hand it to their sexual partners without prior medical assessment of 
their partners by a healthcare professional (Golden et al., 2005; Kissinger et al., 
2005). Home sampling kits are given to index patients diagnosed with STI like 
chlamydia for their sex partners to collect urine specimens at home to improve 
uptake of testing among partners (Andersen et al., 1998; Østergaard et al., 2003). 
This review concluded that PDPT reduces the risk of re-infection compared to 
patient referral, especially for patients with chlamydia, gonorrhoea and syndromic 
diagnosis, but not in women with trichomonas. It also reported that the use of a 
home sampling kit for partner notification for chlamydia and gonorrhoea showed 
weak evidence of an increase in partner notification among those whose partners 
were given a kit and asked to post specimens to the laboratory instead of bringing 
them in person to the clinic. It also indicated that interventions that combine 
patient referral with some additional written or verbal information might be 
superior to simple patient referral. PDPT and patient referral, with additional 
information given to the index case for their partner, showed an increase in the 
number of partners treated but had no effect on the recurrence/persistence of these 
infections.  
Irrespective of the method of partner notification, the co-operation of the index 
cases is a pre-requisite for its success. If the index cases withhold the details of 
their contacts, partner notification in any form, patient-driven or provider-driven 
may be ineffective. Given the inherent conflict between the index patient’s need 
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for confidentiality and the contact’s right to know, and the interdependence of 
sexual health of partners, it is crucial to understand the barriers and challenges to 
partner notification among patients. A narrative review of studies on HIV 
conducted in the USA (Passin et al., 2006) indicates that type of sexual partnership, 
sexual orientation, drug-use, and cultural and regional factors can affect partner 
notification choices. However, this review was restricted to studies conducted in 
the USA and related to HIV.  
Systematic review of qualitative literature on partner notification 
The aim of the systematic review presented in this chapter was to synthesise 
qualitative literature on adolescents and adult men and women’s attitudes to and 
experiences of STI and HIV partner notification, and preferred methods of partner 
notification in industrialised countries. In this chapter I present a systematic review 
only for STI partner notification (excluding HIV partner notification) STI partner 
notification is the focus of this thesis. The review of qualitative literature on 
partner notification was considered important to enable exploration of the 
‘meanings’ of the phenomenon under investigation and understand the contextual 
factors that may influence attitudes towards partner notification for STI.  In the 
following section, I describe the scope, methodology, and results of this systematic 
review.  
Scope of the review and study inclusion criteria 
Studies conducted in any industrialised country, as defined by the Development 
Assistance Committee of the Organisation for Economic Co-operation and 
Development (OECD) were included. The details of the inclusion criteria for the 
review are presented in Table 41.  
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Table 41:  Inclusion criteria for selection of studies for the systematic review 
Category Criteria for inclusion 
Intervention Any intervention described as partner notification, contact 
tracing or any activities describing location and notification of 
partner 
Setting Health care settings (specialist i.e. STI clinics and non-
specialist clinics), and non-health care settings (e.g. needle 
exchanges, homeless shelters) 
 Any industrialised country (OECD). 
STI Chlamydia, gonorrhoea, non-gonococcal urethritis; syphilis; 
trichomonas; Hepatitis B or HCV 
Study population No restrictions 
Study design  Studies using any method of collecting qualitative data e.g. 
focus group discussions, individual in-depth interviews, in-
depth interviews. 
 
Studies that used any qualitative data collection method such as focus group 
discussions, individual in-depth or in-depth interviews were included in the review. 
Any intervention described as partner notification, contact tracing or any activities 
describing location and notification of sexual or needle-sharing partners of people 
with STI specified in the search strategy was included. Studies conducted in health 
care settings (specialist or non-specialist), and non-health care settings (e.g. needle 
exchanges, homeless shelters) were eligible for inclusion. There were no 
restrictions on the study population: studies conducted among adolescent 
heterosexual girls and boys, MSM, IDUs were included. The scope of this review 
was not restricted to partner notification only among PLHIV or MSM due to the 
lack or paucity of data on partner notification among these groups. 
Search Strategy 
The following databases: MedLine, Embase, PsychoINFO, CINHAL, and JSTOR 
were searched using a pre-specified search strategy for literature on partner 
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notification for syphilis, gonorrhoea, chlamydia, non-specific urethritis, genital 
herpes, warts. An example of the search strategy used for Medline is specified in 
Table 42 and similar search strategies were used for other databases. These search 
strategies were used earlier for a systematic review of quantitative studies on 
partner notification from 1990 to 2005 for similar STI (Trelle et al., 2007). The 
search strategy was updated to identify papers published from January 1, 2006 
through August 31, 2009, and search for literature on STI like trichomonas, 
Hepatitis B and C, Human Papilloma Virus (HPV), which were not included in the 
NICE review, from 1990 through August 31, 2009. Medical subject headings or 
thesaurus terms and free text covering different STI including HIV were used. 
These were combined with free text terms for partner notification methods 
including EPT and PDPT. The reference lists of retrieved articles for publications 
before 1990 were also searched and researchers who work in the field of partner 
notification were contacted for unpublished papers or reports.  
Selection of studies 
I, along with another independent reviewer, screened titles and abstracts of all 
potentially relevant articles identified during the search. Discrepancies were 
resolved by discussion or through adjudication by a third reviewer. 
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Table 42. Search strategy for systematic review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. exp Sexually Transmitted Diseases/ 
2. exp HIV Infections/ 
3. exp Chlamydia Infections/ 
4. exp Condylomata Acuminata/  
5. exp Gonorrhea/  
6. exp Herpes Genitalis/ 
7. exp Syphilis/ 
8. sexually transmitted infection$.mp. 
9. sexually transmitted disease$.mp.  
10. venereal disease$.mp.  
11. (STI or STIs or STD or STDs).mp.  
12. (Acquired Immunodeficiency Syndrome or HIV or AIDS).mp. 
13. chlamydia.mp.  
14. genital wart$.mp.  
15. (gonorrhea or gonorrhoea).mp.  
16. genital herpes.mp.  
17. or/1-16   
18. exp Contact Tracing/  
19. partner notification.mp.  
20. contact tracing.mp. 
21. (contract referral or conditional referral).mp. 
22. provider referral.mp. 
23. patient referral.mp. 
24. (patient$ adj deliver$ adj (treat$ or therap$)).mp. 
25. (patient$ adj partner$ adj (treat$ or therap$)).mp. 
26. expedited partner.mp. 
27. or/18-26 
28. 17 and 27 
29. limit 28 to (humans and yr="1990 - 2006") 
30. exp Sexually Transmitted Diseases/ 
31. exp HIV Infections/ 
32. exp Chlamydia Infections/ 
33. exp Condylomata Acuminata/  
34. exp Gonorrhea/  
35. exp Herpes Genitalis/ 
36. exp Syphilis/ 
37. sexually transmitted infection$.mp. 
38. sexually transmitted disease$.mp.  
39. venereal disease$.mp.  
40. (STI or STIs or STD or STDs).mp.  
41. (Acquired Immunodeficiency Syndrome or HIV or AIDS).mp. 
42. chlamydia.mp.  
43. genital wart$.mp.  
44. (gonorrhea or gonorrhoea).mp.  
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Results 
A total 3480 references were identified; of which 400 potentially relevant 
references were identified (Figure 12). The abstracts of these references were 
screened and 132 references were included for full-text manuscript review. During 
the initial screening of the manuscripts, it was obvious that there were very few 
qualitative studies on partner notification. Thus, in addition to the qualitative 
studies, quantitative studies that also collected data using open-ended questions 
were also included in the review. One unpublished article from a researcher related 
to the focus of the review was acquired.   
In total 13 articles that met the inclusion criteria were included in the synthesis. A 
brief summary of the characteristics of all these studies is presented in Table 43 
and the quality assessment of these studies is presented in Table 44. Three of these 
were quantitative studies that used open-ended questions to collect qualitative data 
(Rosenthal et al., 1995; Tydén and Ramstedt, 2000; Shivasankar et al., 2008). Of 
the 13 studies, 6 studies were conducted in the USA, 5 in the UK, 1 in Ireland and 
1 in Sweden. The American studies were largely conducted among African-
American population.  
The majority of these studies were conducted among patients recently diagnosed 
with STI and two studies included contacts (Gorbach et al., 2000; Coleman and 
Lohan, 2009). Studies were conducted on partner notification for bacterial STI, 
particularly chlamydia. One study was conducted among women diagnosed with 
genital warts/HPV (Nack, 2000). Some studies were conducted among at-risk 
populations such as MSM, African American men (Lichtenstein, 2003; 
Lichtenstein and Schwebke, 2005; Coleman and Lohan, 2009). The majority of 
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studies were conducted among heterosexual men and women but three studies 
included MSM (Gorbach et al., 2000; Coleman and Lohan, 2009; Sutcliffe et al., 
2009). The assessment of the studies included in the review was conducted using 
NICE guidelines (National Institute for Health and Clinical Excellence, 2005) and 
it showed that only a handful of good qualitative studies have been conducted on 
partner notification. 
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Figure 12. Flow diagram of the studies from 1990- August 2009 screened and 
included in the review   
 
Excluded, n=114 
Study design not relevant, =112 
Developing country, n=2 
 
Excluded, n=268  
Study design not relevant, n=253 
Developing countries, n=15 
 
Systematic reviews 
(N=2) 
Abstracts screened  
(N=400) 
Full manuscript screened 
(N=132) 
Full manuscript text included  
(N=18) 
Excluded, n=2134  
Topic/design not relevant, n=2134 
Titles screened  
(N=2534) 
Excluded, n=946  
Duplicates, n=946 
Total references identified (N=3480) 
Medline (n=1519), EMBASE (n=1331), CINAHL (n=438), PsycInfo (n=120), 
JSTOR (n=30), Handsearching (n=41), expert (n=1) 
Patient-based studies 
(N=13) 
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Table 43. Summary of all the studies included in the systematic review 
 First author, date published and study 
aims 
Disease(s) 
studied 
Setting, study 
duration 
Sample size and characteristics  Data collection and analysis 
Chacko et al (2000) 
-To qualitatively assess patient-referral 
method from the perspective of the 
adolescent and young adult female who 
either did or did not notify their sexual 
partners. 
-Chlamydia 
and 
gonorrhoea 
Urban hospital 
based family 
planning 
clinic, 
Houston, 
Texas, USA 
-1995-96 
-54 females, aged 14-20 years 
(median 18); 81% diagnosed with 
chlamydia and 15% with 
gonococcal cervicitis and 4% had 
both 
-Structured face-to-face interview 
by trained nurse 
-Two reviewers conducted content 
analysis.  
Coleman and Lohan (2007) 
-To explore experiences of partner 
notification from the perspective of gay, 
bisexual and other MSM. 
-Syphilis -2 STI clinic 
and gay 
venues (2 
bars, 2 clubs 
and 1 sauna), 
Greater 
Dublin, 
Ireland 
-Dec 2002 -
Feb 2004 
-40 gay/ bisexual MSM 
-Age range 20-60 years, 15 cases,  
15 contacts and 10 non-patient 
with an urban-rural, age and social 
class diversity 
 
 
 
-In-depth interviews 
- NUD*IST was used for systematic 
thematic analysis 
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Table 43. Continued     
First author, date and study aims Disease(s) 
studied 
Setting, study 
duration 
Sample size and characteristics Data collection and analysis 
Daker-White et al (Unpublished) 
-To assess social and emotional effects of 
PN 
-To compare subjective acceptability of 
primary care and STI clinics as settings for 
partner notification for Chlamydia 
-Chlamydia  -UK -25 participants (8 men and 17 
women) aged 18-28 years 
-In-depth interviews conducted after 
partner notification was completed 
using a topic guide 
- Participants in both the trial arms 
and those who refused 
randomisation were compared 
during the analysis.  
Darroch et al (2003) 
-To explore men’s and women’s accounts 
of Chlamydia testing with a view to 
understand sex differences in attitudes and 
in behaviours 
-Chlamydia -STI 
clinic,UK 
-24 index cases (12 men and 12 
women) 
-Mean age 27 years (29 in men and 
24 in women), mixed ethnicity, 
employed and educated till A 
levels 
-In-depth interviews 
Duncan et al (2001) 
- To explore psychosocial impact of 
Chlamydia diagnosis on women 
-Chlamydia -STI and 
family 
planning 
clinic, 
Glasgow, UK 
-17 women (10 GUM and 7 family 
planning clinic), aged 18 -28 years 
 
 
 
 
-In-depth interviews 
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Table 43. Continued 
    
First author, date and study aims Disease(s) 
studied 
Setting, study 
duration 
Sample size and characteristics Data collection and analysis 
Gorbach et al (2000) 
- To describe self-reported patterns of 
partner notification among STI clients 
diagnosed with gonorrhoea, chlamydia, 
nongonoccocal urethritis and understand 
reasons for notifying or not notifying 
partners and examine differences, if any, 
by gender and sexual orientation 
Chlamydia, 
gonorrhoea, 
non-
gonoccocal 
urethritis 
-STI clinic 
and referrals 
from private 
practitioners, 
Seattle, USA 
-June 1996-
June 1998 
-79 patients (30 women, 30 
heterosexual men and 19 MSM) 
-Women: mean age 22 (15-46 
range),  
-Mixed ethnic group 
(white/black/other) 
-Men: mean age 28 (18-46 range), 
mixed ethnic group 
(white/black/other) 
-Interviewers were gender-matched 
-In-depth interviews using 
ethnographic techniques were 
conducted. 
-Ethnograph software was used for 
content-analysis.  
Lichtenstein (2003) 
-To identify stigma related barriers to 
treatment that affect screening, treatment 
and partner services 
-Any STI -Public health 
clinics and 
students from 
a college and 
high school, 
West and 
Central 
Alabama, 
USA 
 
-42 heterosexual men and women 
from mixed ethnic background, 
aged 15-53, predominantly 
African-American, unemployed, 
single with children and uninsured.  
-4 Focus group discussions (1 with 
only women, 1 with only men and 2 
mixed groups) 
-Transcripts were analysed to study 
effect of stigma on partner 
notification 
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Table 43. Continued     
First author, date and study aims Disease(s) 
studied 
Setting, study 
duration 
Sample size and characteristics Data collection and analysis 
Lichenstein and Schwebke (2005) 
- To assess African-American men’s 
preferences in relation to 3 partner 
notification methods i.e. patient referral, 
provider referral and PDPT 
-Trichom-
oniasis 
-Public STI 
clinic, 
Southern city 
in USA 
-FGD 1: 10  African-American 
heterosexual men aged 21-51, 
(mean: 32 years);  FGD 2:  men 
aged 21-27, (mean: 22 years) 
-Only one man was married but 10 
men had children. All these men 
were diagnosed with 
trichomoniasis. 
-2 Focus group discussions and a 
short questionnaire on socio-
demographic background.  
-Data was analysed using constant 
comparison for thematic patterns 
i.e. age, social and partnership 
status 
Nack (2000) 
-To understand how sexual self-concept is 
transformed among women diagnosed with 
chronic STI 
-Genital 
herpes and 
HPV 
-Women’s 
health care 
clinic, USA 
- Snowball sample of 28 women 
aged 19-56 years 
-Unstructured interviews  
-Data analysed according to the 
principles of grounded theory 
 
Rosenthal et al, (1995) 
-To examine adolescent girls discussion of 
STI acquisition with partners. 
- Any STI -Urban 
Hospital, USA 
 
 
 
-182 sexually active girls who had 
history of STI, mean age: 17 (12-
21 years), majority African 
American 
-Interviewer administered 
questionnaire with in-depth 
questions on experience of having 
told/been told about STI acquisition 
and reasons for not telling. 
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Table 43. Continued     
First author, date and study aims Disease(s) 
studied 
Setting, study 
duration 
Sample size and characteristics Data collection and analysis 
Shivasankar et al (2008) 
To investigate patient’s opinions regarding 
acceptability of PDPT 
-Any 
bacterial STI 
-STI clinic, 
Plymouth, UK 
-599 participants of whom 47% 
were men and 53% women. 97% 
were heterosexual and 28% 
educated up to university degree 
-Questionnaire with open ended 
questions were completed after 
consultation of these patients 
-No information on analysis of 
open-ended data 
Sutcliffe et al (2009) 
To explore factors that influence STI 
clinic attenders choice of PN method and 
the acceptability and feasibility of  two 
partner notification strategies i.e. 
accelerated partner therapy (APT) in form 
of telephone consultation of sexual 
partners and treatment, and pharmacy 
consultation and treatment 
-Bacterial 
STI 
-STI clinic in 
Central 
Middlesex 
Hospital, 
London, UK 
-37 participants diagnosed with an 
acute STI or contacts of people 
with acute STI, aged 16to >30, 
mixed ethnicity, 14 and 21 
heterosexual men and women 
respectively and 2 MSM 
-In-depth interviews with STI clinic 
attenders. 
 -Analysis using Framework 
approach 
Tyden and Ramstedt (2000) 
-To evaluate patients perceptions towards 
legal enforcement of partner notification 
and their  views about impact on 
legislation on their sexual behaviour 
-Chlamydia - STI clinics in 
4 hospitals, 
Stockholm, 
Sweden 
-1997 
-240 consecutive patients 
diagnosed with Chlamydia 
-46% men and 54% women, mean 
age: 25 years (16-52) 
- Cross sectional survey with open-
ended questions 
-No information on analysis of 
open-ended data was provided 
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Table 44. Quality assessment of studies included in the systematic review 
First author, 
(date)  
Appro-
priate and  
clearly 
focused 
question 
Study type 
appropriate 
Recruit-
ment/ 
sampling 
strategy 
appropriate 
Methods of 
data 
collection 
appropriate 
Ethical 
issues 
addressed 
Data 
analysis 
appropriate 
Methods 
adequate to 
research 
question 
Reflexivity 
addressed 
Clear 
statement of 
findings 
Implica-
tions of 
study 
reported 
clearly 
Discussion 
of 
limitations 
performed 
Overall 
assessment 
Chacko et al, 
(2000) 
Yes Yes No No Yes Yes No No Yes Yes Yes (-) 
Coleman and 
Lohan, (2007) 
Yes Yes Yes Yes Yes Yes Yes No Yes Yes No (+) 
Darroch et al, 
(2003) 
Yes Yes Yes Inadequate 
information 
Yes Inadequate 
information 
Yes No Yes Yes Yes (-) 
Duncan et al, 
(2001) 
Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes (+) 
Gavin Daker-
White et al, 
(Unpublished) 
 
 
 
 
 
 
 
Yes 
 
Yes Yes Yes Yes Yes Yes No Yes Yes No (+) 
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Table 44. Continued 
First 
author, 
(date) 
 
Appro-
priate & 
clearly 
focused 
question 
Study type 
appropriate 
Recruit-
ment or 
sampling 
strategy 
appropriate 
Methods of 
data 
collection 
appropriate 
Ethical 
issues 
addressed 
Data 
analysis 
appropriate 
Methods 
adequate to 
research 
question 
Reflexivity 
addressed 
Clear 
statement of 
findings 
Implica-
tions of 
study 
reported 
clearly 
Discussion 
of 
limitations 
performed 
Overall 
assessment 
Gorbach et 
al, (2000) 
Yes Yes Yes Yes Yes Yes Yes No Yes Yes No (+) 
 
Lichenstein 
and 
Schwebke, 
(2005) 
Yes Yes Yes Yes yes Yes Yes Yes Yes Yes Yes (++) 
Lichenstein, 
(2003) 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes ++ 
Nack, (2000) Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No (+) 
Rosenthal et 
al, (1995) 
Yes Yes Inadequate 
information 
Inadequate 
information 
Yes No Yes No Yes Yes Yes (-) 
 
Shivasankar 
et al, (2008) 
 
 
 
 
 
Yes Yes Yes Yes No No Yes NA Yes Yes No (-) 
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Table 44. Continued 
First 
author, 
(date)  
Appro-
priate and  
clearly 
focused 
question 
Study type 
appropriate 
Recruit-
ment/ 
sampling 
strategy 
appropriate 
Methods of 
data 
collection 
appropriate 
Ethical 
issues 
addressed 
Data 
analysis 
appropriate 
Methods 
adequate to 
research 
question 
Reflexivity 
addressed 
Clear 
statement of 
findings 
Implica-
tions of 
study 
reported 
clearly 
Discussion 
of 
limitations 
performed 
Overall 
assessment 
Sutcliffe et 
al, (2009) 
Yes Yes Yes Yes Yes No Yes No Yes Yes No (-) 
Tyden and 
Ramstedt 
(2000) 
Yes Yes Yes No Yes No No NA Yes Yes Yes (-) 
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Data Synthesis 
I used an interpretative approach called meta-ethnography for data synthesis. This 
approach was developed by Noblit and Hare (Noblit and Hare, 1988) and is 
interpretative rather than aggregative in nature. Meta-ethnography aims to 
maintain the uniqueness of individual accounts by translating the meanings of 
these accounts into each other (Noblit and Hare, 1988 pp10). They have proposed 
the stages described in Box 3 during the process of translating studies. As 
indicated in Box 3, once the area of research interest is specified, studies included 
in the review are read and re-read following which key themes and metaphors that 
convey the meaning of the study are identified. The themes identified from one 
study are compared and contrasted with those from the other studies. These 
similarities and differences identified in the studies are collectively examined to 
enable further interpretation of these studies.  
 I organised studies into the following groups: 1) studies on views, and attitudes of 
patients towards partner notification, 2) studies on the perceived barriers and 
experiences of notifying partners, 3) studies on the preferred methods for notifying 
partners or being notified. Studies were further organised according to the 
population studied: for example, studies conducted among adolescents, women, or 
MSM. I extracted pre-defined data items into standardised tables and identified 
key themes and metaphors to reflect the essence of each study. A second reviewer 
checked these for completeness and accuracy. 
The themes or metaphors identified in each study were compared with those 
identified in other studies to enable ‘comparative explanation’ (Noblit and Hare, 
1988). I used the process adopted by Pound and co-authors (Pound et al., 2005) 
and Campbell and co-authors (Campbell et al., 2003) to enable comparison of 
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these studies. I compared key themes, metaphors, and concepts from one study 
with those of another study for similarities and differences. I also identified any 
new themes from the second study and documented any contradictions in the 
studies. These themes were then compared in a similar fashion to themes and 
metaphors from another study and so on.  
Box 3. Phases of Meta-Ethnography 
 
The data synthesis is presented in the following categories: 1) social meanings of 
STI diagnosis, 2) views towards partner notification and perceived barriers to 
partner notification, 3) experiences of partner notification and 4) preferences 
regarding partner notification. 
Social meanings of STI diagnosis  
Several studies reported that STI diagnosis evoked feelings of guilt and shame. 
Participants, mainly adolescent girls and women, reported experiencing a range of 
negative emotions due to their STI diagnosis such as feeling of contamination, 
delinquency, being dirty, disgust, shock, distress (Rosenthal et al., 1995; Chacko et 
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al., 2000; Nack, 2000; Duncan et al., 2001; Darroch et al., 2003; Lichtenstein, 
2003). For some women these reactions were linked to perceptions of lack of 
personal vulnerability to STI (Daker-White et al., n.d.; Duncan et al., 2001; 
Darroch et al., 2003). Chlamydia diagnosis led to anxiety among women about 
their reproductive health (Duncan et al., 2001; Darroch et al., 2003). Older 
African-American heterosexual men in Southern USA were embarrassed due to 
their diagnosis with trichomoniasis (Lichtenstein, 2003). They were concerned 
about the religious connotations of homosexuality, drug-use, and extra-marital sex 
as “sins” and STI diagnosis as “wages of sin” and immoral. Men also feared loss 
of sexual capital due to the socio-cultural association of STI diagnosis with 
homosexuality in their community (Lichtenstein and Schwebke, 2005). However, 
some young men interpreted STI diagnosis as a sign of sexual machismo 
(Lichtenstein, 2003). African-American men were suspicious of the ‘blackness’ of 
STI rates in USA and did not trust the healthcare system due to a history of racial 
discrimination against Black population in the USA. Thus, the meanings of STI 
are embedded in socio-cultural norms which influence the experience of being 
diagnosed with STI.  
Views towards and perceived barriers to partner notification 
Studies reflect that the connotations of STI as stigmatised conditions shape 
people’s views towards partner notification. At the partnership level, STI diagnosis 
is a proof of current or previous non-exclusivity in the partnership and partner 
notification a threat to the secrecy engulfing this lack of exclusivity. However, in 
the context of partner notification for STI, some studies report that the participants 
viewed partner notification with a moralistic perspective. Partner notification was 
considered as ‘a right thing to do’ (Daker-White et al., n.d.), a moral responsibility 
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to others and to control disease, and its rejection was seen as evidence of not 
having a conscience (Gorbach et al., 2000; Coleman and Lohan, 2009). Among 
MSM, these altruistic connotations also had a subtext of self-protection from re-
infection (Gorbach et al., 2000) and freedom of sexual pleasure (Coleman and 
Lohan, 2009). Despite these positive attitudes, the stigma associated with STI 
diagnosis led to feelings of guilt and ‘embodied shame’ (Coleman and Lohan, 
2009). Men who are not ‘out’ as gay or bisexual were worried about being exposed 
due to partner notification and MSM feared being perceived as ‘carriers of 
infection’ among their peers (Gorbach et al., 2000; Coleman and Lohan, 2009).  
Women were concerned about being labelled as ‘loose’ women (Gorbach et al., 
2000) or ‘freaks’ if they disclosed information about multiple sexual partners to 
health care providers (Lichtenstein, 2003). Some men who had a “main woman” 
(not necessarily a wife but someone with whom they have children) were 
concerned about the negative implications of partner notification on their 
relationship with their main woman which was considered important for their 
social status (Lichtenstein and Schwebke, 2005). 
All these factors make ‘breaking the bad news’ (Coleman and Lohan, 2009) to the 
partners a difficult and potentially ‘troublesome task’ (Daker-White et al., n.d.). 
Participants experienced range of emotions like stress, anxiety, guilt, discomfort, 
lack of trust, anger, embarrassment, fear, apprehension prior to notifying their 
partners (Rosenthal et al., 1995; Chacko et al., 2000; Gorbach et al., 2000; Nack, 
2000; Duncan et al., 2001; Coleman and Lohan, 2009; Sutcliffe et al., 2009). 
Women were more likely to be concerned about their partner’s negative reaction 
(Rosenthal et al., 1995; Chacko et al., 2000; Darroch et al., 2003). Both, men and 
women, feared gossip, abuse, and isolation and were worried about the impact of 
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partner notification on their social standing (Daker-White et al., n.d.; Rosenthal et 
al., 1995; Chacko et al., 2000; Gorbach et al., 2000; Duncan et al., 2001; 
Lichtenstein and Schwebke, 2005) Adolescent girls and women were concerned 
about violence from their partner, irrespective of the nature of infection they were 
diagnosed with (Rosenthal et al., 1995; Chacko et al., 2000; Gorbach et al., 2000).  
Experiences of notifying partners 
These above-mentioned factors translated into either the index patients avoiding 
disclosure of their diagnosis by ‘passing’ (i.e. concealing their diagnosis) (Nack, 
2000) or ‘covering’ (i.e. using deceptive stories to cover their diagnosis) (Gorbach 
et al., 2000; Nack, 2000; Lichtenstein, 2003) or ‘stigma transference’ i.e. blaming 
their partner for their diagnosis (Nack, 2000) acting as a catalyst for partner 
notification (Gorbach et al., 2000).  
Despite intense emotional experiences post-diagnosis and concerns about negative 
implications of notifying partners, several studies indicate that participants usually 
notified their main current sexual partner (Daker-White et al., n.d.; Rosenthal et al., 
1995; Chacko et al., 2000; Gorbach et al., 2000; Nack, 2000; Duncan et al., 2001; 
Darroch et al., 2003; Sutcliffe et al., 2009). Acceptance and openness of non-
monogamy symbolised trust and facilitated partner notification (Daker-White et al., 
n.d.; Gorbach et al., 2000). However, the experience of notifying a long-term and 
serially monogamous partner was stressful (Daker-White et al., n.d.; Gorbach et al., 
2000; Coleman and Lohan, 2009). While notifying their partners women 
sometimes resorted to ‘covering’ by using non-incriminating explanations, for 
example saying that they got ‘yeast infection from a toilet seat’ (Gorbach et al., 
2000). Similarly, one study indicates that a bisexual man informed his female 
partner that his infection was a result of sexual encounter with a woman (Coleman 
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and Lohan, 2009) instead of disclosing his bisexuality. In the context of recurrent 
infections where the symptoms can resolve after a few days, some women resorted 
to passing by insisting on condom use (Nack, 2000). Men avoided disclosure to 
partners either by not seeing them or not having sex with them until their treatment 
was completed (Lichtenstein and Schwebke, 2005) or expected their partners to 
read between the lines (Daker-White et al., n.d.). 
However, for participants’ who had notified their partners, the experience was not 
as bad as they had expected (Daker-White et al., n.d.; Nack, 2000; Duncan et al., 
2001; Coleman and Lohan, 2009). Nevertheless, blaming appears to be a 
commonly accompanied with partner notification, with men being more likely to 
blame their female partners for the diagnosis (Darroch et al., 2003; Lichtenstein, 
2003). Some women and adolescent girls reported being blamed by their male 
partner for chlamydial infection (Rosenthal et al., 1995; Chacko et al., 2000; 
Duncan et al., 2001; Darroch et al., 2003). Men blamed their female partners, 
especially for STI like trichomoniasis, under the guise that ‘it’s a woman’s 
disease’ (Lichtenstein and Schwebke, 2005). Women too confronted their partners 
and retaliated by ‘outing’ them i.e. telling others about their diagnoses or blaming 
them for their diagnoses (Daker-White et al., n.d.; Gorbach et al., 2000; Nack, 
2000; Lichtenstein, 2003). This process of deflecting responsibility usually 
resulted from feelings of betrayal by partner and from an attempt avoid negative 
labelling, nevertheless leading to informing the partner about the diagnosis 
(Chacko et al., 2000; Gorbach et al., 2000; Nack, 2000; Darroch et al., 2003; 
Lichtenstein, 2003; Lichtenstein and Schwebke, 2005). Only one study reported 
that notifying partners had led to the end of long-term relationships (Coleman and 
Lohan, 2009).  
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Participants felt it was important to convey the bad news to their partners 
themselves, especially their current main partner, rather than via a health 
professional (Daker-White et al., n.d.; Chacko et al., 2000; Gorbach et al., 2000; 
Darroch et al., 2003; Coleman and Lohan, 2009) to avoid gossip. Notifying 
partners face-to-face (Daker-White et al., n.d.; Chacko et al., 2000; Gorbach et al., 
2000; Darroch et al., 2003; Coleman and Lohan, 2009) or via phone (Chacko et al., 
2000) was common. Provider referral was equated with confusion about the 
identity of the transmitter of infection and a sense of powerlessness (Coleman and 
Lohan, 2009). However, some men resorted to help from health advisors to 
overcome their reluctance to notify partners (Darroch et al., 2003). Women who 
feared violence chose to notify their partner via provider referral (Gorbach et al., 
2000).  
Studies that included contacts showed that the lack of knowledge about 
asymptomatic nature of STI and perceptions of low severity of the infection, 
particularly among men, led to delays in seeking care despite notification (Nack, 
2000; Darroch et al., 2003; Lichtenstein, 2003). Contacts expressed feeling 
ambivalent, humiliated and at times preferred not to attend the clinic (Coleman and 
Lohan, 2009). Men were also less likely to seek care despite notification due to 
denial, pride, or fear of being seen in clinic (Darroch et al., 2003; Lichtenstein, 
2003). 
Misconceptions like the lack of STI symptoms at the time of sex, in some cases, 
led to non-notification of the partners with whom they had had sex, especially by 
adolescent girls (Rosenthal et al., 1995; Gorbach et al., 2000). Some gay men did 
not perceive oral sex as a risk factor for transmission, leading to oral sex partners 
not being notified (Gorbach et al., 2000). Heterosexual men and MSM were 
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unlikely to notify partners perceived as deliberate transmitters of infection, 
although the means by which they classified partners in this way were unreliable 
(Gorbach et al., 2000; Coleman and Lohan, 2009). Participants were also less 
likely to contact ex-partner(s) if the break-up was difficult, while casual and one-
night stand partners were less likely to be contacted due to concerns of ensuing 
gossip or fear of being blamed (Daker-White et al., n.d.; Rosenthal et al., 1995; 
Chacko et al., 2000; Gorbach et al., 2000; Tydén and Ramstedt, 2000; Duncan et 
al., 2001). However, in some situations, the lack of a social relationship with the 
ex-partners or casual partners facilitated partner notification as it was considered 
harmless for their social standing (Gorbach et al., 2000; Lichtenstein and 
Schwebke, 2005). In such scenarios, provider-led notification was often preferred 
(Gorbach et al., 2000). Difficulty in locating ex-partners, particularly among IDUs 
or anonymity of partners were practical barriers to partner notification (Gorbach et 
al., 2000; Tydén and Ramstedt, 2000; Coleman and Lohan, 2009). 
Preferences regarding partner notification in the future 
Overall, provider referral was considered intrusive, confusing, and associated with 
social stigma. Paradoxically, it was preferred to avoid negative impact of partner 
notification on social standing, violence, abuse, or gossip. As shown in a study 
conducted among African-American men in Southern USA, men’s economic 
position influenced the nature of their sex partnerships and their perceptions of 
control (or lack of it) over female partner’s sexuality. For example: Men in casual 
partnerships and who were relatively less well-off financially reported being aware 
of their position as a ‘throw away guy’ and felt that their female partners would 
not notify them and thus preferred provider referral (Lichtenstein and Schwebke, 
2005). Wealthier men did not want to be notified by health providers due to the 
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fear of implications for their partnership with their main woman. However, these 
men viewed health provider led outreach as being ‘chased down’ for their 
masculinity and treated as vectors of disease (Lichtenstein, 2003; Lichtenstein and 
Schwebke, 2005). 
Studies reported reluctance among participants to use PDPT due to fear of 
allergies and lack of trust in their partners (Lichtenstein, 2003; Lichtenstein and 
Schwebke, 2005; Shivasankar et al., 2008). However, some considered it useful 
for couples and to reduce embarrassment associated with coming to the clinic 
(Shivasankar et al., 2008). With regards to the acceptability of APT, there was 
greater preference for telephone assessment of main sexual partner by a health 
advisor and taking medication for him post-assessment due to its convenience in 
terms of time and the need for re-assurance, especially among older participants. 
The telephone model was also preferred for being notified by their partners and 
was influenced by the need for interaction with a health professional (Sutcliffe et 
al., 2009). Compared to the older participants, younger participants reported the 
self-test kits for partners to be acceptable.  
With regards to the venue for STI care, index patients diagnosed with chlamydia 
preferred to attend primary care compared to a STI clinic (Daker-White et al., 
n.d.). STI clinics were perceived as an “unknown quantity” and a dirty place for 
unpleasant people (Daker-White et al., n.d.; Duncan et al., 2001; Lichtenstein, 
2003), affecting its acceptability. However, some considered them as a necessary 
evil (Daker-White et al., n.d.; Coleman and Lohan, 2009). ‘Visibility’ i.e. being 
seen in a sexual health clinic was perceived as a challenge to ‘passing’ by men, 
especially from small cities, who were concerned about being ‘spotted’ and feared 
ensuing gossip (Lichtenstein, 2003). 
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Only one study reported on views towards legislation for chlamydia control and 
police enforcement of sexual contacts to attend testing for chlamydia (Tydén and 
Ramstedt, 2000). The majority of participants felt that legislation for chlamydia 
would normalise notification and some were willing to provide names of their 
partners to health care providers. However, participants were not in favour of use 
of police enforcement against contacts who did not attend the clinic. 
Discussion 
Although studies using open-ended questions provided some information, their 
approach to analysing open-ended data was largely quantitative. A few studies 
addressed partner notification among MSM and none among HIV positive MSM. 
Only one study addressed disclosure and notification of chronic STI (Nack, 2000). 
The majority of studies focused on notification for STI like chlamydia, 
gonorrhoea, syphilis, NSU, and trichomoniasis. Since 2000, there has been a 
steady increase in the studies of novel partner notification strategies focusing on 
timely treatment of sexual partners like PDPT in the USA, or the APT model in 
the UK. However, these methods are useful only for selected curable STI like 
chlamydia and gonorrhoea and increasing drug resistance for gonorrhoea, 
especially among MSM can be a challenge. Most studies focused on participants 
aged 18-40 years. Given the increase in life expectancy in many developed 
countries, there is a need to examine the prevalence of STI among people aged 40 
and above who are sexually active, and their views towards partner notification. 
Rates of sex partner acquisition remain higher and for longer in MSM than in 
heterosexual population (Johnson et al., 2001).  
Several studies were conducted from a psychological perspective with an 
individualistic focus around STI management and partner notification choices, 
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especially in the UK. The sociological and ethnographic studies that examined 
partner notification in the context of the broader socio-economic, legal, and 
cultural milieu were mostly conducted in the USA. Contrary to our preliminary 
assumptions prior to the synthesis, the review revealed that the experience of 
shame and stigma associated with STI and partner notification is cross-cultural and 
without continental boundaries, although its manifestations can be different. Thus, 
the translation of these studies enabled a ‘line of argument’ synthesis described as 
“enabling inference about the whole based on the selective studies of the part” 
(Noblit and Hare, 1988) (pp.: 62). Despite the common experience of shame 
associated with STI diagnosis, the experience and manifestations of stigma varied 
according to age, gender, race, religion, sexuality and region. This synthesis 
provides an insight into how people diagnosed with STI view, experience and 
manage the stigma of STI diagnosis, and cope with their ‘diseased identity’ and 
how this affects partner notification. 
STI diagnosis and stigma 
The experience of STI diagnosis and the operationalization of partner notification 
is influenced not only by the type of infection; but also by gender, socio-cultural, 
religious, legal and policy framework governing STI control and drug use in the 
society. A strong sense of immorality, influenced by religious underpinnings and 
societal norms of monogamy, is associated with STI diagnosis. The shame and 
immorality associated with STI influences the strategies adopted for 
(non)disclosure of STI diagnosis to sexual partners. The characteristics of STI, (for 
example, treatable, symptomatic, or recurrent) also influence participants’ partner 
notification strategies. MSM, women, and African American heterosexual men 
were worried about being perceived as ‘vectors of diseases’. MSM and bisexual 
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men feared double discrimination due to their perceived ‘deviant’ sexuality. 
African American heterosexual men were wary of their STI diagnosis due to the 
history of racial discrimination. Women feared the stigma associated with 
transgressing the gendered boundaries governing their sexuality. IDUs were 
concerned about the illegality of drug-use and the negative implications of partner 
notification, especially on their needle-sharing partners.  
Partner notification strategies to manage the stigma of STI diagnosis 
The legal and moral underpinnings associated with STI diagnosis translate into 
‘internalised stigma’ (described as the acceptance of the social stigma associated 
with STI/HIV diagnoses as valid) (Steward et al., 2008), especially among women. 
Sexual health programmes should be mindful of these social meanings associated 
with STI diagnosis, and the index patients’ social positioning in that community. 
Historically, STI interventions referred to groups with high STI prevalence such as 
MSM and IDUs, as ‘high risk groups’, thereby reinforcing the societal views 
towards these groups as ‘vectors of disease’. With regards to partner notification, 
the decisions to notify partners involve risk-assessment by the index of the impact 
of notification on their personal wellbeing, relationships with their partners, and 
social status. People diagnosed with STI/HIV face real fear of societal stigma and 
discrimination, which motivates them to adopt strategies to protect themselves 
from this ‘felt normative stigma’ (Steward et al., 2008). Thus index cases are 
likely to choose non-disclosure or covering, selective disclosure (i.e. informing 
some but not all partners) or partial disclosure (i.e. lying about the cause of their 
infection in an attempt to manage the stigma associated with their condition) and 
stigma transference (Nack, 2000; Lichtenstein, 2003). This need to manage stigma 
also translates in to a preference for notifying partners themselves.  
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However, due to the interdependent nature of sexual health with sexual 
partnerships (i.e. the risk of re-infection), the challenges to hide symptomatic STI 
from sex partners, the chronic nature of some infections, and the intimate nature of 
sexual partnerships, especially with main partners, the usefulness of coping 
strategies like covering, or passing, is limited, explaining the greater willingness to 
notify main current partners. Given the uncertainty in assessing the direction of 
transmission, even in situations where notification takes place ‘stigma 
transference’ (Nack, 2000), to some extent is likely to occur to protect one’s self-
esteem and social standing where the social norm is monogamy. However, among 
MSM a mutual acceptance of non-monogamy can facilitate notification and 
symbolise trust. Thus, both trust and blame enable partner notification, especially 
in the context of current main partners. Notifying casual and ex-partners is 
challenging due to its perceived threat to social standing. Other partner notification 
methods requiring less interaction may be preferred for such partners. It is in this 
context that novel methods like pharmacy models or provider referral can be 
offered.  
Implications 
These data indicate that the broader context of stigma attached to STI should not 
be ignored in efforts to improve effectiveness and uptake of partner notification. 
Partner notification policies and programs need to acknowledge the impact of STI 
related stigma on both index patients and their contacts and offer them 
psychological support. Whether perceived or experienced, stigma is a barrier to 
accessing sexual health services. Efforts to destigmatise and normalise testing and 
treatment for STI and to make sexual health services non-judgemental and 
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accessible are needed (Duncan et al., 2001; Darroch et al., 2003; Lichtenstein, 
2003; Coleman and Lohan, 2009).  
Notifying partners is an emotionally challenging task and different methods of 
partner notification must be offered for different types of partnerships as ‘no one 
size fits all’ (Gorbach et al., 2000). Provider support should be offered and a focus 
on anonymity and confidentiality of the index case is crucial in this context (Gable 
et al., 2007). The evidence highlights that despite notification, the stigma 
associated with STI affects healthcare seeking in sexual health clinics, especially 
among men. Partner notification services should make special efforts to encourage 
men to seek care, especially for infections widely considered to be ‘women’s 
diseases’. This may be the reason why a previous review has reported that none of 
the partner notification methods were effective for trichomonas (Trelle et al., 
2007). Similarly, among IDUs, different partner notification methods are needed 
for needle-sharing and sexual partners. Novel methods of partner notification like 
STI home sampling and testing kits, PDPT, pharmacy or the telephone model, may 
provide more choices for STI testing and should be further investigated, 
particularly among men. Further research is also needed to understand the effects 
of legislation regulating partner notification on notifying partners. Last but not the 
least, this synthesis highlights the need to continue health education to tackle 
misconceptions about STI transmission.  
Conclusion 
Partner notification is affected not only by partnership level factors and the type of 
infection, but also by myriad structural, socio-cultural and legal factors. Stigma is 
a considerable barrier to sexual health care and partner notification. People 
diagnosed with STI should be offered support to cope with feelings of embodied 
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shame and address felt normative stigma. The UNAIDS encourages voluntary 
partner notification and the provision of professional counselling for the index 
patient and their contacts (UNAIDS/WHO, 2000). Patients should be offered a 
‘choice’ of partner notification methods and should be involved in decision-
making to eliminate the risk of stigma and discrimination. Efforts should be made 
to destigmatise sexual health programmes and these should not perpetuate or 
enhance stigma associated with STI. This synthesis highlights that there is a need 
for further research on partner notification for STI among most-at-risk groups like 
MSM, African-American populations, and partner notification for STI among 
PLWH.  
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Appendix 5: SHARPN display board write-up 
HAVE YOUR SAY! We want to know your views on how to contact sexual 
partners following diagnosis. We also want to know about your experiences of 
taking HIV medication. Ask any nurse in the Bloomsbury clinic for further 
information about the SHARPN study. Your views can help us improve your 
health care.  
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Appendix 6: Participant information sheet for cognitive 
interviews 
                           
 
Sex, Health, Antiretroviral Treatment and Partner Notification (SHARPN) 
Project 
Participant Information Sheet Questionnaire Pilot 
Version: 2 
Date: 10 November 2009 
You are being invited to take part in Sex, Health, Antiretroviral Treatment, and 
Partner Notification (SHARPN) Project. Please read this information sheet 
carefully. Please feel free to ask questions if any part of the information is unclear 
to you.  
 
Who is conducting this study? 
This study is being conducted by Centre for Sexual Health and HIV Research, 
University College London in collaboration with the Department of Primary Care 
and Public Health, Brighton and Sussex Medical School, Falmer, Brighton. The 
study has been reviewed and approved by an independent NHS Research Ethics 
Committee and the Camden PCT Research & Development department. 
 
What is the purpose of the study? 
We are conducting this study to understand views and experiences of people living 
with HIV. We want to know if and how HIV has affected sexual behaviour and 
practices of people living with HIV and their experiences of using anti-retroviral 
treatment and using partner notification services i.e. contacting sex partners to get 
tested following diagnosis with sexually transmitted infections. We will be 
conducting a questionnaire survey to understand the impact of these factors on the 
lives of people living with HIV. We want you to read this questionnaire and let us 
know if you understand the questions and how you derived your answers. We also 
want to know if there are any questions in the questionnaire that you did not 
understand and how we can change them. 
 
Why have you been invited? 
All men who identify themselves as men who have sex with men and are accessing 
the HIV clinic at Mortimer Market Centre are invited to participate in the study. 
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Do you have to take part in the study? 
It is entirely your choice whether you want to take part in the study. If you have 
any questions or concerns about participating in the study, please ask the 
researcher. You can also discuss about your study participation with the 
representatives of clinic’s patient network. If you decide to take part in the study, 
you are free to withdraw at any time without giving any reason. If you decide not 
to participate in the study, it will not affect the standard of health care you receive 
from this clinic.  
 
What will you have to do if you take part in the study? 
If you decide to participate you will be requested to sign a consent form indicating 
that you have voluntarily agreed to participate in the study. We will then ask you 
to complete a questionnaire survey either online or using a pen and paper in a 
separate quiet room in the clinic. These questions will be about your sexual 
behaviour and practices, HIV medication and your sexual partnerships, and/or 
your preferences towards various partner notification methods. You are not 
obliged to answer any questions that make you feel uncomfortable. We will ask 
you to answer one section of the questionnaire or ten questions at a time. The 
researcher will ask you if you understood the questions and how you arrived at the 
response for that question. If you do not understand the questions then it will be 
helpful for us to know that and to hear your suggestions about how to improve the 
question. These discussions will be audio-recorded. There will be no reference on 
the audio-recording or the questionnaire to your name or information that will link 
your survey responses to you. These audio files will be destroyed after analysis of 
the discussion. All the information you provide in the survey will be anonymous 
and confidential. We anticipate that you will take approximately 35-45 minutes to 
complete this interview.  
 
Who will know you are taking part in the study? 
The clinic staff that provides you with medical care will not have access to your 
interview responses or audio-recording. The audio-recorded files will be kept on a 
secure password protected computer in the researcher’s office. Your doctor will 
not be paid for your participation in the study. Nor will your GP be notified about 
your study participation. The research team will manage the interview responses 
and analyse the data.  
 
Are there any disadvantages of you participating in the study? 
There are no disadvantages of you participating in the study. You may find some 
questions sensitive and personal. You are not obliged to answer those questions 
that make you feel uncomfortable. 
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What are the possible benefits of you participating in the study? 
There will be no direct benefit to you for participating in the study. It is anticipated 
that the wider men who have sex with men (MSM) community will benefit in 
future from the study results. Findings from the interviews will help us improve 
the survey questionnaire that will be conducted to help inform, modify, and 
develop partner notification and other health care services that are responsive to 
the needs and preferences of patients.  
 
What will happen to the study results? 
Results of the interview will be used to revise the survey questionnaire for the 
study that is planned to be conducted in the Bloomsbury clinic once. This survey 
will be conducted after we finalise the questionnaire with your feedback. If you 
would like to be informed of the study findings, please do let us know and we are 
happy to share the publication with you when the study will be completed. We will 
also put a poster of the study findings in the Bloomsbury. The study results will be 
disseminated through interim report, posters, and articles in journals and 
magazines like NAM, HIV Treatment Update.   
 
What if there is a problem? 
If you have concerns or are unhappy with any aspect of this study, you can discuss 
these with the researchers whose details are mentioned below. They will do their 
best to answer your questions. If you remain unsatisfied and wish to complain 
formally, you can do this with the help of the hospital’s patient support service: 
Tel:  Email:   More information is 
available at  
If you have any questions or concerns please contact the researchers: 
Ms Sonali Wayal  
 
 
   
  
 
Professor Graham Hart 
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Appendix 7: Consent form for cognitive interviews 
                                                        
 
Study R&D Number: □□□□□□□□ 
 
CONFIDENTIAL 
 
Consent Form _Questionnaire pilot 
Version: 1 
Date: 10
th
 November 2009 
 
Sex, Health, Antiretroviral Treatment and Partner Notification (SHARPN) Project 
 
An interview to explore if patients understand the questions of the survey on sexual 
behaviour, ART and partner notification 
 
Study Investigators: Ms Sonali Wayal, Professor Graham Hart, Professor Jackie Cassell 
 
                                                                                                                   Please initial the box 
I confirm that I have read and understood the participant information sheet    
dated 10
th
 November 2009_version 2 for the above mentioned study.    
I have had the opportunity to ask questions and discuss the study. I have 
received satisfactory answers to all my questions. 
 
 
I understand that my participation is voluntary and I am free to withdraw at 
any time, without giving any reason. 
 
 
I understand that refusal to participate in the study will not affect my 
medical care or legal rights. 
 
I understand the interview will be audio-recorded and I give my consent for 
the same.  
 
I understand that the information provided by me will be kept confidential 
and anonymous. 
 
I agree to take part in the above-mentioned study.  
 
____________________ ____________________________________ 
Name of Patient Signature and Date 
 
_________________________          ___________________________________ 
Name of Person taking consent Signature and Date 
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Appendix 8: Patient information sheet for SHARPN 
survey 
                              
 
Sex, Health, Anti-retroviral Treatment and Partner Notification (SHARPN) 
Project 
Participant Information Sheet_Questionnaire Survey 
Version: 2 
Date: 10 November 2009 
You are being invited to take part in Sex, Health, Anti-retroviral Treatment, and 
Partner Notification (SHARPN) Project. Please read this information sheet 
carefully. Please feel free to ask questions if any part of the information is unclear 
to you.  
 
Who is conducting this study? 
This study is being conducted by Centre for Sexual Health and HIV Research, 
University College London, London in collaboration with Department of Primary 
Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton. 
The study has been reviewed and approved by an independent NHS Research 
Ethics Committee and the Camden PCT Research & Development department. 
 
What is the purpose of the study? 
We are conducting a questionnaire survey to understand views and experiences of 
people living with HIV. We want to know if and how HIV has affected your 
sexual behaviour and practices. We also want to know about your experiences of 
using anti-retroviral treatment and using partner notification services i.e. 
contacting sex partners to get tested following diagnosis with sexually transmitted 
infections. This survey is about your views towards partner notification and aims 
to understand which methods of partner notification are acceptable to you. 
Information from this survey will help us modify and develop effective health 
interventions for the care and treatment of people living with HIV. We will also be 
conducting individual in-depth interviews with some chosen participants. These 
face-to-face interviews will allow us to talk to you in detail about your experiences 
of the effect of HIV on your sexual life and health in general, about using 
antiretroviral treatment and your views about new methods of partner notification.  
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Why have you been invited? 
All men who identify themselves as men who have sex with men and are accessing 
the HIV clinic at Mortimer Market Centre are being invited to participate in the 
study. 
 
Do you have to take part in the study? 
It is entirely your choice whether you want to take part in the study. If you have 
any questions or concerns about participating in the study, please ask the 
researcher. You can discuss the study with the clinic’s patient representatives. If 
you decide to take part in the study, you are free to withdraw at any time without 
giving any reason. If you decide not to participate in the study, it will not affect the 
standard of health care you receive from this clinic.  
 
What will you have to do if you take part in the study? 
If you decide to participate, you will be requested to sign a consent form indicating 
that you have voluntarily agreed to participate in the questionnaire survey. We will 
then request you to complete a questionnaire survey online in a separate quiet 
room in the clinic. You will be asked questions about your sexual behaviour and 
practices, HIV medication and your sexual partnerships, and your preferences 
towards various partner notification methods. There will be no reference on the 
survey questionnaire to your name or information that will link your survey 
responses to you. All the information you provide in the survey will be anonymous 
and confidential.  
Some men participating in the questionnaire survey will also be invited to 
participate in a face-to-face interview. If you would like to participate in a face-to-
face interview and share your experiences about HIV, antiretroviral treatments and 
partner notification then we will document your contact details i.e. email address 
and phone number and some basic information i.e. your age and if you are taking 
antiretroviral treatment. We will contact you at a later stage to arrange a face-to-
face interview in the clinic on a day and time convenient for you. All the 
information collected during face-to-face interviews will be treated with 
confidentiality.  
 
Who will know you are taking part in the study? 
The clinic staff that provides you with medical care will not have access to your 
survey responses. Your doctor will not be paid for your participation in the study. 
Nor will your GP be notified about your study participation. The research team 
will manage the questionnaire responses.  
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How much time is involved? 
We would like you to complete an online questionnaire survey. We request you to 
complete all the questions. We anticipate that you will take approximately 25-45 
minutes to complete this survey. You can complete the survey online in your own 
time if you have access to computer and internet. We will document your email 
address and send you the questionnaire web link. 
 
Are there any disadvantages of you participating in the study? 
There are no disadvantages of you participating in the study. You may find some 
questions sensitive and personal. You are not obliged to answer those questions 
that make you feel uncomfortable. 
 
What are the possible benefits of you participating in the study? 
There will be no direct benefit to you for participating in the study. It is anticipated 
that the wider men who have sex with men (MSM) community will benefit in 
future from the study results. Findings from our survey can help inform, modify, 
and develop health care services that are responsive to the needs and preferences 
of patients.  
 
What will happen to the study results? 
Results of the questionnaire survey will be analysed as an aggregate of participants’ 
responses and published as reports, posters, and articles in journals and magazines 
like NAM, HIV Treatment Update. If you would like to be informed of the study 
findings, please do let us know and we are happy to share the publication with you 
when the study will be completed.  
 
What if there is a problem? 
If you have concerns or are unhappy with any aspects of this study, you can 
contact the researcher whose details are mentioned below. They will do their best 
to answer your questions. If you remain unsatisfied and wish to complain formally, 
you can do this with the help of the hospital’s patient support service: Tel:  
; Email:   More information is available at 
 
 
If you have any questions or concerns please contact the researchers: 
Ms Sonali Wayal  
 
 
   
  
 
Professor Graham Hart 
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Appendix 9: Consent form for the SHARPN survey 
                                                  
Study R&D Number: □□□□□□□□ 
 
CONFIDENTIAL 
Consent Form_questionnaire survey 
Version: 1 
Date: 10th November 2009 
 
Sex, Health, Antiretroviral Treatment and Partner Notification (SHARPN) 
Project 
A study to understand patients views towards HIV and Antiretroviral 
treatments, sexual behaviour, and acceptability and preferences regarding 
partner notification methods. 
 
Study Investigators: Ms Sonali Wayal, Professor Graham Hart, Professor Jackie 
Cassell 
  Please initial in the box 
 
I confirm that I have read and understood the participant information sheet    
dated 10
th
 November 2009 version 2 for the above mentioned study.   
 
 
I have had the opportunity to ask questions and discuss the study. I have 
received satisfactory answers to all my questions. 
 
I understand that my participation in the survey is voluntary and I am free to 
withdraw at any time, without giving any reason. 
 
I understand that refusal to participate in the study will not affect my medical 
care or legal rights. 
 
I understand that the information provided by me will be kept confidential 
and anonymous. 
 
I agree to take part in the above-mentioned study.  
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____________________ ____________________________________ 
Name of Patient Signature and Date 
 
_________________________          ___________________________________ 
Name of Person taking consent Signature and Date 
  
I agree to be contacted at a later stage by a researcher to take part in 
a one-to-one interview (Please leave blank if you do not wish to be 
contacted) 
 
 
If you have agreed to participate in a face-to-face interview, please provide the 
following information: 
 
Age:…………………………years 
Are you currently taking antiretroviral treatments:   Yes / No 
Please let us know how you would prefer to be contacted: 
- Via phone……………………………………………………………..  
(Please give your telephone number and your preferred time for being contacted) 
- Via email address: ……………………………………………………….. 
 
 
.
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Appendix 10: Modified patient information sheet 
(following pilot for survey) 
                                                        
Sex, Health, Anti-retroviral Treatment and Partner Notification (SHARPN) 
Project 
Participant Information Sheet_Questionnaire Survey 
Version: 3 
Date: 19
th
 March 2010 
You are being invited to take part in Sex, Health, Anti-retroviral Treatment, and 
Partner Notification (SHARPN) Project. Please read this information sheet 
carefully. Please feel free to ask questions if any part of the information is unclear 
to you.  
 
Who is conducting this study? 
This study is being conducted by Centre for Sexual Health and HIV Research, 
University College London, London in collaboration with Department of Primary 
Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton. 
The study has been reviewed and approved by an independent NHS Research 
Ethics Committee and the Camden PCT Research & Development department. 
 
What is the purpose of the study? 
We are conducting a questionnaire survey to understand views and experiences of 
people living with HIV. We want to know if and how HIV has affected your 
sexual behaviour and practices. We also want to know about your experiences of 
using anti-retroviral treatment and using partner notification services i.e. 
contacting sex partners to get tested following diagnosis with sexually transmitted 
infections. This survey is about your views towards partner notification and aims 
to understand which methods of partner notification are acceptable to you. 
Information from this survey will help us modify and develop effective health 
interventions for the care and treatment of people living with HIV. We will also be 
conducting individual in-depth interviews with some chosen participants. These 
face-to-face interviews will allow us to talk to you in detail about your experiences 
of the effect of HIV on your sexual life and health in general, about using 
antiretroviral treatment and your views about new methods of partner notification.  
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Why have you been invited? 
All men who identify themselves as men who have sex with men and are accessing 
the HIV clinic at Mortimer Market Centre are being invited to participate in the 
study. 
 
Do you have to take part in the study? 
It is entirely your choice whether you want to take part in the study. If you have 
any questions or concerns about participating in the study, please ask the 
researcher. You can discuss the study with the clinic’s patient representatives. If 
you decide to take part in the study, you are free to withdraw at any time without 
giving any reason. If you decide not to participate in the study, it will not affect the 
standard of health care you receive from this clinic.  
 
What will you have to do if you take part in the study? 
If you decide to participate, we will ask you to complete a questionnaire survey 
online in a separate quiet room in the clinic. By completing the questionnaire 
survey you are implicitly giving your consent to participate in the study. In the 
survey, you will be asked questions about your sexual behaviour and practices, 
HIV medication and your sexual partnerships, and your preferences towards 
various partner notification methods. There will be no reference on the survey 
questionnaire to your name or information that will link your survey responses to 
you. All the information you provide in the survey will be anonymous and 
confidential.  
 
Who will know you are taking part in the study? 
The clinic staff that provides you with medical care will not have access to your 
survey responses. Your doctor will not be paid for your participation in the study. 
Nor will your GP be notified about your study participation. The research team 
will manage the questionnaire responses.  
 
How much time is involved? 
We would like you to complete an online questionnaire survey. We request you to 
complete all the questions. We anticipate that you will take approximately 25-45 
minutes to complete this survey. You can complete the survey online in your own 
time if you have access to computer and internet. We will document your email 
address and send you the questionnaire web link. 
 
Are there any disadvantages of you participating in the study? 
There are no disadvantages of you participating in the study. You may find some 
questions sensitive and personal. You are not obliged to answer those questions 
that make you feel uncomfortable. 
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What are the possible benefits of you participating in the study? 
There will be no direct benefit to you for participating in the study. It is anticipated 
that the wider men who have sex with men (MSM) community will benefit in 
future from the study results. Findings from our survey can help inform, modify, 
and develop health care services that are responsive to the needs and preferences 
of patients.  
 
What will happen to the study results? 
Results of the questionnaire survey will be analysed as an aggregate of participants’ 
responses and published as reports, posters, and articles in journals and magazines 
like NAM, HIV Treatment Update. If you would like to be informed of the study 
findings, please do let us know and we are happy to share the publication with you 
when the study will be completed.  
 
What if there is a problem? 
If you have concerns or are unhappy with any aspects of this study, you can 
contact the researcher whose details are mentioned below. They will do their best 
to answer your questions. If you remain unsatisfied and wish to complain formally, 
you can do this with the help of the hospital’s patient support service: Tel:  
; Email:   More information is available at 
 
If you have any questions or concerns please contact the researchers: 
Ms Sonali Wayal  
 
 
   
  
 
Professor Graham Hart 
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Appendix 11: SHARPN survey study sheet 
Dear Doctors/Nurses/Phlebotomy Staff/Health Advisors (Bloomsbury Clinic),  
Sex, Health, Antiretroviral Project and Partner Notification (SHARPN) 
Project 
This patient is ELIGIBLE for the SHARPN survey. Eligibility criteria are: 
 HIV positive  
 Age 18 or above  
 Men who have sex with men (MSM) 
 
It will be helpful if you can please do the following: 
 Inform the patient the SHARPN survey is about attitudes towards 
Antiretroviral treatment, sexual behaviour, and their views towards partner 
notification for other STI.  
 Give the patient the attached study information sheet (copies are kept in every 
consulting room on the table and near the nurses station on ground floor).  
 If the patient agrees, please refer them to the nurses station on the ground floor 
and ask them to look for Sonali Wayal ( ) or Nurses: Are Isaksen, 
Taras Flynn, Brian George or Nina Panahmand 
 Patients can complete the survey at home in their own time if they have access 
to computers and internet. 
Did you ask the patient to participate in the survey? (Please tick) 
Yes                                                     No                                                Did not ask 
 
Did the patient agree to participate? (Please tick) 
Yes                                                     No 
 
If the patient agrees to participate, please ask them to write their EMAIL 
ADDRESS in capital letters and keep this sheet in the SHARPN study 
folder: .................................................. 
Thank you for your co-operation 
  
  
 
528 
 
Appendix 12: Topic guide for qualitative interviews 
Meanings of implications of HIV diagnosis on health and sexual behaviour: 
 HIV diagnosis: year of diagnosis; impact of diagnosis and how contracted HIV 
(perceptions to risk) 
 Attitude towards HIV: manageable condition/treatment optimism/stigma/gay 
community  
 Meaning and knowledge of HIV: effect of HIV on viral load, CD4 count, 
implications  
 Advice given by clinicians/nurse about sexual practices and behaviour 
 Source of information for sexual behaviour and medical advice 
 
Hepatitis C Diagnosis:  
 Why tested (symptoms or other reasons)?  
 How do you think you got infected with Hep C (risk perceptions)?  
 Impact of diagnosis (on health, (treatment and sex) and partner notification / 
Any other STI equally stigmatised 
 
HIV Medication 
 Knowledge and attitudes towards cART  
 Currently taking cART: self or friends/since when/experience of taking 
cART/effects on sexual behaviour and practices 
 Sexual dysfunction/loss of sexual libido 
 
Disclosure, sexual behaviour, and Swiss statement 
 Are you currently in a relationship? Nature of relationship and type of partners 
 How do you meet your partners? 
 Do you inform sexual partners about your HIV status? When do you disclose 
to sex partners? If does not disclose HIV status, then why so? 
 Condom less sex with HIV positive men  
 Sexual strategies used instead of disclosure of HIV status 
 Views about transmitting HIV to sexual partners and strategies: negative 
experiences and fear of transmission occurring, strategies used for prevention 
 Views towards ART and HIV transmission: Knowledge of Swiss Statement 
 
Recent STI diagnosis, Partner notification (PN), sexual episode 
 Recent STI diagnosis: which/why tested/ any co-infections [Hep C] 
 Experience of interaction with Health Advisors on recent occasion  
 Experience of PN for past episode: who/how/barriers/reasons 
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 PN for HIV when diagnosed 
 
Attitudes towards PN, and towards PN by type of sexual partnership 
 Views towards partner notification per se and towards provider referral and 
patient referral 
 Views towards notifying regular partner vs. other partners: is there any 
difference and why? 
 Preferred methods for PN (scenario 5) and partnership type  
 Monogamy with HIV positive partner and Hepatitis C diagnosis 
 PN for Syphilis when sexual partner is not aware of HIV status 
 Views about being notified by partner for Syphilis and Hep C 
 Website bareback party, Group sex, Syphilis 
 LGV outbreak and extended PN 
 HSK and APT for CT and NG 
Views towards PN and Law 
 PN for newly diagnosed HIV 
 PN for other STI (curable and non-curable) 
 Legal obligation for PN for HIV and other STI 
 Criminalisation of HIV transmission 
Views towards Female researcher 
 How are you feeling after the interview? Anonymity/other issues/Views 
towards researcher 
 How are you feeling after the discussion? 
 
Vignettes on partner notification used during in-depth interviews and FGD 
 
SCENARIO 1:  
 
Preferences for Partner notification (please tick 3 most preferred methods) 
1. Not contact any sexual partner  
2. Contact sexual partner face-to-face and tell them 
3. Contact sexual partner face-to-face and give them clinic referral slip 
4. Contact via email from personal account  
5. Contact via anonymous e-card (assuming such a service of anonymous e-card 
is provided by the clinic)  
6. Contact via personal telephone/mobile  
7. Contact via text message from personal mobile  
8. Contact via online chat  
9. Ask the health advisor/clinic staff to contact your partners (anonymously) 
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SCENARIO 2: 
 
SCENARIO 3:  
 
SCENARIO 4: 
 
Assume that you have a boyfriend who is HIV positive. You both have agreed to 
have a monogamous relationship and practice unprotected anal sex. You went to 
a party with your friends where you met ‘Y’ and had sex with him only that one 
time. Unfortunately, you were diagnosed with Hepatitis C a few weeks later. 
Your doctor tells you that Hepatitis C is not curable but tells you about the 
treatment for Hepatitis C. He asks you to send your boyfriend to test for 
Hepatitis C. What are you most likely to do?  
 
 
Assume that you are diagnosed with Chlamydia and Gonorrhoea and are treated 
for these infections in the clinic. You have a boyfriend who lives with you. The 
doctor offers you two options:  
-One is to take a home sampling kit, which contains a pot to collect urine, swabs 
to collect specimens from rectum and tube to put that swab. It also contains 
instruction sheet on how to collect the specimens and pre-addressed package to 
post the specimens to the clinic.  
-The second option is to call your boyfriend while you are in the clinic so the 
doctor can assess your partner on the phone and if needed give you medication 
for your partner for Chlamydia and Gonorrhoea.  
Do you think you may use any of these two options? 
Assume that you have a regular fuck buddy and 2 other casual partners. Your 
regular fuck buddy has been diagnosed with Syphilis and Hepatitis C. Do you 
think he should contact you to tell you that you should get tested for these 
infections?  
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SCENARIO 5:  
 
SCENARIO 6: 
Assume you have your profile on Gaydar.com (a website of social/sexual 
networking for gay men). On this website, you read information about a party 
where only HIV positive men who have sex with men are invited to have anal 
sex without condom. The rule is if you express interest to attend the party and 
are invited, you must attend the party. If you don’t attend, you will be excluded 
from future events. You express interest and are invited for the party. You go to 
the party and have group sex. Within days, you develop symptoms and are 
diagnosed with Syphilis and treated for it. Your doctor asks you to contact your 
sexual partners so they can test for Syphilis.  
Do you think you will contact the group sex members to tell them that maybe 
Syphilis was transmitted during that party?  
Assume that there is an outbreak of Lymphogranuloma Venerum (LGV) in 
London. LGV is a sexually transmitted infection. Your sexual partner is 
diagnosed with LGV. So you also go to the clinic and get tested for LGV but 
you are not infected. The doctor informs you about the outbreak and mentions 
that many people with LGV do not have symptoms i.e. are asymptomatic. 
Your doctor asks you to refer your gay friends who, you know, practice 
unprotected sex to test for LGV. They may or may not be your sex partners.  
Will you ask your gay friends to test for LGV if there is an outbreak? 
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Appendix 13: Patient information sheet for focus group 
discussion 
                              
 
Sex, Health, Antiretroviral Treatment and Partner Notification (SHARPN) 
Project 
 
Participant Information Sheet_Focus group discussion 
Version: 2 
Date: 10th November 2009 
 
You are being invited to take part in Sex, Health, Antiretroviral Treatment, and 
Partner Notification (SHARPN) Project. Please read this information sheet 
carefully. Please feel free to ask questions if any part of the information is unclear 
to you.  
 
Who is conducting this study? 
This study is being conducted by Centre for Sexual Health and HIV Research, 
University College London, London in collaboration with Department of Primary 
Care and Public Health, Brighton and Sussex Medical School, Falmer, Brighton. 
The study has been reviewed and approved by an independent NHS Research 
Ethics Committee and the Camden PCT Research & Development department. 
 
What is the purpose of the study? 
We are conducting this study to understand views and experiences of people living 
with HIV. We want to know about your experiences of using partner notification 
(PN) services i.e. contacting sex partners to get tested following diagnosis with 
sexually transmitted infections. This study is about your views towards partner 
notification and aims to understand which methods of partner notification are 
acceptable to you. Information from this study will help us modify and develop 
effective health interventions for care and treatment of people living with HIV.  
 
Why have you been invited? 
We want to conduct a group discussion with members of the Bloomsbury Clinic 
Patient Network to understand their views about partner notification services. We 
will present you with different scenarios to understand your preferences and 
acceptability of various PN methods.  
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Do you have to take part in the study? 
It is entirely your choice whether you want to take part in the study. If you have 
any questions or concerns about participating in the study, please ask the 
researcher for further information. You can also discuss with the representative of 
the clinic’s patients network. If you decide to take part in the study, you are free to 
withdraw at any time without giving any reason. If you decide not to participate in 
the study, it will not affect the standard of health care you receive from this clinic.  
 
What will you have to do if you take part in the study? 
If you decide to participate you will be requested to sign a consent form indicating 
that you have voluntarily agreed to participate in the study. We will then request 
you to participate in a group discussion with 6-8 other members of the clinic’s 
patient network in a separate quite room in the clinic. We anticipate that the 
discussion will last for approximately an hour. The discussion will be around 
issues related to screening for sexually transmitted infections, sexual partners and 
your preferences towards various partner notification methods. The discussion will 
be audio-recorded with your permission. We will not audio-record your name or 
identifiable data. 
 
Who will know you are taking part in the study? 
The clinic staff that provides you with medical care will not have access to the 
discussion details or audio-recording. The audio-recorded files will be stored in the 
researcher’s office on a secure password protected. These audio files will be 
destroyed immediately after transcription. Your doctor will not be paid for your 
participation in the study. Nor will your GP be notified about your study 
participation. The research team will manage the responses and analyse the data. 
The discussion will be analysed and no references to the names of participants will 
be made in the study publications. During the group discussion if there is a 
disclosure of information that indicates the possibility of self-harm or harm to 
others, we will be obliged to report this information to appropriate clinic staff to 
ensure your safety. Due to the discussion of sensitive issues if you feel the need to 
talk to a counselor, the researcher can refer you to an appropriate counseling 
service. 
 
Are there any disadvantages of you participating in the study? 
There are no disadvantages of you participating in the study. You may find some 
questions sensitive and personal. You are not obliged to answer those questions 
that make you feel uncomfortable. 
 
What are the possible benefits of you participating in the study? 
There will be no direct benefit to you for participating in the study. It is anticipated 
that the wider community will benefit in future from the study results. Findings 
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from the discussion will help us understand your views and suggestions about the 
issues explored in the discussion.  
What will happen to the study results? 
The study findings can help inform, modify, and develop partner notification 
services that are responsive to the needs and preferences of patients. Direct quotes 
from the discussion may be used for journal articles and posters but identifiable 
data or your name will not be disclosed. Results of the discussion will also be used 
to revise the topic guide of in-depth interviews that will be conducted in the 
patients in the Bloomsbury clinic. If you would like to be informed of the study 
findings, please do let us know and we are happy to share the study summary with 
you on completion of the study. We will also put a poster of the study findings in 
the Bloomsbury clinic.   
 
What if there is a problem? 
If you have concerns or are unhappy with any aspect of this study, you can 
discuss these with the researchers whose details are mentioned below. They will 
do their best to answer your questions. If you remain unsatisfied and wish to 
complain formally, you can do this with the help of the hospital’s patient support 
service: Tel: ; Email:   More information 
is available at  
 
If you have any questions or concerns please contact the researchers: 
 
Ms Sonali Wayal  
 
 
   
  
  
 
 
Professor Graham Hart 
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Appendix 14: Consent form for focus group discussions 
                                                      
 
Study R&D Number: □□□□□□□□ 
Consent Form_Focus group discussion 
Version: 1 
Date: 10 November 2009 
 
Sex, Health, Antiretroviral Treatment and Partner Notification (SHARPN) 
Project 
 
A study to understand patients views towards HIV, Antiretroviral treatments, 
sexual behaviour, and acceptability and preferences regarding partner notification 
methods 
 
Study Investigators: Ms Sonali Wayal, Professor Graham Hart, Professor Jackie 
Cassell 
Please initial the box 
I confirm that I have read and understood the participant information 
sheet    dated 10th November 2009_version 2 for the above mentioned 
study.   
 
I have had the opportunity to ask questions and discuss the study. I 
have received satisfactory answers to all my questions. 
 
I understand that my participation in the group discussion is voluntary 
and I am free to withdraw at any time, without giving any reason. 
 
 
Refusal to participate in the study will not affect my medical care or 
legal rights. 
 
 
I understand that the group discussion will be audio-recorded and I 
agree for the same.    
 
 
I understand that if I disclose information during the discussion that 
indicates that I am at risk of serious self-harm or harm to others, the 
researcher may have to disclose this information to an appropriate 
clinic staff 
 
 
I understand that if due to the discussion I feel distressed, the 
researcher can help me meet a counsellor 
 
I understand that the information provided by me will be kept 
confidential and anonymous 
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I understand that direct quotes from group discussion will be used for 
journal articles and posters but identifiable data or my name will not 
be disclosed 
 
I agree to take part in the above-mentioned study.  
 
___________________ ____________________________________ 
Name of Patient Signature and Date 
 
_________________________          ___________________________________ 
Name of Person taking consent Signature and Date 
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Appendix 15: Study information sheet for in-depth 
interviews 
                                                      
                           
Sex, Health, Antiretroviral Treatment and Partner Notification 
(SHARPN) Project 
 
Participant Information Sheet_In-depth interviews 
Version: 2 
Date: 10 November 2009 
 
You are being invited to take part in Sex, Health, Antiretroviral Treatment, and 
Partner Notification (SHARPN) Project. Please read this information sheet 
carefully. Please feel free to ask questions if any part of the information is unclear 
to you.  
 
Who is conducting this study? 
The SHARPN project is being conducted by Centre for Sexual Health and HIV 
Research, University College London, London in collaboration with Department 
of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, 
Brighton. The study has been reviewed and approved by an independent NHS 
Research Ethics Committee and the Camden PCT Research & Development 
department. 
 
What is the purpose of the study? 
We will be conducting face-to-face individual interviews with some participants. 
These interviews will allow us to talk to you in detail about your experiences and 
the effect of HIV on your sexual life and health in general. We want to know about 
your experiences of using antiretroviral treatment and partner notification services 
i.e. contacting sexual partners following diagnosis with sexually transmitted 
infections (STI) to advise them to test for the infections. Talking to you face-to-
face will help us understand your views and opinion towards new methods of 
contacting sexual partners after being diagnosed with STI and if you have used any 
of these methods in the past.  
 
Why have you been invited? 
All men who identify themselves as men who have sex with men and are accessing 
the Mortimer Market Centre HIV clinic are being invited to participate in the study. 
 
Do you have to take part in the interview? 
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It is entirely your choice whether you want to take part in the interview. Your 
participation is voluntary. If at any point, you feel that you do not want to 
participate in the interview, you are free to withdraw from the study. If you decide 
not to participate in the study, it will not affect the standard of health care you 
receive from this clinic.  
 
What will happen if you decide to take part in the study?  
If you agree to participate in the study, you will be invited to talk to a trained 
researcher in a quiet room in the clinic on a day and time convenient for you. You 
will be requested to give your written consent to participate in the interview and to 
audio-record the interview. We will not audio-record your name or identifiable 
data. You can refuse for the interview to be recorded. However, we assure you that 
recording is done for purposes of convenience and audio-recorded data will be 
stored on password-protected computer. We will not maintain a link your name 
and the audio-files. The audio-recorded file will be transferred to the computer and 
given a study number e.g. IDI_1001. These files will be destroyed immediately 
after transcription. 
 
How much time is involved? 
The interview is likely to last for approximately 60-70 minutes. The researcher 
will talk to you about your sexual experiences and practices since being diagnosed 
with HIV, antiretroviral treatment and your sexual partnerships, and your 
preferences towards various partner notification methods.  
 
Are there any disadvantages of you participating in the study? 
There are no disadvantages of you participating in the study. You may find some 
questions sensitive and personal. You are not obliged to answer those questions 
that make you feel uncomfortable. 
 
What are the benefits of you participating in the study? 
There will be no direct benefit to you for participating in the study. It is anticipated 
that the wider community will benefit in future from the study results. Findings 
from the discussion will help us understand your views and suggestions about the 
issues explored in the discussion.  
 
What will happen to the study results? 
All the information provided by you during the interview will be treated with 
confidentiality. During the interview if there is disclosure of information that 
indicates possibility of self-harm or harm to others, we will be obliged to report 
this information to appropriate clinic staff. Due to the discussion of sensitive issues 
if you feel the need to talk to a counselor the researcher can refer you to an 
appropriate service. All the interviews will be analysed by the researcher. We will 
use direct quotes from your interview in the reports and articles but we will not 
refer to your name or identifiable data. If you would like to be informed of the 
study findings, please do let us know and we are happy to share the results 
summary with you when the study will be completed. We will also publish articles 
in journals and magazines like NAM, HIV Treatment Update.  
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What if there is a problem? 
If you have concerns or are unhappy with any aspects of this study, you can 
contact the researcher whose details are mentioned below. They will do their 
best to answer your questions. If you remain unsatisfied and wish to complain 
formally, you can do this with the help of the hospital’s patient support service: 
Tel: ; Email:   More information is 
available at  
 
If you have any queries, please do not hesitate to contact the researchers: 
Ms Sonali Wayal  
 
 
   
  
  
 
Professor Graham Hart 
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Appendix 16: Consent form for in-depth interviews 
                                                      
Study R&D Number: □□□□□□□□ 
 
Consent Form_In-depth interviews 
Version: 1 
Date: 10th November 2009 
Sex, Health, Antiretroviral Treatment and Partner Notification (SHARPN) 
Project 
A study to understand patients views towards HIV, Antiretroviral treatments, 
sexual behaviour, and acceptability and preferences regarding partner notification 
methods. 
 
Study Investigators: Ms Sonali Wayal, Professor Graham Hart, Professor Jackie 
Cassell 
                       Please initial in the box 
I confirm that I have read and understood the participant information sheet    
dated 10th November 2009 _version 2 for the above mentioned study.   
 
I have had the opportunity to ask questions and discuss the study. I have 
received satisfactory answers to all my questions. 
 
I understand that my participation in the survey is voluntary and I am free 
to withdraw at any time, without giving any reason. 
 
Refusal to participate in the study will not affect my medical care or legal 
rights. 
 
I understand that the interview will be audio-recorded and I agree for the 
same.  
 
I understand that if I disclose information during the interview that 
indicates that I am at risk of serious self-harm or harm to others, the 
researcher may have to disclose this information to an appropriate clinic 
staff. 
 
I understand that if due to the interview I feel distressed then the 
researcher can help to meet a counsellor. 
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I understand that the information provided by me will be kept confidential 
and anonymous. 
 
I understand that direct quotes from my interview will be used for journal 
articles and posters but identifiable data or my name will not be disclosed.  
 
I agree to take part in the above-mentioned study.  
 
____________________ ____________________________________ 
Name of Patient Signature and Date 
________________________          ___________________________________ 
Name of Person taking consent Signature and Date 
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Appendix 17: Broad tree nodes (broad themes) identified 
during coding of qualitative data 
The process of analysing qualitative data started with identifying broad tree nodes. 
The following broad tree nodes of interest were identified during the process of 
coding. The transcripts were coded using these tree nodes and the description of 
these nodes was documented to maintain consistency in coding. New tree nodes 
were added to this list as the process of coding transcripts progressed. The data in 
each tree node was further analysed to indentify emerging themes: 
Added on 6
th
 August when coding IDI_001 
1. Age and sex: change in sexual behaviour and attitudes due to age 
2. Age at HIV diagnosis 
3. Views towards anonymous e-card 
4. cART and sex behaviour: views about cART and sexual behaviour 
5. cART medication: views towards cART c and experience of starting cART  
6. Attitudes to HIV: change over time and current attitudes towards HIV as an 
illness 
7. Being gay and stigma: experiences as a gay man 
8. CD4 count: perceptions/meaning of CD4 cell count and its relevance 
9. Change in gay sex over time 
10. Criminalisation of HIV transmission 
11. Disclosure about HIV status: attitudes towards and experience of HIV 
disclosure on relationships in general and if the person has told anyone about 
his status, why etc.  
12. Disclosure of HIV status to sex partners: views and attitudes towards 
disclosure of HIV status for sex purposes and what methods does the person 
use. 
13. Serodiscordant primary partnership 
14. Recreational drug use 
15. Expanded partner notification: views towards referring social network people 
in event of outbreak of STI 
16. Experience as a contact: participants experience as a contact of an index 
patient and views about it 
17. Experience of HIV diagnosis: psychological and other experiences of being 
diagnosed with HIV 
18. Experience of notifying for STI: participants experience of notifying sex 
partners after being diagnosed with STI (not HIV) 
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19. Experience of HIV partner notification Female interviewer: experience of the 
participant of being interviewed by me 
20. Group sex and partner notification: views about scenario for group sex and 
partner notification Group sex: experience of engaging in group sex and 
reasons for the same 
21. Health advisor for partner notification: experience of interaction with health 
advisors/other professionals for partner notification 
22. HCV diagnosis: Participants sexual practices and behaviour and reasons for 
them 
23. HIV and sex: Participants sexual practices and behaviour and reasons for 
them 
24. HIV and stigma: views and perceptions towards HIV and stigma, participants 
own views towards HIV and internalised shame 
25. Home sampling and APT 
26. How infected with HIV: perceptions about how the participant thinks he got 
infected with HIV 
27. Internet and sex: use of internet for sex partners, profile types etc. 
28. Internet PN: views towards contact or being contacted via email, online chat, 
anonymous e-card (any internet related tool) or ways of contacting partners 
met online.  
29. London 
30. Mandatory partner notification 
31. Medical advice: Is the participant given any medical advice about sex 
behaviour, medication, HIV etc. or does the participant ask for it. 
32. mental health 
33. Migration: is the participant a non-UK citizen, when migrated, why 
34. Partnership type and partner notification methods: what are the preferred 
methods of contacting different types of sex partners? are there any 
differences in preferred methods of notifying different types of partners 
35. Preference as a contact: what are participants views and preferences about 
being a contact and method of being notified 
36. Provider referral  
37. risk perceptions: perceptions about the risk of acquisition or transmission of 
STI and HIV 
38. Risk reduction strategies: knowledge, understanding and use of strategies or 
practices to minimise transmission of HIV or lack of awareness of such 
strategies 
39. Sex partner at the time of HIV diagnosis 
40. Sexual partnerships: views towards sexual partners’ status of HIV. hep c etc. 
and current type of partners 
41. Sexual preference: does the participant have sexual position preference i.e. 
does he like to be only top or bottom or both? Why? Is it for risk reduction or 
personal preference? 
42. Sexual problems 
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43. Social support 
44. SOPV: sex on premises venues and experience of meeting sex partners in 
such venues, frequency of visit , disclosure 
45. STI screening and diagnosis: does the participant screen for STI, when and 
experience of diagnosis with recent STI 
46. Swiss statement: views towards having undetectable viral load and sexual 
behaviour 
47. Syphilis diagnosis and unaware HIV partner: scenario where the partner is 
unaware that the participant has HIV and then participant is diagnosed with 
syphilis and may want to notify the partner 
48. Testing for HIV: why tested for HIV, experience of HIV testing, reasons for 
not testing etc. 
49. Unprotected sex: experiences of unprotected sex and bare backing 
50. Views towards HIV partner notification: what are participants views towards 
HIV PN and why 
51. Views towards partner notification (overall) 
52. Viral load 
53. Year HIV diagnosed 
Additional themes included on 8
th
 August when coding IDI_002 
54. Other health problems 
55. HIV and employment 
56. Vignettes and challenges 
57. Sexual pleasure 
Additional themes included on 10th August when coding IDI_003 
58. Shared stigma: feelings towards other HIV positive people and feelings of 
community/commonness 
Additional themes included on 12th August when coding IDI_004 
59. ART immediately at diagnosis 
60. Cure for HIV 
61. Need for health promotion: participants views about the kind of information 
they need, advice they would like etc. 
62. Sexual behaviour of gay men in general 
63. PEP 
Additional themes included on 8th August when coding IDI_005 
64. HSK for HIV  
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Appendix 18: Charting of qualitative data using excel data 
Participant details 
HIV and sex Risk perceptions Disclosure to sex partners Internet and sex 
IDI_0001,White British 
man in mid-fifties 
living with HIV since 2 
years, on cART and 
has a boyfriend, 
educated till NVQ level 
He was completely put off sex 
after HIV diagnosis, didn't have 
sex for 2 months; he loves his 
current partner; continues to 
have penetrative sex with 
boyfriend but 'of course' uses 
condoms. 
Being passive during UAI 
and IDU are risky for HIV 
trans; thinks there are "grey 
areas" for HIV transmission. 
Does not disclose HIV status in 
saunas; norm is to assume 
men are HIV positive in these 
venues; thinks its sex partners 
responsibility to protect him 
and he should protect himself. 
He doesn't have a 
computer but thinks of 
getting one and things 
may change for dating. 
IDI_002,Black British 
man in mid-twenties 
living with HIV since 4 
years, not on cART, 
educated till NVQ level 
He didn't have sex for a year 
post-diagnosis because he was 
depressed; but later said he got 
drunk and had UAI; after a year 
when started dating again felt 
things were new and didn't 
know how to handle sex, 
disclosure to partners of HIV 
status; was surprised when he 
disclosed and sex partner was 
fine with it.  
Thinks HIV transmits through  
contact with blood so was 
worried when he had nose 
bleed at work;  HIV can be 
prevented by safe sex, being 
careful with ejaculation i.e. 
cum shouldn’t go near anal 
or mouth areas. 
He has decided to be honest 
because earlier he lied and 
thinks he got HIV because of 
his situation full of lies; men 
appreciated him informing 
them of HIV diagnosis but in 
some cases it meant end of 
relationship; never asks sex 
partners their status unless 
they volunteer. 
He has online profile but 
has not disclosed his HIV 
status; doesn't feel the 
need as he always 
discloses his status to 
person before sex or has 
safe sex. 
     
 
 
